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Abstract 
NADH:ubiquinone oxidoreductase (complex I) is the largest and most complicated 
enzyme in the mitochondrial electron transfer chain. It catalyses the oxidation of NADH 
and the reduction of ubiquinone, coupled to the translocation of protons across the 
mitochondrial inner membrane, maintaining the proton motive force used for ATP 
synthesis. Complex I is the least understood of the respiratory enzymes; although the 
mechanisms of NADH oxidation and intramolecular electron transfer are gradually 
becoming appreciated, the mechanisms of quinone binding and reduction and proton 
translocation remain unknown. Complex I dysfunction has been implicated in a wide range 
of pathologies including mitochondrial diseases such as Leigh’s disease, as well as 
neurodegenerative diseases such as Alzheimer’s and Parkinson’s. 
 The work described in the first part of this thesis is aimed at elucidating the 
structure of either a subcomplex of mitochondrial complex I, or of the intact enzyme itself. 
A comprehensive investigation revealed that hydrophilic subcomplexes of complex I from 
bovine heart mitochondria are not suitable for use as models of the intact enzyme. 
Attempts to prepare intact complex I of sufficient quality for structural work were 
successful; however, results from a large set of crystallization trials were disappointing. 
 The second part of this thesis describes three studies of the function and 
mechanism of complex I from bovine heart mitochondria. First, the flavin mononucleotide, 
the site of NADH oxidation, was identified as the site of the ‘inhibitor-insensitive’ 
NADH:ubiquinone oxidoreduction reaction. The formation of semiquinones initiates redox 
cycling reactions with oxygen, producing vast amounts of reactive oxygen species; further 
studies revealed that other oxidants, such as paraquat, also react at the flavin site and 
initiate redox cycling reactions. Second, kinetic studies showed that the reaction between 
NADH and positively charged oxidants such as HAR (hexaammineruthenium (III)) 
proceeds by an unusual ternary reaction mechanism at the flavin site of complex I. Finally, 
double electron-electron resonance spectroscopy was used to show unambiguously that 
iron sulphur cluster 4Fe[TY]1 gives rise to electron paramagnetic resonance signal N4; the 
data provide an alternating potential energy profile for electron transfer along the cluster 
chain between the flavin and the quinone-binding site.   
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Chapter 1: 
Introduction 
 
 
1.1 The need for adenosine triphosphate 
Life on Earth relies on a plethora of biochemical reactions that are energetically 
unfavourable: reactions such as the synthesis of biological macromolecules, the pumping 
of ions across membranes against electrochemical gradients, and intracellular and 
extracellular transport events cannot occur ‘spontaneously’. Organisms have overcome this 
problem by coupling these processes to reactions that release energy, such as the 
hydrolysis of ATP (adenosine triphosphate) (Nicholls and Ferguson, 2002).  
 
  
 
 
Figure 1.1: Schematic representation of an energy transducing membrane. The 
primary pumps (green) drive the protons across an ion-impermeable membrane to generate 
a proton motive force, represented as a difference in proton concentration (see text for 
details). The secondary pump (red) uses the proton motive force to drive ATP synthesis. 
Adapted from (Nicholls and Ferguson, 2002).    
 
 
The majority of ATP synthesis occurs across energy-transducing membranes, such as the 
inner membrane of mitochondria and the thylakoid membrane of chloroplasts. The 
mechanism of ATP synthesis is very similar in both cases, and forms the basis of the 
chemiosmotic theory first proposed by Peter Mitchell (Mitchell, 1961). The two 
fundamental features of these membranes are their impermeability to ions, and the 
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presence of two distinct types of proton pump, shown in figure 1.1 (Nicholls and Ferguson, 
2002). In mitochondria, primary proton pumps catalyse the oxidation of substrates such as 
NADH, the reduction of molecular oxygen, and the generation of a proton motive force, 
∆p, across the mitochondrial inner membrane. 
 The proton motive force is utilised by a secondary pump, ATP synthase, to drive 
the energetically unfavourable synthesis of ATP from adenosine diphosphate (ADP) and 
inorganic phosphate (Nicholls and Ferguson, 2002). In the absence of a proton motive 
force, ATP synthase can act as a primary proton pump, hydrolysing ATP and translocating 
protons into the inter-membrane space; in both cases substrate metabolism is tightly 
coupled to proton translocation across the membrane (Nicholls and Ferguson, 2002). The 
proton motive force comprises two components related by equation 1.1: first, the 
difference in concentration of protons in the bulk phases on each side of the membrane 
(∆pH) is defined as the pH on the positive side (the inter-membrane space) minus the pH 
on the negative side (the mitochondrial matrix). Second, the difference in electrical 
potential, the charge separation across the membrane, is referred to as the membrane 
potential (∆Ψ).  
 
 
 
F
pH RT 2.303
 - ψp ∆∆=∆  
 
 
 )C 25(at        pH mV) (59 - ψp °∆∆=∆  
 
 
Equation 1.1: F is the Faraday constant (9.65 x 10-2 kJ mol-1 mV-1), R is the molar gas 
constant (8.31 J mol-1 K-1) and T is the temperature (K).  
 
 
In mitochondria, the enzymes of the respiratory chain function at close to neutral pH; 
consequently, ∆Ψ dominates ∆p as ∆pH is small. Conversely, across the thylakoid 
membranes in chloroplasts ∆pH is the major contributor to ∆p, and it can be in excess of 
three pH units (Nicholls and Ferguson, 2002). 
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1.2 Mitochondria 
1.2.1 Mitochondrial structure 
Found in most eukaryotic cells, mitochondria are sub-cellular organelles that play a central 
role in energy metabolism. The key feature of the mitochondrion is the presence of two 
membranes that encapsulate a protein-rich central matrix. Whereas the mitochondrial outer 
membrane contains high concentrations of porins, making it essentially permeable to 
solutes of a molecular weight less than 10 kDa, the mitochondrial inner membrane is 
impermeable to metabolites and ions (Nicholls and Ferguson, 2002). Consequently, a 
family of mitochondrial carriers, of which approximately 50 have been identified in the 
human genome, are present to enable exchange between the inter-membrane space and the 
matrix (Kunji, 2004). The inner membrane also contains the protein complexes and redox 
cofactors involved in electron transfer and ATP synthesis, discussed in section 1.3. The 
area encapsulated by the mitochondrial inner membrane, the mitochondrial matrix, 
contains a highly concentrated mixture of enzymes involved in all aspects of metabolism, 
in addition to the mitochondrial genome which, in mammalian mitochondria, encodes 39 
genes involved in mitochondrial function. 
  
 
 
 
Figure 1.2: The intracellular mitochondrial network of a budding yeast. Surface-
rendered 3D-data stack of the mitochondrial network of Saccharomyces cerevisiae, 
labelled with green fluorescent protein targeted to the mitochondrial matrix. The scale bar 
represents 1 µm. Adapted from (Egner et al., 2002).  
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There is significant evidence that in vivo, mitochondria form highly dynamic, 
interconnected tubular networks throughout the cell, fusing and dividing, and undergoing 
regulated turnover, enabling them to readily adapt to changes in the cellular environment; 
figure 1.2 shows the intracellular mitochondrial network of the budding yeast 
Saccharomyces cerevisiae. When mitochondrial dynamics are disrupted, cellular 
dysfunction ensues; several major neurodegenerative pathologies, including Parkinson's, 
Alzheimer's and Huntington's diseases, can involve the disruption of mitochondrial 
dynamics; remarkably, in several disease models, the manipulation of mitochondrial fusion 
and fission can partially rescue disease phenotypes (for review, see (Chen and Chan, 
2009)).  
 
 
 
 
Figure 1.3: The mitochondrion. Computer models generated from segmented 3D 
tomograms of a mitochondrion in chick cerebellum. Left; the entire model showing the 
cristae in yellow, the mitochondrial inner membrane in light blue, and the mitochondrial 
outer membrane in dark blue. Right; mitochondrial outer membrane, mitochondrial inner 
membrane and four representative cristae in different colours. Taken from (Frey and 
Mannella, 2000). 
 
 
Contrary to the traditional ‘baffle model’ of mitochondrial structure, figure 1.3 shows how 
cristae invaginating from the mitochondrial inner membrane extend throughout the matrix, 
forming compartments that are likely to impede the lateral diffusion of metabolites 
(Mannella, 2006). These cristae junctions not only play an important role in the regulation 
of metabolic processes within the mitochondrion, but also in other processes central to 
cellular biochemistry, such as apoptosis. The models reveal points of contact between the 
mitochondrial inner and outer membranes, postulated to be the sites of large macro-
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molecular assemblies involved in metabolite transport into and out of the mitochondrion 
(Frey and Mannella, 2000). 
 
1.2.2 Mitochondrial function 
1.2.2.1 Energy transduction 
Mitochondrial energy transduction is carried out by five protein complexes in the 
mitochondrial inner membrane. The low potential electrons of NADH (Em = -320 mV at 
pH 7, relative to the standard hydrogen electrode) reduce a flavin mononucleotide which is 
bound non-covalently to NADH:ubiquinone oxidoreductase (complex I). The electrons are 
subsequently passed down a series of redox centres, arranged approximately in order of 
increasing potential, until they are used to reduce molecular oxygen. The energy released 
is used to pump protons across the impermeable mitochondrial inner membrane into the 
inter-membrane space. This maintains a proton motive force that ATP synthase uses to 
synthesise ATP from ADP and an inorganic phosphate (Nicholls and Ferguson, 2002). The 
roles of the major protein complexes involved in the synthesis of ATP are described in 
section 1.3, and summarised in figure 1.4 and table 1.1.  
 In addition to oxidative phosphorylation, the mitochondrion also plays a pivotal 
role in reactions upstream of the electron transfer chain, such as the citric acid cycle. 
Pyruvate, the product of glycolysis, is transported into the mitochondrial matrix and 
converted to acetyl CoA by the enzyme pyruvate dehydrogenase. Acetyl CoA reacts with 
oxaloacetate to form citrate, which undergoes a series of reactions, eventually regenerating 
oxaloacetate. The net result of these reactions is the reduction of three molecules of NAD+ 
to NADH and one molecule of quinone to quinol, the phosphorylation of one molecule of 
GDP to GTP, and the liberation of two molecules of CO2.  
  
1.2.2.2 Additional functions 
In addition to their central role in energy metabolism, mitochondria also perform other 
several other essential functions, some of which are listed below:  
 
Biochemical reactions 
The mitochondrion is the central hub for many biochemical reactions. Citric acid cycle 
intermediates are the precursors for a range of biologically-important compounds; for 
example, fatty acids and steroids are derived from citrate, α-ketoglutarate is the precursor 
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of nucleotides and amino acids such as glutamate, asparagine and aspartate, and 
porphyrins are synthesised from succinyl CoA. 
 
Iron-sulphur cluster maturation 
Owing to their remarkable structural plasticity and versatile chemical features, iron-
sulphur clusters participate in a range of cellular reactions, including electron transfer, 
substrate binding/activation, iron/sulphur storage, and the regulation of gene expression 
and enzyme activity (Johnson et al., 2005). In mammalian cells, iron-sulphur clusters are 
synthesised in both mitochondria and the cytosol, although the export of an unknown 
compound from the mitochondrion appears to be needed for some aspects of cytosolic 
iron-sulphur cluster biogenesis. In contrast to mammalian iron-sulphur cluster biogenesis, 
de novo synthesis in yeast occurs solely in the mitochondrion (for review, see (Ye and 
Rouault, 2010)). 
 
Apoptosis 
There is substantial evidence that mitochondria play a central role in apoptosis, a process 
which is important in many physiological and pathological processes. The Bcl-2 family of 
proteins tightly control cell death by regulating the permeability of the mitochondrial outer 
membrane and hence, the release of cytochrome c and other pro-apoptotic factors. Control 
of the formation of the mitochondrial apoptosis-induced channel is central to the regulation 
of apoptosis by Bcl-2 family proteins; pro-apoptotic members, such as Bax and Bak, 
promote the formation of the channel, whereas anti-apoptotic members inhibit the 
formation of the channel (Dejean et al., 2010; Liu et al., 1996).  
 
Calcium homeostasis 
In concert with the endoplasmic reticulum, mitochondria play a central role in cellular 
Ca2+ homeostasis (Pozzan and Rizzuto, 2000); intra-mitochondrial Ca2+ regulates the 
activity of enzymes such as pyruvate dehydrogenase and the induction of the 
mitochondrial permeability transition.  
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Figure 1.4: The major protein complexes involved in mitochondrial energy transduction. For clarity, other proteins of the mitochondrial 
inner membrane are not shown. Images of three dimensional structures and electron density maps were generated using PyMOL (DeLano 
scientific, 2002). Complex I is the low resolution structure of the enzyme from T. thermophilus (PDB accession code: 3M9S) to 4.5 Å (Efremov 
et al., 2010). Complexes III (PDB: 1BE3) and IV (PDB: 1OCC) are the high resolution structures of the bovine enzymes (Iwata et al., 1998; 
Tsukihara et al., 1996); complex II (PDB: 1ZOY) is the porcine enzyme (Sun et al., 2005). Cytochrome c (PDB: 1CXA) is from Rhodobacter 
sphaeroides (Axelrod et al., 1994). ATP synthase (PDB: 2CLY) is a model from Professor J. E. Walker’s group (Dickson et al., 2006). The 
mitochondrial ADP/ATP carrier (PDB: 1OKC) in complex with carboxyatractyloside is also shown (Pebay-Peyroula et al., 2003).  
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Primary pump Secondary pump 
 
Complex I Complex II Complex III Complex IV ATP synthase 
Mass / kDa 9801 1206 24011 20016 58022 
Different subunits 451 47 1111 1317 1622 
mtDNA subunits 71 08 112 316 222 
Cofactors 1 FMN; 8 or 9 Fe-S1,2 
1 FAD; 
3 Fe-S; 
1 haem6 
3 haems; 
1 Fe-S11 
2 haems; 
2 Cu centres18 None
23,24
 
Structures available 
Bacterial hydrophilic2 
Bacterial/fungal3,27 
(low resolution) 
Mammalian9 
Bacterial10 
Mammalian13 
Bacterial11 
Mammalian19 
Bacterial20 
Incomplete: 
Mammalian23 
Fungal24 
H+ pumped per electron 24 0 114 118 3 – 4 H+ per ATP25 
Reaction 
NADH + H+ + Q + 4H+M 
↓       
NAD+ + QH2 + 4H+IMS 
Succinate + Q 
↓ 
Fumarate + QH2 
QH2 + 2Cyt cox+ 2H+M 
↓ 
Q + 2Cyt cred + 4H+IMS 
8H+ + 4Cyt cred + O2 
↓ 
4H+IMS + 4Cyt cox + 2H2O 
ADP + Pi + nH+IMS 
↓ 
ATP + nH+M 
Mechanism of H+ 
pumping Not Known
5
 - Modified Q-cycle15 Direct couple21 Indirect couple25,26 
 
Table 1.1: Summary of the structural and functional properties of the five major respiratory complexes in mammalian mitochondria. 
1(Hirst et al., 2003), 2(Sazanov and Hinchliffe, 2006), 3(Efremov et al.), 4(Wikström, 1984), 5(Hirst, 2010), 6(Cecchini et al., 2003), 
7(Yankovskaya et al., 2003), 8(Cecchini, 2003), 9(Sun et al., 2005), 10(Iverson et al., 1999), 11(Iwata et al., 1998), 12(Berry et al., 2000), 13(Xia et 
al., 1997), 14(Crofts, 2004), 15(Trumpower, 1990), 16(Saraste, 1999), 17(Khalimonchuk and Rodel, 2005), 18(Salje et al., 2005), 19(Tsukihara et al., 
1996), 20(Iwata et al., 1995), 21(Hosler et al., 2006), 22(Walker et al., 1985), 23(Abrahams et al., 1994), 24(Stock et al., 1999), 25(Walker, 1998),   
26(Boyer, 1997), 27(Hunte et al., 2010). 
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1.3 The respiratory complexes of oxidative phosphorylation 
1.3.1 Complex II (succinate:ubiquinone oxidoreductase) 
Although complex II, succinate:ubiquinone oxidoreductase, does not contribute to the 
proton motive force, it is an essential enzyme in the citric acid cycle; the oxidation of 
succinate to fumarate is coupled to the reduction of ubiquinone to ubiquinol in the 
mitochondrial inner membrane (Cecchini, 2003; Sun et al., 2005).  
 
 
 
 
Figure 1.5: The structure of succinate:ubiquinone oxidoreductase from porcine heart 
mitochondria and the arrangement of its redox cofactors (Sun et al., 2005). Figure 
prepared using PyMol (DeLano scientific, 2002: PDB accession code: 1ZOY). Left; the 
prosthetic groups involved in electron transfer superimposed over a cartoon representation 
of the enzyme; the FAD binding protein is shown in green, the iron-sulphur protein is 
shown in blue, and the membrane proteins are shown in red and yellow. Right; edge-to-
edge distances are given along with the midpoint reduction potentials; blue arrows indicate 
distance between cofactors involved in electron transfer. Adapted from (Moser et al., 
2006). 
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The structure of complex II, and its pathway of electron transfer, is shown in figure 1.5. 
The 120 kDa complex consists of four nuclear-encoded subunits, SdhA, SdhB, SdhC and 
SdhD, arranged in two distinct domains. Subunits SdhA and SdhB form a hydrophilic, 
‘succinate dehydrogenase’ subcomplex: SdhA ligates a flavin dinucleotide, and houses the 
succinate/fumarate binding site; SdhB contains three iron-sulphur clusters (Cecchini, 
2003). They are anchored to the membrane by the SdhC and SdhD subcomplex, which 
contains a single haem group, and either one or two ubiquinone binding sites. Succinate is 
oxidised by the flavin dinucleotide, and the electrons are subsequently passed down the 
‘electron wire’ formed by the iron-sulphur clusters, reducing ubiquinone either directly 
from the final iron-sulphur cluster or via haem b, in the plane of the membrane (Ackrell et 
al., 1975; Ohnishi et al., 1981; Maguire et al., 1985). 
 
1.3.2 Electron-transferring flavoprotein:ubiquinone (ETF:Q) oxidoreductase and 
s,n-glycerophosphate dehydrogenase 
Apart from complexes I and II, at least two additional enzymes can feed electrons into the 
ubiquinone pool. Electron-transferring flavoprotein-ubiquinone (ETF:Q) oxidoreductase 
catalyses the oxidation of the electron-transferring flavoprotein (ETF) and the reduction of 
ubiquinone. Located in the mitochondrial matrix, ETF oxidoreductase oxidises several 
flavin-containing dehydrogenases, including enzymes involved in fatty acid oxidation and 
amino acid catabolism (Nicholls and Ferguson, 2002). 
 Associated with the mitochondrial inner membrane, ETF:Q oxidoreductase 
contains one FAD (flavin adenine dinucleotide), a [4Fe4S] iron-sulphur cluster and a 
ubiquinone binding site (Zhang et al., 2006); a recent study revealed that the [4Fe4S] 
cluster of ETF:Q oxidoreductase is the immediate electron acceptor (Swanson et al., 
2008). As ETF:Q oxidoreductase does not contain any transmembrane helices, its 
association with the membrane has been attributed to a series of hydrophobic residues that 
contribute to an α-helix and a β-sheet, adjacent to the ubiquinone binding site (Nicholls 
and Ferguson, 2002). The structure of ETF:Q oxidoreductase is shown in figure 1.6. 
 S,n-glycerophosphate dehydrogenase is present in the inter-membrane space, and is 
associated with the mitochondrial inner membrane. The enzyme, which oxidises s,n-
glycerophosphate and reduces ubiquinone, contains FAD and at least one iron-sulphur 
cluster, and is similar in structure to ETF:Q oxidoreductase (Nicholls and Ferguson, 2002). 
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Figure 1.6: The structure of electron-transferring flavoprotein:ubiquinone oxido-
reductase from porcine mitochondria and the arrangement of its cofactors (Zhang et 
al., 2006). Figure prepared using PyMol (DeLano scientific, 2002: PDB accession code: 
2GMH). Left; the prosthetic groups involved in electron transfer superimposed over a 
cartoon representation of the enzyme. Right; edge-to-edge distances are given along with 
the midpoint reduction potentials; blue arrows indicate distance between cofactors 
involved in electron transfer. 
 
 
1.3.3 Complex III (ubiquinol:cytochrome c oxidoreductase) 
Complex III, ubiquinol:cytochrome c oxidoreductase, catalyses the oxidation of ubiquinol, 
the reduction of cytochrome c, and the concomitant translocation of four protons from the 
matrix to the inter-membrane space, maintaining the proton motive force used by ATP 
synthase to synthesise ATP. The mammalian enzyme has a mass of approximately 240 
kDa, and is made up of 11 subunits, three of which ligate redox cofactors; two cytochrome 
b haems (bL and bH), a membrane-anchored iron-sulphur protein, and a membrane-
anchored cytochrome c1 (Iwata et al., 1998). Complex III also contains two 
physiologically relevant ubiquinone binding sites: Qo faces the inter-membrane space, and 
catalyses the oxidation of ubiquinol to ubiquinone; Qi faces the mitochondrial matrix and 
catalyses the reduction of ubiquinone to ubiquinol (Saraste, 1999). The structure of 
complex III, and its pathways of electron transfer, is shown in figure 1.7. 
  
  12 
 
 
Figure 1.7: The structure of ubiquinol:cytochrome c oxidoreductase from bovine 
heart mitochondria and the arrangement of its redox cofactors (Iwata et al., 1998). 
Figure prepared using PyMol (DeLano scientific, 2002: PDB accession code: 1BE3). Left; 
the prosthetic groups involved in electron transfer superimposed over a cartoon 
representation of the enzyme. Right; edge-to-edge distances are given along with the 
midpoint reduction potentials; blue arrows indicate distance between cofactors involved in 
electron transfer, grey arrows represent distances between cofactors not directly involved 
in electron transfer. Adapted from (Moser et al., 2006).
 
 
 
Ubiquinol, formed from the reduction of ubiquinone by complexes I, II and ETF:Q 
oxidoreductase, binds at the Qo site. One electron is passed along the thermodynamically-
favoured ‘high potential’ chain consisting of the Rieske iron-sulphur cluster (Em = +280 
mV) and cytochrome c1 (Em = +242 mV) to cytochrome c; the reduction of the Rieske 
cluster results in a conformational change, moving it towards cytochrome c1. This 
movement prevents the second electron taking this route; instead, it is transferred via a 
‘low potential’ pathway consisting of cytochromes bL (Em = -50 mV) and bH (Em = +80 
mV) to the Qi site, where it reduces a bound ubiquinone, forming a stable ubisemiquinone 
anion. A second quinol is subsequently oxidised at Qo; the first electron is passed to 
cytochrome c via the Rieske iron-sulphur cluster and cytochrome c1, and the second 
electron is transferred, via cytochromes bL and bH, to Qi, where it reduces the 
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ubisemiquinone anion to ubiquinol (Trumpower, 1990; Xia et al., 1997; Iwata et al., 1998; 
Zhang et al., 1998; Saraste, 1999). 
 Oxidation of two ubiquinol molecules at Qo results in the release of four protons 
into the inter-membrane space; the reduction of ubiquinone at Qi results in the uptake of 
two protons from the mitochondrial matrix, which are effectively translocated into the 
inter-membrane space upon ubiquinol oxidation. In addition, two cytochrome c molecules 
are reduced per complete catalytic cycle (Nicholls and Ferguson, 2002). 
 
1.3.4  Complex IV (cytochrome c oxidase) 
Complex IV, cytochrome c oxidase, catalyses the oxidation of cytochrome c, the reduction 
of molecular oxygen to water, and the translocation of four protons across the 
mitochondrial inner membrane (Michel, 1999; Wikström, 2004). The structure of complex 
IV, and its pathway of electron transfer, is shown in figure 1.8. 
  
 
 
 
Figure 1.8: The structure of cytochrome c oxidase from bovine heart mitochondria 
and the arrangement of its redox cofactors (Tsukihara et al., 1996). Figure prepared 
using PyMol (DeLano scientific, 2002: PDB accession code: 1OCC). Left; the prosthetic 
groups involved in electron transfer superimposed over a cartoon representation of the 
enzyme and the approximate location of the K- and D- channels. Right; edge-to-edge 
distances are given along with the midpoint reduction potentials; blue arrows indicate 
distance between cofactors involved in electron transfer, grey arrows represent distances 
between cofactors not directly involved in electron transfer. Adapted from (Moser et al., 
2006).  
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Figure 1.9: Simplified catalytic cycle of cytochrome c oxidase. The rectangles depict the 
binuclear centre with haem a3, CuB and a conserved tyrosine residue in different states of 
the cycle. Red arrows show reactions that include proton pumping events. Stages (i/ii); 
oxygen binding to the reduced binuclear centre is followed by a four-electron reduction of 
the bound oxygen, breaking the O-O bond; one oxygen atom is bound to the haem, 
forming a ferryl species, and the other to CuB, forming a hydroxyl group. Two of the 
required electrons come from haem a3, one from CuB, and the fourth from a conserved 
tyrosine residue, forming a neutral tyrosyl radical. Stage (iii); an electron is delivered to 
the tyrosyl radical from haem a; a proton is taken up from the mitochondrial matrix to re-
protonate the tyrosine. Stage (iv); the ferryl species is reduced to a ferric hydroxide 
species; this requires an electron (from haem a) and a proton, taken from the mitochondrial 
matrix. Stages (v/vi); the completion of the cycle requires two additional protons and 
electrons to release water and regenerate the catalytic site. The complete cycle removes 
four protons from the mitochondrial matrix and four electrons from cytochrome c in the 
inter-membrane space, contributing to ∆Ψ; four additional protons are translocated from 
the matrix to the inter-membrane space, contributing to both ∆pH and ∆Ψ (see figure 1.10). 
Adapted from (Nicholls and Ferguson, 2002; Wikström and Verkhovsky, 2006). 
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Figure 1.10: Simplified mechanism of proton pumping by cytochrome c oxidase. Blue 
arrows show the movement of electrons; red arrows show the movement of protons (blue 
spheres). Left; electron transfer from haem a to the binuclear centre is coupled to an 
internal proton transfer from Glu242 via haem a3 to a ‘pump site’ on the inter-membrane 
side of the haem groups. Re-protonation of Glu242 via the D-pathway involves 
isomerisation of its side chain (not shown in figure). Right; proton transfer from Glu242 to 
the binuclear centre produces the equivalent of water. Together with the re-protonation of 
Glu242, this causes ejection of the proton from the ‘pump site’ into the inter-membrane 
space. Adapted from (Tsukihara et al., 1996; Wikström and Verkhovsky, 2006). 
 
 
The mammalian enzyme is a functional dimer, comprises 13 subunits, three of which are 
encoded by the mitochondrial genome and form the ‘core’ of the complex (Saraste, 1999). 
Electrons from cytochrome c are transferred to active site of oxygen reduction, comprising 
haem a3 and CuB, via a dinuclear copper centre, CuA, and a low spin haem, haem a. The 
free energy released by the reduction of oxygen to water drives the pumping of four 
protons from the matrix into the inter-membrane space. Two proton channels have been 
identified in complex IV; the K-channel feeds two substrate protons to the active site for 
the reduction of oxygen, and the D-channel allows transfer of both substrate and 
translocated protons (Ruitenberg et al., 2000). A third H-channel has been proposed, based 
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on the high resolution structure of the bovine enzyme (Tsukihara et al., 1996). This 
channel passes by the low-spin haem a group, and it has been proposed that redox changes 
in this group may provide the driving force to translocate protons through the channel. 
 Figure 1.9 shows the binuclear centre of cytochrome c oxidase, and the proposed 
mechanism of oxygen reduction; figure 1.10 shows a proposed mechanism of proton 
pumping by complex IV (Nicholls and Ferguson, 2002; Wikström and Verkhovsky, 2006). 
In stages (iii) - (vi) of the cycle, one electron is transferred to the binuclear site, 
accompanied by net uptake of a ‘substrate proton’; each of these four reaction steps is 
coupled to translocation of one proton across the mitochondrial inner membrane. The 
reduction of oxygen to water and the translocation of protons across the membrane 
contribute to the proton motive force utilised by ATP synthase to generate ATP. 
 
1.3.5 ATP synthase 
F1-Fo-ATP synthase utilises the proton motive force maintained by the respiratory enzymes 
described above to synthesise ATP from ADP and phosphate. The mammalian enzyme has 
a molecular mass of approximately 580 kDa, and is made up of 16 different subunits 
arranged in two distinct domains. The hydrophobic, Fo, domain contains 8 to 14 copies of 
the ~8 kDa c-subunit, which forms a proton conductive pore through the mitochondrial 
inner membrane (Watt et al., 2010); the structure of the c-ring from yeast mitochondrial 
ATP synthase is shown in figure 1.11. The hydrophilic, globular domain, known as F1, 
extends into the mitochondrial matrix, and contains three copies of each of the α and β 
subunits; the interfaces between the α and β subunits contain binding sites for ADP and Pi, 
(Abrahams et al., 1994). The two domains are linked by an asymmetric central stalk and a 
peripheral stalk, which acts as a stator to prevent the F1 domain rotating freely during 
catalysis (Dickson et al., 2006). The structure of the globular domain from bovine heart 
mitochondria is shown in figure 1.12. 
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Figure 1.11: The structure of the c-ring and mechanism of proton translocation 
through the Fo domain of ATP synthase. Images of three dimensional structures were 
generated using PyMOL (DeLano scientific, 2002). Left; structure of the c-ring within the 
Fo domain of ATP synthase ((Stock et al., 1999), PDB accession code: 1QO1). Right; the 
two-half-channel model proposes that the c subunits contain a binding pocket for protons 
in the middle of the membrane. The proton enters the pocket via a channel in the a subunit 
from the inter-membrane space, resulting in the rotation of the c-ring, stays associated for 
almost a complete turn, and dissociates into the matrix via the second channel. Adapted 
from (Stock et al., 1999).  
 
 
The movement of protons down their chemiosmotic gradient through the c-ring of the Fo 
domain causes rotation of the γ-subunit of the central stalk. The asymmetry of the central 
stalk results in differential interactions with the α and β subunits of the F1 domain, 
endowing them with different nucleotide affinities; one site binds ADP and Pi (the loose 
site), one binds ATP formed from the phosphorylation of ADP (the tight site) and the third 
is the empty site from which ATP is released. As the γ-subunit rotates, the tight site alters 
to the open site, releasing the newly formed ATP. The open site is converted to the loose 
site, binding ADP and orthophosphate. The loose site is converted to the tight site as ADP 
is phosphorylated; the mechanism of ATP synthesis is shown in figure 1.12 (Boyer, 1997; 
Walker, 1998). 
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Figure 1.12: The structure of the F1 domain (without the peripheral stalk) and the 
mechanism of ATP synthesis by ATP synthase. Images of three dimensional structures 
were generated using PyMOL (DeLano scientific, 2002). Top; two views of the F1 domain 
of ATP synthase. The α and β subunits (red and yellow respectively) are arranged 
alternately around the asymmetric γ subunit (blue). Adapted from (Abrahams et al., 1994). 
Bottom; schematic of the three different conformations of the β subunit.   
 
 
1.3.5 The ADP/ATP carrier  
The ADP/ATP carrier catalyses the equimolar exchange of cytosolic ADP for ATP 
synthesised by ATP synthase (Kunji, 2004). As with all mitochondrial transporters, the 
ADP/ATP carrier consists of three homologous sequence repeats of ~100 amino acids, 
each of which contains the signature motif P-X-[D/E]-X-X-[R/K]. The structure of the 
enzyme from bovine mitochondria in complex with the inhibitor carboxyatractyloside 
confirmed the structural fold of the protein has threefold pseudosymmetry, consisting of a 
barrel of six-transmembrane α-helices (Pebay-Peyroula et al., 2003).  
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1.4  Complex I (NADH:ubiquinone oxidoreductase) 
Complex I, NADH:ubiquinone oxidoreductase, is the first enzyme in the membrane-bound 
electron transfer chain in many aerobic organisms; it oxidises NADH formed from the 
‘controlled combustion’ of food stuffs, and reduces ubiquinone (equation 1.2).  
 
 
NAD+ + H+ + 2e- ↔ NADH       Em = -0.33 V 
 
Q + 2H+ + 2e- ↔ QH2     Em = +0.07 V 
 
Equation 1.2: The redox reaction catalysed by complex I. Taken from (Hirst, 2010). 
 
 
This oxidoreduction reaction concomitantly pumps four protons across the mitochondrial 
inner membrane, removing two additional protons from the mitochondrial matrix as 
quinone is reduced; both processes contribute to the proton motive force used by ATP 
synthase to synthesise ATP from ADP and inorganic phosphate (Walker, 1992; Hirst, 
2005; Hirst, 2010).  
   
1.4.1 Distribution, topography and subunit composition of complex I 
Complex I has been found in all the major domains of life, including many eukaryotes 
(notable exceptions being S. cerevisiae and Schizosaccharamyces pombe (Friedrich and 
Weiss, 1997)), bacteria and archaea (Yagi et al., 1998).  
 The composition of the enzyme varies between species, though common to all are 
fourteen ‘core’ subunits sufficient to catalyse the basal reactions of the enzyme. Seven of 
these subunits constitute the hydrophilic arm, protruding into either the mitochondrial 
matrix or the bacterial cytoplasm, and ligate all the known co-factors of the enzyme. The 
remaining seven are hydrophobic, membrane-spanning subunits, and, in the eukaryotic 
enzyme, encoded by the mitochondrial genome. Electron microscopy images have 
revealed that complexes I from all domains of life have a common L-shaped profile, 
shown in figure 1.13. 
 Complex I from bovine heart mitochondria is composed of 45 different subunits 
with a combined mass of ~980 kDa, and shares high sequence identity with the human 
enzyme (Carroll et al., 2006). There is much debate as to the function of the additional 31 
‘supernumerary’ subunits present in the mammalian enzyme, which are included in table 
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1.2. Some of the supernumerary subunits may have specific roles due to their sequence 
similarity to other proteins with known functions. One such example is subunit B16.6, 
which is 83% identical to human GRIM-19 (Gene associated with Retinoid-IFN induced 
Mortality), a protein involved in the interferon-β pathway of cell-death induction; 
however, there is no direct evidence as to the function of this subunit in complex I 
(Fearnley et al., 2001). The functions of the other supernumerary subunits remain 
undefined, but they may be involved in protecting the complex from oxidative damage, 
aiding structural stability or complex assembly, or regulating catalytic activity. 
 
 
 
 
Figure 1.13: Electron microscopy images of complex I from various species. 
Comparison of the three structures of complex I from Yarrowia lipolytica (24 Å 
resolution), Bos taurus (27 Å resolution) and Aquifex aeolicus (45 Å resolution). Scale bar 
represents 10 nm. Taken from (Clason et al., 2010). 
 
 
Mammalian complex I is one of the most complex enzymes known. As well as its size, the 
extreme hydrophobicity and asymmetry of the intact enzyme make it difficult to work 
with; consequently, numerous reports have aimed at preparing subcomplexes of the 
enzyme, with the ultimate goal of simplifying functional and structural studies (Finel et al., 
1992, Finel et al., 1994, Sazanov et al., 2000). Chapter 3 introduces these subcomplexes, 
and describes work assessing their suitability as models for the intact enzyme. 
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Nomenclature3 Subunit Observed 
mass/ Da1,2 T. thermophilus E. coli 
Cofactors, transmembrane helices 
and other notes4,5 
75 kDa 76960.5a Nqo3 NuoG [2Fe2S], 2 x [4Fe4S] 
ND5 68328.8 Nqo12 NuoL 14 transmembrane helices 
ND4 52131.1 Nqo13 NuoM 14 transmembrane helices 
49 kDa 49207.2 Nqo4 NuoD Fused with NuoC in E. coli 
51 kDa 48503.0 Nqo1 NuoF FMN, [4Fe4S] 
ND2 39284.5 Nqo14 NuoN 14 transmembrane helices 
39 kDa 39117.1 - -  
42 kDa 36710.0 - -  
ND1 35699.5 Nqo8 NuoH 8 transmembrane helices 
30 kDa 26432.0 Nqo5 NuoC Fused with NuoD in E. coli 
24 kDa 23814.9 Nqo2 NuoE [2Fe2S] 
B22 21700.8 - -  
PDSW 20832.2 - -  
TYKY 20192.1 Nqo9 NuoI 2 x [4Fe4S] 
PSST 20094.0 Nqo6 NuoB [4Fe4S] 
PGIV 19952.1 - -  
ND6 19106.7 Nqo10 NuoJ 5 transmembrane helices 
ASHI 18737.2 - - 1 predicted transmembrane helix 
B17.2 17132.1 - -  
SGDH 16726.3 - - 1 predicted transmembrane helix 
B16.6 16584.5 - - 1 predicted transmembrane helix 
B18 16473.9 - -  
B17 15434.7 - - 1 predicted transmembrane helix 
18 kDa 15337.4 - -  
B15 15095.3 - - 1 predicted transmembrane helix 
B14 14964.7 - -  
B14.7 14668.8 - - 3 predicted transmembrane helices 
ESSS 14453.3 - - 1 predicted transmembrane helix 
B14.5b 14096.2 - - 1 predicted transmembrane helix 
B13 13226.5 - -  
ND3 13082.8 Nqo7 NuoA 3 transmembrane helices 
B14.5a 12587.4 - -  
15 kDa 12532.3 - -  
B12 11037.7 - - 1 predicted transmembrane helix 
B8 10991.0 - -  
ND4L 10824.9 Nqo11 NuoK 3 transmembrane helices 
SDAP 10676.1 - -  
13 kDa 10535.3 - -  
MLRQ 9324.7a - - 1 predicted transmembrane helix 
B9 9259.7 - - 1 predicted transmembrane helix 
AGGG 8492.9 - - 1 predicted transmembrane helix 
10 kDa 8437.9 - -  
MWFE 8105.2 - - 1 predicted transmembrane helix 
MNLL 6965.9 - -  
KFYI 5828.7 - - 1 predicted transmembrane helix 
 
Table 1.2: The 45 subunits of complex I from bovine heart mitochondria. 1(Carroll et 
al., 2009), 2(Walker et al., 2009), 3(Yagi and Matsuno-Yagi, 2003), 4(Hirst et al., 2003), 
5(Efremov et al., 2010). Notes: amass not observed; calculated mass shown. Core subunits 
are shown in bold. 
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1.4.2 The structure of complex I 
1.4.2.1 The structure of the hydrophilic domain of complex I from T. thermophilus 
In 2006, Sazanov and Hinchliffe reported the structure of the hydrophilic domain of 
complex I from Thermus thermophilus (Sazanov and Hinchliffe, 2006). Figure 1.14 shows 
the structure of the hydrophilic domain, and the arrangement of the flavin mononucleotide 
and nine iron-sulphur clusters, eight of which are conserved in the bovine enzyme; the 
structures of the individual subunits are shown in figure 1.15. 
 
 
 
 
Figure 1.14: The structure of the hydrophilic domain of T. thermophilus complex I. 
Left; side view. Each subunit is coloured differently; FMN is shown as magenta spheres, 
iron atoms as red spheres and sulphur atoms as orange spheres. A putative quinone-
binding site is indicated by an arrow. Right; arrangement of the redox centres. The clusters 
are named according to their nuclearity (2Fe or 4Fe), their subunit location, and, when 
necessary, as ligated by four cysteines (C), or by three cysteines and one histidine (H). 
Cluster 4Fe[3], shown in grey, is not present in all species. Edge-to-edge distances are 
indicated in Ångstroms, and the most likely electron transfer pathway is denoted by solid 
lines. Adapted from (Sazanov and Hinchliffe, 2006; Yakovlev et al., 2007). 
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Figure 1.15: The structures of the individual subunits of the hydrophilic domain of 
complex I from T. thermophilus. Iron-sulphur clusters are shown as red spheres for iron 
atoms and orange spheres for sulphur atoms; subunits are not shown to the same scale. 
Nqo1 (Bovine homologue = 51 kDa subunit); the N-terminal domain is in purple, a 
Rossman-fold domain in blue, an ubiquitin-like domain in green, and the C-terminal 
helical bundle, coordinating cluster 4[Fe]1, in red. The flavin is shown in stick 
representation. Nqo2 (24 kDa subunit); the N-terminal helical bundle is shown in blue, the 
thioredoxin-like domain coordinating cluster 2Fe[2] in green. Nqo3 (75 kDa subunit); the 
N-terminal [FeFe]-hydrogenase-like domain coordinating clusters 2Fe[3], 4Fe[3]C and 
4Fe[3]H is magenta, sub-domains of the C-terminal molybdoenzyme-like domain are 
shown in I, blue (coordinating cluster 4Fe[3]); II, green; III, yellow; and IV, red. Nqo9 
(TYKY), coordinating clusters 4Fe[9]1 and 4Fe[9]2, is shown in rainbow representation, 
coloured blue to red from N to C terminus. Nqo6 (PSST), coordinating cluster 4Fe[6], is 
shown in rainbow representation, with helix H1 indicated. Nqo4 (49 kDa subunit); the N-
terminal αβ domain is shown in blue, the α-helical bundle in green, the extended helix H2 
in yellow, and the C-terminal αβ domain in orange. Clusters are shown for orientation 
only. Nqo5 (30 kDa subunit); the N-terminal αβ domain interacting with Nqo4 is shown in 
blue, the domain interacting with Nqo3 in yellow. Nqo15 (no bovine homologue), is 
shown in rainbow representation. Taken from (Sazanov and Hinchliffe, 2006). 
 
 
The structure revealed a chain of seven iron-sulphur clusters linking the flavin site to the 
proposed site of ubiquinone reduction in the plane of the membrane. All edge-to-edge 
distances conform to Dutton’s ruler for electron transfer; the greatest distance, 14 Å 
between clusters 4Fe[3]H and 4Fe[9]1, is small enough to allow for electron transfer at 
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physiologically relevant rates (Page et al., 1999). Two additional clusters are present: 
2Fe[2] and 4Fe[3]. Cluster 2Fe[2] is on the opposite side of the flavin, and is not directly 
involved in electron transfer. It has been proposed that this cluster accepts an electron from 
the flavosemiquinone, thus acting as a temporary ‘electron store’, minimising reactive 
oxygen species production during enzyme turnover, although, there is no direct evidence 
that supports this theory (Hirst, 2010). Nqo3, which coordinates cluster 4Fe[3] and is only 
found in some bacterial species, contains a fold very similar to the frataxin family, a group 
of proteins involved in iron storage and maturation of iron-sulphur and haem-containing 
enzymes (Hinchliffe et al., 2006).  
 
1.4.2.2 The low resolution structures of complexes I from T. thermophilus and Y. 
lipolytica 
In a recent study, Efremov and co-workers reported the low resolution structure of 
complex I from T. thermophilus to 4.5 Å resolution (Efremov et al., 2010). As expected, 
the intact enzyme is L-shaped, with the membrane arm 180 Å in length and the peripheral 
arm extending 130 Å above the lipid bilayer. In total, the membrane domain contains 63 
transmembrane helices, consisting of subunits Nqo12 (ND5), Nqo13 (ND4), Nqo14 
(ND2), Nqo7/10/11 (ND3/6/4L) and Nqo8 (ND1).  
 Figure 1.16 reveals that the three largest subunits, Nqo12, 13 and 14 are very 
similar to each other in structure, each containing 14 transmembrane helices, four of which 
form a central ‘core’ surrounded by the remaining helices. Interestingly, each of these 
subunits contain a ‘helix-peptide-helix’ motif known to be important in the function of 
many transporters, including the Escherichia coli Na+/H+ antiporter (Hunte et al., 2005; 
Screpanti and Hunte, 2007). The most striking feature of the hydrophobic domain is a 110 
Å carboxy-terminal extension to subunit Nqo12, helix HL, which runs almost the entire 
length of the domain, perpendicular to the transmembrane helices. This helix, which is not 
present in subunits Nqo13 and 14, terminates in a transmembrane α-helix adjacent to the 
Nqo7/10/11 bundle at the interface of the hydrophobic and hydrophilic domains; the 
potential functional implications of helix HL in proton pumping are discussed in section 
1.4.3.4.  
 Hunte and co-workers recently published the structure of complex I from Y. 
lipolytica to 6.3 Å resolution (Hunte et al., 2010). As expected, the positions of all eight 
iron-sulphur clusters were localised in the peripheral arm, and the distances between them 
were similar to those reported for the hydrophilic domain of T. thermophilus (Sazanov and 
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Hinchliffe, 2006). The authors successfully modelled 71 membrane-spanning helices into 
the electron density map of the hydrophobic domain, and observed similar features to 
those described for the bacterial enzyme, including the discontinuous helices present in the 
three largest membrane-spanning subunits, and the alpha-helical structure orientated 
perpendicular to the membrane (Hunte et al., 2010). 
 
 
 
 
Figure 1.16: The architecture of complex I from T. thermophilus. The structure consists 
of the atomic model for the hydrophilic domain, determined previously (Sazanov and 
Hinchliffe, 2006), and the α-helical model for the membrane domain. Top; side view, in 
the membrane plane. Bottom; top view, from the cytoplasm into the membrane. Taken 
from (Efremov et al., 2010). 
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1.4.3 The mechanism of complex I 
1.4.3.1 The flavin mononucleotide and NADH oxidation 
The flavin mononucleotide (FMN) of complex I is the entry point into the electron transfer 
chain, catalysing the oxidation of NADH, and subsequent reduction of iron-sulphur cluster 
4Fe[51]. The flavin is non-covalently bound to the 51 kDa subunit by a network of 
hydrogen bonds, and is located at the end of a deep solvent exposed cavity, shown in 
figure 1.17.  
 
 
 
 
Figure 1.17: The NADH binding site of complex I from T. thermophilus. Left; the 
structure of the flavin mononucleotide (FMN) of complex I. The hydride acceptor, atom 
N5, is shown in red. Right; the site viewed from the solvent-accessible side. FMN and 
residues involved in NADH binding are shown as sticks, with carbon in yellow and NADH 
with carbon in salmon. Hydrogen bonds are shown as dotted line in green, stacking 
interactions are in grey, and the hydride transfer path in red. Adapted from (Berrisford and 
Sazanov, 2009). 
 
 
The oxidation of NADH to NAD+ is believed to proceed via a hydride transfer, rather than 
by the transfer of two electrons and one proton, thus avoiding the highly unstable NAD. 
radical (Hirst, 2010). The structure of the hydrophilic domain from T. thermophilus with 
bound NADH, shown in figure 1.17, reveals that the nicotinamide ring of the NADH 
stacks above the flavin isoalloxazine system, allowing the donor hydride (C4 of the 
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nicotinamide ring) and acceptor (N5 of the flavin) to come within 3.5 Å of each other, as is 
the case with other flavoenzymes (Berrisford and Sazanov, 2009). 
 The flavin mononucleotide of complex I from B. taurus has a reduction potential of     
-0.38 V at pH 7.8 (Sled et al., 1994), close to that of NAD+, meaning that it can catalyse 
both NADH oxidation and NAD+ reduction, is kinetically fast and thermodynamically 
efficient. As the rate of NADH oxidation is significantly faster than the rate of ubiquinone 
reduction, complex I is thought to exist in a predominantly reduced state (Hirst, 2010). 
 
1.4.3.2 The iron-sulphur clusters and intramolecular electron transfer 
The 3.3 Å structure of the hydrophilic domain of T. thermophilus complex I reveals how 
seven iron-sulphur clusters (one [2Fe2S] cluster and six [4Fe4S] clusters) form an 
extensive chain between the flavin and the quinone binding site in the plane of the 
membrane (Sazanov and Hinchliffe, 2006); the eighth cluster (a [2Fe2S] cluster) is on the 
opposite side of the flavin. The role of these iron-sulphur clusters is to transfer electrons 
efficiently between the sites of NADH oxidation and quinone reduction. Table 1.3 presents 
a brief description of the iron-sulphur clusters of complex I, and figure 1.18 shows their 
structures.  
 
 
 
 
Figure 1.18: The structures of the iron-sulphur clusters of complex I. Left; [4Fe4S] 
iron-sulphur cluster ligated to the protein by four cysteine residues. Right; [2Fe2S] iron-
sulphur cluster ligated to the protein by four cysteine residues. 
 
 
The best technique with which to detect iron-sulphur clusters is electron paramagnetic 
resonance (EPR). The data in table 1.3 summarises the properties of the iron-sulphur 
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clusters of complex I, and defines the nomenclature used throughout this thesis. Five 
reduced iron-sulphur clusters are typically observed by EPR in complex I from B. taurus 
reduced by NADH in EPR, and their spectra are denoted N1b, N2, N3, N4 and N5. 
Although spectra N1b, N2 and N3 have been unambiguously assigned to clusters 2Fe[75], 
4Fe[PS] and 4Fe[51], respectively (Sled et al., 1994; Yano et al., 2005), controversy 
surrounds the assignment of signals N4 and N5 to their structurally defined clusters; 
chapter seven describes work aimed at resolving these ambiguities. 
 
 
Subunit Cluster1 Ligation EPR 
signal1 Em /V Comment on EPR signals 
24 kDa 2Fe[24] C.X4.C.X35.C.X3.C N1a Est. -0.5 Not observed in intact  B. taurus complex I 
51 kDa 4Fe[51] C.X2.C.X2.C.X39.C N3 -0.25 
Spin interactions with 
flavosemiquinone2,  
EpH7 from redox titration3,4 
2Fe[75] C.X10.C.X2.C.X13.C N1b Est. -0.4 Partially reduced by NADH5 
4Fe[75]C C.X2.C.X2.C.X43.C N5 -0.26 
See chapter seven for assignment 
N5 signal fast relaxing  
EpH7 from redox titration3,4 
75 kDa 
4Fe[75]H H.X3.C.X2.C.X5.C - N.D. Not observed by EPR 
4Fe[TY]1 C.X2.C.X2.C.X42.C N4 -0.25 
TYKY 
4Fe[TY]2 C.X28.C.X2.C.X2.C - N.D. 
See chapter seven for assignment 
EpH7 from redox titration3,4 
PSST 4Fe[PS] C.C.X63.C.X29.C N2 -0.15 
Spin interactions with 
ubisemiquinone6,  
EpH7 from redox titration3,4 
 
Table 1.3: The eight conserved iron-sulphur clusters in complex I from bovine heart 
mitochondria. 1(Yakovlev et al., 2007), 2(Sled et al., 1994), 3(Ohnishi, 1998), 4(Sled et 
al., 1993), 5(Reda et al., 2008), 6(Yano et al., 2005). Notes: N.D., not determined, Est., 
estimated. Adapted from (Hirst, 2010). 
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1.4.3.3 The quinone binding sites and quinone reduction 
Whereas the mechanisms of NADH oxidation and electron transfer within complex I are 
now relatively well understood, the mechanisms of quinone reduction and proton pumping 
are not. Studies of quinone binding, reduction and proton pumping are complicated by the 
lack of a high resolution structure of the membrane domain, the lack of cofactors, limiting 
the possibility for spectroscopic assays, and the extreme hydrophobicity of the natural 
quinone substrate, Q10, which precludes its use in studies of the isolated enzyme. 
 A putative binding site for the quinone head group was identified in the structure of 
the hydrophilic domain of complex I from T. thermophilus at the interface of the 49 kDa 
and PSST subunits (Sazanov and Hinchliffe, 2006). As expected, this site is close to both 
cluster 4Fe[PS], from which ubiquinone accepts electrons, and the membrane interface, 
and it is in agreement with mutational analyses on Rhodobacter capsulatus (Prieur et al., 
2001) and Y. lipolytica (Tocilescu et al., 2007), which identified the 49 kDa and PSST 
subunits as critical in quinone binding and catalysis. However, additional subunits may be 
involved in quinone binding, in particular, hydrophobic subunits involved in binding the 
hydrophobic tail of coenzyme Q10; detailed analyses of the quinone binding sites of 
complex I is given in section 5.1.2. 
 NADH:quinone oxidoreduction can be inhibited by a diverse set of hydrophobic 
compounds, such as rotenone and piericidin A (their structures are shown in figure 5.5). 
They are termed ‘Q-site’ inhibitors, as they do not inhibit the NADH oxidoreduction 
reaction with hydrophilic electron acceptors which react at the flavin mononucleotide, 
such as ferricyanide (Degli Esposti, 1998). Although the reaction between NADH and the 
quinone analogue decylubiquinone (DQ) is essentially completely abolished in the 
presence of rotenone or piericidin A, the reaction with more hydrophilic quinone 
analogues is incompletely inhibited. For example, the reaction between NADH and Q1 
(coenzyme Q1), is only 90% sensitive to the presence of Q-site inhibitors (Degli Esposti et 
al., 1996). This has led to the proposal that additional sites for quinone reduction are 
present on complex I; work described in chapter five introduces this problem further, and 
aims to identify this second, non-physiological quinone binding site. 
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1.4.3.4 The mechanism of proton pumping 
The mechanism by which complex I couples the oxidoreduction of NADH and ubiquinone 
to the pumping of protons across the mitochondrial inner membrane is not known. 
However, based on the proton-pumping strategies of the other respiratory enzymes, 
various mechanisms have been proposed for complex I: 
 i) A direct coupling mechanism (as exemplified by complex IV) 
 ii) An indirect coupling mechanism (as exemplified by ATP synthase) 
 iii) A Q-cycle-like mechanism (as exemplified by complex III) 
 
Directly coupled mechanisms 
In directly coupled mechanisms, such as that of cytochrome c oxidase, proton transfer is 
directly controlled by a gating reaction at the same site as the electron transfer event that 
drives it (Hirst, 2005). If this mechanism were to be utilised by complex I, it would require 
the proton-translocation machinery to be located close to both the quinone binding site and 
cluster 4Fe[PS]. The pH-dependence of the midpoint potential of cluster 4Fe[PS] has been 
proposed to play an important role in this mechanism (Ingledew and Ohnishi, 1980). Such 
a mechanism requires an ionisable amino acid in the vicinity of the cluster whose 
protonation state is dependent on the redox state of cluster 4Fe[PS]; among the contenders 
are Tyr114 and Tyr139 in subunit NuoB of E. coli (Flemming et al., 2003) and the conserved 
His226 in the 49 kDa subunit of Y. lipolytica (Zwicker et al., 2006) which is involved in 
hydrogen bonding to cluster 4Fe[PS] (Berrisford and Sazanov, 2009). 
 Using the structure of the hydrophilic domain from T. thermophilus with NADH 
bound, Berrisford and Sazanov proposed a direct coupling mechanism based on changes in 
the electron density, and thus the ligation, of cluster 4Fe[PS] in three states of the enzyme 
(figure 1.19). They suggest that, although the oxidised cluster is ligated by four cysteine 
residues (Cys45, Cys46, Cys111 and Cys140 in subunit Nqo6 (PSST)), the reduced cluster is 
only ligated by three; when cluster 4Fe[TY]2 is oxidised, Cys45 is dissociated and 
protonated; when cluster 4Fe[TY]2 is reduced, Cys46 is dissociated and protonated 
(Berrisford and Sazanov, 2009).  
 
  31 
 
 
Figure 1.19: Direct coupling of electron transfer to proton pumping in complex I. 
Iron-sulphur clusters 4Fe[PS] and 4Fe[TY]2 are depicted as oxidised or reduced by empty 
or filled circles, respectively. Cys46 and Cys45 are from PSST, and the possible proton 
acceptors from Cys45 (Tyr87, Y-O) and Cys46 (Glu49, E-O) are shown. H-path indicates 
proton delivery pathway from the matrix to the tandem cysteine residues. H1 indicates 
helix H1 from subunit PSST, and 4HB indicates the four-helix bundle from the 49 kDa 
subunit, which are show in dark boxes when helices are shifted relative to the oxidised 
state. Abbreviations: H+mat = protons taken up from the matrix, H+ims = protons delivered to 
the inter-membrane space. Adapted from (Berrisford and Sazanov, 2009).  
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Indirectly coupled mechanisms 
The phosphorylation of ADP by the ATP synthase operates by an indirect coupling 
mechanism; the flow of protons across the mitochondrial inner membrane drives rotation 
of the c-ring and the central stalk, resulting in conformational changes in F0 which catalyse 
the synthesis of ATP, a reaction which occurs at least 45 Å away from the site of proton 
translocation (Walker, 1998). Conformational changes in complex I have been described 
on the basis of results from electron microscopy (Bottcher et al., 2002; Sazanov et al., 
2003); however, both observations are now believed to be artefacts (Mamedova et al., 
2004; Morgan and Sazanov, 2008). Subunits ND2, ND4 and ND5 have been proposed to 
be important in proton translocation, as they share homology to Na+/H+ antiporters 
(Mathiesen and Hagerhall, 2002). Furthermore, amiloride-based compounds, known to 
inhibit Na+/H+ antiporters, inhibit proton pumping by complex I (Nakamaru-Ogiso et al., 
2003; Stolpe and Friedrich, 2004).  
  
 
 
 
Figure 1.20: Indirect coupling of electron transfer to proton pumping in complex I. 
Left; in the oxidised enzyme, subunits Nqo12 (shown in yellow; bovine homologue, ND5), 
Nqo13 (orange; ND4) and Nqo14 (red; ND2) open toward the mitochondrial 
matrix/bacterial cytoplasm, allowing proton binding. Right; the oxidation of NADH, and 
concomitant reduction of ubiquinone, causes a conformational change in helix HL which 
results in the reorganisation of the ‘broken helices’ of subunits Nqo12, 13 and 14 (shown 
as open black rectangles). These local conformational changes allow the translocation of 
three protons across the mitochondrial or bacterial inner membranes. The fourth proton is 
translocated by a direct mechanism at the interface of the hydrophilic (shown in grey) and 
hydrophobic domains. Adapted from (Efremov et al., 2010). 
 
 
The structure of the hydrophobic domain of complex I from T. thermophilus revealed a 
long C-terminal extension from subunit Nqo12 (ND5) running parallel with the membrane, 
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directly contacting both Nqo13 (ND4) and Nqo14 (ND2) (Efremov et al., 2010). The 
authors propose a ‘combined’ mechanism of proton pumping for complex I, in which one 
proton is translocated by a directly coupled mechanism at cluster 4Fe[PS], and the rest are 
driven by conformational changes involving the four-helix bundle of Nqo4 and helix H1 of 
Nqo6, which move upon quinone reduction (Efremov et al., 2010). The authors suggest a 
mechanism by which conformational changes in subunit Nqo8 and the Nqo7/10/11 bundle 
affect the C-terminal helix of Nqo12; a tilt of this helix leads to a piston-like motion of 
helix HL along the membrane domain. This movement synchronously tilts the three nearby 
discontinuous helices, resulting in proton translocation. During turnover, ionisable residues 
predicted to be located deep within the membrane, bind and release protons on the 
opposite sides of the membrane via conformational changes driven by helix HL; the 
proposed mechanism is shown in figure 1.20 (Efremov et al., 2010). 
 
Q-cycle-like mechanisms 
In a Q-cycle mechanism, quinol is used as a mobile electron-proton carrier to transport 
protons across the membrane; a reverse Q-cycle mechanism, the mirror-image of that of 
complex III, has been proposed for complex I by Dutton and co-workers (Dutton et al., 
1998).  
  The key feature of this model is the presence of two ubiquinone binding sites; one 
faces the inter-membrane space, Qo, and the other faces the mitochondrial matrix, Qi. 
Quinone binds at Qi, and is reduced by one electron from a quinol bound at Qo, and one 
electron from cluster 4Fe[PS]. Two protons are subsequently taken up from the matrix, 
with the semiquinone formed being retained at Qo. The semiquinone is oxidised to 
ubiquinone upon completion of the second ‘half-cycle’. Using distinct species of Q and 
QH2, Sherwood and Hirst found no evidence for ubiquinol oxidation, suggesting that 
complex I does not function by this mechanism (Sherwood and Hirst, 2006). 
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1.4.4 The sites of reactive oxygen species production by complex I 
The electron transport chain in mitochondria is a significant source of cellular reactive 
oxygen species (ROS), such a superoxide and hydrogen peroxide. Historically, respiratory 
complexes I and III have been considered two major sources of superoxide and hydrogen 
peroxide in mitochondria, with their relative contributions, determined by the effects of 
appropriate inhibitors, being tissue-specific (Boveris and Chance, 1973; Boveris et al., 
1976; Cino and Del Maestro, 1989). However, there is now mounting evidence that 
complex I produces most of the reactive oxygen species generated in intact mammalian 
mitochondria in vitro (Turrens and Boveris, 1980; McLennan and Degli Esposti, 2000; Liu 
et al., 2002), suggesting that reactive oxygen species generation by complex III is of 
limited physiological importance (Brand, 2004; Adam-Vizi and Chinopoulos, 2006).  
 Figure 1.21 summarises the consequences of superoxide generation by complex I, 
and the cellular antioxidant defence mechanisms present to minimise the harmful effects of 
reactive oxygen and nitrogen species (Raha and Robinson, 2000; Temple et al., 2005). 
Despite these mechanisms, intracellular ROS is implicated in many mitochondrial 
pathologies (Balaban et al., 2005; Wallace, 2005), and the free radical theory of ageing 
proposes that it is a major determinant of life span through the accumulation of damage to 
mitochondrial proteins, lipids and DNA (Lass and Sohal, 1999; Barja and Herrero, 2000).   
 The structure of the hydrophilic arm of complex I from T. thermophilus provides 
the best current model for the structure of complex I from mitochondria (Sazanov and 
Hinchliffe, 2006). It shows that the majority of the cofactors in the enzyme are shielded 
from solvent, and therefore unlikely to react readily with molecular oxygen. It is most 
likely that oxygen accesses the ‘live’ parts of the enzyme at each end of the cofactor chain, 
either the flavin moiety or the quinone binding site. 
 In isolated complex I, in the absence of a proton motive force, there is substantial 
evidence that superoxide is produced only by the reduced flavin (Kussmaul and Hirst, 
2006). Superoxide and hydrogen peroxide production by isolated complex I have been 
detected in the presence of NADH only, and all the electrons from NADH oxidation were 
found to be conserved in oxygen reduction. Superoxide (or hydrogen peroxide) production 
appears to be dependent on the ratio of NADH to NAD+, and is inhibited by NAD+. These 
data can be explained by considering the population of the fully reduced flavin; as the 
nucleotides react with the flavin much faster than oxygen, they produce a ‘pre-equilibrium’ 
and the experiment is equivalent to a redox titration. The addition of decylubiquinone 
stops superoxide production because catalysis rapidly converts the NADH to NAD+; 
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rotenone and piericidin A does not affect the rate of superoxide production except to stop 
catalysis. Similarly, the addition of rotenone or piericidin A to mitochondrial membranes 
in the presence of a complex III inhibitor and a defined NADH concentration does not 
affect H2O2 production (Kussmaul and Hirst, 2006). 
 A number of studies in intact mitochondria have linked ROS production to the 
flavin in complex I. Diphenyleneiodonium (DPI) reacts specifically with the flavin 
cofactor in complex I, and inhibits ROS production by rat heart mitochondria under 
conditions which favour succinate-supported reverse electron transport (Liu et al., 2002). 
Kushnareva and co-workers used β-hydroxybutyrate to poise the potential of the NAD+ 
pool in rat heart mitochondria, and in a ‘redox titration’ of ROS production against NAD+ 
potential they determined an E1/2 value of -0.392 V, close to values from isolated complex 
I and to the potential of the flavin (Kushnareva et al., 2002). In a detailed study using rat 
brain mitochondria, Starkov and Fiskum elucidated the relationships between ROS 
production, NAD(P)H potential and membrane potential during forward electron transfer, 
and proposed that the ROS-producing site of complex I is in redox equilibrium with the 
pyridine nucleotides, so that its degree of reduction depends on the NAD+/NADH ratio 
(Starkov and Fiskum, 2003). 
 Information about the site of ROS production of complex I is provided by 
differences in the rates of ROS production, observed in mitochondria and 
submitochondrial particles (SMPs), in the forward and reverse electron transfer directions 
and in the presence and absence of inhibitors. During forward electron transport, driven by 
NADH-linked substrates, complex I exhibits only minimal H2O2 production, but the 
addition of a ‘Q-site inhibitor’, such as rotenone, results in a significant increase in its rate. 
During reverse electron transport, driven by succinate, H2O2 production by complex I is 
increased significantly, and in this case, inhibited by the addition of Q-site inhibitors 
(Hansford et al., 1997; Kushnareva et al., 2002; Han et al., 2003). Qualitatively, these 
observations are consistent with the site of ROS production being located ‘upstream’ of the 
inhibitor binding site. During forward electron transport, rotenone prevents the electrons 
from exiting the enzyme, causing them to ‘back-up’ onto NADH, where they are available 
for ROS formation. During reverse electron transport the enzyme is reduced, unless 
rotenone prevents the electrons from moving upstream to the site of ROS production. 
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Figure 1.21: The fate of reactive oxygen species produced by complex I. Cellular 
antioxidant defence enzymes are shown in green; damage caused by reactive 
oxygen/nitrogen species is shown in red. Dismutation of superoxide by MnSOD generates 
H2O2, which is converted to H2O by catalase (CAT), glutathione peroxidase (GPX) or 
peroxiredoxin (Pxr). Like MnSOD, catalase catalyses a dismutation reaction; one H2O2 is 
reduced to form H2O and the other oxidised to O2. GPX removes H2O2 by coupling its 
reduction to the oxidation of reduced glutathione (GSH) to GSSG. Present at 
concentrations between 5 - 10 mM, GSH is a simple tripeptide consisting of glutamic acid, 
cysteine and glycine. The ratio of GSH to GSSG in normal cells is high; this is achieved 
by the glutathione reductase (GR) enzymes, which use NAD(P)H produced by the 
oxidative pentose phosphate pathway to regenerate GSH from GSSG. Two isoforms of Prx 
exist in mitochondria; PrxIII and PrxV. Both are homodimers, reacting with H2O2 to form 
a sulphenic acid which is rapidly converted to an intra-protein disulphide by a second 
thiol; like GPX, Prx uses NAD(P)H to regenerate the oxidised form by the actions of 
thioredoxin and thioredoxin reductase. Superoxide can also directly react with the active 
centres of iron-sulphur containing enzymes, such as aconitase; the resultant Fe2+ and 
hydrogen peroxide partake in Fenton chemistry, forming the highly reactive hydroxyl 
radical. Finally, superoxide can react with nitric oxide, forming peroxynitrite; both the 
hydroxyl radical and peroxynitrite cause lipid peroxidation, enzyme inactivation and DNA 
damage, comprising cellular structure and function. Adapted from (Halliwell and 
Gutteridge, 1999). 
 
 
  37 
Using intact mitochondria and SMPs, Brand and co-workers have proposed that, during 
reverse electron transfer in the presence of ∆pH, the quinone binding site is also a source 
of reactive oxygen species from complex I (Lambert and Brand, 2004a; Lambert and 
Brand, 2004b). ROS production is negligible during forward electron transport in the 
presence of ∆pH and the absence of a Q-site inhibitor, but can be driven in the presence of 
a Q-site inhibitor and ∆pH. Lambert and Brand proposed that superoxide is formed at a 
semiquinone radical in complex I (Lambert and Brand, 2004a), and EPR studies have 
described several ubisemiquinone radicals (Kotlyar et al., 1990; Yano et al., 2000). It is 
hoped that future research on the putative second site of superoxide production in 
submitochondrial particles and isolated complex I, building on knowledge of the 
conditions under which it is most active, will help to define further both its location and 
mechanism of oxygen reduction under physiological conditions. 
 
1.4.5 Complex I and disease 
It is difficult to draw direct causative connections between increased reactive oxygen 
species production by a specific enzyme and a pathological effect. Even when a 
mitochondrial defect can be attributed to complex I, it is hard to determine whether the 
effects observed arise from a loss of complex I activity, an increase in its reactive oxygen 
species production, or both. Robinson and co-workers have provided evidence that 
complex I deficiency is associated with the excessive production of hydroxyl radicals in a 
host of mitochondrial pathologies, including fatal infantile lactic acidosis, cardiomyopathy 
with cataracts and Leigh's disease (Pitkänen et al., 1996; Luo et al., 1997). Similarly, when 
superoxide production and complex I activity were compared quantitatively in cultured 
skin fibroblasts from seven control subjects and 21 children with inherited isolated 
complex I deficiency, superoxide production was significantly increased in all but two of 
the deficient cell lines, and an inverse relationship between superoxide production and 
enzyme activity was observed (Koopman et al., 2007). Sherer and co-workers investigated 
oxidative stress as a mechanism for rotenone toxicity in models relevant to Parkinson’s 
disease, and suggested that complex I mediated oxidative damage, rather than rotenone-
induced ATP depletion per se, is responsible for the rotenone-induced degeneration of 
dopaminergic neurons (Sherer et al., 2003). Furthermore, it has been proposed that the 
reduced complex I function in brain mitochondria from Parkinson’s subjects results 
directly from oxidative damage to the complex I subunits (Keeney et al., 2006).  
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1.5 Aims of results chapters  
Complex I can be resolved into subcomplexes which provide a simplified model system 
for studies of the intact enzyme; the work described in chapter three presents the first 
comprehensive investigation assessing the suitability of two such subcomplexes, Iλ and Iα, 
for structural and functional studies.  
 At present, there is no atomic resolution structural information for complex I from 
any mammalian species. Using the enzyme from bovine heart mitochondria, the work 
described in the first half of chapter four aims at preparing complex I of sufficient purity, 
stability, monodispersity and catalytic activity for crystallisation trials. The second half of 
chapter four describes attempts to grow crystals of complex I of sufficient size and quality 
for X-ray crystallography. 
 Although the reaction between NADH and the quinone analogue decylubiquinone 
(DQ) is essentially completely abolished in the presence of rotenone or piericidin A, the 
reaction with hydrophilic quinone analogues is incompletely inhibited. This has led to the 
proposal that additional sites for quinone reduction are present on complex I; work 
described in chapter five aims to characterise the reaction and consequences of quinone 
reduction at the non-physiological quinone binding site. 
 Whereas the mechanism of the reactions between NADH and FeCN, and NADH 
and APAD+ have been established, little is known about the reaction between NADH and 
the canonical artificial electron acceptor HAR. Chapter six describes work aiming to 
characterise the reaction between positively charged electron acceptors, such as HAR, and 
complex I. 
 The best technique with which to detect iron-sulphur clusters is EPR. Five reduced 
iron-sulphur clusters are typically observed in complex I from B. taurus reduced by 
NADH in EPR, and their spectra are denoted N1b, N2, N3, N4 and N5. Although spectra 
N1b, N2 and N3 have been unambiguously assigned to clusters 2Fe[75], 4Fe[PS] and 
4Fe[51], respectively, controversy surrounds the assignment of signals N4 and N5 to their 
structurally defined clusters; using a pulsed-EPR technique known as double electron-
electron resonance (DEER), chapter seven describes work aimed at unambiguously 
assigning signal N4 to its structurally defined cluster.  
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Chapter 2: 
Materials and methods 
 
 
2.1  Materials 
All chemicals were purchased from Sigma-Aldrich (Sigma-Aldrich Company Ltd., 
Gillingham) unless otherwise stated, and were of analytical, biochemical or HPLC grade. 
Ultra-pure water was obtained from a Milli-Q purification system (Millipore, Watford). 
Detergents were purchased from Anatrace (Ohio, USA) or glycon (Luckenwalde, 
Germany), unless otherwise stated. 
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2.2  Preparation of complex I and its subcomplexes 
The isolation of mitochondria from bovine hearts, the preparation of mitochondrial 
membranes and the purification of complex I and subcomplexes Iλ, Iα and Iβ were carried 
out at 4 °C. 
 
2.2.1  Isolation of mitochondria from bovine hearts 
Mitochondria were prepared from the hearts of freshly slaughtered cows according to a 
protocol described by Walker and co-workers (Walker et al., 1995). The fatty tissue of the 
heart was removed, and the cardiac muscle diced and minced using a butcher’s grinder. To 
1 kg of minced heart, 1400 mL of buffer A (0.25 M sucrose, 5 mM 2-mercaptoethanol, 10 
mM tris-HCl pH 7.8) was added, and the solid matter collected by filtration through a 
single layer of muslin. To this, 1600 mL of buffer B (0.25 M sucrose, 10 mM tris-HCl pH 
7.8, 5 mM 2-mercaptoethanol, 0.2 mM EDTA (ethylenediaminetetraacetic acid), 1 mM 
tris-succinate pH 7.8) and 25 mL 2 M tris (not pH corrected)) was added. The suspension 
was homogenised for 30 seconds in a Waring blender, centrifuged (2,600 g, 15 minutes), 
and the supernatant filtered through a single layer of muslin. After a further centrifugation 
step (20,500 g, 27 minutes), pellets from 24 hearts were pooled and resuspended in 3.6 
litres of buffer B. The suspension was centrifuged (20,500 g, 42 minutes), the supernatant 
discarded and pellets containing isolated mitochondria stored at -20 °C. 
 
2.2.2  Preparation of mitochondrial membranes  
The preparation of mitochondrial membranes was based on a protocol reported by Walker 
and co-workers (Walker et al., 1995). One bottle of thawed bovine heart mitochondria 
(equivalent to two hearts) was resuspended in two litres of milliQ water, blended for two 
minutes in a Waring blender, potassium chloride added to a final concentration of 150 mM 
and the suspension blended for a further 3 minutes. The resulting membranes were 
centrifuged (13,500 g, 40 minutes) and the pellet resuspended in 250 mL buffer (20 mM 
tris-HCl pH 7.5, 1 mM EDTA, 10% v/v glycerol). The mitochondrial membranes were 
split into 15 mL aliquots and frozen at -20 °C. 
 
2.2.3  Preparation of complex I 
The preparation of complex I was based on a protocol reported by Sharpley and co-
workers (Sharpley et al., 2006). To a suspension of thawed membranes, 0.005% PMSF 
(phenylmethanesulphonyl fluoride), 2 mM DTT (dithiothreitol, Melford labs) and 1% 
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DDM (n-dodecyl-β-D-maltopyranoside) was added in a drop-wise manner, and stirred on 
ice for 30 minutes. The solubilised membranes were centrifuged (48,000 g, 30 minutes), 
filtered through a 0.22 µm membrane, and the supernatant loaded onto a Q-Sepharose HP 
column (Amersham Biosciences) equilibrated in buffer A (20 mM tris-HCl, pH 7.5, 10% 
ethylene glycol, 2 mM EDTA, 0.005% fresh asolectin, 0.1% DDM, 2 mM DTT). The 
constituents of the electron transfer chain were eluted in a gradient of buffer B (buffer A + 
1 M NaCl); a typical chromatogram is shown in figure 2.1.  
 
 
 
 
Figure 2.1: Purification of complex I using Q-Sepharose ion exchange 
chromatography. Chromatographic trace of the purification of respiratory complexes 
from solubilised mitochondrial membranes. Absorbance was monitored at 280 nm (red 
line); complex I (shown by the arrow) eluted in 350 mM NaCl (blue line). 
 
 
Fractions containing complex I were pooled, concentrated using Vivaspin 20 centrifugal 
concentrators (100 kDa MWCO (molecular weight cut-off)) and injected onto a Superose 
6 10/300 GL gel filtration column (Amersham Biosciences) equilibrated in buffer C (20 
mM tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, 0.1 mM TCEP (tris (2-carboxyethyl) 
phosphine), 0.03% DDM); a typical trace is shown in figure 2.2. Complex I was 
concentrated to ~10 mg mL-1 using Vivaspin 20 centrifugal concentrators (100 kDa 
MWCO) and glycerol added to a final concentration of 20%. Aliquots of protein were snap 
frozen in liquid nitrogen, and stored at -80 °C. 
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Figure 2.2: Purification of complex I using size exclusion chromatography. Chromato-
graphic trace of the resolution of complex I from cytochrome c oxidase using a Superose 6 
10/300 GL gel filtration column. Absorbance was monitored at 280 nm. Complex I eluted 
after ~12 mL (shown by the arrow). 
 
 
2.2.4  Preparation of subcomplex Iλ
 
The preparation of subcomplex Iλ was based on a protocol reported by Fearnley and co-
workers (Fearnley et al., 2001). Complex I purified using ion exchange chromatography 
was precipitated (1% DDM, 1.8% sodium cholate, 50% ammonium sulphate), centrifuged 
(28,500 g, 30 minutes) and the pellet resuspended in dissolving buffer (0.5% LDAO 
(lauryldimethylamine oxide, Anatrace), 50 mM potassium phosphate, 0.2 mM TCEP). 
Typically, 1 mL was layered onto 5 - 20% w/v sucrose gradients made up in buffer 
containing 200 mM potassium phosphate pH 7.5, 0.5% LDAO and 0.2 mM TCEP. The 
sucrose gradients were centrifuged using a SW40Ti rotor (285,000 g, 18 hours), and the 
resulting brown band, located in the centre of the gradient, was collected and dialysed for 
one hour (20 mM tris-HCl pH 7.5, 10% glycerol, 1 mM DTT). The protein was 
concentrated using Vivaspin centrifugal concentrators (100 kDa MWCO), and injected 
onto a Superose 6 gel filtration column equilibrated in buffer C. Subcomplex Iλ was 
concentrated to ~5 mg mL-1 using Vivaspin centrifugal concentrators (100 kDa MWCO) 
and glycerol added to a final concentration of 20%. Aliquots of protein were snap frozen in 
liquid nitrogen, and stored at -80 °C.  
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2.2.5  Preparation of subcomplexes Iα and Iβ 
The preparation of subcomplexes Iα and Iβ was based on the protocol reported by Carroll 
and co-workers (Carroll et al., 2002). Complex I was purified as described in section 2.2.3, 
except the protein was precipitated (described in section 2.2.4) and resuspended in buffer 
A prior to gel filtration. The peak fractions were pooled and stored at 4 °C overnight.  
 Complex I was diluted to a concentration of ~3 mg mL-1 with buffer D (0.1% 
LDAO, 20 mM tris-HCl, pH 8.0, 0.5 mM EDTA, 10% ethylene glycol, 1 mM DTT), and 
an equal volume of 2.3% LDAO in 20 mM tris-HCl pH 8.0 and 1% 2-mercaptoethanol 
was added. The protein was stirred on ice for 60 minutes, diluted with an equal volume of 
buffer D and loaded onto a Q-Sepharose HP column (Amersham Biosciences) equilibrated 
in buffer D; subcomplexes Iα and Iβ eluted in 260 and 325 mM NaCl, respectively, using a 
gradient of buffer E (buffer D + 1 M NaCl; figure 2.3). Fractions corresponding to the 
subcomplexes were pooled, diluted with an equal volume of buffer A, loaded onto a 
second Q-Sepharose HP column equilibrated in buffer A, and eluted using a gradient of 
NaCl.  
 
 
 
 
Figure 2.3: Resolution of complex I into subcomplexes using Q-Sepharose ion 
exchange chromatography. Chromatographic trace showing the resolution of 
subcomplexes Iγ, Iα and Iβ. Absorbance was measured at 280 nm (red line). The 
subcomplexes were eluted in a stepped gradient of NaCl (blue line). Subcomplexes Iα and 
Iβ eluted in 260 and 325 mM NaCl respectively. 
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Fractions containing each subcomplex were pooled, concentrated using Vivaspin 
centrifugal concentrators (100 kDa MWCO) and injected onto a Superose 6 gel filtration 
column equilibrated in buffer C. The subcomplexes were concentrated to ~5 mg mL-1 
using Vivaspin centrifugal concentrators (100 kDa MWCO) and glycerol added to a final 
concentration of 20%. Aliquots of protein were snap frozen in liquid nitrogen, and stored 
at -80 °C. 
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2.3  Analysis of protein composition 
2.3.1  SDS-PAGE analysis 
SDS-PAGE (sodium dodecyl sulphate polyacrylamide gel electrophoresis) was performed 
using pre-cast 4 - 20% polyacrylamide gels (Invitrogen, Renfrewshire). Protein samples 
were loaded to a final concentration of 0.5 - 2 mg mL-1, and were prepared by mixing with 
an equal volume of sample buffer (125 mM tris-HCl pH 6.8, 20% glycerol, 4% w/v SDS, 
0.005% v/v bromophenol blue, 100 mM DTT). The running buffer comprised 192 mM 
glycine, 0.25 mM tris (pH not adjusted) and 1% w/v SDS. Electrophoresis was performed 
for 2 hours at 125 V and 30 mA. 
 
2.3.2  Instant Blue staining 
Protein bands were visualised using Instant Blue stain (Novexin, Cambridge), according to 
manufacturer’s instructions. In brief, 40 mL of solution was added to a gel incubated at 
room temperature and gently agitated for one hour; the stained gel was subsequently 
scanned. 
 
2.3.3  Silver staining 
In cases where detection of smaller amounts of protein was required, a silver stain was 
used. This involves bathing the gel in a series of reagents (post Instant Blue staining) as 
follows: 
1. 5 minutes in a solution of 50% v/v methanol, 12% w/v trichloroacetic acid and 2% 
w/v copper (II) chloride. 
2. 5 minutes in a solution of 10% v/v ethanol and 5% v/v acetic acid. 
3. 5 minutes in a solution of 0.01% potassium permanganate. 
4. 1 minute in a solution of 10% ethanol and 5% acetic acid. 
5. 5 minutes in a solution of 10% ethanol. 
6. 5 minutes in water. 
7. 5 minutes in a solution of 0.1% silver nitrate. 
To develop the gel and visualise the protein bands, the gel was bathed in a solution of 2% 
w/v potassium carbonate and 0.04% v/v formaldehyde. The gel was gently agitated until 
the protein bands were clearly visible (typically 10 minutes); the reaction was stopped by 
washing the gel in Milli-Q water. 
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2.4  Determination of protein, flavin and detergent concentrations 
2.4.1  Determination of protein concentration 
The concentration of protein was determined using the Pierce BCA (bicinchoninic acid) 
protein assay kit. Bovine serum albumin (BSA) standards were prepared from a stock 
solution (typically in the range of 0.25 to 2 mg mL-1); 10 µL of suitably diluted protein and 
the standards were transferred to a 96 well plate. To each well, 190 µL of working reagent 
(50 parts reagent A, 1 part reagent B) was added, mixed for 30 seconds, and incubated at 
37 °C for 30 minutes. The samples were allowed to cool to room temperature, and their 
absorbencies read at 562 nm using a microtiter plate reader (Spectra Max Plus- Molecular 
Devices, California, USA). Protein concentration was estimated from the standard curve. 
 
2.4.2  Determination of flavin concentration 
Complex I contains one non-covalently bound FMN which can be used to measure 
complex I concentration directly. The protocol used for FMN determination was adapted 
from that of Burch (Burch, 1957) and has been described by Sharpley and co-workers 
(Shapley et al., 2006). 
 The FMN of complex I was extracted by incubating the sample in 11 % w/v 
trichloroacetic acid for 15 minutes in the dark; a concentration range of FMN standards 
(0.2 - 10 µg mL-1) were prepared and treated similarly. The solutions were centrifuged 
(16,000 g, 3 minutes), and 40 µL of the supernatants pipetted into a 96-well plate (Corning 
Incorporated). To this, 200 µL of 2 M potassium phosphate solution, pH 6.8 was added. 
The fluorescence was measured using a plate reader (Molecular Devices Spectra Max 
Gemini XS, California, USA); fluorescence emission was measured at 525 nm with 
excitation at 450 nm. The FMN content of the complex I sample was estimated from the 
standard curve. 
 
2.4.3  Determination of detergent concentration  
The assay used is based on that reported by Urbani and Warne (Urbani and Warne, 2005) 
and is only applicable to maltoside and glucoside-based detergents. To 40 µL sample, 300 
µL 5% phenol was added, the mixture was vortexed for 5 seconds, and 720 µL 
concentrated sulphuric acid was added. The mixture was vortexed for 10 seconds, allowed 
to cool for 15 minutes, and the absorbance was measured at 490 nm. The detergent 
concentration was determined by comparison to standards of known concentration. 
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2.5 Protein crystallisation 
2.5.1 Screening 
Crystallisation screening was carried out using sitting drop vapour diffusion with MRC-96 
well microplates (Swissci AG, Zug, Switzerland). Reservoir solutions were mixed with 
protein solutions at a 1:1 ratio (typically 200 nL reservoir solution + 200 nL protein 
solution) using a Screenmaker 96+8 series robot (Innovadyne Technologies, California, 
USA) and equilibrated against the reservoir solution (90 µL). Crystallisation plates were 
sealed using transparent EASYseal plate sealer (Greiner BioOne Ltd, Gloucestershire) and 
stored at 4, 10 or 18 °C. Trials were viewed using a Leica microscope (Leica Micro-
systems, Buckinghamshire), typically after 3, 7 and 28 days. 
 
2.5.2 Analysing the crystals 
2.5.2.1 Izit crystal dye 
To differentiate biological macromolecule crystals from small molecule and inorganic 
crystals, the small molecule dye Izit was used (Hampton Research, California, USA). 
Typically, one microlitre of dye (diluted ten-fold with milli-Q) was pipetted into the 
crystal mother liquor; protein crystals would develop an intense blue-colour after three 
hours. 
 
2.5.2.2 SDS-PAGE analysis of crystals  
Approximately ten crystals (50 – 100 µm in size, 15 mg mL-1 protein) were harvested and 
individually washed in mother liquor three times before being dissolved in 5 µL milli-Q. 
The crystals were analysed by SDS-PAGE as described in section 2.3.1, and stained using 
Instant Blue and/or silver stain. Purified complexes I and IV were used as controls.    
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2.6  Spectroscopic techniques 
2.6.1  UV-visible spectroscopy 
UV-visible spectra were recorded using a Shimadzu UV-1601 spectrophotometer, in either 
1.5 mL or 3 mL quartz cuvettes, typically between the wavelengths of 250 and 700 nm. 
 
2.6.2  Standard assays of complex I catalytic rate 
Kinetic measurements were carried out at 32 °C in 20 mM tris-HCl pH 7.5 using either an 
diode array spectrophotometer (Ocean Optics, Florida, USA), or a microtiter plate reader. 
When required, asolectin (Fluka) was added to 0.4 mg mL-1 from a 10 mg mL-1 stock 
solution in 2% w/v CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propane-
sulfonate), and rotenone or piericidin A, to 2.3 or 1 µM, respectively, from ethanolic stock 
solutions. Complex I was added to the assay buffer at concentrations that gave linear rates 
for at least 30 seconds. 
   
  
 
 
Figure 2.4: Typical assay trace for the complex I-catalysed reaction between HAR 
and NADH, monitored by NADH oxidation using UV-visible spectroscopy (340 – 380 
nm). The red line defines the linear phase of the assay trace (typically 30 seconds) used for 
rate determination. All assays were carried out at 32 °C in 20 mM tris pH 7.5 and initiated 
by the addition of substrate. 
 
 
Reactions were initiated by the addition of substrate; typical concentrations used are 
shown in parentheses. For reactions of DQ (100 µM), Q1 (100 µM), Q0 (100 µM), 
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idebenone (100 µM), HAR (hexaammineruthenium (III) chloride, 3.5 mM), FeCN 
(ferricyanide, 1 mM), paraquat (250 µM) and diquat (250 µM), the rate of reaction was 
monitored by NADH oxidation (∆ε340 – 380 nm = 4.81 mM-1 cm-1); the transhydrogenation 
reaction (250 µM or 1 mM APAD+) was monitored by the formation of APADH (∆ε400 – 
460 nm = 3.16 mM-1 cm-1). The initial rates were calculated using linear regression over 30 
seconds; a typical trace is shown in figure 2.4. Anaerobic assays were performed in a 
nitrogen-containing glove box (Belle Technology, Portesham, O2 < 5 ppm) using either a 
diode array spectrophotometer, or a microtiter plate reader as above. 
 
2.6.3  Measuring H2O2 and O2.- production by complex I 
H2O2 production was determined stoichiometrically at 32 °C using the HRP (horseradish 
peroxidase)-dependent oxidation of Amplex Red to resorufin (∆ε557-620 nm = 51.6 ± 2.5 
mM-1 cm-1 at pH 7.5). Typically, assays comprised 20 mM tris-HCl pH 7.5, 30 µM 
NADH, 2 units mL-1 HRP, 10 µM Amplex Red (Invitrogen) and ~15 µg mL-1 complex I. 
The NADH concentration used was limited to 30 µM to minimise artefacts from the 
Amplex Red detection system (Kussmaul and Hirst, 2006). When required, catalase (from 
bovine liver) was added to 1,000 or 10,000 units mL-1.  
 Superoxide production was determined stoichiometrically by monitoring the 
reduction of 50 µM cytochrome c (partially acetylated equine heart cytochrome c, ∆ε550 – 
541 nm = 18.0 ± 0.6 mM-1 cm-1 at pH 7.5). Typically, assays comprised 20 mM tris-HCl (pH 
7.5), 30 µM NADH and ~15 µg mL-1 complex I. When required, superoxide dismutase 
(SOD) (Cu-Zn-SOD from bovine erythrocytes) was added to 50 units mL-1. 
 
2.6.4 EPR analysis 
2.6.4.1 EPR experiments of chapter 3 
Complex I was prepared as described in section 2.2.3, reduced with 5 mM NADH under 
anaerobic conditions and frozen immediately in liquid nitrogen. Spectra were recorded on 
a Bruker EMX X-band spectrometer using an ER 4119HS high sensitivity cavity, 
maintained at low temperature by a ESR900 continuous flow liquid helium cryostat 
(Oxford instruments, Abingdon), monitoring sample temperature with a calibrated Cernox 
resistor (Lake Shore Cryotronics Inc., Ohio, USA). For each spectrum, the receiver gain 
was set appropriately for the signal intensity, and the scans were averaged to give an 
acceptable signal to noise ratio. 
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Spectra were typically recorded at 5, 9, 12 and 25 K, and the following parameters were 
used (Reda et al., 2008):  
• Microwave frequency, 9.38 – 9.39 GHz 
• Modulation frequency, 100 KHz 
• Modulation amplitude, 5 G 
• Time constant, 81.92 ms 
• Conversion time, 20.48 ms 
• Microwave power, 0.5 mW 
 
2.6.4.2 Preparation of complex I for EPR experiments described in chapter 7 
Complex I was purified as described above, except ethylene glycol, not glycerol, was used 
in the membrane preparation, and PMSF and asolectin were omitted. Where possible 
ultrapure chemicals (Fluka) were used to minimise contamination by manganese and 
eliminate the Mn2+ signal from W-band EPR spectra. The ultrapure chemicals were DTT 
(Mn ≤ 5 ppm), EDTA (Mn ≤ 5 ppm), ethylene glycol (Mn ≤ 0.05 ppm), KCl (Mn ≤ 0.01 
ppm), NaCl (Mn ≤ 0.01 ppm), and trizma base (Mn ≤ 5 ppm). Purified complex I was 
concentrated to ~70 mg mL−1 using Vivaspin centrifugal concentrators (100 kDa MWCO), 
and imported into an anaerobic glove box (O2 ~2 ppm). Typically, complex I was reduced 
by 10 mM NADH (-0.4 V), or by 140 mM NAD+ and 2 mM NADH (-0.3 V), to a final 
concentration of ~55 mg mL−1 (~55 µM), and the samples were frozen in liquid nitrogen 
under anaerobic conditions.  
 The pulsed-EPR experiments described in chapter seven were performed and 
analysed by Maxie Roessler and Dr. Jeffrey Harmer (Centre for Advanced Electron Spin 
Resonance, Department of Chemistry, University of Oxford).  
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Chapter 3: 
Assessing the suitability of subcomplexes Iλ and Iα for functional assays 
and structural studies 
 
 
3.1 Introduction 
3.1.1 The need for subcomplexes 
With a mass of approximately 980 kDa spread over 45 subunits, NADH:ubiquinone 
oxidoreductase from bovine heart mitochondria is a most complex enzyme (Hirst et al., 
2003). As well as its size, its extreme hydrophobicity and asymmetry make the intact 
enzyme difficult to work with; consequently, numerous reports have aimed at preparing 
subcomplexes of the enzyme, with the ultimate goal of providing a simplified model 
system for functional and structural studies (Finel et al., 1992, Finel, 1994, Sazanov, 2000; 
Hirst et al., 2003).  
 Many important discoveries have been made using subcomplexes of complex I. 
The overall position of the redox centres within the enzyme was deduced after resolution 
revealed that the iron-sulphur centres were present in a predominantly hydrophilic 
subcomplex of the protein, subcomplex Iλ (Finel et al., 1992; Finel et al., 1994). Studies 
using the smallest subcomplex of complex I, subcomplex Fp, allowed the two-electron 
potential of the active site flavin to be measured for the first time under conditions which 
the enzyme is catalytically active (Barker et al., 2007). However, the most notable success 
came when the structure of the hydrophilic domain of the thermophilic bacterium T. 
thermophilus was solved to 3.3 Å (Sazanov and Hinchliffe, 2006). The predominantly 
soluble nature of the subcomplex was the key to crystallisation and subsequent structural 
determination of the protein, the first atomic resolution structure available of complex I or 
its subcomplexes.  
 Figure 3.1 shows the approximate positions of the subcomplexes of complex I from 
bovine heart mitochondria with respect to the intact enzyme. Subcomplex Iλ represents the 
hydrophilic domain of the enzyme, and contains all the cofactors involved in NADH 
oxidation and electron transfer. Subcomplex Iα encompasses the hydrophilic domain and a 
small portion of the hydrophobic domain. Subcomplexes Iβ and Iγ contain hydrophobic 
subunits present in the membrane domain of the enzyme, and subcomplex Fp, as prepared 
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by Barker and co-workers, contains the 51 and 24 kDa subunits, and their associated 
cofactors (Barker et al., 2007).  
 
 
 
 
Figure 3.1: Schematic representation of complex I depicting the approximate location 
of subcomplexes Iα, Iβ, Iλ, Iγ and Fp. Electron microscopy has revealed complex I to be 
L-shaped, with subcomplexes Iβ (purple) and Iγ (red) lying in the plane of the membrane, 
and subcomplex Iλ (green) protruding approximately 100 Ǻ into the mitochondrial matrix. 
Subcomplex Iα (blue) encompasses both the hydrophilic domain and a portion of the 
membrane-embedded hydrophobic domain. Subcomplex Fp (gold), as prepared by Barker 
and co-workers (Barker et al., 2007), contains the 51 and 24 kDa subunits. Adapted from 
(Clason et al., 2010). 
 
 
3.1.2  Subcomplex Iλ   
Subcomplex Iλ represents the peripheral, hydrophilic arm of complex I and consists of 
seven core and eight supernumerary subunits (see table 3.1 and figure 3.2; Hirst et al., 
2003). With a mass of approximately 370 kDa, it represents about one-third of the total 
mass of the enzyme, and contains the flavin mononucleotide and eight iron-sulphur 
clusters, seven of which form a ~100 Å electron wire linking the site of NADH oxidation 
to the site of quinone reduction (Sazanov and Hinchliffe, 2006). Although it is 
significantly larger and more complex than the equivalent domain from its bacterial 
counterpart, the largely hydrophilic nature of the subcomplex makes it a very amenable 
target for crystallisation.  
 Subcomplex Iλ can be purified directly from complex I by sucrose-gradient 
centrifugation in the presence of the zwitterionic detergent LDAO (Finel et al., 1994) (see 
section 2.2.4). In brief, complex I purified by ion exchange chromatography is precipitated 
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using ammonium sulphate and resuspended in buffer containing 1% LDAO. Portions are 
layered onto a sucrose gradient containing 0.5% LDAO and centrifuged for 18 hours at 
200,000 g. Subcomplex Iλ is isolated from the middle of the gradient, dialysed to remove 
excess phosphate and detergent, and gel filtrated in a buffer containing DDM. Sazanov and 
co-workers reported a second method of isolating subcomplex Iλ, the ‘indirect’ protocol 
(Sazanov et al., 2000). In this technique, subcomplex Iλ is formed from the prolonged 
exposure of subcomplex Iα to LDAO; the additional subunits present in Iα dissociate, and 
the resultant subcomplex is purified by size exclusion chromatography. 
 A variant of subcomplex Iλ which lacks subunit B16.6 can be produced by the 
addition of the detergent dodecyl-trimethylammonium bromide (DTAB) to the sucrose 
gradient. Subunit B16.6, a homologue of the apoptotic protein GRIM-19, has one 
predicted transmembrane helix; consequently, subcomplex ‘IλDTAB’ has the advantage of 
being more hydrophilic than subcomplex Iλ (Fearnley et al., 2001). 
 
3.1.3  Subcomplex Iα 
With a total mass of 580 kDa, subcomplex Iα has the same composition as subcomplex Iλ 
plus eleven subunits (table 3.1 and figure 3.2). In addition to the hydrophilic subunits, 
subcomplex Iα contains up to 12 predicted transmembrane spanning helices, making it 
more hydrophobic than subcomplex Iλ (Hirst et al., 2003). 
 The purification of subcomplexes Iα and Iβ has been described previously (Carroll 
et al., 2002) (see section 2.2.5). In brief, complex I is incubated for one hour in 1% LDAO 
and then loaded onto a Q-Sepharose ion exchange column equilibrated in buffer containing 
0.1% LDAO; subcomplexes Iα and Iβ elute in 260 and 325 mM NaCl, respectively. The 
fractions corresponding to the subcomplexes are pooled, and re-applied to a second Q-
Sepharose column equilibrated in 0.1% DDM. Once again, the subcomplexes are eluted 
with a gradient of NaCl, pooled, concentrated, and finally gel filtrated. 
 
3.1.4  Subcomplexes Iβ, Iγ and Fp  
Three additional subcomplexes can be prepared from complex I; subcomplexes Iβ, Iγ and 
Fp (see table 3.1). Subcomplex Iβ, which represents a portion of the membrane domain, is 
isolated along with subcomplex Iα during ion exchange chromatography (figure 2.3). 
Composed of fifteen subunits, subcomplex Iβ has a total molecular mass of ~300 kDa with 
a predicted total of 37 transmembrane helices (tables 1.2 and 3.1).  
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Figure 3.2: Comparison of the subunit composition of subcomplexes Iλ and Iα. SDS-
PAGE gels of left, subcomplex Iλ and right, subcomplex Iα. For details of subcomplex 
preparation, see materials and methods. 
 
 
Not all of the subunits are accounted for within these subcomplexes; some of the most 
hydrophobic subunits are isolated in the flowthrough fraction during the preparation of 
subcomplexes Iα and Iβ. Sazanov and co-workers have proposed that this subcomplex, Iγ, 
forms a hydrophobic fragment of the membrane domain distinct from subcomplex Iβ, 
containing subunits ND1, ND2, ND3, ND4L and KFYI (table 3.1) (Sazanov et al., 2000). 
 Subcomplex Fp contains only two subunits and their associated co-factors: the 51 
kDa subunit, which coordinates a [4Fe4S] iron-sulphur cluster and the flavin, and the 24 
kDa subunit, which coordinates a [2Fe2S] cluster (table 3.1). It is prepared under 
anaerobic conditions from complex I using sodium perchlorate (Barker et al., 2007). 
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Bovine complex I subcomplexes Subunit Observed  
mass/ Da1,2 Iλ3 Iα3 Iβ3 Iγ4 Fp5 
75 kDa 76960.5a 75 kDa 75 kDa - - - 
ND5 68328.8 - - ND5 - - 
ND4 52131.1 - - ND4 - - 
49 kDa 49207.2 49 kDa 49 kDa - - - 
51 kDa 48503.0 51 kDa 51 kDa - - 51 kDa 
ND2 39284.5 - - - ND2 - 
39 kDa 39117.1 - 39 kDa - 39 kDa - 
42 kDa 36710.0 - (42 kDa) - 42 kDa - 
ND1 35699.5 - - - ND1 - 
30 kDa 26432.0 30 kDa 30 kDa - - - 
24 kDa 23814.9 24 kDa 24 kDa - - 24 kDa 
B22 21700.8 - - B22 - - 
PDSW 20832.2 - - PDSW - - 
TYKY 20192.1 TYKY TYKY - - - 
PSST 20094.0 PSST PSST - - - 
PGIV 19952.1 - PGIV - - - 
ND6 19106.7 - ND6 - - - 
ASHI 18737.2 - - ASHI - - 
B17.2 17132.1 B17.2 B17.2 - - - 
SGDH 16726.3 - - SGDH - - 
B16.6 16584.5 B16.6b B16.6 - - - 
B18 16473.9 - - B18 - - 
B17 15434.7 - - B17 - - 
18 kDa 15337.4 18 kDa 18 kDa - - - 
B15 15095.3 - (B15) (B15) - - 
B14 14964.7 - B14 - - - 
B14.7 14668.8 (B14.7) B14.7 - - - 
ESSS 14453.3 - - ESSS - - 
B14.5b 14096.2 - - (B14.5b) - - 
B13 13226.5 B13 B13 - - - 
ND3 13082.8 - - - ND3 - 
B14.5a 12587.4 B14.5a B14.5a - - - 
15 kDa 12532.3 - 15 kDa - 15 kDa - 
B12 11037.7 - - B12 - - 
B8 10991.0 B8 B8 - - - 
ND4L 10824.9 - - - ND4L - 
SDAP 10676.1 - SDAP SDAP - - 
13 kDa 10535.3 13 kDa 13 kDa - - - 
MLRQ 9324.7a - - - - - 
B9 9259.7 - B9 - - - 
AGGG 8492.9 - - AGGG - - 
10 kDa 8437.9 10 kDa 10 kDa - - - 
MWFE 8105.2 - MWFE - - - 
MNLL 6965.9 - - MNLL - - 
KFYI 5828.7 - - - KFYI - 
 
Table 3.1: Comparison of the subunit composition of subcomplexes Iλ, Iα, Iβ, Iγ and 
Fp. Notes: amass not observed; calculated mass shown. bSubunit B16.6 not present in 
subcomplex IλDTAB. Parentheses indicate a consensus that the subunit is present in minor 
amounts. Core subunits are shown in bold. 1(Carroll et al., 2009), 2(Walker et al., 2009), 
3(Hirst et al., 2003), 4(Sazanov et al., 2000), 5(Barker et al., 2007). 
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3.1.5 Crystallisation trials of subcomplexes Iλ and Iα of complex I from bovine 
heart mitochondria 
The determination of the structure of the hydrophilic domain of complex I from T. 
thermophilus provided a starting point for crystallisation trials of the two most hydrophilic 
domains of the mitochondrial enzyme, subcomplexes Iλ and Iα. The subcomplexes were 
prepared according to published protocols (Fearnley et al., 2001; Carroll et al., 2002) in 
either DDM or OG (n-octyl-β-D-glucoside), the detergent used for studies on the bacterial 
enzyme.   
 Two approaches were taken to try and crystallise subcomplexes Iλ and Iα; first, a 
logical approach, using the conditions that were successful for the crystallisation of the 
hydrophilic domain from T. thermophilus, was tested. Sazanov and Hinchliffe reported 
that crystals were grown in a precipitant solution comprising 100 mM HEPES pH 7.5, 400 
- 500 mM NaCl, 100 mM CaCl2 and 8 - 10% PEG 4000 at 22 °C (Sazanov and Hinchliffe, 
2006). Figure 3.3 shows the crystallisation strategy for subcomplexes Iλ and Iα; initial 
crystallisation trials of the hydrophilic subcomplexes from the bovine enzyme using the 
Thermus conditions were unsuccessful; subsequent trials aimed at exploring a wider range 
of conditions. A major advantage of the thermophilic enzyme is its inherent stability; as 
such, the second round of trials investigated the effect of temperature on crystallisation of 
subcomplexes Iλ and Iα; again, success was very limited. Further rounds of trials 
investigated the effect of pH, precipitant type, the concentration of precipitant, and the 
presence of salt on crystallisation. In total, more than 5,000 crystallisation trials using the 
two subcomplexes were conducted, but no promising hits were observed. 
 The second approach involved the use of eight commercially available sparse 
matrix screens, listed in table 4.4, specifically chosen to maximise the number of 
conditions tested. These screens have also been the most successful at providing hits of the 
intact enzymes from T. thermophilus and E. coli (Drs. Rozbeh Baradaran and Christopher 
Thompson, PhD theses). Again, the subcomplexes were prepared according to the 
published protocols (Fearnley et al., 2001; Carroll et al., 2002) in either DDM or OG (n-
octyl-β-D-glucoside), and crystallisation trials were conducted at 4, 10, 17 or 22 °C. In 
total, more than 5,000 trials were set up using the commercially available screens, but 
again, no promising hits were observed. 
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Figure 3.3: Crystallisation strategy of subcomplexes Iλ and Iα. See text for details.  
 
 
In total, over 10,000 crystallisation trials were set up using subcomplexes Iλ and Iα; no 
promising hits were observed. This raised questions about the suitability of the 
subcomplexes of complex I from bovine heart mitochondria as a simplified system for 
structural studies of the intact enzyme; an extensive literature search revealed no 
comprehensive analysis of the effects of resolution on the stability and catalytic activity of 
the enzyme has ever been undertaken. 
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3.1.6 Aims  
If subcomplexes Iλ and Iα are going to be used successfully for functional and structural 
studies of complex I, three criteria must first be fulfilled. They must: 
1. Contain all the cofactors present in the intact enzyme 
2. Catalyse the same reactions as the intact enzyme at a similar rate per mole of flavin 
3. Remain stable and monodisperse 
Subcomplexes Iλ and Iα were prepared according to the published protocols (Fearnley et 
al., 2001; Carroll et al., 2002). The following work aims to determine the effect of 
subcomplex resolution on the integrity of the flavin mononucleotide, the iron-sulphur 
clusters and the quinone binding site, using functional assays, EPR and size exclusion 
chromatography.  
 Modifications to the published protocols are subsequently discussed, which aim to 
fulfil the criteria stated above and prepare protein of suitable quality for functional and 
structural studies. 
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3.2  Investigating the effects of resolution on the structural and functional integrity 
of subcomplexes Iλ and Iα 
3.2.1 The flavin mononucleotide 
3.2.1.1 The reaction with hydrophilic electron acceptors 
Subcomplex resolution occurs at the interface between the hydrophilic and hydrophobic 
domains; as such, reactions at the flavin between NADH and hydrophilic electron 
acceptors should be unaffected. This group of electron acceptors includes FeCN 
(ferricyanide/potassium hexacyanoferrate (III)) and APAD+ (3-acetylpyridine adenine 
dinucleotide, an NAD+ analogue), that react at the flavin by ping-pong reaction kinetics 
and that are unaffected by Q-site inhibitors such as rotenone (Dooijewaard and Slater, 
1976; Yakovlev and Hirst, 2007). Although the precise location and mechanism of the 
reaction of HAR (hexaammineruthenium (III) chloride) with complex I is unknown, it is 
also thought to react at a site upstream of iron-sulphur cluster 4Fe[PS] in the hydrophilic 
domain (Sled and Vinogradov, 1993). 
 The reactions between NADH and FeCN, APAD+ and HAR were investigated 
using complex I and subcomplexes Iλ and Iα; rates are reported in µmoles NADH per 
second per µmole flavin to allow for direct comparison. The rates expressed per µmole 
flavin were identical to the rates expressed per µmole protein, suggesting that the flavin 
does not dissociate from the protein during subcomplex resolution. 
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Equation 3.1: [S] is the substrate concentration, KM is the Michaelis constant, equal to the 
concentration of substrate at half the maximum rate, and Vmax is the maximum rate. 
 
 
Figure 3.4 shows how the rate of NADH:FeCN oxidoreduction depends on the 
concentrations of FeCN and NADH. The dependence of rate on FeCN concentration 
follows simple saturation kinetics, and the data were modelled using the Michaelis-Menten 
equation (equation 3.1). For all three proteins, KMFeCN is 1300 µM. Although kcatFeCN for 
subcomplexes Iλ (2000 s-1) and Iα (1800 s-1) are similar, they are approximately half that 
of the intact enzyme (3500 s-1), suggesting that subcomplex resolution is affecting the 
flavin site. The data in figure 3.4, right, was modelled using a ping-pong reaction 
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mechanism (Birrell et al., 2009); substrate inhibition is seen with increasing NADH 
concentrations for all three proteins, but again, the absolute rates of NADH:FeCN 
oxidoreduction for subcomplexes Iα and Iλ are approximately half that of the intact 
enzyme. 
 
 
 
 
Figure 3.4: Dependence of the catalytic rate of the NADH:FeCN reaction by complex 
I and subcomplexes Iα and Iλ on left, FeCN and right, NADH, concentrations. Initial 
rates, background corrected (defined as µmoles NADH consumed per second per µmole 
flavin) were calculated using linear regression over 30 seconds. The reaction was 
monitored at 340 – 380 nm, corresponding to NADH oxidation (∆ε340–380 nm = 4.81 mM-1 
cm-1). Experimental data points for the dependence of rate on FeCN concentration were 
modelled using the Michaelis-Menten equation (equation 3.1), and for NADH dependence, 
using the ping-pong equation (Birrell et al., 2009). Error bars represent the standard 
deviation of three assays. Conditions: 32 °C, 20 mM tris-HCl pH 7.5, ~ 3 µg mL-1 purified 
protein. 
 
 
Yakovlev and Hirst reported that the transhydrogenase reaction between NADH and 
APAD+ occurs at the flavin of complex I by ping-pong reaction kinetics (Yakovlev and 
Hirst, 2007); a comparison between the NADH:APAD+ rates of complex I and 
subcomplexes Iλ and Iα is shown in figure 3.5. The dependence of rate on APAD+ 
concentration follows saturation kinetics, and the data have been modelled using the 
Michaelis-Menten equation (equation 3.1). Although KMAPAD+ for each protein is 
essentially the same (325 – 330 µM), kcatAPAD+ varies dramatically; 280 s-1 (complex I), 
125 s-1 (subcomplex Iλ) and 150 s-1 (subcomplex Iα). The dependence of rate on NADH 
can be modelled using ping-pong reaction kinetics, and the experimental datasets have 
been fitted to a model derived from the transhydrogenase study (Yakovlev and Hirst, 
2007). Again, the only kinetic parameter that differs between the three proteins is 
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kcatAPAD+; it has values of 410 s-1 (complex I), 230 s-1 (subcomplex Iα) and 220 s-1 
(subcomplex Iλ). 
  
 
 
 
Figure 3.5: Dependence of the catalytic rate of the NADH:APAD+ reaction by 
complex I and subcomplexes Iα and Iλ on APAD+ and NADH concentrations. Initial 
rates, background corrected (defined as µmoles NADH consumed per second per µmole 
flavin) were calculated using linear regression over 30 seconds. The reaction was 
monitored at 400 – 460 nm, corresponding to APADH formation (∆ε400–460 nm = 3.16 mM-1   
cm-1). Experimental data points for the dependence of rate on FeCN concentration were 
modelled using the Michaelis-Menten equation (equation 3.1), and for NADH dependence, 
using the ping-pong equation (Yakovlev and Hirst, 2007). Error bars represent the standard 
deviation of three assays. Conditions: 32 °C, 20 mM tris-HCl pH 7.5, ~ 3 µg mL-1 purified 
protein. 
 
 
Previous studies have shown that the NADH:HAR reaction follows simple saturation 
kinetics for its dependence on both NADH and HAR concentrations (Sled and 
Vinogradov, 1993). The data comparing the rates of the intact enzyme and the 
subcomplexes are shown in figure 3.6, and have been modelled using the Michaelis-
Menten equation (equation 3.1). Once again, the datasets for subcomplexes Iα and Iλ are 
similar to each other, but they differ from the intact enzyme. One interesting point to note 
is that the difference between complex I and the subcomplexes is not as significant as that 
seen for the NADH:FeCN and APAD+ reactions; further investigation into the reaction of 
HAR with complex I is presented in chapter 6. 
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Figure 3.6: Dependence of the catalytic rate of the NADH:HAR reaction by complex I 
and subcomplexes Iα and Iλ on HAR and NADH concentrations. Initial rates, 
background corrected (defined as µmoles NADH consumed per second per µmole flavin) 
were calculated using linear regression over 30 seconds. The reaction was monitored at 
340 – 380 nm, corresponding to NADH oxidation (∆ε340–380 nm = 4.81 mM-1 cm-1). 
Experimental data points were modelled using the Michaelis-Menten equation (equation 
3.1). Error bars represent the standard deviation of three assays. Conditions: 32 °C, 20 mM 
tris-HCl pH 7.5, ~ 3 µg mL-1 purified protein. 
 
 
3.2.1.2 The production of reactive oxygen species  
Kussmaul and Hirst demonstrated that the flavin mononucleotide is the predominant 
source of reactive oxygen species from complex I in the absence of a proton motive force 
(Kussmaul and Hirst, 2006).  
 Figure 3.7, left, illustrates how the rate of hydrogen peroxide formation by complex 
I and subcomplexes Iα and Iλ depends on the potential of the [NADH]/[NAD+] pool; table 
3.2 shows how the potential of the flavin is dependent on the concentrations of NADH and 
NAD+, calculated using the Nernst equation. The Amplex Red/Horseradish peroxidase 
detection system was used to monitor the production of hydrogen peroxide; previous work 
has shown this system to be prone to artefacts at high (> 30 µM) NADH (Kussmaul and 
Hirst, 2006). Therefore, the NADH concentration was held at 30 µM, and the NAD+ 
concentration was varied accordingly. It is evident that there is no difference in the rate of 
hydrogen peroxide formation between complex I and subcomplexes Iα and Iλ; 
furthermore, the reduction potential of the flavin, approximately equal to the inflexion 
point of the curve, does not vary between the three species. This finding is particularly 
surprising, given the effects of subcomplex resolution on the rates of FeCN, APAD+ and 
HAR reduction. 
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Eset/ mV NADH NAD+ Eset/ mV NADH NAD+ 
-0.410 30 µM 0.08 µM -0.388 30 µM 23.7 µM 
-0.398 30 µM 0.21 µM -0.326 30 µM 61.0 µM 
-0.386 30 µM 0.54 µM -0.314 30 µM 157 µM 
-0.374 30 µM 1.38 µM -0.302 30 µM 405 µM 
-0.362 30 µM 3.56 µM -0.290 30 µM 1046 µM 
-0.350 30 µM 9.18 µM -0.278 30 µM 2700 µM 
 
Table 3.2: Calculating Eset. Top; the Nernst equation. EpH7 is the standard reduction 
potential at pH 7 (-0.335 V (Zu et al., 2003)); R is the gas constant (8.31 J K-1 mol-1); T is 
the temperature (K); F is the Faraday constant (9.65 x 10-2 kJ mol-1 mV-1); [NADH], 
[NAD+] are the concentrations of NADH and NAD+, respectively. Bottom; table of 
NADH/NAD+ concentrations, calculated from the Nernst Equation, required to ‘set’ the 
potential of the flavin.  
 
 
 
 
Figure 3.7: Measuring reactive oxygen species generation by complex I and 
subcomplexes Iα and Iλ. Left; initial rates, background corrected (defined as nmoles 
H2O2 min-1 nmole flavin-1) were calculated using linear regression over 30 seconds. 
Measurements were obtained at 557 – 620 nm (∆ε557 – 620 nm = 51.6 ± 2.5 mM-1 cm-1 at pH 
7.5). Blue circles report previously published values (Kussmaul and Hirst, 2006). 
Conditions: ~ 3 µg protein, 20 mM tris-HCl pH 7.5, 32 °C, 30 µM NADH, x µM NAD+, 
according to the Nernst equation, 2 units mL-1 HRP and 10 µM Amplex Red. Right; initial 
rates, background corrected (defined as nmoles O2.- min-1 nmole flavin-1) were calculated 
using linear regression over 30 seconds. Measurements were obtained at 550 – 541 nm 
(∆ε550–541 nm = 18.0 ± 0.6 mM-1 cm-1 at pH 7.5). Error bars represent the standard deviation 
of three assays. Conditions: ~ 3 µg mL-1 protein, 20 mM tris-HCl pH 7.5, 32 °C, 50 µM 
acetylated cytochrome c. 
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Figure 3.7, right, shows how increasing NADH inhibits superoxide formation by complex 
I and subcomplexes Iα and Iλ (Kussmaul and Hirst, 2006). Again, the absolute rates of 
superoxide production, measured using the reduction of acetylated cytochrome c, do not 
vary between the intact enzyme and the subcomplexes. The reaction of oxygen with the 
reduced flavin to form hydrogen peroxide (~20 nmoles H2O2 min-1 nmole flavin-1) or 
superoxide (~50 nmoles O2.- min-1 nmole flavin -1) is three orders of magnitude slower than 
the reduction of 1 mM FeCN (~100,000 nmoles min-1 nmole flavin-1) and 3.5 mM HAR 
(~75,000 nmoles min-1 nmole flavin-1), and two orders of magnitude slower than the 
reaction of APAD+ (~7,500 nmoles min-1 nmole flavin-1) with the flavin. It is likely that 
the reactions of FeCN, HAR and APAD+ are more susceptible to slight structural 
perturbations caused by subcomplex resolution than the reaction of oxygen with the flavin, 
whose rate is limited by oxygen reduction rather than NADH oxidation. 
 
3.2.1.3 The stability of the flavin site 
The differences in NADH:HAR, FeCN and APAD+ activities between complex I and 
subcomplexes Iα and Iλ suggest that the flavin mononucleotide, or its immediate 
environment, may be adversely affected by subcomplex resolution. Forneris and co-
workers have reported a simple fluorescence-based technique to assess the stability of 
flavin-containing enzymes, ThermoFAD (Forneris et al., 2009). Based on the 
Thermofluor® assay, flavin cofactors are used as intrinsic probes to monitor protein 
unfolding (figure 3.8). Such an approach negates several problems associated with the 
original Thermofluor® assay. First, as SYPRO® orange binds hydrophobic surfaces, 
working with membrane proteins and detergents can be problematic and yield artifactual 
results. Second, as this new method uses flavin as an intrinsic probe, the assay reports 
directly on the stability of the flavin-binding region, which is useful when working with an 
enzyme as large as complex I. Finally, the assay requires only small amounts of protein, 
allowing large quantities of information to be gathered. 
 Changes in fluorescence intensity can be followed as a function of temperature in a 
real-time PCR machine; the data are subsequently modelled using a sigmoidal function, 
with the melting temperature defined as the midpoint of the curve - the higher the melting 
temperature, the more stable the protein (Forneris et al., 2009).  
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Figure 3.8: Investigating the stability of proteins. Top; a solvatochromic dye is used as 
an indicator of protein unfolding. Binding of the dye to unfolded protein results in a 
significant increase in its intrinsic fluorescence. Bottom; an increase in fluorescence is 
generated by exposure of the flavin cofactor to the solvent upon protein unfolding (Figure 
taken from (Forneris et al., 2009))  
 
 
  
Figure 3.9: Comparing the stability of the flavin mononucleotide in complex I and 
subcomplexes Iα and Iλ. Complex I and subcomplexes Iα and Iλ were prepared according 
to the published protocols and assayed in, left; no additive or right; reduced with 5 mM 
NADH. Typically, 20 µL of sample (1 - 2 mg mL-1) was pipetted into a 96-well 
MicroAmpTM PCR plate. The plate was sealed with optical-quality sealing tape, 
centrifuged (3000 g, 10 minutes), then heated in a 7900HT fast real-time PCR system from 
20 to 80 °C in 1.5 °C intervals over 30 minutes. The detection filter of the RT-PCR 
instrument for ThermoFAD is the one that is commonly used for SYBR green dye 
(fluorescence emission, 523 – 543 nm). The melting temperatures are indicated by the 
dashed lines. 
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As shown in figure 3.9, ThermoFAD assays on complex I and subcomplexes Iα and Iλ 
revealed no difference in the apparent melting temperature of the oxidised flavin, which is 
60 °C for all three proteins. Reduced with 5 mM NADH, the melting temperature for the 
intact enzyme decreased by 10 °C to 50 °C, for subcomplex Iα, by 11 °C to 49 °C, and for 
subcomplex Iλ, the melting temperature of the flavin site decreased by 12 °C to 48 °C. 
Although the differences in the melting temperature of the reduced flavin are small, these 
data suggest that there may be a slight difference between the stability of the reduced 
flavin site in the three proteins that may account for some of the difference in rates. 
 
3.2.2 The iron-sulphur clusters 
EPR spectroscopy is the most powerful means of studying the iron-sulphur clusters of 
complex I; a brief explanation of the technique is given below in section 7.1.2. Signals 
from six reduced iron-sulphur clusters from bovine complex I, or its subcomplexes have 
been observed, as described in section 1.4.3.2. However, due to the complicated nature of 
the protein, assignment of signals to specific clusters has proved to be controversial; 
chapter seven describes efforts to try and resolve these ambiguities. However, terminal 
iron-sulphur cluster 4Fe[PS] has been unambiguously assigned to signal N2 (Yano et al., 
2005); therefore, EPR can be used to investigate the effect of resolution on the region 
surrounding cluster 4Fe[PS].  
 Previous reports have suggested that the FMN and all the iron-sulphur clusters of 
complex I are present in the subcomplexes, but that the shape of signal N2 (cluster 
4Fe[PS]) is modified in subcomplex Iλ (Finel et al., 1994; Finel et al., 1992). Figure 3.10 
shows a comparison of the EPR spectra recorded at 12 K for complex I and subcomplexes 
Iλ and Iα, reduced anaerobically with 5 mM NADH. Although signals N4, N1b and N3 are 
very similar in subcomplexes Iα and Iλ compared to complex I, signal N2 is abolished in 
subcomplex Iλ, and compromised in subcomplex Iα. The problem may be that cluster 
4Fe[PS] is close to the region at which the hydrophilic domain dissociates from the 
hydrophobic domain. Although PSST, the subunit that ligates cluster 4Fe[PS], is present in 
subcomplex Iλ, structural perturbations within this region upon resolution may result in 
cluster damage, for example, an alteration in its reduction potential, or loss. 
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Figure 3.10: EPR spectra of the iron-sulphur clusters in complex I and subcomplexes 
Iα and Iλ. Complex I and subcomplexes Iα and Iλ were prepared according to the 
published protocols and reduced anaerobically by 5 mM NADH, and EPR spectra were 
recorded. Conditions: temperature, 12 K; microwave frequency, 9.38 – 9.39 GHz; 
microwave power, 0.5 mW. The positions of the signals are indicated. 
 
 
3.2.3 The quinone binding site 
A putative binding site for the quinone head group was identified in the structure of 
complex I from T. thermophilus at the interface of the 49 kDa and PSST subunits (Sazanov 
and Hinchliffe, 2006; Efremov et al., 2010). As expected, this site is close to both cluster 
4Fe[PS] and the membrane interface, and it is in agreement with mutational analyses on R. 
capsulatus (Prieur et al., 2001) and Y. lipolytica (Tocilescu et al., 2007), which identified 
the 49 kDa and PSST subunits as critical in quinone binding and catalysis. Although 
subcomplexes Iλ and Iα contain the PSST and 49 kDa subunits, neither exhibits DQ 
activity (figure 3.11). This suggests that additional subunits are required for quinone 
reduction, or that resolution has rendered cluster 4Fe[PS] and/or the quinone binding site 
non-functional, a theory consistent with the EPR data presented in figure 3.10.   
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Figure 3.11: Dependence of the catalytic rate of the NADH:DQ reaction by complex I 
and subcomplexes Iα and Iλ on DQ and NADH concentrations. Initial rates, 
background corrected (defined as µmoles NADH consumed per second per µmole flavin) 
were calculated using linear regression over 30 seconds. The reaction was monitored at 
340 – 380 nm, corresponding to NADH oxidation (∆ε340–380 nm = 4.81 mM-1 cm-1). 
Experimental data points were modelled using the Michaelis-Menten equation (equation 
3.1). Error bars represent the standard deviation of three assays. Conditions: 32 °C, 20 mM 
tris-HCl pH 7.5, ~ 3 µg mL-1 purified protein. 
 
 
 
 
 
Figure 3.12: Dependence of the catalytic rate of the NADH:Q1 reaction by complex I 
and subcomplexes Iα and Iλ on Q1 and NADH concentrations. Initial rates, background 
corrected (defined as µmoles NADH consumed per second per µmole flavin) were 
calculated using linear regression over 30 seconds. The reaction was monitored at 340 – 
380 nm, corresponding to NADH oxidation (∆ε340–380 nm = 4.81 mM-1 cm-1). Experimental 
data points were modelled using the Michaelis-Menten equation (for dependence on Q1 
concentration, equation 3.1), or using a model developed in chapter 5 (for dependence on 
NADH concentration). Error bars represent the standard deviation of three assays. 
Conditions: 32 °C, 20 mM tris-HCl pH 7.5, ~ 3 µg mL-1 purified protein. 
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Another quinone analogue used for functional studies of complex I is coenzyme Q1, a 
coenzyme Q10 analogue containing one isoprenoid unit. Although Q1 predominantly reacts 
at the physiological Q-site, approximately 10% of the rate is inhibitor-insensitive, 
suggesting that there is a second quinone binding site on complex I capable of bypassing 
the inhibition of rotenone and piericidin A (Degli Esposti et al., 1996). Figure 3.12 shows 
the dependence of rate of NADH:Q1 oxidoreduction on both Q1 and NADH concentration. 
Although the reaction between NADH and DQ is essentially abolished in the 
subcomplexes, there is a measurable rate with Q1 which is completely rotenone-
insensitive. Furthermore, the dependence of rate on NADH does not follow saturation 
kinetics; substrate inhibition is observed. This is qualitatively similar to the behaviour 
exhibited by FeCN and APAD+, and suggests that Q1 can react at the flavin; this 
possibility is explored further in chapter 5. 
 
3.2.4 The stability and oligomeric state of the subcomplexes  
One of the potential advantages of using the subcomplexes is the likelihood of their 
amenability for crystallisation trials. If subcomplexes Iα and Iλ are to be successfully used 
in crystallisation trials, it is vital that are homogeneous, monodisperse and retain their 
structural integrity over time. 
 Size exclusion chromatography was used to investigate the oligomeric state of the 
subcomplexes prepared using the published protocols; the data are presented in figure 
3.13. The elution profile for complex I (~980 kDa) shows the protein elutes as a sharp, 
symmetrical peak at 12 mL. Subcomplex Iλ (~360 kDa) elutes as a broad, symmetrical 
peak at 12.3 mL, suggesting it forms higher order oligomers. Subcomplex Iα also elutes as 
a very broad peak; unlike the intact enzyme and subcomplex Iλ, the peak is asymmetric, 
with protein eluting at 12.3 and 13.6 mL (indicated with blue arrows in figure 3.13). This 
suggests that the subcomplex is heterogeneous; either the protein is not stable, and 
subunits are lost during preparation, or the protein is present in two or more oligomeric 
states. 
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Figure 3.13: Comparing complex I with subcomplexes Iλ and Iα. Gel filtration 
chromatographic data of complex I and subcomplexes Iλ and Iα. The protein was injected 
onto a superose 6 10/300 GL gel filtration column. The blue arrows indicate the major 
peak and the shoulder present in the subcomplex Iα trace. Buffer conditions: 20 mM tris-
HCl pH 7.5, 0.03% DDM, 10% glycerol, 150 mM NaCl. 
 
 
In order to estimate the apparent molecular mass of the subcomplexes, and investigate 
their oligomeric state further, the Superose 6 10/300 gel filtration column was calibrated 
with the standards thyroglobulin (669 kDa), ferritin (440 kDa) and aldolase (158 kDa), as 
well as the intact enzyme (~1,000 kDa). Kav for the standards and complex I was 
calculated from equation 3.2, and plotted against the logarithm of molecular mass (figure 
3.14).   
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Equation 3.2: Vo is the void volume of the column, as judged by the elution of Dextran 
Blue 2000 (7.5 mL); Vt is the total column volume (24 mL); Ve the elution volume of the 
protein of interest. 
 
 
From the elution volumes of the subcomplexes, one can estimate the approximate mass of 
each protein. However, there are two caveats of using this method to estimate molecular 
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mass. Firstly, size exclusion chromatography is critically dependent on the shape of the 
protein as well as its size; this is especially important when working with an asymmetrical 
protein such as complex I. Secondly, larger proteins tend to run anomalously on the 
Superose 6 gel filtration column, which is problematic when constructing a calibration 
curve. Caveats aside, using these data, estimates of the size of the protein eluting from the 
gel filtration column can be made. 
 
 
 
        
Figure 3.14: Calibration of the Superose 6 gel filtration column. A 4 mg mL-1 solution 
of aldolase (♦), thyroglobulin (♦) and complex I (♦), and of 0.3 mg mL-1 ferritin (♦) were 
injected onto a Superose 6 10/300 gel filtration column. Kav was calculated as stated in the 
text. Abbreviations: MW, molecular mass. 
 
 
Subcomplex Iλ elutes with an apparent molecular mass of approximately 900 kDa, 
confirming that it is present in a higher oligomeric form. Subcomplex Iα elutes with 
estimated masses of 930 and 520 kDa, which is close to the theoretical value of 560 kDa, 
suggesting the shoulder observed in the chromatograph represents a monomeric form of 
subcomplex Iα, whereas the major peak represents a dimeric form of the enzyme. SDS-
PAGE analysis revealed that there is no discernable difference in either the subunit 
composition or relative band intensity of fractions across the peak, suggesting that subunit 
dissociation does not account for the shoulder (figure 3.15).  
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Figure 3.15: Comparing complex I with subcomplexes Iλ and Iα. Left; elution profiles 
of complex I and subcomplexes Iλ and Iα from gel filtration chromatography. Right: SDS-
PAGE analysis of fractions from the gel filtration. The lane number corresponds to 
fraction number. 
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3.2.5 Conclusions and discussion 
The criteria in section 3.1.6 stated that any subcomplex of complex I must; 
 
Contain all the cofactors present in the hydrophilic domain 
EPR studies revealed that the region surrounding the quinone binding site is perturbed 
during subcomplex resolution, resulting in the complete loss of signal N2 in subcomplex 
Iλ, and its partial loss in subcomplex Iα. These data suggest that cluster 4Fe[PS] is either 
damaged, for example, by altering its reduction potential, or lost upon subcomplex 
resolution. All other detectable redox cofactors are present in the two subcomplexes as in 
the intact enzyme. 
 
Catalyse the same reactions as in the intact enzyme 
The rates of NADH:HAR, FeCN and APAD+ oxidoreduction, per mole of flavin, differ 
significantly between the intact enzyme and the subcomplexes, suggesting that resolution 
has an undesirable effect on the flavin. However, the rates of reactive oxygen species 
generation, and the potential of the flavin, are similar for all three proteins. The stability of 
the oxidised flavin is not altered by subcomplex resolution, as judged from the 
ThermoFAD assay; however, there is a very small disparity between the melting 
temperatures of the reduced enzymes which may account for some of the difference. 
Unsurprisingly, inhibitor-sensitive NADH:DQ and NADH:Q1 activity is lost from the 
subcomplexes. 
 
Remain stable and monodisperse 
Size exclusion chromatography and SDS-PAGE analysis revealed that the subcomplexes 
are heterogenic and present as higher order oligomers.  
 
These assays have revealed that the subcomplexes, prepared according to the published 
protocols, are not suitable for either structural or functional studies. The remainder of this 
chapter describes work that aimed to optimise the resolution and purification of 
subcomplexes Iα and Iλ to prepare protein that is suitable for structural and functional 
studies. 
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3.3  Optimising the purification of the subcomplexes 
3.3.1 Optimising the purification of subcomplex Iλ 
3.3.1.1 The direct protocol 
Optimisation of the established sucrose density ultracentrifugation protocol involved 
investigating the effect of various alterations to the sucrose gradient, the step in which 
resolution occurred, with the aim of finding conditions that increased both the amount of 
cluster 4Fe[PS] and the homogeneity of the subcomplex.  
 
 
 
 
Figure 3.16: Altering the sucrose gradients. The existing protocol uses a linear 5 – 20% 
sucrose gradient containing 0.5% LDAO, spun at 200,000 g for 18 hours in an SW40 Ti 
rotor. Three possibilities were explored to try optimise cluster 4Fe[PS] retention. Left; 
linear sucrose gradient, 5 – 20%, spun at 370,000 g for 6 hours in a SW60Ti rotor. Middle; 
stepped sucrose gradient containing 0.5% LDAO, spun at 200,000 g for 18 hours in a 
SW40 Ti rotor. Right; stepped sucrose gradient with the top step containing 0.5% LDAO, 
and the bottom two steps containing 0.5% DDM, spun at 200,000 g for 18 hours in an 
SW40 Ti rotor. 
 
 
Two solutions were considered, both aimed at reducing the amount of time complex I is in 
buffer containing LDAO (figure 3.16). First, increasing the speed of centrifugation should 
decrease the time needed for subcomplex resolution, thus reduce contact time with LDAO. 
The existing protocol makes use of a linear gradient from 5% to 20% sucrose; a stepped 
sucrose gradient may provide more efficient separation. Second, if a non-ionic detergent is 
used in the lower steps of the gradient, the contact time of protein with LDAO will be 
minimised. 
 In both modified protocols, the subcomplex was still formed, as judged by the 
appearance of a brown band in the centre of the gradient and subsequent SDS-PAGE 
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analysis (data not shown). However, the EPR spectra presented in figure 3.17 shows that 
these modifications make no difference to cluster 4Fe[PS] retention.  
 
 
 
 
Figure 3.17: EPR spectra of the iron-sulphur clusters of subcomplex Iλ. Subcomplex 
Iλ was prepared according to the existing protocol (green trace), and using the two 
modified protocols (subcomplex Iλ split for 6 hours in a SW60Ti rotor, blue trace, and 
subcomplex Iλ split using the stepped sucrose gradient in DDM, red trace) as described in 
the text. The complex I trace is shown for comparison (grey trace). In each case, the 
protein was reduced anaerobically by 5 mM NADH, and EPR spectra were recorded. 
Conditions: temperature 12 K; microwave frequency, 9.38 – 9.39 GHz; microwave power, 
0.5 mW. The positions of the signals are indicated. 
 
 
Analysis by size exclusion chromatography revealed subcomplex Iλ prepared using the 
modified protocols still elutes as a wide peak at an apparent molecular mass two to three 
times that of the theoretical mass, suggesting the subcomplex still elutes as either dimers or 
trimers, or a mixture of both (shown in figure 3.18). These data suggest that the 
modifications tested make little difference to the retention of cluster 4Fe[PS] or to the 
homogeneity of the protein. 
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Figure 3.18: Investigating the resolution of subcomplex Iλ. Gel filtration 
chromatographic data of subcomplex Iλ. Protein prepared using the existing protocol is 
shown by the green trace; subcomplex Iλ split for 6 hours in a SW60Ti rotor is shown by 
the blue trace, and subcomplex Iλ split using the stepped sucrose gradient in DDM by the 
red trace. The complex I trace (grey) is shown for comparison. 
 
 
Cluster 4Fe[PS] retention has also been shown to be dependent on pH in the resolution of 
the hydrophilic domain of complex I from Y. lipolytica (Dr. Hannah Bridges, PhD thesis). 
When the hydrophilic domain was resolved at pH 6.5, cluster 4Fe[PS] was lost; when split 
at pH 8.5, half the signal intensity was retained, relative to the intact protein. Similar tests 
were carried out for the bovine enzyme; altering the pH of resolution had no effect on the 
retention of cluster 4Fe[PS] (data not shown). 
 
3.3.1.2 The indirect protocol 
The indirect protocol of producing subcomplex Iλ varies in the technical detail of 
resolution. Subcomplexes Iα and Iβ are initially resolved from complex I using LDAO, 
after which subcomplex Iα is further treated with LDAO, producing subcomplex Iλ 
(Sazanov et al., 2000). Previous studies have shown that complete dissociation of 
subcomplex Iα to Iλ occurs in about 4 hours (Sazanov et al., 2000).  
 To test this, subcomplex Iα was incubated in 1% LDAO for 6 or 24 hours, the 
resultant protein gel filtrated, and the subunit composition investigated by SDS-PAGE; the 
results are shown in figure 3.19. Dissociation of subcomplex Iα to Iλ did not occur; 
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subunits unique to subcomplex Iα, such as the 42 and 39 kDa subunits, were still present 
after incubation in LDAO for 24 hours.  
 
 
 
 
Figure 3.19: Investigating the preparation of subcomplex Iλ using the indirect 
protocol. Subcomplex Iα was prepared and incubated in 1% LDAO for either 6 or 24 
hours (Sazanov et al., 2000). After 6 hours, an aliquot of protein was removed, gel 
filtrated, and the composition of fractions 1, 2 and 3 analysed using SDS-PAGE, visualised 
using silver stain (see materials and methods for technical details). After 18 hours, the 
remaining protein was gel filtrated, and fractions 1, 2 and 3 analysed as before. Arrows 
indicate the positions of the 42 and 39 kDa subunits. 
 
 
3.3.1.3 Alternative methods of preparing subcomplex Iλ 
Preparation of the hydrophilic domain from T. thermophilus involves incubating the intact 
enzyme in 3% DDM for two hours on ice, followed by centrifugation to remove non-
solubilised material (Hinchliffe and Sazanov, 2005). In the presence of DDM, the 
membrane domain of the enzyme dissociates from the peripheral arm, and is lost during 
purification. However, similar experiments revealed that the bovine enzyme is stable in 
3% DDM, and subcomplex resolution does not occur (data not shown).  
 Preparation of the hydrophilic domain from E. coli involves incubating the intact 
enzyme with 3 mM NAD+ for 5 minutes, then with 400 mM CaCl2 for seven hours. The 
sample is subsequently loaded onto a MonoQ ion exchange column pre-equilibrated in a 
buffer containing 20 mM MES pH 6.0, 2 mM CaCl2 and 0.1% DDM, and the resolved 
domains eluted using a gradient of NaCl (Dr. Christopher Thompson, PhD thesis). This 
technique, however, did not resolve the hydrophilic domain using the bovine enzyme (data 
not shown). 
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3.3.2  Optimising the purification of subcomplex Iα 
Modifications to the published protocol for the purification of subcomplex Iα involved 
optimising the conditions of resolution with the aim of increasing cluster 4Fe[PS] retention 
and protein homogeneity. Two changes were made to the established protocol; first, the 
time of splitting was reduced from one hour to 15 minutes. Second, the first ion exchange 
chromatographic step in LDAO was eliminated; the effects of these changes on the 
retention of cluster 4Fe[PS] are shown in figure 3.20. Cluster 4Fe[PS] is present in 
subcomplex Iα at a far greater intensity when prepared using the modified method than in 
enzyme prepared using the published protocol.   
  
 
 
 
Figure 3.20: EPR spectra showing the effect of modifying the conditions for 
resolution of complex I. Subcomplex Iα was prepared either using the existing protocol or 
using the modified protocol (see text for details); the complex I trace is shown for 
comparison. Protein was reduced anaerobically with 5 mM NADH. Conditions: 
temperature 12 K; microwave frequency, 9.38 – 9.39 GHz; microwave power, 0.5 mW. 
The positions of the signals are indicated. 
 
 
After demonstrating that contact time with LDAO is an important determinant in cluster 
4Fe[PS] retention during the preparation of subcomplex Iα, additional modifications were 
tested with the aim of further optimising the conditions of resolution. This involved 
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investigating the effect of time and LDAO concentration on subcomplex resolution; figure 
3.21 shows the results of these tests. Decreasing both the contact time between complex I 
and LDAO, and the concentration of LDAO, decreased the amount of subcomplex Iα 
formed; complex I did not resolve when exposed to 0.1% LDAO for 5 minutes. The 
shoulder present in figure 3.13 becomes the predominant peak as both the time and 
concentration of LDAO are decreased, suggesting that a monomeric subcomplex is 
initially formed during resolution, but, after prolonged exposure to LDAO, higher order 
oligomers are formed.  
  
 
 
 
Figure 3.21: Investigating the resolution of subcomplex Iα. Gel filtration 
chromatographic data of subcomplex Iα split for different times in 1% LDAO (left) and 
0.1% LDAO (right). Subcomplex Iα was injected onto a Superose 6 gel filtration column 
pre-equilibrated in buffer containing 20 mM tris-HCl pH 7.5, 0.03% DDM, 10 % glycerol 
and 150 mM NaCl. Absorbance was measured at 280 nm. 
 
 
There seems to be a trade-off between the quantity and quality of subcomplex prepared; 
the greater the incubation time and concentration of LDAO, the larger the quantity of 
higher-order oligomeric subcomplex is formed; shorter incubation times with lower LDAO 
concentrations produces more monodisperse enzyme, but in quantities that are not 
sufficient for either structural or functional studies. 
 The structure of the hydrophilic domain from the T. thermophilus enzyme has 
suggested that the iron-sulphur clusters in complex I are well shielded from the aqueous 
phase (Sazanov and Hinchliffe, 2006). One would expect the additional subunits present in 
the bovine enzyme to provide further shielding from the aqueous phase; one possible 
explanation for the supernumerary subunits present in mammalian complex I is additional 
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protection for the iron-sulphur clusters, as iron-sulphur clusters are very susceptible to 
oxidative damage (Tilley et al., 2001). It is possible that during subcomplex resolution 
oxidative damage to cluster 4Fe[PS] may render it non-functional. 
 
 
 
 
Figure 3.22: EPR spectra of the iron-sulphur clusters in subcomplex Iα resolved 
aerobically and anaerobically. Subcomplex Iα was split either aerobically or 
anaerobically (Belle Technology glove box, oxygen < 10 ppm) and reduced by 5 mM 
NADH, and EPR spectra were recorded. Conditions: temperature 12 K; microwave 
frequency, 9.38 – 9.39 GHz; microwave power, 0.5 mW. The positions of the signals are 
indicated. 
 
 
Although it is technically challenging to prepare subcomplex Iλ anaerobically using 
sucrose density ultracentrifugation, it is possible to prepare subcomplex Iα in the absence 
of oxygen. Figure 3.22 shows EPR spectra of subcomplex prepared both in aerobic and 
anaerobic environments; the spectra are essentially identical, suggesting that the presence 
of oxygen is not the cause of the loss of cluster 4Fe[PS]. 
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3.3.3  Summary 
The aims of this work presented in this section were to modify the protocols for the 
preparation of subcomplexes Iλ and Iα so that they; 
 
Contain all the cofactors present in the hydrophilic domain 
EPR studies revealed that modifications to the protocol for preparing subcomplex Iλ had 
no effect on the retention of cluster 4Fe[PS]. Modifications to the subcomplex Iα protocol 
were more promising; although never reaching the level of the intact enzyme, a significant 
increase in cluster 4Fe[PS] was observed relative to enzyme prepared using the published 
protocol.  
 
Catalyse the same reactions as the intact enzyme 
Activity assays were not performed on protein prepared using the modified protocols. 
 
Remain stable and monodisperse 
Size exclusion chromatographic analysis revealed that subcomplex Iλ prepared using the 
modified protocol is still heterogenic and present as higher order oligomers. Altering the 
LDAO concentration had a dramatic effect on the oligomeric state of subcomplex Iα; 
lowering the concentration of LDAO produced protein that eluted at 14 mL, the theoretical 
elution volume for a protein of the size of subcomplex Iα. However, at these 
concentrations, the resolution of complex I is poor, and insufficient yields of the 
subcomplex were obtained. 
 
To conclude, these tests have revealed that the subcomplexes prepared using the modified 
protocols are still not suitable for either structural or functional studies.  
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3.4 Discussion 
3.4.1 The effect of subcomplex resolution on protein function 
The work described in this chapter is the first comprehensive assessment of the suitability 
of subcomplexes Iα and Iλ as a model of bovine complex I. Assays using soluble artificial 
electron acceptors which react at the flavin have revealed significant differences between 
the rates of the intact enzyme and the subcomplexes; other reactions catalysed by the 
flavin, such as the production of reactive oxygen species, have similar rates. Fluorescence-
based ThermoFAD assays revealed that resolution does not affect the stability of the flavin 
per se; it is possible that the resolution of subcomplexes using LDAO alters the binding or 
reaction of NADH or the substrates. This could have a more dramatic effect on the faster 
reacting species, such as FeCN and HAR, than on reactive oxygen species production, 
which is significantly slower.  
 Comparisons between the rates of NADH:FeCN, DQ and Q1 oxidoreduction of 
complex I and subcomplexes Iα and Iλ have been reported previously (Finel et al., 1992; 
Finel et al., 1994). The authors show that the NADH:DQ oxidoreductase activity is 
essentially abolished in subcomplex Iλ, a finding that is in agreement with the data 
presented in this study. These data suggest that either additional subunits are needed for 
DQ reduction which are not present in the subcomplex, or subcomplex resolution has 
rendered the quinone binding site or cluster 4Fe[PS] non-functional, a theory that is 
supported by the EPR data presented above. However, Finel and co-workers observed no 
loss in either NADH:FeCN or Q1 activity upon subcomplex resolution. Whereas the 
reaction of Q1 with complex I was found to be 77% sensitive to rotenone, the reaction of 
subcomplexes Iα and Iλ was completely rotenone-insensitive (Finel et al., 1992; Finel et 
al., 1994). This suggests the inhibitor binding is destroyed during subcomplex resolution, 
and the reaction of Q1 occurs upstream of cluster 4Fe[PS]. However, these findings are 
inconsistent; how can the rates, per µmole flavin, be the same for the intact enzyme and 
the subcomplexes when their sensitivity to inhibitors vary so greatly?  
 Using the smallest subcomplex of complex I from bovine heart mitochondria, Dr. 
Chérise Barker (PhD thesis) showed that the rate of NADH:FeCN oxidoreduction is 
significantly lower for subcomplex Fp than for the intact enzyme, and substrate inhibition 
is not observed over the range of NADH concentrations tested, consistent with previous 
reports (Dooijewaard and Slater, 1976). Although the rate of NADH:FeCN oxidoreduction 
varied dramatically, the rate of H2O2 production from subcomplex Fp was found to be very 
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similar to the intact enzyme, consistent with the data for subcomplexes Iα and Iλ (Dr. 
Chérise Barker, PhD thesis). 
   
 
Bos taurus Complex I Subcomplex Fp 
NADH:FeCN 483  45 
NADH:HAR 242  383 
 
Yarrowia lipolytica Complex I Subcomplex Iλ 
NADH:FeCN 2193.3 + 48.6 1528.1 + 85.6 
NADH:HAR 1077.9 + 203.7 907.7 + 90.5 
NADH:Q1 62.7 + 1.4 14.1 + 1.2 
NADH:DQ 59.5 + 8.6 0 
 
Table 3.3: Comparing the rates of complex I and subcomplexes from B. taurus and Y. 
lipolytica. Rates are expressed in µmoles NADH s-1 µmole flavin-1. Assays of complex I 
and subcomplex Fp from complex I from B. taurus were performed by Dr. Chérise Barker 
(PhD thesis); assays of complex I and subcomplex Iλ from Y. lipolytica were performed by 
Dr. Hannah Bridges (PhD thesis). Conditions (for subcomplex Fp): 32 °C, 20 mM tris-HCl 
pH 7.5, 100 µM NADH, 2 mM HAR, 1 mM FeCN. Conditions (for Y. lipolytica): 32 °C, 
20 mM tris-HCl pH 7.5, 100 µM NADH, 100 µM DQ, 3.5 mM HAR, 2 mM FeCN. 
 
 
A decrease in the rate of flavin-catalysed reactions has also been observed in subcomplex 
Iλ of complex I from Y. lipolytica. Work by Dr. Hannah Bridges showed that the rates of 
both NADH:FeCN and HAR oxidoreduction are lower for Iλ than the intact enzyme. 
Further assays revealed the subcomplex did not react with DQ; the reaction with Q1 was 
severely compromised and insensitive to rotenone. Both of these observations are 
consistent with the theory that resolution perturbs the quinone binding site (Dr. Hannah 
Bridges, PhD thesis). 
 
3.4.2 The effect of subcomplex resolution on structural integrity  
Finel and co-workers reported that the only difference between the EPR spectra of 
complex I and subcomplex Iλ is that the gz value of cluster 4Fe[PS] shifted from 2.05 to 
2.04 upon resolution (Finel et al., 1994). In this study, EPR analysis revealed that cluster 
4Fe[PS] is completely lost from subcomplex Iλ, despite the presence of subunit PSST; the 
reason for the difference in these two studies is unclear. Another study by Finel and co-
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workers revealed that the spectra of subcomplex Iα is far more similar to the intact enzyme 
than subcomplex Iλ (Finel et al., 1992), consistent with data presented here. Subcomplex 
Iα contains an additional eleven subunits compared to subcomplex Iλ, which may protect 
cluster 4Fe[PS] from damage during resolution. 
 The loss of cluster 4Fe[PS] has been documented with isoforms of complex I from 
other species. Neurospora crassa grown in the presence of the antibiotic chloramphenicol 
produces a predominantly hydrophilic isoform of complex I devoid of hydrophobic 
subunits (Friedrich et al., 1989). EPR spectroscopy has shown that this isoform lacks 
cluster 4Fe[PS], even though subunit PSST is present and the spectra of the remaining 
detectable clusters are unaffected (Wang et al., 1991).  
 Size exclusion chromatography has revealed that subcomplexes Iα and Iλ are 
heterogenic, oligomeric and prone to aggregation, emphasising the deleterious nature of 
LDAO treatment. These data are consistent with similar studies of subcomplex Iλ from Y. 
lipolytica; Dr. Hannah Bridges found that the subcomplex eluted as a broad peak at an 
apparent molecular mass significantly greater than that predicted from the subunit 
composition of the protein (Dr. Hannah Bridges, PhD thesis). Interestingly, chaotropic 
detergents are not used in the preparation of the hydrophilic arm from T. thermophilus; the 
membrane domain of the enzyme dissociates from the peripheral arm when the enzyme is 
solubilised on ice for two hours in 3% DDM (Hinchliffe et al., 2006). The thermophilic 
nature of the subcomplex coupled with the relatively simple method of preparation may 
explain the differences in the stability and structural integrity of the domains of the 
Thermus and bovine enzymes. 
 In conclusion, the data presented in this chapter suggest that neither subcomplex Iλ 
nor Iα are suitable for use as models of the intact enzyme; the criteria stated in section 
3.1.5 have not been fulfilled, even after extensive rounds of optimisation.  
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Chapter 4: 
Crystallisation trials of complex I from bovine heart mitochondria 
 
 
4.1  Introduction 
4.1.1 X-ray crystallography 
Complex I plays a pivotal role not only in energy transduction, but also in the pathogenesis 
of an increasing number of diseases. Knowledge of the molecular structure of complex I, 
as well as its mechanisms of energy transduction and reactive oxygen species production, 
are prerequisites for understanding the role of complex I in disease, and for the 
development of effective therapies. 
 The most useful technique for obtaining atomic resolution structures of large 
protein complexes is X-ray crystallography. The maximum resolution of an image is 
dictated by the wavelength of the electromagnetic radiation used to observe it; as such, the 
most powerful light microscopes can distinguish details down to a resolution of 0.5 µm. In 
order to determine the atomic structure of a protein, electromagnetic radiation of a 
corresponding wavelength must be used. As covalent and hydrogen bonds are in the order 
of one angstrom in length, X-rays, which have wavelengths between 0.2 and 10 Å, are 
used. Crystals of protein are bombarded with X-rays, and interpretation of the diffraction 
patterns allows for structural determination. Key to this technique is the growth of well 
ordered protein crystals; without crystals of suitable quality, structure determination is 
impossible. 
 
4.1.2 The importance of the protein sample 
The most important factor in protein crystallisation is the quality of the protein sample 
itself; McPherson identifies four key considerations when preparing protein for 
crystallisation trials (McPherson, 2004): 
 
Homogeneity: Arguably, the single most important property of the system under study is 
its purity. Crystallisation presupposes that identical units are available for incorporation 
into a periodic lattice; a uniform population of molecules is therefore essential. Any 
contaminant, either a co-purified protein or heterogenic forms of the protein under study, 
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will either inhibit crystal formation or lead to poisoning of the crystal lattice and cessation 
of crystal growth (Bergfors, 1999).  
 
Solubility: Before a molecule can be crystallised, one must ensure the creation of a 
monodisperse solution free of aggregates, non-specific oligomers and molecular clusters 
(Bergfors, 1999).  
 
Stability: No homogeneous population can remain so if its members alter their form, 
folding or association state independently of one another. Hence, it is important that 
macromolecules in solution do not denature, form oligomers, or undergo significant 
conformational change (Bergfors, 1999). 
 
Activity: The protein must be catalytically active, and retain its activity during the 
timeframe of a crystallisation experiment. The fulfilment of this criterion lends confidence 
that any crystals one obtains are of a physiologically relevant form of the protein. 
 
4.1.3 Aims  
The first half of the chapter describes work aiming to prepare active, monodisperse and 
stable complex I from bovine heart mitochondria, suitable for crystal trials. The effects of 
factors known to be important in membrane protein stability such as detergent, temperature 
and glycerol will be investigated using a range of techniques such as size exclusion 
chromatography and activity assays. 
 The second half of this chapter describes attempts to crystallise complex I, with the 
end goal of obtaining structural information using X-ray crystallography. There are 
essentially two strategies for screening crystallisation conditions (McPherson, 2004); the 
first is a systematic approach, screening variables such as pH, salt and concentration, 
precipitant and concentration- variables that are considered important in the crystallisation 
of macromolecules. As such, numerous ‘grid’ screens will be formulated, primarily based 
around the polyoxyethylene glycol precipitants. The second ‘shotgun’ method uses 
commercially available sparse matrix kits, specifically formulated from conditions that 
have been successful previously. The effects of phospholipids, detergents, protein 
heterogeneity and additives such as rotenone, piericidin A, NAD+ and ADP-ribose on 
crystallisation will also be investigated.  
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4.2  Investigating the stability of complex I
 
4.2.1  Detergents
 
Much has been written about the use of detergents in the solubilisation of membrane 
proteins and their subsequent crystallography; it is widely agreed that detergent type, 
purity and concentration are three of the most important factors in membrane protein 
crystallography (for example, see reviews by (Helenius et al., 1979; Neugebauer, 1990; le 
Maire et al., 2000; Privé, 2007)).  
 All detergents contain both hydrophilic and hydrophobic moieties; however, their 
physical properties vary enormously, and can be defined by a few characteristics. Every 
detergent can be characterised by its critical micelle concentration (CMC), the 
concentration above which monomers self-assemble into non-covalent aggregates, known 
as micelles. At concentrations below this value, detergent monomers are free in solution; 
however, above this value, monomers and micelles exist in equilibrium (Helenius et al., 
1979). The CMC is an inexact parameter whose value is highly dependent on factors such 
as temperature, pH, ionic strength, and detergent homogeneity and purity, and it is related 
to the nature of both the hydrophobic and hydrophilic moieties (Helenius et al., 1979). As 
excessive detergent may inhibit crystallisation and compromise protein stability, it is 
advantageous to try and keep the free detergent concentration below three times that of the 
CMC when setting up crystal trials (Wiener, 2004). At low temperatures, detergents can 
form cloudy, crystalline suspensions; as the temperature increases, the crystals dissolve to 
form monomers if the concentration is below the CMC or micelles if the concentration is 
above the CMC. The temperature below which micelles form from crystals is known as the 
critical micelle temperature (CMT). Another property of detergents is their aggregation 
number; this is the number of detergent monomers present within a micelle, and can vary 
from three or four to several hundred - most detergents used for biochemical analyses have 
aggregation numbers in the range of 50 to 100 (Privé, 2007). 
 Detergents can be divided into four groups based on the charges of their 
hydrophilic headgroup. Non-ionic detergents tend to be ‘mild’, disrupting only lipid-lipid 
and lipid-protein interactions, and are therefore commonly used to characterise membrane 
proteins in the native state (Helenius et al., 1979). Some of the most commonly used non-
ionic detergents contain either maltoside or glucoside headgroups; examples include n-
dodecyl-β-D-maltoside (12M), n-octyl-β-D-glucoside (8G) and Cymal 7 (7C). A second 
group of non-ionic detergents, the polyoxyethylene detergents, have also been used 
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successfully in the crystallisation of membrane proteins (Iverson et al., 1999; Horsefield et 
al., 2003).  
 Ionic detergents, such as sodium dodecyl sulphate (SDS) tend to be harsher, 
disrupting not only lipid-lipid and lipid-protein interactions, but also protein-protein 
interactions; their use in membrane protein crystallography is thus limited (Helenius et al., 
1979). The final group, the zwitterionic detergents, contain both a positive and negative 
charge in the headgroup. Like non-ionic detergents, these are neutrally-charged molecules; 
however, as they disrupt protein-protein interactions as well as protein-lipid and lipid-lipid 
interactions, they can be viewed as an intermediate class of detergents. The structures and 
properties of the detergents used in this study are shown in table 4.1. 
 
4.2.2  Detergent purity 
An excellent example of detergent purity effecting crystallisation is explored by Fromme 
and co-workers in their analysis of the crystallisation of photosystem I (Fromme, 1998). 
Using 12M, it was found that if the detergent contained more than 2% of the α-isomer 
form, no crystals were grown. Using detergent of an α-isomer content between 2 and 0.5%, 
crystals were obtained, but diffracted to only low resolution (5 - 6 Å). The resolution was 
dramatically improved to 3.5 Å with the use of stereochemically pure 12M with an α-
isomer content below 0.1%.  
 Consequently, the detergents used in this study were of the highest purity (≥ 99%) 
as judged by HPLC, purchased from either Anatrace (C12E8, C12E9, 6C, 7C and 8G) or 
glycon (10M, 11M, 12M, 13M and LDAO). 
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Detergent MW (monomer) CMC (%) 
Actual % 
used 
Aggregation 
number 
Mw  
(micelle) 
LDAO 229.4 0.023 N/A 76 17,343 
8G 292.4 0.530 1.00 27 – 100 14,620 
10M 482.6 0.087 0.30 69 33,299 
11M 496.6 0.029 0.10 71 35,259 
12M 510.6 0.009 0.03 78 – 149 69,000 
13M 524.6 0.001 0.03 186 97,576 
6C 508.8 0.028 0.10 91 46,301 
7C 522.5 0.010 0.05 150 78,375 
C12E8 538.0 0.005 0.01 123 66,174 
C12E9 583.0 0.003 0.01 NOT KNOWN NOT KNOWN 
 
Table 4.1: Summary of the detergents used in this study. Top; structures of the alkyl 
maltoside, cymal and polyoxyethylene detergents. Bottom; properties of the detergents 
used in this study. Abbreviations: G = glucoside, M = maltoside, C = cymal, Mw = 
molecular mass, CMC = critical micelle concentration, actual % used = the amount (w/v) 
of detergent used in the final gel filtration purification step. Data from the Anatrace 
website, www.anatrace.com. 
 
  90 
4.2.3  The effect of detergent and temperature on the stability of complex I
 
The stability of membrane proteins in different detergents can be assayed using a variety 
of techniques (Wiener, 2004). The elution profile from size exclusion chromatography can 
be very informative; protein aggregation and oligomerisation are easily detectable, and the 
dissociation of subunits may also be evident; typical gel filtration traces are shown in 
figure 4.1. Complex I was prepared in different detergents at three times the CMC 
(Wiener, 2004), and an initial elution profile recorded; after storing the protein in the test 
conditions for seven days, a second elution profile was obtained. 
 
 
 
 
Figure 4.1: Using size exclusion chromatography to investigate the stability of 
proteins. After protein incubation in the test condition, there are four possible outcomes. 
Ideally, the protein will remain stable and monodisperse, retaining its initial elution profile 
(shown in green). If denaturation and aggregation occurs, the protein will elute in the void 
volume of the column (red trace). The formation of higher order oligomers will result in a 
peak at an apparent higher molecular mass than the initial sample (blue trace). Protein 
instability will result in subunit dissociation, and peak(s) at an apparent lower molecular 
mass than the initial sample (yellow trace).  
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A number of respiratory complexes have been crystallised in the alkyl maltoside series of 
detergents. The structure of cytochrome c oxidase from R. sphaeroides was solved in 10M 
(Svensson-Ek et al., 2002), 12M was used to crystallise the bovine cytochrome bc1 
complex (Iwata et al., 1998) and cyanobacterial photosystem I (Jordan et al., 2001) and 
13M was used to crystallise complex I from T. thermophilus (Efremov et al., 2010). 
   
 
 
 
Figure 4.2: The effects of the alkyl maltoside detergents and temperature on the 
stability of complex I. The traces are gel filtration chromatographic data of complex I 
stored for seven days at 4 °C and 18 °C in 20 mM tris-HCl pH 7.5, 150 mM NaCl and 10% 
glycerol and detergent. Top left; 0.3% 10M, top right; 0.1% 11M, bottom left; 0.03% 12M 
and bottom right; a mixture of 0.06% 12M:13M. The protein was injected onto a Superose 
6 10/300 gel filtration column at the same concentration used in crystal trials (5 mg mL-1). 
Absorbance was measured at 280 nm. 
 
 
The results of stability tests in the alkyl maltosides are shown in figure 4.2. The size 
exclusion elution profile shows that complex I is not stable in 10M (figure 4.2, top left). 
When stored at 18 °C, significant aggregation and subunit dissociation is observed, 
suggesting 10M is not suitable for crystallisation trials. When prepared in 11M and stored 
at 4 °C, complex I remains stable and mostly monodisperse with only limited aggregation. 
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After storage at 18 °C, there is significantly less aggregation than with 10M, consistent 
with the fact that 11M is a less ‘harsh’ detergent. A second peak at a higher mass than the 
initial sample is also present, suggesting that in 11M at 18 °C, complex I forms oligomers 
over the course of a week (figure 4.2, top right). The data presented in figure 4.2, bottom 
left, reveal that the stability of complex I in 12M is similar to that in 11M. At 4 °C 
essentially all the protein remains monodisperse; at 18 °C no aggregation is detected, 
although the oligomeric peak dominates the monomeric peak; it is most likely that this 
peak represents a dimeric form of the enzyme rather than a higher order oligomer. Finally, 
a mixture of 0.03% 12M and 0.03% 13M was tested (figure 4.2, bottom right). Again, 
these data look promising, with a greater proportion of the protein remaining monodisperse 
at both 4 and 18 °C compared to 12M alone. These data suggest 11M, 12M and 12M:13M 
are all suitable for crystallisation trials of complex I. 
  
  
 
 
Figure 4.3: The effect of temperature on subunit composition of complex I in 12M. 
Top; the stability of complex I in 0.03% 12M after seven days at 4 °C (left) and 18 °C 
(right). Bottom; the fractions indicated were analysed by SDS-PAGE (see materials and 
methods). Mr = molecular mass markers. 
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Although these initial tests were promising, size exclusion chromatography provides only 
limited information about the effect of temperature and detergent on subunit retention. 
Fractions from the 12M stability tests were analysed by SDS-PAGE to investigate the 
subunit composition of the sample; the results are shown in figure 4.3. It is clear that 
neither the protein composition, nor the relative band intensity varies significantly between 
fractions, suggesting complex I is stable at both temperatures over the course of the test, 
and subunit dissociation does not occur.  
 Another popular detergent used in crystallography is 8G (le Maire et al., 2000). It 
has been used in the crystallisation of the hydrophilic domain of complex I from T. 
thermophilus (Sazanov and Hinchliffe, 2006), and ubiquinol oxidase (Abramson et al., 
2000) and formate dehydrogenase (Jormakka et al., 2002) from E. coli. Due to its short 
carbon chain length and high CMC, it is one of the harshest non-ionic detergents; when 8G 
was used to prepare complex I, significant aggregation was seen after the first size 
exclusion step, suggesting that this detergent is not suitable for crystallisation trials (data 
not shown). 
 The third group of non-ionic detergents that have been successful in crystallising 
membrane proteins is the cymal series. The mammalian microsomal cytochrome P450 
monooxygenase was crystallised in the presence of 5C (Williams et al., 2000), the 
structure of cytochrome bc1 complex from the photosynthetic purple bacterium R. 
sphaeroides was determined in 6C (Esser et al., 2008) and the voltage-dependent 
potassium channel was successfully crystallised in a mixture of 6C and 7C (Long et al., 
2007). The results of the stability tests using 6C and 7C are shown in figure 4.4. At 4 °C in 
7C, complex I remains predominantly monomeric, although a small dimeric peak is 
evident. At 18 °C, the complex is unstable, with aggregation and subunit dissociation 
observed; similar results are seen for 6C, although the amount of aggregation and 
dissociation is greater at 18 °C than for 7C. These data suggest that both 6C and 7C are 
suitable detergents for the crystallisation of complex I at 4 °C; however, the cymal series 
of detergents may not be appropriate for crystallisation trials at 18 °C.  
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Figure 4.4: The stability of complex I in the cymal series of detergents. The traces are 
gel filtration chromatographic data of complex I stored for seven days at 4 °C and 18 °C 
in, left; 0.1% 6C and right; 0.03% 7C, and 20 mM tris-HCl pH 7.5, 150 mM NaCl and 
10% glycerol. The protein was injected onto a Superose 6 10/300 GL gel filtration column 
at the same concentration used in crystal trials (5 mg mL-1). Absorbance was measured at 
280 nm. 
 
 
The fourth set of non-ionic detergents tested here was the polyoxyethylene series. The 
most notable successes using C12E9 are the determination of the structures of succinate 
dehydrogenase (Horsefield et al., 2003), fumarate reductase (Iverson et al., 1999) from E. 
coli, and complex I from Yarrowia lipolytica (Hunte et al., 2010). However, the resolution 
of complex I from cytochrome c oxidase during ion-exchange chromatography was very 
poor, and the yield of complex I was low. Initial optimisation focused on modifying the 
concentrations of C12E8 and C12E9 in the buffers; however, these alterations did not 
increase resolution. As several promising detergents had been previously indentified, the 
effect of the polyoxyethylene series on complex I stability was not investigated further, 
although more extensive optimisation of the preparation of complex I in these detergents 
may yield more success. 
  
4.2.4  Other factors that may contribute to the stability of complex I
 
The presence of stabilising agents, such as glycerol, can have a dramatic effect on the 
crystallisation of membrane proteins. To investigate the effect of glycerol on the stability 
of complex I, size exclusion stability tests were carried out in the presence of no glycerol, 
10% glycerol or 20% glycerol. As shown in figure 4.5, increasing the glycerol 
concentration decreases the apparent level of dimerisation, judged by the size of the peak 
at 9 mL; there is approximately five-times more dimer present in the buffer containing no 
glycerol compared to in that containing 20%. These data suggest that the oligomeric state 
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of complex I is affected not only by temperature and detergent, but also by the 
concentration of glycerol in the buffer; low temperatures and high glycerol concentrations 
favour the monomeric form of the protein, whereas high temperatures and low glycerol 
concentrations favour dimerisation. 
 
 
 
 
Figure 4.5: Investigating the effect of glycerol on the oligomeric state of complex I. 
Gel filtration chromatographic data of complex I (5 mg mL-1) after incubation at 4 °C for 7 
days in 20 mM tris-HCl pH 7.5, 0.03% 12M, 150 mM NaCl and either 0%, 10% or 20% 
glycerol. Absorbance was measured at 280 nm. 
 
 
As crystallisation often requires high protein concentrations, a further consideration is the 
effect of protein concentration on the stability and oligomeric state of complex I. Complex 
I was concentrated to 5, 10 or 15 mg mL-1 in 12M and 10% glycerol and stored for seven 
days at 4 °C. As shown in figure 4.6, the oligomeric state of complex I is independent of 
protein concentration over the range tested. 
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Figure 4.6: Investigating the effect of protein concentration on the stability of 
complex I. Gel filtration chromatographic data of complex I at either 5, 10 or 15 mg mL-1 
after incubation at 4 °C for 7 days in 20 mM tris-HCl pH 7.5, 0.03% 12M, 10% glycerol 
and 150 mM NaCl. Absorbance was measured at 280 nm. 
 
 
4.2.5 The effect of detergent and temperature on the catalytic activity of complex I 
Although size exclusion chromatography can provide information about the structural 
integrity of the complex, it does not report on the retention of catalytic activity; figure 4.7 
shows the effect of different temperatures and detergents on the rate of NADH:DQ 
oxidoreduction. Unlike the soluble substrates HAR and FeCN, DQ reacts at the 
hydrophobic Q-site, and is therefore well suited to assessing the physiological reactions 
catalysed by complex I. 
 Initial assays show that complex I prepared in 12M has the highest NADH:DQ 
activity, with significant decreases in rate resulting from decreasing carbon chain length. 
This may be due to either direct inhibition by the detergent, the removal of functionally 
critical phospholipids from the complex or the differing effects of detergent of the 
solubility of DQ (Sharpley et al., 2006). In all cases, the rate of NADH:DQ oxidoreduction 
fell significantly over the course of seven days, with the biggest decreases in activity from 
samples stored at 18 °C. The smallest decrease was seen for complex I prepared in 12M 
and 12M:13M, retaining approximately 50% and 70% of the activity, respectively. The 
biggest drop in activity was seen with 10M and 6C; there are several possible explanations 
for these data. As 10M and 6C are present at higher concentrations, the loss of 
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phospholipids from the enzyme may be more pronounced. Alternatively, the dimeric form 
of the complex may not catalyse the NADH:DQ reaction as efficiently as the monomeric 
form; aggregated enzyme will not react at all.  
 
 
 
 
Figure 4.7: NADH:DQ oxidoreductase activities following the storage of complex I in 
different detergents and at different temperatures. Error bars represent the standard 
deviation of three assays. Assay conditions: 32 °C, 20 mM tris-HCl pH 7.5, 100 µM 
NADH, 100 µM DQ, 0.4 mg mL-1 asolectin in 0.4 mg mL-1 CHAPS. 
 
 
These functional data suggest that 12M and 12M:13M are the most suitable detergents for 
retaining NADH:DQ oxidoreduction activity, consistent with the findings from the size 
exclusion chromatography studies suggesting that long-chained detergents are the most 
suitable detergents when working with complex I. 
 
4.2.6  Determining the amount of detergent bound to complex I 
The vast majority of proteins isolated from membranes exist in a protein:detergent:lipid 
micelle (PDLM); it is this complex of protein, naturally-occurring lipids and detergent that 
will crystallise. Crystallisation requires significant regions of protein to be solvent 
accessible in order to form crystal contacts, a factor highlighted in attempts to crystallise 
members of the mitochondrial carrier family of proteins. These single-chain proteins, 
approximately 30 kDa in mass, are often completely encapsulated by detergent, hindering 
attempts at crystallisation (Dr. Edmund Kunji, personal communication); characterising 
the PDLM provides information that is useful in efforts to grow crystals. 
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Figure 4.8: Investigating the composition of the protein:detergent:lipid micelle. 
Complex I was gel filtrated in buffer containing 0.03% 12M, and 0.5 mL fractions were 
collected. The concentration of protein in each fraction was determined using the Pierce 
BCA assay kit and the detergent concentration was measured as described by Urbani and 
Warne (Urbani and Warne, 2005). Concentrations are reported in mg mL-1. The detergent 
concentration data can be transformed onto the protein concentration data (the ‘mapped’ 
curve); it is this ratio between the two datasets (~ 3.65) that gives an estimate of the mass 
of detergent bound per unit mass of protein. 
 
 
In order to estimate the amount of detergent bound per complex I, the total concentration 
of detergent was calculated using a protocol developed by Urbani and Warne; this 
technique is applicable only to detergents with sugar headgroups, such as the alkyl 
maltoside and cymal series of detergents (Urbani and Warne, 2005). Briefly, the p-
semiquinoid formed from the condensation of furfural derivatives, generated by the 
dehydration of sugars in concentrated sulphuric acid, with aromatic compounds such as 
phenol, is quantified by its absorbance at 490 nm. An estimate of the amount of detergent 
bound was subsequently calculated by subtracting the concentration of detergent present in 
the buffer from the total detergent detected and comparing the values to standards of 
known concentration. The concentration of protein was estimated using the Pierce BCA 
assay, as described in materials and methods. 
 The ratio of protein concentration to detergent concentration was calculated, and 
from this an estimate of how much detergent is bound per complex I; figure 4.8 suggests 
there is approximately 270 kDa 12M bound to each complex I (980 kDa), which equates to 
about 530 molecules of DDM. This estimate seems realistic, considering complex I has in 
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excess of 60 membrane-spanning helices (Hirst et al., 2003). Similar assays yielded 
estimates of 390 kDa and 340 kDa of detergent bound per complex I prepared in 11M and 
7C, respectively. 
 
4.2.7 Optimising the preparation of complex I 
Modifications to the ion-exchange and concentration steps allowed complex I to be 
prepared and crystallisation trials set up just five hours after membrane solubilisation, 
allowing the entire preparation to be carried out in a day, and avoiding the freezing or cold 
storage of protein. Analysis revealed that freezing has an adverse effect on the rate of 
NADH:DQ oxidoreductase activity; complex I prepared and assayed before freezing had 
an activity of 4.19 + 0.22 µmoles NADH min-1 mg-1. After freezing and subsequent 
thawing, the activity fell to 3.53 + 0.19 µmoles NADH min-1 mg-1; the reason for the 
decrease is not known.  
 A further modification was made to the published protocol. The resolution between 
complex I and cytochrome c oxidase was far greater when 0.2% 12M was used in the ion-
exchange chromatography buffers as opposed to 0.1% 12M; less cytochrome c oxidase 
contamination in the protein injected onto the size exclusion chromatography column led 
to a further increase in purity. 
 
4.2.8  Conclusions and discussion 
Extensive size exclusion chromatography studies using complex I have revealed that the 
enzyme is stable in long-chain detergents, such as 11M, 12M, 12M:13M and 7C; a 
complete summary of the stability of complex I in a range of detergents is presented in 
table 4.2. The effect of glycerol and temperature on the oligomeric state of the protein is 
striking; higher temperatures and lower glycerol concentrations favour oligomerisation, 
whereas lower temperatures and higher glycerol concentrations promote monodispersity.  
  Assays revealed that the most NADH:DQ oxidoreductase activity is retained when 
complex I is prepared in 12M or 12M:13M, and that ~270 kDa of 12M binds complex I 
(980 kDa), suggesting that large portions of the enzyme are solvent-accessible, and thus 
available to form crystal contacts. Although a larger amount of 11M (392 kDa) and 7C 
(338 kDa) is bound to complex I, solvent accessible protein should still be available. 
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Detergent Stability of complex I 
0.3% 10M Aggregation/instability 
0.3% 11M Stable 
0.03% 12M Stable 
0.03% 12M : 0.03% 13M Stable 
0.1% 6C Aggregation/instability 
0.03% 7C Stable 
1.0% 8G Aggregation/instability 
0.1% LDAO Aggregation/instability 
C12E8 Stability not determined 
C12E9 Stability not determined 
 
Table 4.2: Summary of the stability of complex I from bovine heart mitochondria in a 
range of detergents.  
 
 
Similar stability analyses by Drs. Christopher Thompson, Rozbeh Baradaran and Hannah 
Bridges have suggested that the complexes I from E. coli, T. thermophilus and P. pastoris 
are stable in a comparable range of detergents (PhD theses); the stability data are 
summarised in table 4.3. The most successful detergents with respect to the stability of 
complex I are long chain non-ionic detergents, such as 12M, 13M and 7C; short-chain 
non-ionic detergents tend to be significantly harsher, and can interfere with protein-protein 
interactions. 
 These data will not only aid crystallisation trials: knowledge of the factors that 
affect the stability of complex I from bovine heart mitochondria will also play a crucial 
role in future functional studies on the isolated enzyme, as well as influencing any attempts 
to reconstitute it into proteoliposomes. 
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Species 
Detergent 
E. coli T. thermophilus P. pastoris 
8M Aggregation/instability - - 
10M Stable Aggregation/instability Not stable 
11M - Stable Stable 
12M Stable Stable Stable 
13M Stable Stable Stable 
DDTM - Stable - 
4C - Aggregation/instability Not stable 
5C Aggregation/instability - Not stable 
6C - Stable Stable 
7C - Stable Stable 
8G Loss of NuoL and M Aggregation/instability - 
FOS-CHOLINE-10 - Aggregation/instability - 
Big-CHAP - Aggregation/instability - 
CHAPS Aggregation/instability - - 
C12E8 (v/v) - Stable - 
C12E9 (v/v) Aggregation/instability Stable Stable 
fluorinated 8M - Stable - 
 
Table 4.3: Data addressing the stability of complexes I from E. coli (Dr. Christopher 
Thompson), T. thermophilus (Dr. Rozbeh Baradaran) and P. pastoris (Dr. Hannah 
Bridges). E. coli complex I was concentrated to 15 mg mL-1, incubated at 4 °C for 72 
hours in buffer containing 18% glycerol, 50 mM NaCl, 20 mM bis tris pH 6.0 and 2 mM 
CaCl2 before being gel filtrated. Protein stability was assessed by comparing the test 
sample gel filtration column chromatography profile with the elution profile of intact 
complex I. T. thermophilus complex I was analysed as E. coli complex I, except samples 
were left for 24 hours at room temperature before analysis. The stability of complex I from 
P. pastoris was analysed using the ThermoFAD assay, and the data compared to a control 
using 12M. 
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4.3 Crystallisation trials of complex I from bovine heart mitochondria 
4.3.1 Introduction to protein crystallisation 
The crystallisation process of molecules of any compound from its solution represents a 
reversible equilibrium phenomenon, driven by the minimisation of the free energy of the 
system. There are three stages of crystallisation common to all systems: nucleation, 
growth, and cessation of growth (Feher and Kam, 1985; Chirgadze, 2001 (protein 
crystallisation in action, www.mordred.bioc.cam.ac.uk/~dima)). 
 Nucleation occurs when there is insufficient solvent to maintain full hydration of 
the protein molecules- the supersaturated state. Individual molecules lose their rotational 
and translational independence by forming non-covalent chemical bonds, driving the 
system towards a new equilibrium with a new free energy minimum (Feher and Kam, 
1985). Molecules partition between the soluble and solid phases, which appears either as 
amorphous precipitate or crystal nuclei; precipitates are usually more kinetically 
favourable, so they tend to dominate (Chirgadze, 2001). The growth of macroscopic 
crystals is dependent on points of nucleation exceeding a critical size: below the critical 
size, crystals will spontaneously dissolve; above the critical size, aggregates will form 
supercritical nuclei capable of further growth (Feher and Kam, 1985). Following the 
formation of supercritical nuclei, sustained crystal growth occurs until equilibrium 
between free protein in solution and crystalline protein is reached, or until foreign or 
damaged molecules are incorporated into the crystal face. This last scenario, known as 
lattice poisoning, is dependent on both protein purity and stability; the purer, more stable 
the protein, the lower the probability of lattice poisoning (Chirgadze, 2001).  
 A classical explanation of crystal nuclei formation and growth is given by the 
solubility diagram shown in figure 4.9. The solubility curve divides the space into two 
distinct regions - the undersaturated and supersaturated zones (Chirgadze, 2001). Protein in 
solution is undersaturated, represented in the phase diagram by the area under the 
solubility curve. Above the solubility curve is the supersaturation zone; for a given 
concentration of precipitating agent, the protein concentration is higher than that at 
equilibrium. This region can be subdivided into three zones; the precipitation zone is 
where protein immediately separates from solution to form amorphous aggregates. The 
nucleation zone is where the excess of protein molecules aggregates in a crystalline form. 
To grow well-ordered, large crystals, the optimal conditions would have to begin with the 
formation of a (preferably) single nucleus in the nucleation zone, just beyond the 
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metastable zone. As the crystals grow, the solution would return to the metastable region 
so no more nuclei form (Chirgadze, 2001).  
 
 
 
 
Figure 4.9: Crystallisation phase diagram. Schematic representation of a two-
dimensional phase diagram, showing the changes in protein and precipitant concentrations. 
The concentration space is divided, by the solubility curve, into two areas corresponding to 
the undersaturated and supersaturated states of the protein solution. The supersaturated 
area comprises the metastable, nucleation and precipitation zones. Details of the 
crystallisation process are described in the text. 
 
 
One of the most successful methods for achieving the supersaturating conditions that are a 
prerequisite for protein crystallisation is to concentrate the protein in a controlled manner 
by vapour diffusion; a typical ‘sitting drop’ experiment is shown in figure 4.10. In a typical 
experiment, the protein sample is mixed in a 1:1 ratio with precipitating solution. The drop 
is subsequently equilibrated against a much larger volume of precipitating solution in a 
sealed system. The difference in precipitant concentration between the drop and the well 
solution is the driving force which causes water to evaporate from the drop until the 
concentration of the precipitant in the drop equals that in the well solution. During a 
vapour-diffusion experiment, the protein concentrates from an unsaturated state (point A in 
figure 4.9) to reach a supersaturated state (point B in figure 4.9). As the first crystals 
appear the concentration of protein will decrease; the crystals grow until the concentration 
of the protein in the drop reaches the solubility curve (point C in figure 4.9). 
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Figure 4.10: Schematic of diagrams of sitting drop (left) and hanging drop (right) 
vapour diffusion experiments. The protein solution is mixed with the precipitant 
solution, the system is sealed, and maintained at constant temperature. Water evaporates 
from the drop, and is taken up by the much larger reservoir solution. 
 
 
4.3.2 Crystallisation trials of complex I 
The tests described above identified 11M, 12M, 12M:13M and 7C as the most promising 
detergents with respect to maintaining the stability and catalytic activity of complex I. It 
was also shown that the oligomeric state of complex I can be manipulated by altering the 
temperature and glycerol content of the buffer; high glycerol and low temperature promote 
monodispersity, whereas low glycerol and high temperature result in dimerisation and the 
formation of higher order oligomers.  
 There are many additional factors which can determine whether a protein 
crystallises. The key to identifying potentially successful conditions is to efficiently and 
effectively sample n-dimensional space; two approaches were taken to try and locate 
potentially promising conditions (McPherson, 2004): 
 
Homemade grid screens 
As a significant number of respiratory proteins have been crystallised from PEG/salt 
solutions, the first approach involved constructing grid screens that systematically varied 
conditions which are known to be important in membrane protein crystallography. A four-
dimensional grid screen was constructed varying, in the first and second dimensions, 
precipitant and precipitant concentration, in the third dimension, salt species, and in the 
fourth dimension, pH. The precipitants used were PEG 400, 1500 and 4000, each at six 
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different concentrations centred on precipitation points that had been determined from 
preliminary experiments. 
 Franz Hofmeister demonstrated that salts varied in their effect on the solubility of 
proteins. Therefore, they have a major effect on the crystallisation process, as summarised 
in figure 4.11 (Collins, 2004; Zhang and Cremer, 2006). Analysing the data in the 
Membrane Protein Data Bank suggested that potassium chloride, sodium chloride, 
magnesium chloride and calcium chloride are amongst the most successful salt additives in 
crystallisation. Consequently, in the third dimension, either 150 mM KCl, NaCl, MgCl2 or 
CaCl2 was added.  
  
 
 
 
Figure 4.11: The effect of salts on protein solubility. The effect of salts on the solubility 
and stability of proteins has been well documented. The species “to the left” of Cl- are 
referred to as kosmotropes, while those to the right are chaotropes. Kosmotropes are 
strongly hydrated and have stabilising and salting-out effects on proteins. Chaotropes, 
however, are known to destabilize folded protein and increase protein solubility. 
 
 
Finally, each of these combinations was tested at pH values of 6.5, 7.0, 7.5 or 8.0, 
producing 288 unique solutions (listed in appendices 9.1 – 9.3). This range of conditions 
has been successful in the crystallisation of a significant number of respiratory complexes. 
Cytochrome bc1 from bovine heart mitochondria was crystallised in a solution containing 6 
– 8% PEG 4000, 100 mM NaCl and 50 mM potassium phosphate pH 6.6 (Iwata et al., 
2006). Ubiquinol oxidase and succinate dehydrogenase from E. coli were crystallised in 
precipitant solutions containing 9 – 10% PEG 1500, 100 mM NaCl, 100 mM MgCl2 and 
20 mM tris-HCl pH 7.5, and 29% PEG 400, 200 mM CaCl2 and 100 mM tris-HCl, pH 8.2, 
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respectively (Abramson et al., 2000; Horsefield et al., 2003). Cytochrome c oxidase from 
R. sphaeroides was crystallised in a solution of 18 – 22% PEG 400, 50 – 150 mM NaCl, 
20 mM MgCl2 and 100 mM sodium citrate, pH 6.0 (Svensson-Ek et al., 2002). A 
precipitant solution containing 9% PEG 4000 was used to crystallise complex I from T. 
thermophilus (Efremov et al., 2010).  
 
Commercially available sparse matrix screens 
The second approach involved the use of eight commercially available sparse matrix 
screens, listed in table 4.4, specifically chosen to maximize the number of conditions 
tested. These screens have also been the most successful at producing hits using T. 
thermophilus and E. coli complexes I (Drs. Rozbeh Baradaran and Christopher Thompson, 
PhD theses).  
 
 
Screen Name Company Number of conditions 
MemGold Molecular Dimensions 96 
MemStart/Sys Molecular Dimensions 96 
Morpheus Molecular Dimensions 96 
JCSG+ NeXtal 96 
Classics Lite NeXtal 96 
ProComplex NeXtal 96 
PEG/Ion1 Hampton Research 96 
HTS Jena Biosciences 96 
Total number of conditions 768 
 
Table 4.4: The commercial screens used for crystallisation trials of complex I from 
bovine heart mitochondria. For screen compositions, see the manufacturers’ websites: 
www.moleculardimensions.com, www.qiagen.com, www.hamptonresearch.com and 
www.jenabioscience.com. Notes: 1the PEG/Ion screen was diluted two-fold with 20 mM 
tris-HCl pH 7.5 prior to use, as initial experiments demonstrated that the precipitant 
concentration is uniformly too high, resulting in immediate protein precipitation. 
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4.3.2.1 Round 1: initial trials 
Using both the homemade and commercially available screens, the initial crystallisation 
trials investigated the effect of some of the most important variables in protein 
crystallisation. These included: 
• Detergent: 0.1% 11M, 0.03% 12M,  0.5% 12M:13M and 0.03% 7C 
• Temperature: 4 °C, 10 °C and 18 °C 
• Glycerol concentration: 0%, 10% and 20% 
• Protein concentration: 5 - 6 mg mL-1 and 10 - 12 mg mL-1 
 
Crystallisation trials using the homemade screens 
Over 10,000 crystallisation trials were conducted using the homemade screens listed in 
appendices 9.1 – 9.3. Unfortunately, despite the success of these conditions for the 
respiratory proteins listed above, no crystals of complex I from bovine heart mitochondria 
were produced. However, it was possible to identify the precipitation points of complex I 
in commonly used precipitants, such as PEG 400, PEG 1500 and PEG 4000, as well as to 
investigate the effects of glycerol, salt and temperature; an example dataset is shown in 
figure 4.12. Several interesting points are apparent. First, the concentration of PEG 400 
needed for precipitation is dependent on the temperature; generally, complex I was more 
susceptible to precipitation at 18 °C than 4 °C, possibly reflecting its greater stability at 
lower temperatures. Second, the influence of salt on the precipitation point: the more 
chaotropic the salt, the greater tendency for complex I to aggregate. For example, the 
presence of CaCl2, which is the most chaotropic salt tested (see figure 4.11), appears far 
more destabilising than the presence of KCl, the least chaotropic salt examined. Finally, as 
a general rule, complex I precipitates to a greater extent in more alkaline solutions. 
 Using these data, finer screens were constructed around the points of precipitation 
and used in future experiments. For each screen, this involved using 1% PEG increments 
around the point of precipitation as opposed to 3% increments (see appendix 9.3 for 
details). 
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Figure 4.12: The effects of temperature, salt, pH and precipitant concentration on the 
precipitation point of complex I. Complex I was prepared in 0.03% 12M, 10% glycerol 
and 150 mM NaCl, and crystal trials set up with a PEG/ion-based homemade screen (using 
PEG 400 in this example). The trials were monitored over the course of 28 days, and any 
precipitation classified as either ‘light’, ‘medium’ or ‘heavy’; see table 4.5. Notes: the 
percentage is of the precipitant in the reservoir solution. 
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Crystallisation trials using the commercially available screens 
The second strategy made use of eight commercially available screens, specifically chosen 
to maximise the total number of conditions. In total, over 20,000 trials were conducted 
using these screens; the vast majority of trials resulted in clear drops, non-amorphous and 
amorphous precipitate or phase separation; a typical selection of observations is described 
in table 4.5. However, three promising hits were observed using the MemGold, 
MemStart/Sys and PEG/Ion screens; images of the microcrystals are shown in figure 4.13. 
Interestingly, the crystals were only observed at 10 °C in 0.03% 12M and 10% glycerol; 
equivalent experiments at 4 or 18 °C, with no glycerol or 20% glycerol, or using 0.03% 7C 
yielded no hits, suggesting that the crystals were extremely sensitive to variations in 
detergent, temperature and glycerol.  
 Optimisation of the conditions involved systematically varying the precipitant 
concentration and pH around the initial ‘hit’ condition; the homemade screens constructed 
are listed in appendices 9.4 – 9.6. The effect of detergent, glycerol concentration, protein 
concentration, temperature and additives, such as salt, was also investigated. Although the 
crystals were reproducible, this extensive screening programme produced needle crystals 
of only 30 - 50 µm in size; an example is shown in figure 4.13. It was apparent that other 
factors, such as phospholipid content and protein homogeneity, would have to be 
considered to increase the size of the crystals. The work presented below describes the 
second and third rounds of experiments, investigating the effect of phospholipids, additives 
and heterogeneity on crystallisation, with the aim of increasing the size of the crystals 
shown in figure 4.13, bottom right.   
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Screen Name C H M L  A PS MC 
MemGold 45 1 12 7 30 0 1 
MemStart/Sys 54 2 8 4 26 1 1 
Morpheus 41 6 39 10 0 0 0 
JCSG+ 50 10 9 4 21 2 0 
Classics Lite 61 3 10 1 21 0 0 
ProComplex 53 13 12 6 10 2 0 
PEG/Ion1 41 22 15 13 2 2 1 
HTS 45 17 15 12 6 1 0 
 
Table 4.5: Phenomena observed in trials of the commercially available screens. In this 
example, complex I was prepared to a final concentration of 10 mg mL-1 in 0.03% 12M, 
10% glycerol. Trials were stored at 10 °C, and observed after seven days. Drops were set 
up as described in materials and methods. Key: C = clear drop, H = heavy non-amorphous 
precipitate, M = medium non-amorphous precipitate, L = light non-amorphous precipitate, 
A = amorphous precipitate, PS = phase separation, MC = microcrystals. Note: 1the 
PEG/Ion screen was diluted two-fold with 20 mM tris-HCl pH 7.5. 
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Figure 4.13: Photographs of some of the promising leads from the first round of 
crystallisation trials, and subsequent optimisation. Complex I was prepared in 0.03% 
12M, 10% glycerol and stored at 10 °C; the crystals were photographed after seven days. 
Top left; PEG/Ion (condition G1: diluted two-fold) - 50 mM sodium acetate trihydrate pH 
7.0, 6% w/v PEG 3350. Top right; MemGold (condition C7) - 20 mM bis tris pH 7.0, 15% 
w/v PEG 2000. Bottom left; MemStart/Sys (condition G8) - 100 mM MES pH 6.5, 12% 
w/v PEG 4000. Bottom right; Home made PEG 4000 screen based around MemStart/Sys 
condition G8 (appendix 9.6) 100 mM MES pH 6.3, 10% w/v PEG 4000. 
 
 
4.3.2.2 Round 2: the effect of phospholipids and detergent on crystallisation 
One potential problem in trying to crystallise integral membrane proteins is that over-
purification may result in delipidation. This problem initially hampered crystallisation of 
the cytochrome b6f complex; extensive purification provided a high level of purity, but 
also resulted in the loss of lipids from the protein. The purified complex was found to 
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contain < 0.5 molecules of monogalactosyldiacyl glycerol (MGDG) of bound lipid per 
monomer (Zhang and Cramer, 2005), and only poorly diffracting crystals could be grown. 
 Subsequently, Cramer and co-workers pioneered a technique known as lipid-
augmentation. Addition of dioleolylphosphatidylcholine (DOPC), a common lipid from 
gram-negative bacteria, after the last stage of purification promoted the growth of 
hexagonal crystals up to 0.2 mm in size, with a resolution of 3.4 Å. Indeed, examination of 
the structure revealed that the DOPC lipid has a structural role in the complex. Two 
molecules were resolved in the inter-monomer quinone binding site, acting as scaffolding 
that stabilises the complex (Zhang et al., 2003). A structural role has also been proposed 
for the specific lipids digalactosyl-diacylglycerol and phosphatidylglycerol in the 
crystallisation of the plant light-harvesting chlorophyll-protein complex (Nussberger et al., 
1993), and for cardiolipin bound to the bacterial photosynthetic reaction centre (Camara-
Artigas et al., 2002). 
  
 
Average number of phospholipids per CxI 
Preparation Rate 
PE PC Cardiolipin 
0.005% asolectin (n = 6) 4.1 + 0.7 7.4 + 1.8 11.8 + 4.0 9.4 + 0.9 
No phospholipid (n = 7) 1.8 + 0.6 2.3 + 0.7 3.2 + 0.5 10.4 + 0.8 
0.005% PC (n = 2) 3.8 + 0.5 3.5 + 0.1 25.2 + 3.8 10.2 + 0.3 
0.005% PE (n = 1) 4.1 21.5 4.2 10.2 
 
Table 4.6: Average phospholipid contents and catalytic activities of complex I 
prepared with and without asolectin, PC and PE. NADH:DQ oxidoreduction rates are 
reported in µmoles NADH min-1 mg-1 complex I, and the average number of phospholipids 
per complex I is reported in moles of complex I to moles of phospholipid (taken from 
(Sharpley et al., 2006)). 
 
 
Phospholipids have also been shown to play a crucial role in both the stability and activity 
of complex I. Previous work in this lab has shown that complex I prepared in the absence 
of phospholipids is not stable (Dr. Steven Sherwood, personal communication). Sharpley 
and co-workers also demonstrated that the rate of NADH:DQ oxidoreduction is critically 
dependent on the presence of phospholipids in the Q-Sepharose buffers, in the form of 
either asolectin, phosphatidylcholine (PC) or phosphatidylethanolamine (PE) (Sharpley et 
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al., 2006). In addition, by high performance liquid chromatography, the authors showed 
how many molecules of phospholipid remained bound per complex I after purification 
(table 4.6). Although some cardiolipin remains bound to complex I, both PC and PE are 
essentially completely lost after ion exchange chromatography, if asolectin is not present 
in the buffers. As expected, when the buffers are augmented with either PC or PE alone, 
the respective lipid dominates after purification (Sharpley et al., 2006). Although asolectin 
is present in the Q-Sepharose buffers during the preparation of complex I for crystal trials, 
no phospholipids are present in the gel filtration buffer. This raises the possibility that loss 
of phospholipids from the complex may be hindering crystallisation. 
 In order to overcome the possibility of complex I delipidation, the technique of 
lipid augmentation was applied. Highly purified PE, PC and cardiolipin were added to the 
Q-Sepharose buffers (in place of asolectin) to a final concentration of 0.005%, and also to 
complex I after the gel filtration step. Commercial screens were used to investigate the 
effect of exogenous phospholipids on the crystallisation of complex I, as well as the 
homemade screens listed in appendices 9.1 – 9.6. There was no discernable difference 
between the trials set up in the presence of the phospholipids compared to those set up 
without; indeed, the conditions which provided the promising hits in round one produced 
crystals that were even smaller than grown previously, suggesting the addition of 
PC/PE/cardiolipin to complex I may have an inhibitory effect on crystallisation. 
 An alternative solution to the problem of delipidation is to reduce the number of 
purification steps; when the final purification step was omitted, large, brown crystals were 
grown in precipitant solutions containing PEG 400, shown in figure 4.14. Unfortunately, 
SDS-PAGE analysis revealed that these crystals were of cytochrome c oxidase, 
emphasising the importance of the gel filtration purification step. 
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Figure 4.14: Cytochrome c oxidase crystals. ‘Complex I’ was prepared as usual (0.03% 
12M, 10% glycerol, 150 mM NaCl), except the final size exclusion chromatographic step 
was omitted. Crystal trials were set up as described in materials and methods (section 2.5) 
using a PEG 400-based homemade screen; the crystals shown were grown at 22% PEG 
400, 100 mM HEPES pH 6.9. Crystals were observed after 2 days. The crystals were 
harvested, washed three times in mother liquor, and analysed using SDS-PAGE. 
 
 
Classical approaches to crystallisation try to limit the concentration of free detergent to 
less than three times the CMC (Wiener, 2004). Whilst this may be the best approach for 
small membrane proteins, such as the mitochondrial carriers (Pebay-Peyroula et al., 2003), 
large integral membrane proteins may require considerably more detergent to keep them 
monodisperse and stable. Work carried out in the laboratory of Dr. Leo Sazanov by Drs. 
Christopher Thompson and Rozbeh Baradaran revealed that bacterial homologues of 
complex I require significantly more detergent than smaller membrane proteins; optimal 
crystals of the enzyme from E. coli and T. thermophilus were grown in 0.5% - 1% 12M 
and 0.5% - 1% 13M, respectively. 
 Trials were set up using both strategies described in section 4.3.2.1 in a final 
concentration of 0.75%, 1.0% or 1.5% 12M or 7C, and the differences in crystal growth 
monitored; figure 4.15 shows the results from a typical experiment. No crystals were 
observed at 0.5% for either 12M or 7C after 3 days; however, when the protein was 
supplemented with detergent to a final concentration of 1.5%, hexagonal, muffin-like 
crystals were seen, typical of detergent crystals (Dr. Edmund Kunji, personal 
communication). SDS-PAGE analysis suggested that these crystals were not composed of 
protein (data not shown), a result supported by X-ray crystallography. 
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Figure 4.15: The effect of detergent concentration on crystal growth. Protein was 
prepared as usual (0.03% 7C, 10% glycerol, 150 mM NaCl), and crystallisation trials were 
set up at either 10 or 18 °C in a precipitation solution containing 24% PEG 2000, 100 mM 
MgCl2 and 100 mM MES pH 5.9. Left: trials supplemented with 7C to a final 
concentration of 0.75%. Right: trials supplemented with 7C to a final concentration of 
1.5%. Crystal trials were set up as described in materials and methods (section 2.5) and 
crystals were observed after 3 days.  
 
 
4.3.2.3 Round 3: improving the homogeneity of the protein 
One of the most important properties of the system under study is its purity; a uniform 
population of molecules is essential. Although the work described in section 4.2 produced 
preparations of complex I free of exogenous contaminants, it did not investigate inherent 
heterogeneity in the state of the protein. Two potential problems which may introduce 
heterogeneity into the protein sample were identified, and were investigated further:  
 
The active/deactive transition 
A transition from a deactive (‘D’) form to an active (‘A’) form of complex I has been 
recognised in some species including B. taurus, suggesting that complex I can exist in at 
least two distinct forms (Galkin and Moncada, 2007; Galkin et al., 2008).  
 
Conformational changes 
The mechanism of proton pumping may involve long-range conformational changes 
(Efremov et al., 2010); it may be necessary to ‘lock’ the protein in one form with 
substrates or inhibitors to ensure homogeneity.  
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Two distinct forms of complex I can be prepared; a catalytically-competent active ‘A’ 
form and a deactive ‘D’ form. The transition from the ‘D’ to ‘A’ form is observed as a 
considerable lag phase in the onset of NADH:DQ oxidoreductase activity, which is not 
observed for either NADH:FeCN or HAR activity (Galkin et al., 2008). After incubation 
of the enzyme in conditions which permit turnover (the presence of NADH and an electron 
acceptor such as endogenous Q10), complex I converts from the ‘D’ form, to the ‘A’ form. 
The reversible transition from ‘A’ to ‘D’ occurs upon incubation of the enzyme at 
temperatures ranging from 30 - 37 °C. The ‘A’ to ‘D” transition remains poorly 
characterised; however, the high apparent activation energy of the deactivation process 
may indicate the occurrence of a significant conformational change in the internal 
organisation of the enzyme (Galkin and Moncada, 2007). Recently, Galkin and co-workers 
identified modifications to a loop connecting subunits ND3 and PSST which may be 
important in the transition; however, this modification is unlikely to be the only change, 
and further work needs to be carried out to fully characterise this phenomenon (Galkin et 
al., 2008).  
 The presence of two catalytically-distinct forms of the enzyme may introduce 
enough heterogeneity to inhibit crystallisation; interestingly, the ‘D’ to ‘A’ transition is not 
observed in either the E. coli or T. thermophilus complexes I, which have been 
crystallised. Thus, thawed mitochondrial membranes were either incubated at 35 °C for 
one hour to ensure the protein was in the ‘D’ form, or treated with four aliquots of 2.5 mM 
NADH every 5 minutes for 20 minutes to convert the enzyme to the ‘A’ form (Kenneth 
Pryde, personal communication). The enzyme was subsequently isolated as usual at 4 °C.  
 Trials of ‘A’ form complex I were carried out at either 4 or 10 °C, and trials of ‘D’ 
form complex I, at 10 or 18 °C to prevent the ‘A’ to ‘D’ or ‘D’ to ‘A’ transitions, 
respectively. Trials were set up in 0.03% 12M and 10% glycerol using the commercial 
screens listed in table 4.4, and the homemade screens listed in appendices 9.1 – 9.6. The 
results were, however, extremely disappointing. There was no discernable difference 
between either the active and deactive forms of the enzyme compared to the trials set up in 
section 4.3.2.1. 
 The use of additives has often played a significant role in the crystallisation of 
membrane proteins (Wiener, 2004). One notable example of the use of additives is the 
crystallisation of complex I from Y. lipolytica (Hunte et al., 2010). The authors use the 
substrate NAD(P)H and the Q-site inhibitor DQA (2-decyl-4-quinazolinyl-amine) as 
additives during crystallisation, producing crystals that diffract to 6.3 Å. Incubation of the 
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enzyme with substrate or substrate analogues such as NAD+ and the flavin-site inhibitor 
ADP-ribose, or with Q-site inhibitors such as rotenone or piericidin A, may ‘lock’ the 
enzyme in a specific conformation (table 4.7). This may decrease the flexibility and 
increase the homogeneity of the protein sample; both factors would make crystallisation 
more likely.  
 
 
Additive Concentration 
NAD+ 2.5 mM 
NAD+ + PC/PE/cardiolipin 2.5 mM + 0.005%  
ADP-ribose 1 mM 
ADP-ribose + PC/PE/cardiolipin 1 mM + 0.005% 
Piericidin A 1 µM 
Piericidin A + PC/PE/cardiolipin 1 µM + 0.005% 
Piericidin A + ADP-ribose 1 µM + 1 mM 
 
Table 4.7: Additives used in crystallisation trials. 
 
 
Trials were set up at 4, 10 or 17 °C in 0.03% 12M and 10% glycerol using the commercial 
screens listed in table 4.4 and the homemade screens listed in appendices 9.1 – 9.6. Again, 
the results were disappointing, with no difference in the precipitation patterns between 
trials with and without additive. 
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4.3.3 Crystallisation trials of complex I from pig and sheep heart mitochondria 
One possible solution to the ‘unwillingness’ of complex I from bovine heart mitochondria 
to crystallise is homology screening. First pioneered in the 1950’s by Kendrew and co-
workers, this technique assumes that homologous proteins exhibit small but distinct 
differences in their solvent-exposed surfaces, rendering the homologue more amenable to 
crystallisation (Kendrew, 1962).  
 Work has started in this lab to prepare complex I from various mammalian species. 
Dr. Steven Sherwood successfully purified complex I from both Sus scrofa (domestic pig) 
and Ovis aries (domestic sheep) heart mitochondria using a protocol based on that used for 
the bovine enzyme. Using mass spectrometry, Dr. Hannah Bridges characterised the 
subunits present in the complexes I from S. scrofa and O. aries, confirming that both 
contain homologous subunits to the bovine enzyme; the percentage identity calculated 
after pairwise alignment is reported in figure 4.16 (Dr. Hannah Bridges, PhD thesis). 
Unsurprisingly, there is a high level of sequence conservation amongst complex I from 
these species; however, there are differences in how the subunits of complex I from the 
different species migrate through an SDS-PAGE gel (figure 4.16). Owing to the high level 
of sequence identity, it was assumed that complexes I from S. scrofa and O. aries would 
share the same properties regarding stability as the bovine enzyme. Complex I from S. 
scrofa was prepared in 0.03% 12M and 10% glycerol, and crystallisation trials were set up 
using the eight commercial screens listed in table 4.4 and the six homemade screens listed 
in appendices 9.1 – 9.6.  
 The initial results from the crystallisation trials of complex I from S. scrofa were 
disappointing. No hits were observed from any of the eight commercial screens used, and 
the patterns of precipitation were almost identical when comparing equivalent trials of 
complex I from bovine heart mitochondria to the enzyme from pig heart mitochondria. 
Further investigation into the effect of other detergents such as 7C and 12M:13M may 
prove to be more successful. 
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Subunit B. taurus v 
S. scrofa 
B. taurus v    
O. aries 
75 kDa 95 98 
ND5 81 90 
ND4 86 93 
49 kDa 97 99 
51 kDa 99 99 
ND2 75 91 
39 kDa 86 94 
42 kDa 86 96 
ND1 88 94 
30 kDa 92 96 
24 kDa 95 99 
B22 99 98 
PDSW 93 97 
TYKY 95 99 
PSST 91 98 
PGIV 95 98 
ASHI 93 98 
B17.2 95 100 
SGDH 89 95 
B16.6 93 95 
B18 93 99 
B17 92 98 
18 kDa 92 98 
B15 87 88 
B14 93 98 
B14.7 90 95 
ESSS 89 97 
B14.5b 100 93 
B13 94 98 
ND3 90 95 
B14.5a 100 96 
15 kDa 88 90 
B12 95 98 
B8 94 100 
ND4L 86 93 
SDAP 87 98 
13 kDa 86 95 
MLRQ 92 98 
B9 85 100 
AGGG 84 98 
10 kDa 86 96 
MWFE 81 97 
MNLL 84 94 
KFYI 86 97 
ND6 88 93 
Average 90.3 96.2 
 
Figure 4.16: Subunit composition of complexes I from Bos taurus, Ovis aries and Sus 
scrofa, and their sequence homology. Left; complexes I from B. taurus (bovine), O. aries 
(sheep) and S. scrofa (pig) heart mitochondria were isolated according to the preparation 
for the bovine enzyme, and analysed using SDS-PAGE (Dr. Steven Sherwood). Right; 
unprocessed sequences were aligned using ClustalW; values represent percentage identity 
between B. taurus and S. scrofa, and between B. taurus and O. aries (Dr. Hannah Bridges). 
Notes: Mr = molecular mass markers. 
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4.4 Conclusions and discussion 
4.4.1 Crystallisation trials of mammalian complex I 
Despite extensive stability trials, which led to the preparation of protein that remained 
stable and monodisperse over the course of a week, and the preparation of over 40,000 
crystallisation trials, only three promising hits were observed. Exhaustive optimisation 
around these ‘hits’ failed to produce crystals of sufficient size to analyse; table 4.8 
summarises the different conditions tested during the quest to crystallise complex I from 
bovine heart mitochondria.  
 
 
Variable  Range tested 
Species B. taurus, S. scrofa 
Detergent 0.5% 13M, 0.03 – 1% 12M, 0.1% 11M, 0.03 – 2% 7C 
Glycerol 0, 5, 10 and 20% 
Temperature 4, 10, 18 and 22 °C 
pH pH 5.5 – 8.5 
Buffer tris, MES, MOPS, HEPES 
Precipitants PEG 400, PEG 1500, PEG 2000,  PEG 2000 MME, PEG 3350, PEG 4000 
Technique Sitting drop, hanging drop, microbatch 
Commercial screens 8 screens used (listed in table 4.3) 
Additives 0.005% PC/PE/Cardio, 0.005% asolectin, 1 µM piericidin,  2.3 µM rotenone, 2.5 mM NAD+, 1 mM ADP-Ribose 
 
Table 4.8: Summary of the variables tested in the attempt to crystallise complex I 
from bovine heart mitochondria. Conditions in bolded italics represent variables tested 
by Dr. Jiapeng Zhu in the laboratory of Dr. Judy Hirst. 
 
 
Realistically, the crystals observed in the three ‘hit’ conditions could be composed of salt, 
detergent, cytochrome c oxidase or complex I; however, there is evidence for and against 
each of these possibilities. The crystals were analysed at the Diamond synchrotron in 
Oxfordshire by Drs. Edmund Kunji and Jonathan Ruprecht (MRC MBU); no diffraction 
was detected, revealing they are not crystals of salt. Furthermore, the work described in 
section 4.3.2 revealed that cytochrome c oxidase from B. taurus crystallises readily in a 
range of detergents, precipitants, temperatures and pH values; the crystals grown are 
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specific to only a few conditions, suggesting that they are not cytochrome c oxidase. The 
final possibility is detergent; however, the crystals do not share the morphological 
properties of detergent crystals, described in section 4.3.2. 
 
4.4.2 The lack of crystals  
Any process in nature is dictated by the change in Gibbs free energy, ∆G°, which is 
governed by two factors; the change of enthalpy of the system, ∆H°, and the change in 
entropy of the system, ∆S°. As with all processes, crystallisation can proceed only if ∆G° 
is negative; 
 
∆G° = ∆H° - T∆S°
 
 
Equation 4.1 
 
In contrast to the crystallisation of inorganic salts, ∆G° for the crystallisation of proteins 
is only moderately negative (Vekilov, 2003); even slight changes in the system can make 
crystallisation thermodynamically impossible. Evaluation of the individual contributions of 
∆H° and ∆S° suggests that protein crystallisation is primarily an entropically-driven 
process, as ∆H° is often insignificant (Derewenda and Vekilov, 2006). The incorporation 
of protein molecules into an ordered, three-dimensional crystal lattice, and the subsequent 
loss of degrees of freedom, is entropically prohibitive; it is the release of bound water and 
solvent from the surface of protein molecules as they are incorporated into the crystal 
lattice that provides the entropic compensation that allows for crystallisation (Vekilov, 
2003). If this entropic barrier is not overcome, crystallisation will not occur, irrespective of 
protein stability.  
 Estimates suggest that only 20% of successfully expressed, soluble proteins 
produce crystals of suitable quality for structural determination using X-ray 
crystallography (Hui and Edwards, 2003); the success rate for membrane proteins is far 
less. Established in May 2004 with a total budget of over €10 million, the European 
Membrane Protein Consortium (E-MeP) is devoted to the structural biology of integral 
membrane proteins (www.e-mep.org). Of the 173 proteins successfully expressed by the 
end of 2009, only 40 had been crystallised, of which the structures of 11 had been solved. 
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4.4.3 Future perspectives 
Hunte and co-workers recently reported the structure of complex I from Y. lipolytica to 6.3 
Å (Hunte et al., 2010). The enzyme was crystallised using the hanging drop vapour 
diffusion method at 18 °C, over wells containing 6% PEG 3350, 40 mM calcium-acetate, 
12% glycerol, pH 6.2 to pH 7.0. The authors observed that the largest single-diamond 
shaped crystals reached a size of up to 1 mm in length after about one week. Complex I 
from Y. lipolytica, composed of 40 subunits and with a mass of 946 kDa, is significantly 
larger than its bacterial counterpart, and provides a proof-of-principle that enzymes of this 
size and asymmetry can be crystallised.  
 Although extensive crystallisation trials of complex I from bovine heart 
mitochondria proved unsuccessful, only a very brief investigation was been carried out 
into the crystallisation properties of complexes I from other mammalian species. 
Furthermore, Dr. Hannah Bridges in our laboratory has isolated complexes I from two 
Picchia species, providing two additional eukaryotic models for structural studies (Bridges 
et al., 2009). It is hoped that crystals of sufficient size and quality for structural 
determination will be obtained of eukaryotic complex I in the near future.  
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Chapter 5: 
Reaction of hydrophilic ubiquinones with the reduced flavin mono-
nucleotide in complex I 
 
 
5.1 Introduction 
In most mammalian mitochondria, complex I reduces ubiquinone-10 (Q10), comprising the 
hydrophilic ubiquinone headgroup and ten isoprenoid units. The isoprenoid chain renders 
Q10 extremely hydrophobic, confining it to the membrane, and excluding any possibility of 
its dissociation into the mitochondrial matrix. The extreme hydrophobicity of Q10 also 
precludes its use in studies of the isolated enzyme, as assays require a significant 
concentration of quinone to be present in predominantly aqueous solutions; consequently, 
relatively hydrophilic quinones are used in functional studies of complex I. Many studies 
have shown that hydrophilic ubiquinones are also reduced in a second, non-energy 
transducing reaction (which is insensitive to inhibitors such as rotenone and piericidin A); 
however, this pathway has not been well defined. It is of use, therefore, to characterise 
these reactions to see whether they are of physiological importance, or just an 
experimental inconvenience. 
 
5.1.1 Inhibitors of complex I    
Over sixty different families of compounds are known to inhibit complex I. The vast 
majority of them specifically inhibit the NADH:quinone oxidoreductase activity of the 
enzyme without inhibiting the reduction of hydrophilic electron acceptors such as FeCN 
and HAR (Gutman et al., 1970). Therefore, these inhibitors are thought to specifically bind 
to, and inhibit at, the physiological quinone binding site (Degli Esposti, 1998). 
 Two classification systems for compounds which inhibit the NADH:quinone 
oxidoreductase activity of complex I have been proposed (Friedrich et al., 1993; Degli 
Esposti, 1998). Using complex I from bovine heart, N. crassa and E. coli, and the glucose: 
ubiquinone oxidoreductase from Gluconobacter oxidans, Friedrich and co-workers 
investigated the inhibitory effect of ten naturally occurring compounds on the 
NADH:ubiquinone oxidoreductase activities. They found that the inhibitors could be 
divided into two classes with respect to their specificity and mode of action. Class I 
inhibitors, exemplified by piericidin A, inhibit complex I from all three species in a 
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partially competitive manner and glucose dehydrogenase in a competitive manner. Class II 
inhibitors, exemplified by rotenone, inhibit complex I from all three species in a non-
competitive manner, but have no effect on glucose dehydrogenase (Friedrich et al., 1993). 
A second classification, based on the fundamental mode of action, was proposed by Degli 
Esposti. Type A complex I inhibitors, exemplified by piericidin A and rolliniastatin-2, are 
antagonists of the ubiquinone substrate, and broadly correlate to the class I inhibitors 
proposed by Friedrich and co-workers. Type B inhibitors, exemplified by rotenone, 
displace the ubisemiquinone intermediate, and are equivalent to class II inhibitors. Finally, 
type C inhibitors are antagonists of the ubiquinol product, and are exemplified by 
mxyothiazol and stigmatellin (Degli Esposti, 1998). 
 Several groups have proposed that the inhibitor binding site is made up of the 49 
kDa and PSST subunits of complex I. Darrouzet and co-workers showed that a single 
missense mutation in the gene encoding the 49 kDa subunit conferred rotenone and 
piericidin resistance in the bacterium R. capsulatus (Darrouzet et al., 1998), a result 
confirmed using site-directed mutagenesis in Y. lipolytica (Ahlers et al., 2000; Kashani-
Poor et al., 2001). A photoreactive derivative of the complex I inhibitor pyridaben resulted 
in specific labelling of the PSST subunits in membranes from Paracoccus dentrificans and 
T. thermophilus (Schuler et al., 1999; Nakamaru-Ogiso et al., 2003). Several reports have 
suggested that subunits which are integral to the membrane are also important for inhibitor 
binding. Photolabelling studies using the inhibitor [3H]dihydrorotenone identified subunit 
ND1 as important in inhibitor binding (Earley and Ragan, 1984; Earley et al., 1987), and 
investigations on human disease-causing mutations suggest the ND4 subunit is also 
involved in rotenone binding (Degli Esposti et al., 1994; Majander et al., 1996). 
 Guided by the structure of the hydrophilic domain from T. thermophilus, Fendel 
and co-workers used site-directed mutagenesis of the 49-kDa and PSST subunits of 
complex I from Y. lipolytica to further investigate the inhibitor binding site (Fendel et al., 
2008). Mutagenesis of four hydrophobic residues, which define the opening to the large 
binding pocket around cluster 4Fe[PS], affected the affinities of all three classes of 
inhibitors. Mutations within the proposed binding cavity differentially affected the affinity 
of inhibitors from the different classes. Using these data, the authors concluded that the 
binding sites for class I/type A and class II/type B inhibitors largely overlap, supporting 
previous competitive binding assays which suggested that inhibitors from both classes bind 
to distinct, but partially overlapping, sites in a single, large pocket (Okun et al., 1999). 
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5.1.2 The quinone binding sites of complex I 
5.1.2.1 Quinones as substrates for complex I 
Ubiquinone (coenzyme Q10 or Q10) is a lipid-soluble coenzyme synthesised by respiring 
organisms. In the mitochondrial inner membrane it acts as a mobile electron carrier, 
transporting electrons between complexes I and II and complex III. In most mammalian 
mitochondria, complex I reduces ubiquinone-10 to ubiquinol-10 in two one-electron steps 
(figure 5.1).  
 
 
 
 
Figure 5.1: Quinones, semiquinones and quinols. Top; the physiological oxidant of 
complex I, coenzyme Q10. Bottom; the two steps of quinone reduction/quinol oxidation. 
Em for the Q/Q•- couple (step 1) is usually at least 100 mV more negative than Em for the      
Q•-/QH2 couple (step 2). Adapted from (Nicholls and Ferguson, 2002) 
 
 
The 50-carbon isoprenoid chain renders ubiquinone-10 extremely hydrophobic, excluding 
any possibility of its dissociation into the mitochondrial matrix, and precluding its use in 
studies of isolated complex I. Consequently, relatively hydrophilic quinones are used in 
functional studies of complex I instead, commonly decylubiquinone (DQ), ubiquinone-1 
(Q1) and ubiquinone-0 (Q0); their structures are shown below in figure 5.4. 
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Although rotenone and piericidin A are potent inhibitors of Q10 and DQ reduction by 
complex I, many studies have observed that Q1 and Q0 are also reduced at a second site in 
an ‘inhibitor-insensitive’ reaction (Schatz and Racker, 1966; Ragan, 1978; Di Virgilio and 
Azzone, 1982; Degli Esposti et al., 1996). Here, the physiological, proton-translocating, 
inhibitor-sensitive Q-site is referred to as the ‘hydrophobic site’, and the non-proton 
translocating, non-physiological, inhibitor-insensitive site as the ‘hydrophilic site’. The 
rates of reduction at the two sites are influenced by the identity and hydrophobicity of the 
ubiquinone, and, in studies of the isolated enzyme, by the presence and concentration of 
phospholipids in the assay medium (Estornell et al., 1993; Fato et al., 1996; Lenaz, 1998).  
 
5.1.2.2 The hydrophobic site 
A possible binding site for the quinone headgroup has been identified in the structure of 
the hydrophilic domain of complex I from T. thermophilus, close to cluster 4Fe[PS] and 
the interface with the membrane domain (Sazanov and Hinchliffe, 2006).  
   
 
 
 
Figure 5.2: Possible quinone binding site of complex I from T. thermophilus. Left; 
close-up of the quinone-binding site, viewed from the membrane space up toward the 
peripheral arm. Residues likely to interact with the quinone are shown. Right; the likely 
quinone-binding cavity (Q) at the interface of the hydrophobic and hydrophilic domains. 
Helix H1 from subunit Nqo6 (PSST), the 4-helix bundle from subunit Nqo8 (ND1) and 
cluster 2Fe[PS]/N2 are indicated. Adapted from (Sazanov and Hinchliffe, 2006; Efremov 
et al., 2010) 
 
 
Based on the structure of the hydrophilic domain from T. thermophilus, Tocilescu and co-
workers used site-directed mutagenesis of the 49 kDa and PSST subunits to investigate the 
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proposed ubiquinone binding cavity in Y. lipolytica (Tocilescu et al., 2007). They showed 
that the changes in catalytic activity formed a consistent pattern, allowing them to identify 
three functionally important regions near cluster 4Fe[PS]. Mutations in the 49 kDa subunit 
helped the authors to define a likely entry path for ubiquinone, and to identify a 
functionally critical structural motif in the active site consisting of Tyr114 surrounded by 
three conserved hydrophobic residues (Tocilescu et al., 2007).   
 
5.1.2.3 The hydrophilic site 
The possible location of the hydrophilic site has not been as well defined; figure 5.3 
presents a summary of the proposed locations of the inhibitor-insensitive reaction. Broadly 
speaking, the proposals can be divided into three categories. 
 
 
 
 
Figure 5.3: Possible sources of the inhibitor-sensitive pathway. The possible sources of 
the inhibitor-insensitive reaction are discussed in the text. Adapted from (Clason et al., 
2010; Sazanov and Hinchliffe, 2006) 
 
 
The hydrophobic site 
Several groups have proposed that the hydrophilic reaction occurs at the hydrophobic site. 
Brandt and co-workers have shown that the rate of Q1 reduction using the peripheral 
domain of complex I from Y. lipolytica is comparable to that of the intact enzyme; 
however, this rate is completely insensitive to rotenone. They propose that the 
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physiological ubiquinone binding site is composed of two domains; a hydrophilic site 
found in the peripheral portion of complex I that catalyses the inhibitor-insensitive 
reduction of hydrophilic quinones, and a hydrophobic site, not present in the subcomplex, 
which catalyses the reduction of the physiological quinone in a rotenone-sensitive manner 
(Zickermann et al., 2003).  
 Using the complex I inhibitors rotenone, annonacin and rolliniastatin-2, and the 
quinones DQ and Q1, Tormo and Estornell propose that the physiological quinone binding 
site has both hydrophobic and hydrophilic domains for quinone reduction which are 
differentially sensitive to inhibitors (Tormo and Estornell, 2000). They argue that Q1 can 
only react at the hydrophilic site, whereas DQ can bind to and react at both the 
hydrophobic and hydrophilic sites. 
 Degli Esposti and co-workers have proposed that hydrophilic quinones are reduced 
by a protein-bound semiquinone formed from endogenous quinone during the catalysis of 
complex I at a hydrophilic site (Degli Esposti et al., 1996). Unlike Tormo and Estornell, 
they suggest that the physiological site of quinone reduction is distinct from the 
hydrophilic site and is embedded within the transmembrane domain of the enzyme 
complex, only reacting with exogenous quinones if they are sufficiently hydrophobic to 
partition into the membrane phase (Degli Esposti et al., 1996).  
 
The iron-sulphur clusters 
Genova and co-workers showed that the rate of superoxide production by complex I 
increases dramatically in the presence of short-chain hydrophilic quinones, and proposed 
that this results from direct reduction by the iron-sulphur clusters of complex I. They argue 
that cluster 4Fe[PS] is the most likely reductant of hydrophilic quinones, as it has the 
highest midpoint potential of the iron-sulphur clusters of complex I, its redox potential is 
pH-dependent, and it is located at the interface between the peripheral and membrane 
domains (Genova et al., 2001). Degli Esposti and co-workers have also suggested that the 
residual rotenone-insensitive oxidative of NADH in the presence of hydrophilic quinones 
is mainly due to pro-oxidant interactions with the iron-sulphur cofactors of complex I. 
They go on to conclude that such pro-oxidant interactions are less pronounced for those 
analogues which efficiently penetrate the hydrophobic site (Degli Esposti et al., 1996). 
This theory is not excluded by the structure of the hydrophilic domain of complex I from 
T. thermophilus because some of the iron-sulphur clusters are within 14 Å of the solvent 
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accessible surface (Birrell et al., 2009), the limit of efficient electron transfer (Page et al., 
1999). 
 
The flavin mononucleotide 
Čénas and co-workers showed that NADH is a competitive inhibitor of 5,8-dioxy-1,4-
naphtoquinone reduction, which is insensitive to 2 µM rotenone (Čénas et al., 1991). They 
concluded that the naphtoquinone binding site is close to, but distinct from, the NADH and 
ferricyanide binding sites. 
 
5.1.3 Aims  
As discussed in section 5.1.2.3, every conceivable location has been proposed as the 
source of the inhibitor-insensitive reaction of complex I. In this chapter, I will attempt to 
answer two fundamental questions arising from these observations; 
 i.   Where is the site of the hydrophilic reaction? 
 ii.  What are the consequences of the reaction of quinones at this hydrophilic site? 
I aim to put the findings in context; many compounds have been shown to react with 
complex I, from clinically important medicines such as the anthracyclins (Davies and 
Doroshow, 1986) and idebenone (Genova et al., 2001), to herbicides such as paraquat 
(Cochemé and Murphy, 2008). Does the reaction of the hydrophilic quinones with 
complex I aid our understanding of these reactions? 
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5.2 Investigating the sites of quinone reduction by bovine complex I  
5.2.1 Quinones are reduced at two distinct sites in complex I 
To investigate the inhibitor-insensitive pathway of quinone reduction by isolated complex 
I, four relatively hydrophilic quinones (DQ, Q1, Q0 and idebenone) and two Q-site 
inhibitors (rotenone and piericidin A), were used.  
 DQ, Q1 and Q0 are commonly used in assays on the isolated enzyme; previous 
studies of complex I from bovine heart mitochondria have shown that both Q1 and Q0 
display significant rotenone-insensitive rates, whereas DQ does not (Ragan, 1978; 
Nakashima et al., 2002; Sharpley et al., 2006). The fourth quinone used, idebenone, is a 
short-chain Q10 analogue which, in its reduced form, is a potent antioxidant used as a 
treatment for Friedreich’s Ataxia (FDRA; reviewed in (Pandolfo, 2008)). Genova and co-
workers have shown that idebenone reacts with complex I in an inhibitor-insensitive 
manner, and is particularly effective at stimulating reactive oxygen species production 
(Genova et al., 2001). The structures of the four hydrophilic quinones used in this study 
are shown in figure 5.4. 
   
 
 
 
Figure 5.4: Structures of the hydrophilic quinone analogues used in this study. 
Abbreviations: decylubiquinone, DQ; coenzyme Q0, Q0; coenzyme Q1, Q1; idebenone, 
IDE. 
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Rotenone, a class II/type B complex I inhibitor, is the most potent of the rotenoids, a 
family of isoflavonoids extracted from Leguminosae plants. Piericidin A, a class I/type A 
complex I inhibitor, is a 2,3-dimethoxy-4-hydroxy-5-methyl-6-polyprenyl-pyridine 
antibiotic produced by some Streptomyces species (Degli Esposti, 1998). The close 
structural similarity to ubiquinone allows the effective inhibition by piericidin A of several 
quinone-reacting enzymes (Degli Esposti et al., 1993), however, with a KI of ~1 nM 
(Degli Esposti et al., 1994), complex I remains the most specific site of inhibition. The 
structures of rotenone and piericidin A are shown in figure 5.5. 
 
  
 
 
Figure 5.5: Structures of the complex I inhibitors used in this study. Abbreviations: 
rotenone, Rot; piericidin A, Pier. 
 
 
Figure 5.6 shows an example assay trace for the reaction between NADH and Q1 in the 
presence and absence of rotenone and asolectin. The reaction was monitored at 340 – 380 
nm (ε340 – 380 = 4.81 mM-1 cm-1) corresponding to NADH oxidation, and the initial rate 
determined over the first 30 seconds after quinone addition. 
 Table 5.1 shows how the rate of NADH:quinone oxidoreduction by complex I 
depends on the species of quinone used, the presence of exogenous phospholipids, and on 
the presence of the Q-site inhibitors rotenone and piericidin. Previous work in this 
laboratory using isolated complex I from bovine heart mitochondria showed that 2.3 µM 
rotenone and 1 µM piericidin A are sufficient to maximally inhibit NADH:quinone activity 
at the hydrophobic site of complex I. However, the hydrophobic reaction with idebenone is 
not fully inhibited with 2.3 µM rotenone; subsequent assays revealed that 23 µM rotenone 
was sufficient to inhibit the reaction at the hydrophobic site.  
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Figure 5.6: Investigating the effect of phospholipids and rotenone on the rate of 
NADH:Q1 oxidoreduction by complex I. Rates were determined in the presence and 
absence of 0.4 mg mL-1 asolectin in 0.4 mg mL-1 CHAPS (Aso), and either with or without 
2.3 µM rotenone (Rot). Absorbance was measured at 340 – 380, corresponding to NADH 
oxidation. The dashed lines define the linear phase of the reaction used for initial rate 
determination. Conditions: 100 µM Q1, 100 µM NADH, 20 mM tris-HCl pH 7.5, 32 °C.  
 
 
 
NADH:quinone oxidoreduction (µmoles NADH min-1 mg-1) 
Aso Rot Pier  DQ Q1 Q0 IDE 
+ - - 3.72 + 0.39 3.80 + 0.24 0.37 + 0.17 0.59 + 0.04 
+ + - 0.14 + 0.01 0.42 + 0.05 0.19 + 0.07 0.31 + 0.06 
+ - + 0.24 + 0.11 0.37 + 0.05 0.18 + 0.05 0.20 + 0.04 
- - - 0.37 + 0.02 0.73 + 0.09 0.21 + 0.08 0.75 + 0.08 
- + - 0.04 + 0.02 0.52 + 0.02 0.19 + 0.08 0.65 + 0.08 
- - + 0.02 + 0.02 0.45 + 0.06 0.18 + 0.09 0.43 + 0.19 
 
Table 5.1: Investigating the inhibitor-sensitive and -insensitive NADH:Q activity of 
complex I. Rates were determined in the presence and absence of 0.4 mg mL-1 asolectin in 
0.4 mg mL-1 CHAPS (Aso), and either without inhibitor, with 2.3 µM rotenone (Rot) or 1 
µM piericidin A (Pier). For the IDE reaction, 23 µM rotenone was used, as 2.3 µM did not 
fully inhibit the reaction of IDE at the hydrophobic site. Conditions: 100 µM Q, 100 µM 
NADH, 20 mM tris-HCl pH 7.5, 32 °C. The reported error is the standard deviation of five 
independent measurements.   
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When phospholipids are present, DQ and Q1 both react much more rapidly than Q0 and 
IDE, as the reaction at the hydrophobic site is activated. In the presence of rotenone or 
piericidin A, the rates of all four quinones are decreased, but the relative inhibition of DQ 
(∼95%) and Q1 (∼90%) is much greater than that of Q0 (∼50%) and IDE (∼60%), 
consistent with previous studies (Ragan, 1978; Nakashima et al., 2002). When 
phospholipids are not present the rates of all four quinones are decreased, and, again, the 
effect of the phospholipids is much greater for DQ and Q1 than for Q0 and IDE. The data 
presented in table 5.1 supports the existence of two sites for the reduction of quinones by 
complex I: a ‘hydrophobic site’ which is activated by phospholipids and inhibited by 
rotenone and piericidin A, and a ‘hydrophilic site’ which is not inhibited by rotenone or 
piericidin A.  
 Phospholipids may affect the reactivity of isolated complex I towards short-chain 
ubiquinone analogues in two ways: they may bind to the enzyme, at the active site or as a 
phospholipid annulus, to stabilize active conformations and promote catalytic activity (the 
‘enzyme effect’), or they may alter the availability of the quinone to the enzyme, by 
partitioning it into a ‘hydrophobic phase’ or by dispersing quinone micelles (the ‘quinone 
effect’). The reaction at the hydrophobic site is enhanced strongly by phospholipids in the 
assay medium, an effect that is not mimicked by similar concentrations of detergents, 
suggesting the importance of the enzyme effect. However, the addition of detergents or 
sonicated phospholipids were found to enhance the rate of DQ reduction by complex I in 
SMPs, for which the enzyme effect does not apply, probably by dispersing quinone 
micelles and aiding quinone/quinol exchange between the membrane and the aqueous 
phase (Estornell et al., 1993).   
 Assuming that the rate observed in the presence of phospholipids is the sum of the 
rates at the hydrophilic and hydrophobic sites then, for DQ, Q1, Q0 and IDE, respectively, 
the rates at the hydrophobic site are 3.70, 3.30, 0.19 and 0.15 µmoles NADH min-1 mg-1, 
and at the hydrophilic site they are 0.03, 0.49, 0.18 and 0.49 µmoles NADH min-1 mg-1. 
These data suggest that DQ reacts almost exclusively at the hydrophobic site, whereas Q1, 
Q0 and IDE can react at both sites to differing extents.  
 The relative rates of reaction of the four ubiquinones at the hydrophobic and the 
hydrophilic sites do not correlate in a simple fashion to their hydrophobicity. At the 
hydrophilic site the displacement of bound waters upon binding will tend to increase the 
affinity as the hydrophobic tail lengthens, explaining the lower rate of reaction of Q0. For 
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the more hydrophobic quinones, such as DQ, the entropic effect is opposed by their 
decreasing solubility in the external solution, so the maximum activity is observed for Q1 
and idebenone. It is possible that the binding of idebenone is enhanced by hydrogen 
bonding between its terminal hydroxyl group and a nearby charged residue in the site. For 
the hydrophobic site, Sakamoto and co-workers studied the reduction of a range of 
coenzyme Q2 derivatives by complex I (Sakamoto et al., 1998). They concluded that the 
role of the tail is not simply to enhance the hydrophobicity, and attributed the high affinity 
of Q2 itself to molecular interactions between the binding site and the first isoprene unit. 
The fact that Q2 reacts more slowly than DQ was attributed to slow dissociation of the 
ubiquinol product. The characteristics of Q2 and idebenone reduction by complex I are 
similar (Degli Esposti et al., 1996), suggesting that idebenone reduction is also limited by 
product dissociation. Thus, reactivity at the hydrophobic site requires an ‘intermediate 
affinity’ - high enough for binding and reaction, but not high enough to cause inhibition. 
DQ and Q1 react rapidly because they have intermediate affinities, idebenone reacts slowly 
because it has too high an affinity, and Q0 probably reacts slowly because it has too low an 
affinity. Importantly, the affinities are again affected by how the quinone interacts with the 
external environment, and this may differ considerably between membrane and micellular 
systems.  
 The data described above suggest that DQ is the most appropriate substrate for 
investigating the physiological reactions of complex I in systems which lack endogenous 
quinone. Under appropriate conditions it displays a substantial rate at the hydrophobic 
quinone-binding site, and a minimal rate at the hydrophilic site. For some experiments, in 
which the effects of reaction at the hydrophilic site can be subtracted out, Q1 also displays 
a substantial rate at the hydrophobic site.  
 To further explore the hydrophilic reaction of complex I, submitochondrial 
particles (SMPs) were used. Formed from the treatment of mitochondria with ultrasonic 
vibrations under appropriate conditions, SMPs are derived from the mitochondrial inner 
membrane. The major advantage of SMPs is that the proteins of the mitochondrial inner 
membrane are present within the native membrane, and the hydrophilic domain of 
complex I is accessible to the reaction buffer. Assays using bovine heart SMPs from 
bovine heart mitochondria confirmed that complex I in the mitochondrial membrane 
catalyses the inhibitor-insensitive reduction of hydrophilic quinones, suggesting that the 
hydrophilic reaction is not an artefact of protein purification. The rate of NADH:Q10 
oxidoreduction (using endogenous Q10) was 1.26 µmoles NADH min-1 mg-1, and it was 
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98% sensitive to both rotenone and piericidin A. In the presence of antimycin A (to 
prevent cycling of the endogenous quinone) the rate of Q1 reduction by the SMPs was 0.54 
µmoles NADH min-1 mg-1. In the presence of rotenone or piericidin A, the rate was ∼0.07 
µmoles NADH min-1 mg-1, giving an inhibitor sensitivity of ∼87%. Previous studies have 
investigated the inhibitor sensitivity of a range of ubiquinones using SMPs or broken 
mitochondria from bovine hearts. Estornell and co-workers reported rotenone sensitivity 
values of 72 - 77% for Q0, 95 – 96% for Q1 and 99% for DQ (Estornell et al., 1993), and 
Degli Esposti and co-workers reported values of 89% (Q1), 94% (DQ), and 63% (IDE) 
(Degli Esposti et al., 1996).  
 
5.2.2 The site of the inhibitor-insensitive reaction 
To test the hypothesis that the hydrophilic reaction occurs at the hydrophobic site, the 
inhibitor-insensitive NADH:Q1 reactions of both complex I and subcomplex Iλ were 
compared. As described in section 3.1.2, subcomplex Iλ represents the hydrophilic domain 
of complex I. Extensive EPR studies revealed that it does not contain the terminal iron-
sulphur cluster 4Fe[PS] (figure 3.9) nor does it exhibit NADH:DQ oxidoreductase activity 
(figure 3.10).  
  
 
 
 
Figure 5.7: Investigating the rotenone-sensitive and -insensitive NADH:Q1 activities 
of complex I (left) and subcomplex Iλ (right). Complex I and subcomplex Iλ incubated 
in the presence of 0.4 mg mL-1 asolectin in 0.4 mg mL-1 CHAPS either with or without 2.3 
µM rotenone. Rates are reported as µmoles NADH second-1 µmole protein-1 to allow for 
direct comparison. Conditions: 20 mM tris-HCl pH 7.5, 32 °C, 100 µM NADH. 
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Figure 5.7 compares NADH:Q1 oxidoreduction by complex I and subcomplex Iλ in the 
presence of asolectin and in the presence or absence of rotenone. The NADH:Q1 activity of 
complex I is ~90% inhibited by rotenone. However, Q1 reduction by subcomplex Iλ is 
independent of the presence of rotenone, suggesting the subcomplex is incapable of 
catalyzing the physiological reaction. Furthermore, the rates for Q1 reduction by 
subcomplex Iλ and complex I inhibited by rotenone are the same. This suggests that the 
hydrophilic site of quinone reduction is located ‘upstream’ of cluster 4Fe[PS], is fully 
conserved in subcomplex Iλ, and acts independently of the hydrophobic site, either via 
interactions with the seven remaining iron-sulphur clusters (Genova et al., 2001), or by 
direct reduction by the flavin (Cénas et al., 1991).  
 
5.2.3 The mechanism of the inhibitor-insensitive reaction 
Assays using increasing NADH concentrations displayed substrate inhibition, as observed 
previously for the transhydrogenation reaction. Yakovlev and Hirst demonstrated that the 
transhydrogenase reaction, catalysed by the flavin mononucleotide of complex I, occurs by 
ping-pong reaction kinetics: NADH is oxidised by the flavin, and NAD+ dissociates; 
APAD+ subsequently binds the reduced flavin and is reduced, forming APADH (Yakovlev 
and Hirst, 2007).  
 To test whether hydrophilic quinone analogues react by a similar mechanism at the 
NADH binding site, figure 5.8 shows how the rate of NADH:quinone oxidoreduction by 
complex I in the presence of rotenone depends on both the NADH and quinone 
concentrations for Q0, Q1 and IDE. In all cases the rate increases as the quinone 
concentration is increased, suggesting that quinone does not compete effectively with 
NADH for the oxidised flavin. However, the rate increases, then decreases, as the NADH 
concentration is increased, indicating that NADH does compete effectively with quinone 
for the reduced flavin. 
 The data in figure 5.8 can be explained by two reaction mechanisms, shown in 
scheme 5.1, which are not mutually exclusive. In the ping-pong mechanism, the reduced 
flavin is oxidised by quinone in a single two-electron step to form quinol (see figure 6.2). 
In the ping-pong-pong mechanism, the reduced flavin is oxidised by quinone in two one-
electron steps to form two semiquinones (Q•- or QH•). 
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Figure 5.8: The dependences of the rate of NADH:Q oxidoreduction at the 
hydrophilic site on NADH and Q concentration. Top left; dependence of NADH:Q1 
oxidoreduction on Q1 concentration in 30 and 100 µM NADH. Top right; dependence of 
NADH:Q1 oxidoreduction on NADH concentration in 100 and 250 µM Q1. These data 
have been fitted using the ping-pong mechanism, using the parameters in row 4 of table 
5.2. Bottom left; dependence of NADH:Q0 oxidoreduction on NADH concentration in 100 
and 250 µM Q0. Bottom right; dependence of NADH:IDE oxidoreduction on NADH 
concentration in 100 and 250 µM IDE. These data have been fitted using the ping-pong-
pong mechanism, using the parameters in rows 11 and 12 of table 5.2. Conditions: 32 °C, 
20 mM tris-HCl pH 7.5, 2.3 µM rotenone (Q1 and Q0) or 23 µM rotenone (IDE).  
 
 
Equations 5.1 and 5.2 were derived from scheme 5.1 (the derivations are presented in 
appendices 9.7 and 9.8), for the ping-pong and ping-pong-pong reaction pathways, 
respectively, using the steady-state approximation. Both rate equations contain all the 
kinetic parameters defined in scheme 5.1. To limit the number of potential parameter 
combinations, the NADH dependent values (KMNADH, kcatNADH and KRedNADH) were set to 
the same values for each quinone, using values suggested by the transhydrogenase reaction 
(94 µM, 2700 s-1 and 200 µM, respectively (Yakovlev and Hirst, 2007)), and the quinone-
dependent parameters were allowed to vary freely.  
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Scheme 5.1: The ping-pong and ping-pong-pong mechanisms used to describe the 
rotenone-insensitive NADH:Q1 reaction. The ping-pong and ping-pong-pong reactions 
diverge at [FlRed Q]: the ping-pong reaction follows the dotted arrow to produce QH2 and 
return directly to [FlOx], the ping-pong-pong reaction follows the outside pathway to form 
two semiquinones (QH•).  FlOx/Red - oxidised or reduced state of the flavin; [ ] - enzyme 
bound species; kcat - first order rate constant for substrate transformation and product 
dissociation; KM - Michaelis-Menten constant; KOx/Semi/Red - dissociation constant, referring 
to the oxidised, semi-reduced, or reduced enzyme state. The model shown is for the 
NADH:Q1 reaction, but will be applied to all the hydrophilic quinone analogue reactions 
studied. 
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Equation 5.1: Rate equation for the ping-pong reaction mechanism. The derivation of 
this equation is shown in appendix 9.7. 
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Equation 5.2: Rate equation for the ping-pong reaction mechanism. The derivation of 
this equation is shown in appendix 9.8. 
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Ping-pong 
mechanism 
KMNADH 
(µM) 
kcatNADH 
(s-1) 
KRedNADH 
(µM)  
KMQ 
(µM) 
kcatQ 
(s-1)   
LSQE/ 
LSQEmin 
Q1 354 56.6 2.9 
Q0 292 15.2 1.2 
IDE 
94 2700 200  
5225 660 
  
1.7 
Q1 70 200 47.4 1 
Q0 300 345 16.2 1 
IDE 
94 2700 
300 
 
3770 450 
  
1 
Ping-pong-pong 
mechanism 
KMNADH 
(µM) 
kcatNADH 
(s-1) 
KRedNADH 
(µM) 
KSemiNADH 
(µM) 
KMSQ 
(µM) 
kcatSQ 
(s-1) 
KM2SQ 
(µM) 
kcat2SQ 
(s-1) 
LSQE/ 
LSQEmin 
Q1 354 113.2 354 113.2 2.9 
Q0 292 30.4 292 30.4 1.2 
IDE 
94 2700 200 200 
5225 1320 5225 1320 1.7 
Q1 205 500 205 50.3 1 
Q0 250 14.2 250 242.5 1 
IDE 
94 2700 300 70 
3880 479 3880 20000 1.1 
 
Table 5.2: Kinetic parameters for the reduction of Q1, Q0 and IDE at the hydrophilic, 
flavin site in complex I, determined by fitting experimental data to the ping-pong and 
ping-pong-pong mechanisms. The modelling was carried out by Dr. Judy Hirst. 
 
 
The experimental data sets for the NADH:Q reactions were fitted to equations 5.1 and 5.2 
by Dr. Judy Hirst using a computer program coded in C. First, data sets for the dependence 
of rate on NADH and quinone concentration were fitted for Q0, Q1 and IDE with equation 
5.1, by varying each parameter to minimise the sum of the squares of the errors (the least 
squares error (LSQE)) between the data points and their equivalent calculated values. 
Table 5.2 presents the best fit data derived from modelling. Satisfactory fits were obtained 
in all cases using the ping-pong reaction mechanism, but, for the best fits, Q1 required a 
lower value of KRedNADH (70 µM) than Q0 and IDE (300 µM). Allowing KMNADH and 
kcatNADH to vary did not provide a common best-fit value for KRedNADH.  
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Second, an equivalent analysis was carried out with equation 5.2. With KSemiNADH = 
KRedNADH, KMSQ = KM2SQ, and kcatSQ = kcat2SQ, the fits using the transhydrogenase 
parameters were identical to those described above (see table 5.2).  However, by using 
KRedNADH = 300 µM, and KSemiNADH = 70 µM (consistent with tighter NADH binding when 
the flavin is more oxidised), and by allowing kcat1SQ and kcat2SQ to differ, good fits could be 
derived using the same NADH parameters for each quinone species; differences in kcat1SQ 
and kcat2SQ are expected to result from the differing reactivity of the one and two-electron 
reduced states of the flavin. The important point to note is that the experimental data for 
the reaction of hydrophilic quinones at the flavin can be modelled with the same NADH 
parameters as the transhydrogenase reaction. The simplified nature of scheme 5.1, together 
with the fact that a wide range of parameter values can be used to model the data, makes 
further analysis meaningless. 
 
5.2.4 Conclusions and discussion 
Two pieces of evidence suggest strongly that the hydrophilic site of quinone reduction in 
complex I is the flavin site at which NADH is oxidised: the hydrophilic reaction is 
conserved in a preparation of subcomplex Iλ which lacks the terminal iron-sulphur cluster 
4Fe[PS] and the hydrophobic Q-binding site, and it is inhibited by high NADH 
concentrations and can be explained mechanistically using ping-pong or ping-pong-pong 
kinetics using parameters derived from the study of transhydrogenation reactions at the 
flavin (Yakovlev and Hirst, 2007).  
 Ping-pong reactions involving NADH and quinones at flavins have been studied 
extensively in other NADH:quinone oxidoreductases (Eschemann et al., 2005). Alternative 
NADH:dehydrogenases are respiratory chain enzymes found in many plant, fungal and 
bacterial species that carry out the same redox reactions as the mitochondrial enzyme 
without contributing to the proton motive force across the respiratory membrane. Typically 
~50 kDa in size, they are composed of one single polypeptide chain with no 
transmembrane domain and a bound FAD (Melo et al., 2004). Although they are 
insensitive to the complex I inhibitors rotenone and piericidin A, Eschemann and co-
workers identified a high affinity inhibitor of the alternative dehydrogenase from Y. 
lipolytica. Using this compound, HDQ (1-hydroxy-2-dodecyl-4(1H)quinolone), the 
authors analysed the bisubstrate and inhibition kinetics for NADH and DQ and found that 
the kinetics of the alternative dehydrogenase followed a ping-pong mechanism, suggesting 
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that NADH and the ubiquinone headgroup interact with the same binding pocket in an 
alternating fashion (Eschemann et al., 2005).  
  
 
 
 
Figure 5.9: The binding of duroquinone with the FAD cofactor of NAD(P)H:quinone 
oxidoreductase. Left; duroquinone (shown in orange), stacked below the flavin 
isoalloxazine system of the bound FAD (shown in blue). Right; the structure of 
duroquinone. Adapted from (Faig et al., 2000). PDB accession code: 1DXO. 
 
 
NAD(P)H:quinone oxidoreductase type 1 is a flavoenzyme that catalyses the obligatory 
two-electron reduction of quinones to hydroquinones (Faig et al., 2000). This reaction 
prevents the one-electron reduction of quinones by cytochrome P450 reductase and other 
flavoproteins which result in oxidative cycling of deleterious radical species. In addition to 
its possible role in the detoxification of dietary quinone, the enzyme has been shown to 
catalyse the reductive activation of quinolic chemotherapeutic compounds such as 
anthracyclins and mitomycins (Siegel et al., 1990). The structure of duroquinone bound to 
human NAD(P)H:quinone oxidoreductase has been solved to 2.5 Å (Faig et al., 2000); 
figure 5.9 shows the quinone ring stacks above the flavin isoalloxazine system, providing a 
visual representation for how quinones may bind and react at the flavin site in complex I. 
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5.3 Consequences of quinone reduction at the flavin of complex I 
5.3.1 The super-stoichiometric oxidation of NADH 
Previous studies have shown that the hydrophobic reaction stimulates reactive oxygen 
species production by complex I; unstable semiquinones formed at the hydrophilic site 
reduce oxygen to superoxide and hydrogen peroxide, regenerating quinone (Genova et al., 
2001). As the reaction between NADH and quinone is a two-electron transfer with a 1:1 
stoichiometry, super-stoichiometric oxidation of NADH would provide evidence of semi-
quinone formation and redox cycling with oxygen.    
 Figure 5.10, top left, shows that 50 µM Q1 is able to oxidise more than 50 µM 
NADH, irrespective of the reaction conditions. In the presence of asolectin and absence of 
rotenone, the hydrophobic reaction predominates, reflected by the fast initial rate of 
NADH oxidation; the extent of super-stoichiometry is limited, as quinols formed at the 
hydrophobic site are stable. Conditions which favour the reaction of quinones at the flavin 
increase the super-stoichiometry to differing extents. 
 Figure 5.10, top right, shows that super-stoichiometric reactions do not occur 
unless O2 is present. The rates of NADH oxidation do not depend on the presence of O2, 
suggesting that O2 acts indirectly as a terminal electron acceptor. These data are consistent 
with the theory that semiquinones formed at the hydrophilic site react with oxygen, 
forming reactive oxygen species, regenerating the parent quinone to react again.  
 Figure 5.10, bottom left, shows that NADH:DQ oxidoreduction in the presence of 
asolectin is stoichiometric in both the presence and absence of O2, confirming that the 
physiological reaction produces only quinol, and that super-stoichiometry is associated 
only with reactions at the flavin site.  
 Figure 5.10, bottom right, compares the reactions of Q1, IDE, and Q0 with complex 
I in the presence of both asolectin and rotenone, all of which are super-stoichiometric due 
to the hydrophilic reaction at the flavin. The extent of the super-stoichiometry is dependent 
on the rate of the hydrophilic reaction for the quinones tested. The data in table 5.1 shows 
that the rate of NADH:quinone oxidoreduction is 0.42 µmoles NADH min-1 mg-1 for Q1, 
0.19 µmoles NADH min-1 mg-1 for Q0 and 0.31 µmoles NADH min-1 mg-1 for IDE, a trend 
mirrored in the extent of the super-stoichiometry observed for each quinone. 
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Figure 5.10: Investigating the super-stoichiometric oxidation of NADH. Complex I 
was incubated in the presence of ∼50 µM Q (dotted lines) in varying concentrations of 
NADH (0 to 200 µM). The NADH concentrations were measured at two minute intervals, 
and the amount of NADH oxidised determined by comparing measured and initial NADH 
concentrations. Top left; NADH oxidation by 50 µM Q1 in an aerobic solution in the 
presence or absence of rotenone (Rot) and/or asolectin (Aso). Top right; an experiment 
equivalent to top left but in anaerobic conditions. Bottom left; NADH oxidation by 50 µM 
DQ in aerobic solution in the presence of asolectin, in anaerobic and aerobic solutions. 
Bottom right; NADH oxidation by 50 µM Q1, IDE and Q0 in aerobic solution in the 
presence of rotenone and asolectin. Conditions: 20 mM tris-HCl pH 7.5, 32 °C, 2.3 µM 
rotenone, 0.4 mg mL-1 asolectin. 
 
 
5.3.2 Redox cycling reactions of the quinones at the flavin site 
To investigate the effect of the reaction of hydrophilic quinones at the flavin on the 
production of reactive oxygen species, hydrogen peroxide and superoxide production were 
monitored using two well established detection systems. In the presence of horseradish 
peroxidase (HRP), Amplex Red reacts with hydrogen peroxide with a 1:1 stoichiometry to 
produce the highly fluorescent molecule resorufin, which can be monitored spectrophoto-
metrically. Superoxide production was monitored using the reduction of acetylated 
cytochrome c (Azzi et al., 1975). 
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Figure 5.11, left, shows a typical assay investigating how the rate of hydrogen peroxide 
production by complex I depends on the species of quinone used and on the presence of 
oxygen; table 5.3 presents a comprehensive summary of data using the Amplex Red 
detection system for each of the four quinone species. 
 
 
 
 
Figure 5.11: The effects of DQ, Q1 and O2 on left, resorufin formation (H2O2 
production), and right, cytochrome c reduction (superoxide production). The assay 
traces show resorufin formation (∆ε557-620 nm = 51.6 ± 2.5 mM-1 cm-1) and cytochrome c 
reduction (∆ε550 – 541 nm = 18.0 ± 0.6 mM-1 cm-1) under aerobic and anaerobic conditions. 
The assays began in a solution containing complex I; NADH was added, followed by 
either DQ or Q1. Conditions: 20 mM tris-HCl pH 7.5, 32 °C, 30 µM NADH, 100 µM Q, 
2.3 µM rotenone, 2 units mL-1 HRP, 10 µM Amplex Red and 50 µM cytochrome c. 
 
 
The rate of hydrogen peroxide formation by complex I in the presence of asolectin is 
essentially independent of the presence of DQ, consistent with the theory that quinols 
produced at the hydrophobic site are stable end-products. The rate observed (33.9 nmol 
min-1 mg-1) is similar to the basal rate of hydrogen peroxide production from the direct 
reaction of oxygen with the reduced flavin (29.7 nmol min-1 mg-1), is ~90% sensitive to 
catalase, and is essentially abolished in the absence of oxygen (Kussmaul and Hirst, 2006). 
In the absence of asolectin the rate of hydrogen peroxide formation is enhanced only 
slightly by the formation of semiquinone.  
 In the presence of Q1, the rate of hydrogen peroxide production increases ten-fold 
over basal levels to ~300 nmol min-1 mg-1, consistent with the theory that formation of 
semiquinones at the flavin site initiates redox cycling reactions with oxygen. In the 
absence of oxygen, there is a background reaction between one or more reduced quinone 
species and the Amplex Red detection system which is catalase-insensitive (Winterbourn, 
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1981). The rate of hydrogen peroxide formation using Q0 is significantly lower than that 
for Q1 and idebenone, reflecting the slower rate of reaction at the flavin site. For both 
quinones, the rate of hydrogen peroxide production by complex I in the absence of 
asolectin is significantly higher than in its presence, consistent with the idea that the 
hydrophobic reaction, which is activated by phospholipids, produces only stable quinol. In 
the absence of asolectin, the hydrophilic reaction at the flavin predominates, accelerating 
hydrogen peroxide formation. As with Q1, there is a background reaction between one or 
more reduced quinone species and the Amplex Red detection system which is not sensitive 
to the addition of catalase or oxygen. 
  
 
Resorufin formation (nmol min-1 mg-1) 
Aso Rot O2 CAT DQ Q1 Q0 IDE 
+ - + - 33.9 ± 0.1 303.8 ± 21.0 29.7 ± 3.2 119.7 ± 1.3 
+ + + - 29.4 ± 6.6 234.6 ± 1.2 26.2 ± 0.8 123.0 ± 0.3 
- - + - 40.9 ± 4.6 307.7 ± 4.4 38.0 ± 2.5 246.6 ± 11.4 
- + + - 41.5 ± 2.0 300.1 ± 32.8 38.5 ± 5.7 257.8 ± 12.9 
- + + + 3.6 ± 0.3 23.0 ± 1.2 16.0 ± 0.7 23.5 ± 2.3 
- + - - 1.0 ± 0.4 24.9 ± 1.6 9.6 ± 0.8 25.4 ± 3.6 
 
Table 5.3: The dependence of resorufin formation (H2O2 production) on the species 
of quinone used, and on the presence of asolectin, rotenone, O2 and catalase. 
Conditions: 20 mM tris-HCl pH 7.5, 32 °C, 30 µM NADH, 100 µM Q, + O2 = atmospheric 
O2, - O2 = anaerobic glove box, Aso = 0.4 mg mL-1 asolectin, Rot = 2.3 µM rotenone, or 
10 µM rotenone for IDE, CAT = 10,000 units mL-1 catalase, 2 units mL-1 HRP, and 10 µM 
Amplex Red. 
 
 
Figure 5.11, right, shows equivalent experiments using acetylated cytochrome c, to 
investigate how the rate of superoxide production by complex I depends on the species of 
quinone used and on the presence of oxygen; table 5.4 presents a comprehensive summary 
of data for each of the four quinone species. In the absence of quinone, the basal rate of 
cytochrome c reduction is small, and abolished in the absence of O2 (Kussmaul and Hirst, 
2006). When DQ is added, the rate of superoxide production does not increase 
significantly, and it is ~87% sensitive to superoxide dismutase (SOD). Interestingly, in the 
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absence of oxygen, the reduction of cytochrome c is not fully SOD-sensitive, suggesting 
that there is a background reaction between one or more of the quinol species produced.  
  
 
Cytochrome c reduction (nmol min-1 mg-1) 
Aso Rot O2 SOD DQ Q1 Q0 IDE 
- + + - 48.4 ± 3.3 532.0 ± 32.6 276.8 ± 5.0 432.7 ± 3.0 
- + + + 6.4 ± 2.5 203.4 ± 6.8 125.7 ± 2.5 208.6 ± 18.3 
- + - - 26.2 ± 3.0 609.0 ± 14.6 315.3 ± 4.7 461.6 ± 9.5 
- + - + 24.3 ± 0.9 552.4 ± 5.2 263.1 ± 1.9 419.5 ± 23.2 
 
Table 5.4: Cytochrome c reduction (O2•- formation) in the presence of hydrophilic 
quinones depends on the presence of asolectin, rotenone, O2 and SOD. Conditions: 20 
mM tris-HCl pH 7.5, 32 °C, 30 µM NADH, 100 µM Q, + O2 = atmospheric O2, - O2 = 
anaerobic glove box, Aso = 0.4 mg mL-1 asolectin, Rot = 2.3 µM rotenone, or 10 µM 
rotenone for IDE, CAT = 10,000 units mL-1 catalase, SOD = 50 units mL-1 Cu-Zn-SOD, 50 
µM cytochrome c, 2 units mL-1 HRP, and 10 µM Amplex Red.   
 
 
When Q1 is added, a significant increase in cytochrome c reduction is observed, both in the 
presence and absence of O2. This rate is only partially SOD-sensitive: in addition to being 
reduced by superoxide, cytochrome c is also reduced directly by semiquinone radicals, 
with the interpretation of experimental data complicated further by equilibria being 
established between O2 and semiquinone, and superoxide and quinone (Winterbourn, 
1981). As expected, one-electron cytochrome c reduction (in the absence of asolectin and 
the presence of rotenone) is close to twice as fast as two-electron H2O2 formation. Q0 and 
idebenone cause significantly more cytochrome c reduction than H2O2 formation. It is 
possible that the hydrophilic Q0 semiquinone is more stable in aqueous solution, persisting 
for a longer period of time. Although the absolute rates of hydrogen peroxide formation 
vary between Q0 and idebenone, both show the same dependence of rate on asolectin, 
rotenone and oxygen.  
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5.3.3 Conclusions and discussion 
The super-stoichiometric oxidation of NADH by Q1, Q0 and idebenone, a phenomenon 
which is abolished in the absence of oxygen, initiates redox cycling reactions with oxygen, 
regenerating the parent quinone to react again. This reaction is specific for the flavin site; 
DQ, which reacts at the hydrophobic site, does not participate in these reactions, and 
conditions which favour the reduction of hydrophilic quinones at the hydrophobic site 
decreases the super-stoichiometry. As expected, the rates of superoxide and hydrogen 
peroxide generation are increased dramatically; the production of superoxide is enhanced 
ten-fold from basal levels when incubated Q1. Scheme 5.2 summarises the reaction 
pathways which originate at the flavin site in complex I. 
 
 
 
 
Scheme 5.2: Production, interconversion and detection of the reactive oxygen and 
semiquinone species produced by the reduced flavin in complex I. Abbreviations: CI = 
complex I, Q = quinone, QH. = semiquinone, QH2 = quinol. 
 
 
Although Q1 and Q0 are not found in vivo, many quinoid compounds used in the treatment 
of a range of pathologies have been reported to undergo redox cycling reactions at 
complex I, although the precise sites and mechanisms are not known (Genova et al., 2001; 
Doroshow and Davies, 1986). The finding that hydrophilic quinones can bind to and react 
at the flavin of complex I has potential implications for our understanding of the 
pathological side reactions of some of these compounds. 
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Idebenone is a short-chain Q10 analogue which, in its reduced form, is a potent antioxidant. 
These properties prompted clinical trials of idebenone for the treatment of Alzheimer’s and 
Huntington’s diseases, but the initial results were disappointing (Ranen et al., 1996; Weyer 
et al., 1997). Nevertheless, when the first reports emerged that frataxin deficiencies cause 
oxidative stress in yeast, idebenone was touted as a potential therapy for Friedreich’s 
Ataxia (FRDA). FDRA is an inherited recessive disorder in which oxidative damage lies at 
the core of pathogenesis, and is characterised by progressive neurological disability and 
heart abnormalities that usually present in childhood (Rustin et al., 1999). Initial studies 
that tested idebenone as a treatment for FRDA appear promising (Ribai et al., 2007). 
Although idebenone undoubtedly reacts in several different ways in mitochondria (Degli 
Esposti et al., 1996; Rauchová et al., 2008), its interactions with complex I shall be 
considered here in isolation.  
 Paradoxically, idebenone is reduced by the flavin in complex I, to produce 
semiquinone species which result in increased reactive oxygen species formation, and it is 
reduced slowly at the physiological quinone binding site. The rates of both reactions are 
affected by how idebenone partitions between the membrane and the aqueous phases. The 
‘negative’ effects of idebenone are thus reactive oxygen species production, and the 
inhibition of physiological quinone reduction, caused by slow idebenone product release. 
The ‘positive’ effects of idebenone are that, if Q10 is not sufficiently available, it increases 
the rate of NADH oxidation and regenerates NAD+, and its high affinity means that it may 
be more effective at out-competing an inhibitor or reacting with a damaged binding site.  
    
 
 
 
Figure 5.12: Structures of the anthracyclines daunorubicin and doxorubicin.  
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The anthracyclines doxorubicin and daunorubicin (their structures are shown in figure 
5.12) are widely used chemotherapeutic agents which demonstrate activity against a wide 
range of human cancers including leukaemias, lymphomas and breast cancer. The success 
of these agents, however, is limited by a dose-dependent cardiotoxicity, characterised by 
the development of arrhythmias or cardiomyopathy (Berthiaume and Wallace, 2007). 
Despite a wealth of data, the definitive cause of cardiotoxicity remains uncertain; one of 
the leading theories postulates that damage to cardiac muscle results from the build up free 
radicals (Davies and Doroshow, 1986). 
 Doxorubicin and daunorubicin undergo one-electron reduction to semiquinone 
species catalysed by complex I; in the presence of molecular oxygen, the semiquinone 
radicals are rapidly reoxidised, producing reactive oxygen species and regenerating the 
parent quinone (Davies and Doroshow, 1986). Studies have shown that two additional 
quinonoid anti-cancer agents which exhibit milder cardiotoxic side-effects than 
doxorubicin and daunorubicin, mitomycin C and mitoxantrone, stimulate significantly less 
reactive oxygen species production in SMPs, suggesting that the injury to cardiac 
mitochondria directly results from the redox cycling of these compounds (Doroshow and 
Davies, 1986). 
 The finding that hydrophilic quinones can undergo redox cycling reactions at the 
flavin of complex I may provide a new insight into the cardiotoxic side effects of this 
group of chemotherapeutic agents.  
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5.4 Investigating the promiscuity of the flavin site of complex I 
5.4.1 Paraquat and diquat 
The ability of the flavin site to reduce a range of structurally diverse hydrophilic quinones 
suggests that it is more promiscuous than previously thought: it may be capable of binding 
and reacting with many different compounds, initiating redox cycling reactions and 
reactive oxygen species production. One compound known to redox cycle with complex I 
is paraquat (Cochemé and Murphy, 2008). 
 Paraquat (1,1’-dimethyl-4,4’-bipyridylium dichloride) is a quaternary ammonium 
bipyridyl compound that is widely used as a broad spectrum herbicide, and as a source of 
superoxide when investigating oxidative stress (Cochemé and Murphy, 2008). The 
paraquat dication is capable of being reduced to the paraquat monocation radical (PQ+), 
which rapidly reacts with oxygen to produce superoxide and regenerate the parent paraquat 
molecule (scheme 5.3). However, the very negative reduction potential of paraquat (Em = -
446 mV) limits its pool of possible intracellular reductants (Frank et al., 1987).  
 
  
 
 
Scheme 5.3: Paraquat, and its scheme of redox cycling. Left, the paraquat dication 
(PQ2+) undergoes univalent reduction to generate the paraquat radical PQ•+, which reacts 
rapidly with oxygen to form superoxide (O2•-). Right, the structure of the pesticide diquat, 
1,1’-ethylene-2,2’-bipyridinium. Adapted from (Cochemé and Murphy, 2008). 
 
 
There is a wealth of evidence demonstrating the importance of mitochondria in paraquat-
mediated toxicity (Kirby et al., 2002; Mockett et al., 2003; Van Remmen et al., 2004). The 
redox cycling of paraquat has been shown to be the primary cause of toxicity; 
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overexpression of superoxide dismutase provides protection against paraquat-mediated cell 
damage (Day et al., 1995; Krall et al., 1988), whereas paraquat hypersensitivity arises 
from superoxide dismutase deficiency (Kirby et al., 2002; Sturtz and Culotta, 2002). 
Cochemé and Murphy demonstrated that paraquat is taken up across the mitochondrial 
inner membrane in a carrier-mediated and membrane dependent process, and is reduced to 
the radical form by complex I in mammalian mitochondria, and by NAD(P)H 
dehydrogenases in yeast. The radical then reacts with oxygen to form superoxide, causing 
mitochondrial stress (Cochemé and Murphy, 2008). However, the precise location and 
mechanism of the reaction of paraquat with complex I remains undetermined. 
 It is possible, therefore, that the flavin of complex I catalyses the redox cycling of 
paraquat in a fashion similar to the hydrophilic quinone analogues described in section 5.3. 
To test this hypothesis, two compounds known to redox cycle at complex I were used; 
paraquat and the related molecule diquat (their structures are shown in scheme 5.3). 
 
5.4.2 Paraquat and diquat react at the flavin of complex I 
Figure 5.13 shows the dependence of rate on the concentrations of paraquat/diquat and 
NADH; the data for the hydrophilic reaction with Q1 at the flavin of complex I is shown 
for comparison. The reaction of paraquat and diquat with complex I follows saturation 
kinetics, and the data were modelled using the Michaelis-Menton equation (equation 3.1).  
 Diquat reacts approximately three-times faster with complex I than paraquat. This 
may be due to the reductions potentials of the two compounds; diquat, with a reduction 
potential of -348 mV, is a stronger oxidant than paraquat, whose reduction potential is       
-446 mV (Frank et al., 1987). However, whereas the hydrophilic quinone reaction at the 
flavin shows substrate inhibition with increasing NADH concentrations, and can be 
modelled using ping-pong reaction kinetics, the reaction of both paraquat and diquat 
follow simple saturation kinetics. This observation suggests that they are reacting by a 
different mechanism to the hydrophilic quinones, possibly as a result of their differing 
charges; this is explored further in chapter 6. 
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Figure 5.13: Dependence of the catalytic rate of the NADH:paraquat, diquat and 
inhibitor-insensitive Q1 reactions by complex I on acceptor and NADH 
concentrations. Initial rates (defined as µmoles NADH consumed per second per µmole 
protein) were calculated using linear regression over 30 seconds and background rates 
were subtracted. Measurements were obtained at 340 – 380 nm (∆ε340–380 nm = 4.81 mM-1 
cm-1). Experimental data points were fitted to the Michaelis-Menten equation in the case of 
paraquat and diquat, or the ping-pong equation for the inhibitor-insensitive Q1 reaction. 
Error bars represent the standard deviation of three trials. Conditions: 250 µM paraquat, 
diquat or Q1, 100 µM NADH, 2.3 µM rotenone (for the NADH:Q1 reaction), 32 °C, 20 
mM tris-HCl pH 7.5, ~ 3 µg purified protein. 
 
 
 
NADH:acceptor oxidoreduction (µmoles NADH min-1 mg-1) 
Aso Rot Pier Paraquat Diquat DQ APAD+ 
+ - - 0.50 + 0.05 1.23 + 0.03 3.72 + 0.39 6.50 + 0.40 
+ + - 0.50 + 0.04 1.20 + 0.05 0.14 + 0.01 6.16 + 0.59 
+ - + 0.52 + 0.07 1.26 + 0.03 0.24 + 0.11 5.99 + 0.51 
- - - 0.53 + 0.02 1.13 + 0.09 0.37 + 0.02 6.96 + 0.54 
- + - 0.50 + 0.04 1.18 + 0.02 0.04 + 0.02 6.25 + 0.67 
- - + 0.54 + 0.03 1.14 + 0.04 0.02 + 0.02 7.10 + 0.51 
 
Table 5.5: Investigating the inhibitor-sensitive and -insensitive NADH:acceptor 
oxidoreductase activity of complex I. Rates were determined in the presence and absence 
of 0.4 mg mL-1 asolectin in 0.4 mg mL-1 CHAPS (Aso), and either without inhibitor, with 
2.3 µM rotenone (Rot) or 1 µM piericidin A (Pier). Conditions: 250 µM 
paraquat/diquat/DQ/APAD+ and 100 µM NADH, 20 mM tris-HCl pH 7.5, 32 °C. The 
reported error is the standard deviation of three independent measurements.   
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The effect on rate of asolectin, piericidin A and rotenone was tested with both paraquat 
and diquat, as well as with APAD+, which is known to react solely at the flavin site via 
ping-pong reaction kinetics (Yakovlev and Hirst, 2007), and with DQ, which is known to 
react solely at the physiological Q-binding site. The data are presented in table 5.5. As 
expected, the presence of asolectin, piericidin A or rotenone did not significantly affect the 
rate of NADH:APAD+ oxidoreduction. The reaction of paraquat and diquat with complex I 
are independent of rotenone, piericidin A and asolectin, indicating that these compounds 
react independently of the physiological site, upstream of iron-sulphur cluster 4Fe[PS], and 
probably at the reduced flavin. 
 
5.4.3 Redox cycling reactions of paraquat and diquat at the flavin site 
The paraquat radical, which is only observed in strictly anaerobic conditions, absorbs 
maximally at two wavelengths, 396 and 604 nm. To investigate the formation of the 
radical by the flavin of complex I, assays in the presence of NADH and paraquat were 
performed aerobically and anaerobically (figure 5.14).  
   
 
 
 
Figure 5.14: The paraquat radical. Complex I was incubated with 100 µM NADH and 
10 µM paraquat in either aerobic conditions (red trace) or anaerobic conditions (green 
trace), and the spectra recorded after five minutes. Inset: spectrum of the paraquat radical 
(10 µM), reduced anaerobically with sodium dithionite. The radical extinction coefficients 
were subsequently calculated: ε340 nm = 3.6 mM-1 cm-1; ε396 nm = 39.6 mM-1 cm-1; ε604 nm = 
11.8 mM-1 cm-1. These values are consistent with extinction coefficients measured 
previously (ε396 nm = 46.7 mM-1 cm-1; ε604 nm = 13.6 mM-1 cm-1 (Frank et al., 1987)) 
  154 
In aerobic conditions, the radical reacts instantaneously with oxygen, producing reactive 
oxygen species and regenerating the parent molecule; the steady-state concentration of the 
paraquat radical is extremely low and therefore is undetectable (Frank et al., 1987). In the 
absence of oxygen, these redox cycling reactions cannot occur, causing the build up of the 
radical to levels detectable using spectroscopy. 
 Table 5.6 shows that both paraquat and diquat increase hydrogen peroxide and 
superoxide production by complex I. Using diquat, the rate of hydrogen peroxide 
production by complex I is stimulated fifteen-fold to ~ 475 nmol min-1 mg-1, and 
superoxide production, fifty-fold above basal levels to ~ 2000 nmol min-1 mg-1. As with 
the hydrophilic quinones, hydrogen peroxide and superoxide production is not completely 
abolished by the addition of catalase or SOD, respectively, suggesting that there is a 
background reaction between the diquat radical and the Amplex Red/cytochrome c 
detection systems. The same trend is seen for paraquat, although the absolute rates are 
lower. The apparent production of superoxide in anaerobic conditions is, once again, 
explained by the direct reaction of the paraquat radical with cytochrome c. 
 
 
Resorufin Formation (nmol min-1 mg-1) 
O2 CAT Paraquat Diquat 
+ - 211.1 + 5.6 473.4 + 12.8 
+ + 17.9 + 1.3 23.4 + 1.6 
Cytochrome c reduction (nmol min-1 mg-1) 
O2 SOD Paraquat Diquat 
+ - 660.4 + 40.3 2008.3 + 78.7 
+ + 293.0 + 49.6 618.0 + 28.6 
- - 606.4 + 28.0 1552.9 + 24.5 
 
Table 5.6: Resorufin formation (H2O2 formation) and cytochrome c reduction (O2•- 
formation) in the presence of paraquat and diquat. Conditions: 20 mM tris-HCl (pH 
7.5), 32 °C, 30 µM NADH, 100 µM Q, + O2 = atmospheric O2, - O2 = anaerobic glove 
box, CAT = 10,000 units mL-1 catalase, SOD = 50 units mL-1 Cu-Zn-SOD, 50 µM 
cytochrome c, 2 units mL-1 HRP, and 10 µM Amplex Red.   
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5.4.4 Conclusions and discussion 
Previous studies have concluded that the major site of paraquat reduction by mitochondria 
is complex I, although the precise location and mechanism of the reaction was unknown 
(Cochemé and Murphy, 2008); the data presented above provide evidence that paraquat 
and diquat react at the flavin of complex I, initiating redox cycling reactions with oxygen.  
 From these experiments, it is evident that the structure of a compound may be of 
limited importance in determining whether it is capable of catalyzing redox cycling 
reactions with the flavin of complex I. One important determinant of whether compounds 
will redox cycle with the flavin of complex I is its reduction potential. The reduction 
potentials of both paraquat (Em = -446 mV) and diquat (Em = -350 mV) are comparable 
with the flavin of complex I (-380 mV at pH 7.8 (Sled et al., 1994)) and NAD+ (-350 mV 
at pH 7.8 (Clark, 1960)), which are close enough to allow efficient cycling.  
 MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a neurotoxic compound 
which elicits Parkinsonian-like symptoms in humans (Davis et al., 1979). The toxic form 
of MPTP, MPP+ (1-methyl-4-phenyl-pyridinium), is produced by the action of monoamine 
oxidase B in the brain and accumulates in dopaminergic neurons (Frank et al., 1987). 
Figure 5.15 shows how MPP+ is structurally related to paraquat. It was initially proposed 
that the mode of toxicity resulted from a similar redox cycling mechanism to paraquat 
(Johannessen et al., 1985), an idea which was supported by the finding that the systemic 
administration of MPP+ induces paraquat-like lung damage in rodents (Johannessen et al., 
1986).  
 
 
 
 
Figure 5.15: The structures of MPTP and MPP+.  
 
 
However, MPP+ has a very low reduction potential (Em < -1000 mV), so it is not capable 
of acting as a redox-cycling catalyst (Frank et al., 1987); previous studies suggested that 
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paraquat-like pyridinium compounds with potentials below -500 mV can not be reduced 
by biological systems (Fischer and Summers, 1976; Fischer and Summers, 1980). Ramsay 
and co-workers have since demonstrated that alkyl derivatives of MPP+ inhibit complex I 
in a manner similar to the canonical inhibitors rotenone and piericidin A, suggesting that 
the mode of toxicity does not result from MPP+-catalysed redox cycling reactions at the 
flavin (Ramsay et al., 1987). 
  Kussmaul and Hirst demonstrated that the rate of superoxide production is 
proportional to oxygen concentration (Kussmaul and Hirst, 2006); plausible estimates for 
the mitochondrial oxygen concentration in vivo are in the range of 3 - 30 µM (Turrens, 
2003). Although extremely difficult to measure accurately, tentative estimates for the 
concentration of superoxide in the mitochondrial matrix are in the range of 10 - 200 pM 
(Chance et al., 1979; Cadenas and Davies, 2000); the steady state concentrations of 
mitochondrially-derived reactive oxygen species in vivo are therefore extremely low. The 
finding that a diverse range of structurally unrelated compounds can redox cycle with the 
flavin of complex I, stimulating the generation reactive oxygen species, has profound 
implications.  
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Chapter 6: 
Investigating the reaction of positively charged electron acceptors with 
the flavin mononucleotide in complex I 
 
 
6.1 Introduction 
6.1.1 Reactions catalysed by the flavin in complex I 
During energy transduction, complex I transfers two electrons from NADH to ubiquinone, 
conserving the energy as a proton motive force across the mitochondrial inner membrane 
(Nicholls and Ferguson, 2002). In order to understand how NADH oxidation is linked to 
the conservation of free energy, the thermodynamic and kinetic determinants of NADH 
oxidation need to be understood; however, studying the mechanism of NADH oxidation by 
complex I is complicated by the fact that it is not the rate-limiting step during catalytic 
turnover (Sharpley et al., 2006; Yakovlev and Hirst, 2007). To overcome this problem, 
artificial electron acceptors are used; these hydrophilic substrates do not react at the 
physiological ubiquinone binding site, and their reactions are not energy transducing. The 
four electron acceptors considered in this study are shown in figure 6.1. 
 
 
 
 
Figure 6.1: The artificial electron acceptors used in this study.  
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6.1.1.1 NADH:APAD+ oxidoreduction  
The NAD+ analogue APAD+ (3-acetylpyridine adenine dinucleotide) has been used 
extensively to investigate the transhydrogenation reaction ever since Minakami and co-
workers attributed mitochondrial NADH:APAD+ transhydrogenase activity to complex I 
(Minakami et al., 1962). Vinogradov and co-workers proposed that the transhydrogenation 
reaction involved two or more nucleotide binding sites on complex I; the double reciprocal 
lines obtained at high and low APAD+ concentrations intercepted at different points, 
suggesting that two NADH:APAD+ reactions occur with different rates and different 
affinities for APAD+ (Zakharova et al., 1999; Zakharova, 2002). Yakovlev and Hirst 
demonstrated that the trans-hydrogenation reaction between NADH and APAD+ occurs at 
the flavin site in a ‘ping-pong’ reaction that is inhibited by high concentrations of NADH 
(figure 6.2; Yakovlev and Hirst, 2007). As the stoichiometry of the NADH:APAD+ 
reaction is 1:1, the mechanism alternately involves the fully oxidised and fully reduced 
flavin species. 
 
6.1.1.2 NADH:FeCN oxidoreduction  
Another commonly used artificial electron acceptor in the study of complex I is the 
obligatory one-electron acceptor FeCN (ferricyanide/potassium hexacyanoferrate (III)). 
Hatefi and co-workers first demonstrated that the NADH:FeCN oxidoreductase activity of 
complex I is insensitive to the Q-site inhibitor rotenone, suggesting that it reacts at a non-
physiological site (Hatefi et al., 1962). Dooijewood and Slater investigated the steady-state 
kinetics of the reaction using SMPs and isolated complex I, and observed that it follows a 
ping-pong-(pong) mechanism with double substrate inhibition (see figure 6.2); NADH 
inhibits the reaction of the reduced form of complex I with FeCN, and FeCN prevents 
NADH from reacting with the oxidised form (Dooijewaard and Slater, 1976). These data 
suggest that both NADH and FeCN react at the same site on complex I; otherwise they 
must inhibit each other indirectly.  
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Figure 6.2: Sequential, ping-pong and ping-pong-pong reaction mechanisms. 
Reactions for which there are two substrates and two products fall into two major 
mechanistic categories: sequential and ping-pong reactions. Sequential reactions require all 
substrates to be present before any product is released, and can be ‘ordered’, where there is 
an obligatory order for the addition of substrates and release of products (the reaction 
shown), or ‘random’, with no obligatory order of binding and release. In ping-pong 
reactions, one substrate is bound and a product is released, leaving a modified enzyme, F. 
A second substrate is then bound; the release of a second product restores the enzyme to its 
original form. This is exemplified by the two-electron acceptor APAD+. A derivative of 
the ping-pong mechanism is the ping-pong-pong mechanism, in which a third substrate can 
bind after the second product has dissociated. Reactions such as NADH:FeCN oxido-
reduction follow this mechanism; as FeCN is an obligatory one-electron acceptor, and 
NADH is a two-electron donor, two molecules of FeCN can react sequentially per 
molecule of NADH. In this example, F1 represents the fully reduced flavin, and F2, the 
semi-reduced flavin. The mechanisms presented use Cleland notation, with the sequence of 
steps proceeding left to right (Cleland, 1970). Addition of substrate molecules (A and B) to 
the enzyme and the release of products (P and Q) are indicated by arrows toward (substrate 
binding) or from (product release) the line. The various forms of the enzyme are written 
under the horizontal line; a colon represents an enzyme:substrate/product complex.  
 
 
6.1.1.3 NADH:O2 oxidoreduction  
There has been much debate as to the site(s) and mechanism(s) of oxygen reduction by 
complex I, leading to the production of reactive oxygen species such as superoxide and 
hydrogen peroxide (for review, see (Hirst et al., 2008)). However, oxygen reduction by the 
reduced flavin has been recognised to be an important contributor that links reactive 
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oxygen species production by complex I to the status of the mitochondrial NAD+/NADH 
pool (Kussmaul and Hirst, 2006). In complex I from B. taurus, oxygen reduction by the 
reduced flavin is significantly slower than NADH oxidation; consequently, when complex 
I is incubated in a mixture of NADH and NAD+, an equilibrium is established between the 
oxidised and reduced flavins. As oxygen reacts comparatively slowly with the reduced 
flavin, it does not perturb the equilibrium significantly; consequently, the rate of reaction is 
the product of the reduced flavin and oxygen concentrations, and the corresponding 
bimolecular rate constant (Hirst, 2010). In theory, molecular oxygen can undergo both 
one- and two-electron reduction by complex I; however, as Kussmaul and Hirst 
demonstrated that complex I from bovine heart mitochondria produces predominantly 
superoxide, it is considered a one-electron oxidant in this study (Kussmaul and Hirst, 
2006).  
 
6.1.1.4 NADH:HAR oxidoreduction  
HAR (hexaammineruthenium (III) chloride) has been shown to be an efficient electron 
acceptor for SMPs, purified complex I and subcomplex Fp (Sled and Vinogradov, 1993). 
Vinogradov and co-workers investigated the accessibility of the reactive sites of complex I 
for this acceptor using SMPs. They found that the Ru(NH3)62+/Ru(NH3)63+ couple 
bypassed inhibition of NADH oxidation in SMPs by the complex III inhibitor antimycin 
A, suggesting that Ru(NH3)63+ accepts electrons from a redox component upstream of 
complex III. As NADH:HAR oxidoreductase activity was insensitive to the complex I Q-
site inhibitor rotenone, it was proposed that HAR accepts electrons from a redox 
component in the hydrophilic domain of complex I (Sled and Vinogradov, 1993). In 
contrast to the results found for the NADH:FeCN reaction, the authors could not detect any 
inhibition of the NADH:HAR reaction by either NADH or HAR over a wide range of 
concentrations, suggesting that the reaction does not follow a ping-pong mechanism. Data 
from double reciprocal plots of 1/initial rate versus 1/[NADH] at various HAR 
concentrations, determined for SMPs and the isolated enzyme, was interpreted using an 
ordered mechanism in which the reduced enzyme-NAD+ complex is oxidised by HAR 
through the operation of a single redox site before NAD+ dissociation (Sled and 
Vinogradov, 1993). Similar analysis of subcomplex Fp suggested that HAR reacts with 
complex I using a ternary mechanism; NADH is oxidised by a protein-HAR complex, 
where the positively charged HAR binds at a specific site close to the flavin and stabilises 
the intermediate flavosemiquinone radical (Gavrikova et al., 1995).  
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6.1.2 A unified scheme of reactions catalysed by the flavin in complex I 
As shown in scheme 6.1, hydride transfer between NADH and flavin is common to all 
reactions catalysed by complex I. Using knowledge of the reaction mechanisms of each 
electron acceptor, and sufficiently detailed reaction schemes, it should be possible to 
model all extant data using a common set of NADH parameters. 
 
 
 
 
Scheme 6.1: The oxidation of NADH. Steps common to all the reactions catalysed by 
complex I are shown in black; downstream reactions are shown in grey, and differ between 
substrates. 
 
 
Despite the rates of the NADH:O2, NADH:APAD+ and NADH:FeCN reactions spanning 
three orders of magnitude, Birrell and co-workers successfully presented a unified scheme 
of reactions catalysed by the flavin in complex I (figure 6.3, top; Birrell et al., 2009). By 
combining data from the three reactions in a single analysis, they demonstrated that every 
reaction can be explained by a common set of NADH-dependent parameters; the ‘best fit’ 
results from the modelling are shown in figure 6.3. Clearly, there is excellent agreement 
between the experimentally measured datasets and the modelled data. 
 The authors also attempted to model data from the NADH:HAR reaction using the 
combined scheme; although the reaction could be modelled accurately using the ping-
pong-pong mechanism, they found that it was not possible to combine analysis of the HAR 
reaction with the universal NADH-dependent parameters derived from the modelling of 
the three established ping-pong-(pong) reactions. They concluded that the HAR reaction 
does not follow a ping-pong-pong reaction mechanism (Birrell et al., 2009). 
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Figure 6.3: Combination of the ping-pong reaction mechanism for the 
NADH:APAD+, NADH:FeCN, and NADH:O2 oxidoreduction reactions catalysed by 
the flavin of complex I. The formation and inhibition of [Flred] by NADH (centre) are 
common to all the reactions; the return to [Flox] is dependent on the identity of the electron 
acceptor. Middle left; rate of the FeCN reaction as a function of NADH concentration at 
four FeCN concentrations: 0.1 (◊), 0.2 (♦), 0.5 (○) and 1 mM (●). Middle right; rate of the 
FeCN reaction as a function of FeCN concentration at two NADH concentrations: 50 (●) 
and 100 µM (○). Bottom left; rate of the APAD+ reaction as a function of NADH 
concentration at two APAD+ concentrations: 250 µM (○) and 1.5 mM (●). Bottom right; 
rate of the O2 reaction as a function of NADH concentration in atmospheric O2. The 
parameter values used to model the data are: KMNADH = 200 µM; kcatNADH = 15,000 s-1; 
KRedNADH = 200 µM; KsemiNADH,F = KsemiNADH,O = 5  µM; KMAPAD+ = 240 µM; kcatAPAD+ = 
260 s-1; k1FeCN = k2FeCN = 3.7 x 107 M-1s-1; k1O2 = 2.4 x 103 M-1s-1; k2O2 = 3.7 x 103 M-1s-1. 
Adapted from (Birrell et al., 2009). 
 
 
6.1.3 Aims 
Building on the study by Birrell and co-workers presented above, the aim of this chapter is 
to deduce the mechanism of HAR reduction by complex I, and present a unified scheme of 
the reactions catalysed by the flavin of complex I (Birrell et al., 2009). These analyses 
should determine, or confirm, the reaction mechanism of each electron acceptor, and allow 
kinetic and thermodynamic parameters, which can be applied to any reaction at the flavin 
site, to be estimated. Using this unified scheme, the reactions of paraquat and diquat with 
complex I (see chapter 5) will be investigated to try and ascertain their mechanisms of 
reaction. 
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6.2 Investigating the mechanism of NADH:HAR oxidoreduction 
6.2.1 Comparison of the NADH:FeCN and NADH:HAR oxidoreduction reactions 
Figure 6.4 compares data from the NADH:HAR and NADH:FeCN oxidoreduction 
reactions catalysed by complex I. Both comprise NADH oxidation by the flavin, followed 
by the reduction of an artificial electron acceptor; although both reactions display high 
maximum rates (more than 1000 s-1), they depend differently on NADH concentration. 
The rate of the FeCN reaction increases rapidly to a maximum at ~50 µM NADH, then 
decreases as NADH binds to the reduced flavin and inhibits its oxidation by FeCN; the 
ping-pong-pong mechanism of the FeCN reaction is shown in figure 6.3. Conversely, the 
rate of the HAR reaction increases steadily to a plateau at high NADH concentration, in a 
manner typical of saturation kinetics.   
 
 
 
 
Figure 6.4: Dependence of the catalytic rate of the NADH:HAR and FeCN reactions 
by complex I on left, NADH, and right, FeCN and HAR, concentrations. Initial rates, 
background corrected (defined as µmoles NADH consumed per second per µmole flavin) 
were calculated using linear regression over 30 seconds. The reaction was monitored at 
340 – 380 nm, corresponding to NADH oxidation (∆ε340-380 nm = 4.81 mM-1 cm-1). 
Conditions: 32 °C, 20 mM tris-HCl pH 7.5, 100 µM NADH, 3.5 mM HAR, 1 mM FeCN, 
~ 3 µg mL-1 purified protein. Data taken from (Birrell et al., 2009). 
 
 
The data in presented in figure 6.4, and previous attempts to model the FeCN and HAR 
datasets together with the same mechanism (Birrell et al., 2009), suggest strongly that 
HAR does not react predominantly with the nucleotide-free reduced flavin. Therefore, 
HAR may react with the nucleotide-bound reduced flavin, with one of the iron-sulphur 
clusters, or at the quinone-binding site. HAR reduction is not inhibited by the canonical 
‘Q-site’ inhibitors rotenone and piericidin A, suggesting strongly that it does not react at 
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the quinone-binding site (Sled and Vinogradov, 1993). By using a 3.6 Å diameter probe to 
represent the HAR molecule, Birrell and co-workers scanned the surface of the seven core 
subunits in the nucleotide-bound T. thermophilus structure using the program Surface from 
the CCP4 suite, and calculated the closest approaches of the Ru3+ to each cluster (Birrell et 
al., 2009). The authors found that for seven clusters, the Ru3+ can approach within 15.6 Å, 
and for two of these clusters, it can approach to within 10 Å. Using Dutton’s ruler for 
physiological electron transfer, the authors concluded that these distances are close enough 
to achieve the rates observed for the reaction (Page et al., 1999). Furthermore, as 
NADH:HAR oxidoreduction is catalysed similarly by intact complex I and subcomplex 
Fp, the reduced flavin and clusters 2Fe[24] and 4Fe[51] are viable candidates for the 
reaction (Gavrikova et al., 1995).    
 
6.2.2 HAR reacts by a ternary mechanism at the flavin in complex I 
The following work describes two pieces of evidence that strongly suggest HAR reacts 
with the flavin of complex I in a ternary reaction mechanism with nucleotide. The first is 
an investigation into the activatory effect of low concentrations of nucleotides such as 
ADP, ATP and ADP-ribose on the NADH:HAR reaction. Second, using a combined 
approach that tested both HAR and FeCN datasets together using common values for the 
NADH-dependent parameters that contribute to both schemes, Dr. Judy Hirst evaluated the 
possibility that HAR reacts by one of three possible mechanisms at the flavin (scheme 6.2, 
below). 
 
6.2.2.1 Inhibition and activation of rate by nucleotides 
The NADH analogue ADP-ribose is a well characterised inhibitor of complex I that binds 
competitively in the NADH-binding site (Zharova and Vinogradov, 1997). Kinetic data for 
ADP-ribose inhibition of the FeCN, APAD+ and O2 reactions has been used previously to 
determine dissociation constants of ADP-ribose for the oxidised and reduced flavin (Birrell 
et al., 2009). Figure 6.5 shows the structural relationship between the nucleotides used in 
this study. Relative to ADP, ATP contains an additional phosphate group; ADP-ribose 
contains an additional ribose moiety; and NADH contains an additional ribose moiety 
conjugated to a nicotinamide group.  
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Figure 6.5: Structures of the nucleotides used in this study.  
 
 
Figure 6.6, top, compares the effects of ADP-ribose on the NADH:FeCN and NADH:HAR 
reactions of complex I. At high concentrations, ADP-ribose effectively inhibits both the 
HAR and FeCN reactions, consistent with previous studies (Birrell et al., 2009). 
Surprisingly, at low concentrations, ADP-ribose induces a small activation in the rate of 
NADH:HAR oxidoreduction; this activation is not observed for the NADH:FeCN reaction 
(figure 6.6, top right). The different responses of the FeCN and HAR reactions to low 
concentrations of ADP-ribose underlines the fact that they have different mechanisms, and 
provides the key to deducing the mechanism of the HAR reaction. 
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Figure 6.6: Inhibition and activation of the NADH:HAR reaction by nucleotide 
analogues. Initial rates, background corrected (defined as µmoles NADH consumed per 
second per µmole flavin) were calculated using linear regression over 30 seconds. The 
reaction was monitored at 340 – 380 nm, corresponding to NADH oxidation (∆ε340-380 nm = 
4.81 mM-1 cm-1). Top left; dependence of catalytic rate of NADH:HAR and NADH:FeCN 
oxidoreduction on increasing concentrations of ADP-ribose. Concentrations used: 3.5 mM 
HAR, 1 mM FeCN, 100 µM NADH. Top right; same as top left, plotted on a different 
scale; the activatory and inhibitory phases are marked. Bottom left; dependence of 
catalytic rate of NADH:HAR oxidoreduction on increasing concentrations of ADP and 
ATP. The dashed line represents the concentrations of ATP and ADP required for maximal 
activation. Concentrations used: 250 µM HAR, 100 µM NADH. Bottom right; dependence 
of catalytic rate of NADH:HAR oxidoreduction on NADH concentration in the presence 
or absence of ADP and ATP. Concentrations used: 250 µM HAR, 0.75 mM ADP/ATP. 
Conditions: 32 °C, 20 mM tris-HCl pH 7.5.  
 
 
Figure 6.6, bottom left, shows how the rate of the HAR reaction depends on the 
concentrations of ATP and ADP. At low concentrations, ADP and ATP activate the 
reaction between complex I and HAR; higher concentrations of ADP and ATP inhibit the 
reaction. The trade-off between activation and inhibition suggests that nucleotides activate 
one step of the reaction, but inhibit another, with the overall effect being dependent on 
which step is most rate limiting. At low nucleotide concentrations, the rate limiting step is 
HAR reduction; ADP and ATP augment nucleotide occupation of the reduced-flavin site, 
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increasing the rate of reaction. At high nucleotide concentrations, ADP and ATP compete 
with NADH for binding to the oxidised flavin, reducing the rate of reaction. Figure 6.6, 
bottom right, shows how the rate of the HAR reaction depends on the concentration of 
NADH in the presence of 0.75 mM ADP or ATP. Activation by nucleotides is particularly 
efficient at low NADH concentrations; at higher NADH concentrations, NADH out-
competes the nucleotides for binding to the flavin, negating their activatory effects. These 
data suggest that HAR reacts with the nucleotide-bound flavin; ATP is best at activating 
the HAR reaction when it is bound, followed by ADP, and finally, NADH. 
 
6.2.2.2 HAR reacts with the nucleotide-bound reduced flavin in complex I 
Scheme 6.2 shows the three possible pathways by which NADH:HAR oxidoreduction may 
occur. Each pathway includes the same hydride transfer reaction between OxNADH and 
RedNAD+, followed by a variable return pathway from RedNAD+ to OxNADH. The 
return pathways comprise NAD+, dissociation, NADH binding, and the oxidation of the 
flavin by HAR, but the order of the three stages varies.   
 
 
 
 
Scheme 6.2: Possible mechanisms for the NADH:HAR oxidoreduction reaction. In 
each case the hydride transfer reaction occurs (reversibly) between the OxNADH and 
RedNAD+ states. See text for details. 
 
 
In the ‘empty-site’ pathway, HAR oxidises the reduced flavin without nucleotide bound: 
the return pathway comprises NAD+ dissociation, the reaction with HAR, and NADH 
binding. This pathway is a version of the ping-pong-pong mechanism that was described 
previously for the FeCN reaction, but the NADH oxidation mechanism (which was 
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previously described by the Michaelis-Menten equation) has been broken down into its 
two constituent steps of NADH binding, hydride transfer, and NAD+ dissociation. NADH 
binding is thus described by a true dissociation constant, K1, rather than by the Michaelis-
Menten parameter, KM. In the ‘NAD+-bound’ pathway, HAR reacts before NAD+ 
dissociates; however, as NAD+ dissociation is irreversible, this reaction pathway cannot 
operate alone, as the enzyme ends up trapped in the dead-end Red/Semi and 
RedNADH/SemiNADH states. In the ‘NADH-bound’ pathway, HAR reacts with the 
NADH-bound reduced flavin - NAD+ dissociates and is replaced by NADH before HAR 
reacts (scheme 6.2). 
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Equation 6.1: Rate equation for the ‘empty-site’ reaction pathway. The derivation of 
this equation is shown in appendix 9.9. 
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Equation 6.2: Rate equation for the ‘NADH-bound’ reaction pathway. The derivation 
of this equation is shown in appendix 9.10. 
 
 
Equations 6.1 and 6.2 were derived from the ‘empty-site’ and ‘NADH-bound’ pathways, 
respectively, using the steady-state approximation. The equilibrium constants K1, K6 and 
K7 are defined as dissociation constants, and K2 is defined similarly as k-2/k2. First, 
equations 6.1 and 6.2 were tested for their ability to model accurately the data from the 
HAR reaction.  
 A combined modelling approach was adopted in which equation 6.1 was used to 
model data from the NADH:FeCN oxidoreduction reaction, and either equations 6.1 or 6.2 
were used to model data from the NADH:HAR oxidoreduction reaction. The combined 
approach tested both data sets together, using common values for the NADH-dependent 
parameters that contribute to both schemes. 
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Figure 6.7: Modelling the FeCN and HAR data using equation 6.1 (data taken from 
Birrell et al., 2009; modelling by Dr. Judy Hirst). Top left; rate of the FeCN reaction as 
a function of NADH concentration at four FeCN concentrations. Top right; rate of the 
FeCN reaction as a function of FeCN concentration at two NADH concentrations. Bottom 
left; rate of the HAR reaction as a function of NADH concentration at two HAR 
concentrations. Bottom right; rate of the HAR reaction as a function of HAR concentration 
at two NADH concentrations. Conditions: 20 mM tris-HCl pH 7.5, 32 °C. Best fit 
parameters: k1 = 2.5 x 107 M-1 s-1; K1 = 30 µM; k2 = 5 x 107 M-1 s-1; K2 = 400 mM; k3 = 1 
x 104 M-1 s-1; K6 = 2 µM; K7 = 2 mM; k4F = k5F = 1.3 x 108 s-1; k4F = k5F = 2.1 x 108 s-1. 
This model does not fit the observed data. 
 
 
First, the FeCN data and HAR data were both modelled using equation 6.1, with the same 
values for k1, K1, k2, K2, k3, K6, and K7, and with individual values for k4F = k5F and k4H = 
k5H. Values for k4 and k5, k8 and k9, and k12 and k13 were set to be equal throughout this 
work; such an approach has previously been shown to be viable, and it reduces the number 
of parameters used for fitting to a more reasonable number. The best fit results are shown 
in figure 6.7. As expected, it was not possible to fit both data sets by using equation 6.1 
with common parameters, even if k4F and k5F, and k4H and k5H are allowed to differ. The 
same observation was described previously, using the simplified form of equation 6.1 that 
combines K1, K2 and k3 into a single term, KM (Birrell et al., 2009). The FeCN reaction is  
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Figure 6.8: Modelling the FeCN data using equation 6.1, and the HAR data using 
equation 6.2 (data taken from Birrell et al., 2009; modelling by Dr. Judy Hirst). Top 
left; rate of the FeCN reaction as a function of NADH concentration at four FeCN 
concentrations. Top right; rate of the FeCN reaction as a function of FeCN concentration at 
two NADH concentrations. Bottom left; rate of the HAR reaction as a function of NADH 
concentration at two HAR concentrations. Bottom right; rate of the HAR reaction as a 
function of HAR concentration at two NADH concentrations. Conditions: 20 mM tris-HCl 
pH 7.5, 32 °C. Best fit parameters: k1 = 1.2 x 108 M-1 s-1; K1 = 20 µM; k2 = 2.9 x 104 M-1 s-
1; K2 = 740 mM; k3 = 1.2 x 104 M-1 s-1; K6 = 12 µM; K7 = 12 µM; k7 = 3.6 x 107 M-1 s-1; k4 
= k5 = 3.4 x 107 s-1; k12 = k13 = 2.5 x 106 s-1. This model does fit the observed data. 
 
 
well established as a ping-pong-pong-type reaction (exemplified by the ‘empty-site’ 
pathway) and so this result supports the previous conclusion that data from the HAR 
reaction cannot be explained using the ‘empty-site’ pathway (Birrell et al., 2009). 
  Second, the FeCN data was modelled using equation 6.1 and the HAR data was 
modelled using equation 6.2; the same values were taken for k1, K1, k2, K2, k3, K6, and K7, 
and values were specified for k4F = k5F in equation 6.1 and k12H = k13H and k7 and in 
equation 6.2. As shown in figure 6.8, good fits were obtained for both datasets, using 
common NADH parameters. This result strongly supports the supposition that nucleotide 
binding in the flavin site enables the HAR reaction.   
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Figure 6.9: Combination modelling of data from the flavin-catalysed NADH:HAR, 
FeCN, O2 and APAD+ oxidoreduction reactions (data taken from Birrell et al., 2009; 
modelling by Dr. Judy Hirst). A; the complete scheme of reactions catalysed by the 
flavin of complex I. The NADH-oxidation steps are common for all reactions. Starting at 
RedNAD+ (bottom right), there are four pathways back to OxNADH (top left). The 
reaction of complex I with FeCN and O2 follows the path RedNAD+, Red, Semi, Ox, Ox 
NADH; their rate constants are defined as k4X and k5X, where X is either FeCN or O2. The 
reaction of complex I with APAD+ follows a similar path (RedNAD+, Red, Ox, Ox 
NADH); as APAD+ is an obligatory two-electron acceptor, the mechanism does not 
include ‘Semi’; the rate constant is defined as k14A. Realistically, the reaction of complex I 
with HAR follows a combination of the two nucleotide bound pathways discussed above; 
RedNAD+, SemiNAD+, OxNAD+, Ox, Ox NADH, and RedNAD+, Red, RedNADH, 
SemiNADH, OxNADH. The rate constants are defined as k8H, k9H, k12H and k13H. B; rate 
of superoxide production as a function of NADH concentration. C; rate of the FeCN 
reaction as a function of NADH concentration at four FeCN concentrations. D; rate of the 
FeCN reaction as a function of FeCN concentration at two NADH concentrations. E; rate 
of the HAR reaction as a function of NADH concentration at two HAR concentrations. F; 
rate of the HAR reaction as a function of HAR concentration at two NADH 
concentrations. G; rate of the APAD+ reaction as a function of NADH concentration at two 
APAD+ concentrations. H; rate of the APAD+ reaction as a function of APAD+ 
concentration at two NADH concentrations. Conditions: 20 mM tris-HCl pH 7.5, 32 °C. 
Best fit parameters: k1 = 8 x 107 M-1 s-1; K1 = 9 µM; k2 = 3 x 104 M-1 s-1; K2 = 40 mM; k3 = 
1 x 104 M-1 s-1; K6 = 6 µM; K7 = 150 µM; k6 = 9 x 106 M-1 s-1; k7 = 5.6 x 107 M-1 s-1; k10 = 
2.5 x 103 M-1 s-1; k11= 2 M-1 s-1; k4F = k5 = 3.4 x 107 s-1; k4O = 2.5 x 104 s-1; k5O = 2.2 x 106 
s-1; k4H = 1 x 10-6 s-1; k8H = 1.28 x 105 s-1; k12H = 3.2 x 106 s-1. This model does fit the 
observed data. 
 
 
The results described above suggest that HAR reacts predominantly with the NADH-
bound reduced flavin, but HAR need not be restricted to react with only a single state of 
the enzyme. Therefore, a comprehensive analysis investigating the effects of introducing 
contributions from the ‘NAD+-bound’ and ‘empty-site’ pathways on the combined fitting 
of the HAR and FeCN reactions was carried out. Extensive modelling showed that the 
‘empty-site’ pathway does not contribute to turnover; however, the ‘NAD+-bound’ 
pathway may make a significant contribution to the rate (Dr. Judy Hirst, data not shown). 
 It is known that O2, like FeCN, undergoes a ping-pong-pong reaction, and that 
APAD+ undergoes a ping-pong reaction, since APAD+ reduction is a hydride transfer 
reaction catalysed uniquely by the flavin. Thus, as all four reactions (FeCN, HAR, O2 and 
APAD+) comprise the same NADH oxidation reaction, it should be possible to fit them by 
combination modelling with the same set of NADH-dependent parameters. Thus, data 
from the O2 reaction were modelled using equation 6.1, and data from the APAD+ reaction 
using a previously derived equation to describe the reduction of APAD+ (Birrell et al., 
2009). The equations for modelling are not shown. Figure 6.9 shows sets of data from the 
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FeCN, HAR, O2 and APAD+ reactions, all modelled with a common set of NADH-
dependent parameters. Considering the fact that these data comprise three different 
mechanisms, and span more than three orders of magnitude in rate, the fits are excellent. 
 In conclusion, it is impossible to successfully model the FeCN and HAR datasets 
with common NADH parameters using the ‘empty-site’ reaction mechanism for HAR 
reduction; however, the data can be modelled using common parameters for the ‘empty-
site’ reaction mechanism for FeCN and the ‘NADH-bound’ mechanism for HAR. Further 
modelling has shown that the ‘NAD+-bound’ pathway may make a significant contribution 
to rate in conjunction with the ‘NADH-bound’ pathway, although the ‘empty-site’ 
pathway does not contribute to the rate. Finally, using these universal NADH parameters, 
it is possible to successfully incorporate two additional flavin-catalysed reactions, the 
APAD+ and O2 reactions, into the model. The data modelling presented above provides 
strong evidence that HAR can only react with complex I when a nucleotide is bound to the 
reduced flavin. 
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6.3 Investigating the mechanism of the paraquat and diquat reaction with the 
flavin in complex I 
6.3.1 Activation of rate by nucleotides  
The work presented in chapter 5 showed that paraquat and diquat react at the flavin of 
complex I, initiating redox cycling reactions with oxygen, and stimulating reactive oxygen 
species production. Analysis revealed that the inhibitor-insensitive reaction of hydrophilic 
quinones with the flavin follows ping-pong or ping-pong-pong reaction kinetics. However, 
as substrate inhibition is not observed with increasing concentrations of NADH for the 
paraquat and diquat reactions with the flavin, it is extremely unlikely these positively 
charged electron acceptors react using this mechanism. The work described above shows 
how HAR reacts with the flavin in a ternary complex with either NAD+ or NADH; to test 
whether paraquat and diquat react by a similar mechanism, the effect of the nucleotides 
ADP, ATP and ADP-ribose on the rates of the reactions were investigated. 
 Figure 6.10, top left, shows that the rate of NADH:paraquat oxidoreduction is 
enhanced over the range of ADP and ATP concentrations tested; the concentrations of 
ADP and ATP needed for maximal activation are 5 and 4 mM, respectively. Unlike the 
NADH: HAR reaction, significant inhibition at higher nucleotide concentration is not 
observed over the concentration range tested. This suggests the activation of HAR 
reduction by nucleotides dominates the inhibition in rate caused by the decrease in NADH 
oxidation. The rate of NADH:paraquat oxidoreduction is two orders of magnitude slower 
than the HAR reaction, suggesting the rate limiting step is the reduction of paraquat, not 
the oxidation of NADH; consequentially, this means a far higher concentration of 
nucleotide is needed before inhibition is observed. Figure 6.10, top right, shows the results 
of similar experiments with ADP-ribose. Although activation is clearly evident, significant 
inhibition is not observed over the range of concentrations tested. Figure 6.10, bottom left, 
shows the dependence of rate on paraquat concentration in the presence or absence of 
nucleotide; the rate of reaction is increased dramatically in the presence of activating 
concentrations of nucleotide. Figure 6.10, bottom right, shows the dependence of rate on 
NADH concentration in the presence or absence of nucleotide. Again, the rate of reaction 
increases dramatically: at higher concentrations of NADH the activatory effect of ATP 
becomes less dominant, although the effect is not as dramatic as for the NADH:HAR 
reaction. 
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Figure 6.10: Investigating the effect of nucleotides on the rate of NADH:paraquat 
oxidoreduction. Initial rates, background corrected (defined as µmoles NADH consumed 
per second per µmole flavin) were calculated using linear regression over 30 seconds. The 
reaction was monitored at 340 – 380 nm, corresponding to NADH oxidation (∆ε340-380 nm = 
4.81 mM-1 cm-1). Top left; dependence of NADH:paraquat oxidoreduction on increasing 
concentrations of ADP and ATP. Concentrations: 100 µM NADH, 250 µM paraquat. Top 
right; dependence of NADH:paraquat oxidoreduction on increasing concentrations of 
ADP-ribose. Concentrations: 100 µM NADH, 250 µM paraquat. Bottom left; dependence 
of NADH:paraquat oxidoreduction on paraquat concentration in 5 mM ADP and 4 mM 
ATP. Concentration: 100 µM NADH. Bottom right; dependence of NADH:paraquat 
oxidoreduction on NADH concentration in 5 mM ADP and 4 mM ATP. Concentration: 
250 µM paraquat. Conditions: 32 °C, 20 mM tris-HCl pH 7.5.  
 
 
Figure 6.11 presents data from the same assays using diquat. Although the rates of the 
diquat reaction are approximately twice that of the paraquat reaction, the similarity in the 
trends observed between the two compounds is immediately evident. Figure 6.11, top left, 
shows that the rate of NADH:diquat oxidoreduction is enhanced over the range of ADP 
and ATP concentrations tested; like the paraquat reaction, the concentrations of ADP and 
ATP needed for maximal activation are 5 and 4 mM, respectively. Figure 6.11, top right, 
shows the results of similar experiments with ADP-ribose. Although activation is clearly 
evident, significant inhibition is not observed over the range of concentrations tested. 
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Figure 6.11: Investigating the effect of nucleotides on the rate of NADH:diquat 
oxidoreduction. Initial rates, background corrected (defined as µmoles NADH consumed 
per second per µmole flavin) were calculated using linear regression over 30 seconds. The 
reaction was monitored at 340 – 380 nm, corresponding to NADH oxidation (∆ε340-380 nm = 
4.81 mM-1 cm-1). Top left; dependence of NADH:diquat oxidoreduction on increasing 
concentrations of ADP and ATP. Concentrations: 100 µM NADH, 250 µM diquat. Top 
right; dependence of NADH:diquat oxidoreduction on increasing concentrations of ADP-
ribose. Concentrations: 100 µM NADH, 250 µM diquat. Bottom left; dependence of 
NADH:diquat oxidoreduction on diquat concentration in 5 mM ADP and 4 mM ATP. 
Concentrations: 100 µM NADH. Bottom right; dependence of NADH:diquat 
oxidoreduction on NADH concentration in 5 mM ADP and 4 mM ATP. Concentrations: 
250 µM diquat. Conditions: 32 °C, 20 mM tris-HCl pH 7.5.  
 
 
Figure 6.11, bottom left, shows the dependence of rate on diquat concentration in the 
presence or absence of nucleotide; as with the reactions of HAR and paraquat with 
complex I, the rate of reaction is increased dramatically in the presence of activating 
concentrations of nucleotide. Figure 6.11, bottom right, shows the dependence of rate on 
NADH concentration in the presence or absence of nucleotide. The extent of activation is 
very similar to the paraquat reaction, suggesting the conclusions drawn are also applicable 
to diquat. 
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6.3.2 The effect of MgSO4 on activation by ADP and ATP 
The working hypothesis is that positively charged electron acceptors only react when 
nucleotide is bound to the reduced flavin. The most likely explanation is that they form a 
ternary complex with the negatively charged phosphates of the nucleotides. To test this 
theory, the activatory effect of ADP and ATP were investigated in the presence of 
increasing concentrations of MgSO4; Mg2+ binds to the phosphates of the nucleotides, 
neutralising the charge, and, if the hypothesis is correct, preventing activation; the results 
are shown in figure 6.12.  
 
 
 
 
Figure 6.12: Investigating the effect of Mg2SO4 on the activation of NADH:paraquat 
(left) and NADH:diquat (right) oxidoreduction. Initial rates, background corrected 
(defined as µmoles NADH consumed per second per µmole flavin) were calculated using 
linear regression over 30 seconds. The reaction was monitored at 340 – 380 nm, 
corresponding to NADH oxidation (∆ε340-380 nm = 4.81 mM-1 cm-1). Conditions: 20 mM 
tris-HCl (pH 7.5), 32 °C, 100 µM NADH, 250 µM paraquat/diquat, 5 mM ADP or 4 mM 
ATP. The reported error is the standard deviation of three measurements.   
 
 
With increasing concentrations of MgSO4, the activatory effect of the nucleotides is 
gradually decreased; at 5 mM MgSO4, the rates of NADH:paraquat and NADH:diquat 
oxidoreduction in the presence of ADP and ATP are the same as those in the absence of 
nucleotides. These observations tentatively suggest that the negatively charged phosphates 
of ADP and ATP may be responsible for the observed activation of the reaction of 
positively charged electron acceptors with the flavin of complex I. 
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6.4 Conclusions and discussions 
6.4.1 A ternary mechanism for NADH oxidation by positively charged electron 
acceptors at the flavin site in respiratory complex I 
Three pieces of evidence strongly suggest that a group of positively-charged substrates 
such as HAR, paraquat and diquat react with the flavin of complex I in a ternary complex 
with nucleotide. First, low concentrations of nucleotides, such as ADP, ATP and ADP-
ribose, have an activatory effect on the rate, an observation which is not seen for the 
NADH:FeCN reaction; at high concentrations, nucleotides inhibit the HAR reaction. 
Qualitatively, this suggests that, at low concentrations, nucleotides enhance the reaction of 
positively charged substrates by augmenting nucleotide binding to the flavin; at high 
concentrations, nucleotides out-compete NADH for binding to the oxidised flavin, 
reducing the rate of reaction; whether the nucleotides activate or inhibit the reaction is 
dependent on which ‘half-reaction’ is rate-limiting. Second, using a combined approach 
that tested both HAR and FeCN datasets with common values for the NADH-dependent 
parameters, Dr. Judy Hirst showed that HAR can only react when nucleotide is bound to 
the flavin (either exclusively the ‘NADH-bound’ pathway, or, more realistically, a 
combination of the ‘NADH-bound’ and ‘NAD+-bound’ pathways; the ‘empty-site’ 
pathway does not contribute). Furthermore, the NADH:APAD+ and NADH:O2 reactions at 
the flavin can also be modelled using these universal parameters. Finally, the activatory 
effects of ADP and ATP are completely negated by equimolar concentrations of MgSO4, 
which presumably acts by binding to, and neutralising, the negatively charged phosphates 
crucial for substrate binding. 
 Most probably, positively charged molecules react at the negatively charged patch 
created by the nucleotide phosphates. Similar activatory effects are not seen with the 
pyrimidine nucleotides CDP (cytidine diphosphate) or UDP (uridine diphosphate), 
suggesting that the effect is particular to purine nucleotides that mimic the hydrophobic 
interactions of the adenine moiety of NADH or NAD+ with the three phenylalanines in 
complex I (Berrisford and Sazanov, 2009). Probing the nucleotide bound structure with a 
HAR probe furthermore shows that HAR can approach to within electron transfer distance 
of the reduced flavin in the nucleotide-bound state (figure 6.13 and Birrell et al., 2009).  
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Figure 6.13: The proposed binding site for the positively charged electron acceptors. 
Two views of NADH (shown in red) bound to the flavin (shown in blue) of complex I 
from T. thermophilus. The hydride transfer reaction is indicated by an arrow, and the 
negatively charged phosphates, where the positively charged electron acceptors are 
thought to bind, are highlighted in orange. The distance from the hydride donor (C4 of the 
nicotinamide ring of NADH) and acceptor (N5 of the flavin) is 8 – 12 Å from the centre of 
the highlighted area, close enough for physiologically relevant electron transfer (Page et 
al., 1999). PDB accession code: 3IAM. Adapted from (Berrisford and Sazanov, 2009). 
 
 
6.4.2 Ternary reaction mechanisms catalysed by flavoproteins 
The mechanism described above proposes that positively-charged electron acceptors can 
only react with the reduced flavin in complex with nucleotide. Ternary complexes between 
flavoenzymes, nucleotides and electron acceptors have been shown previously (Berkholz 
et al., 2008); however, there are distinct differences between these mechanisms and the 
proposed mechanism for the reduction of positively-charged electron acceptors by 
complex I.  
 Glutathione reductase is a disulphide oxidoreductase that converts oxidised 
glutathione (GSSG) to two molecules of reduced glutathione (GSH) using reducing 
equivalents from NAD(P)H and a FAD cofactor (Halliwell, 1998). The mechanism of 
GSSG reduction has been described previously (Berkholz et al., 2008); in brief, NAD(P)H 
reduces FAD, which subsequently reduces a cysteine-cysteine disulfide bond, forming a 
stable charge-transfer complex between the flavin and a cysteine thiolate. After formation 
of the charge-transfer complex, NAD(P) + dissociates and is replaced by another 
NAD(P)H. The oxidative half-reaction begins with the binding of GSSG; the reduced 
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cysteine attacks GSSG, forming a mixed disulphide. After the second GSH leaves, the two 
cysteines re-form a disulfide, releasing the second molecule of GSH product. 
 In common with the proposed mechanism of HAR reduction by complex I, 
glutathione reductase binds nucleotide (NAD(P)H) and substrate (GSSG) simultaneously. 
However, there are significant differences between the two proposed reaction mechanisms. 
As shown in figure 6.14, GSSG has a binding site distinct from the nucleotide binding site. 
There are no direct interactions between NAD(P)H and GSSG/GSH during turnover; 
unlike the reaction between complex I and HAR, the presence of NAD(P)H is not a pre-
requisite for the GSSG reaction. 
 
 
 
 
Figure 6.14: Comparing nucleotide and substrate binding for left, complex I, and 
right, glutathione reductase. The flavin cofactors (FMN for complex I, FAD for 
glutathione reductase) are shown in blue; the bound nucleotides (NADH for complex I, 
NAD(P)H for glutathione reductase) are shown in red, and the substrates (the proposed 
HAR binding site for complex I, GSH for glutathione reductase) are shown in orange. 
PDB accession codes: 3IAM (complex I) and 3DK4 (glutathione reductase). Adapted from 
(Berkholz et al., 2008; Berrisford and Sazanov, 2009). 
 
 
The catalytic mechanism of flavoprotein aromatic hydroxylases has been studied 
extensively. One of the most characteristic features is the control of the aromatic substrate 
over the reduction of the flavin by NAD(P)H (Howell et al., 1972). Once a ternary 
complex of the enzyme-bound flavin with substrate and NAD(P)H has formed, the 
enzyme-bound flavin is reduced by NAD(P)H; this ternary complex is kinetically evident 
from a transient long wavelength absorbance characteristic of a charge-transfer complex 
(Howell et al., 1972). Although a ternary complex between flavin, substrate and NAD(P)H 
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is needed for flavin reduction, NAD(P)+ subsequently dissociates, and the remainder of the 
catalytic cycle proceeds in the absence of bound nucleotide. We have demonstrated for 
complex I, unlike this mechanism of the aromatic hydroxylases, the nucleotide forms an 
essential structural element of the HAR binding site.  
 
6.4.3 The substrates and inhibitors of complex I 
Many compounds are proposed to either react with, or inhibit, complex I; characterising 
these compounds is important in understanding the functional and pathological 
implications of complex I turnover.  
 The substrates which react with complex I can be divided into three broad 
categories, based on the location and mechanism of reaction. The physiological substrate 
coenzyme Q10, and the most hydrophobic quinone analogues, such as DQ, react at the 
hydrophobic Q-site, and are inhibited by rotenone and piericidin A. The flavin can catalyse 
two types of reaction, both of which can initiate redox cycling reactions with oxygen. 
Substrates such as FeCN, O2, APAD+ and hydrophilic quinones (chapter 5) react by ping-
pong, or ping-pong-pong, kinetics, and are inhibited by high concentrations of NADH; 
other positively charged substrates, such as HAR, paraquat and diquat react at the reduced 
flavin only when nucleotide is bound (this chapter). 
 The classification system presented in figure 6.16 allows for initial characterisation 
of potential complex I substrates or inhibitors; only ten short experiments can identify 
where the compound reacts, the mechanism it reacts by, the consequences of the reaction 
with respect to the production of reactive oxygen species, or whether it inhibits the 
NADH:FeCN, NADH:HAR or NADH:DQ activity of complex I. Assuming that 
compound X does not react directly with NADH, the following set of reactions will 
provide an initial characterisation of the compound: 
 
1. Does compound X react with complex I?  
 -   100 µM compound X, 100 µM NADH 
2. Is the NADH:X oxidoreduction reaction inhibited by high NADH concentrations? 
 -   100 µM compound X, 25 µM NADH 
 -   100 µM compound X, 250 µM NADH 
3. Does the reaction lead to an increase in reactive oxygen species production? 
 -   100 µM compound X, 30 µM NADH, 2 U mL-1 HRP, 10 µM Amplex Red 
 -   100 µM compound X, 30 µM NADH, 50 µM acetylated cytochrome c 
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4. Is the NADH:X oxidoreduction reaction inhibited by rotenone and piericidin A? 
 -   100 µM compound X, 100 µM NADH, 2.3 µM rotenone 
 -   100 µM compound X, 100 µM NADH, 1 µM piericidin A 
5. Does compound X inhibit the NADH:DQ reaction? 
 -   10 µM compound X, 100 µM NADH, 0.4 mg mL-1 asolectin, 100 µM DQ 
6. Does compound X inhibit the NADH:FeCN and NADH:HAR reactions? 
 -   10 µM compound X, 100 µM NADH, 1 mM FeCN 
 -   10 µM compound X, 100 µM NADH, 3.5 mM HAR 
 
One example compound tested here was benzyl viologen, which is structurally related to 
paraquat (figure 6.15). Initial analyses revealed that it does not react directly with NADH, 
its reaction with complex I is not inhibited by high concentrations of NADH, it is not 
inhibited by rotenone or piericidin A, nor does it inhibit NADH:FeCN, NADH:HAR or 
NADH:DQ oxidoreduction, and it stimulates reactive oxygen species production. A 
tentative conclusion is that it probably reacts at the flavin by a ternary mechanism and 
redox cycles with oxygen. Unsurprisingly, its behaviour is qualitatively similar to the 
behaviour observed for the reactions of paraquat and diquat with complex I.  
 
 
 
Figure 6.15: Structures of paraquat and benzyl viologen.  
 
 
The scheme presented in figure 6.16 is not designed to offer a comprehensive 
characterisation of compounds that react with, or inhibit, complex I; rather, it provides a 
logical, rapid system which will highlight potentially interesting compounds for further 
investigation.   
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Figure 6.16: The substrates and inhibitors of mitochondrial complex I. See text for details. 
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Chapter 7: 
Direct assignment of EPR spectra to structurally defined iron-sulphur 
clusters by double electron-electron resonance (DEER) spectroscopy 
 
 
7.1 Introduction 
7.1.1 Iron-sulphur clusters 
Iron-sulphur clusters are one of the most ubiquitous and functionally versatile prosthetic 
groups in nature (Johnson et al., 2005). They have been identified as important mediators 
of many cellular processes, including the regulation of gene expression, delivery of 
sulphur and iron for the synthesis of biomolecules, and as sensors for iron, oxygen and 
superoxide; however, it is their role in electron transfer for which they are best known 
(Johnson et al., 2005). Figure 1.18 shows the structures of [2Fe2S] and [4Fe4S] clusters, 
the most prevalent iron-sulphur clusters in nature. Although [4Fe4S] clusters can occur in 
the 3+, 2+, 1+ and 0 oxidation states, only two of them occur commonly in proteins: the 
[4Fe4S]2+/1+ redox couple is observed in ferredoxins, as well as hydrogenases and 
reductases (Beinert et al., 1997); the [4Fe4S]3+/2+ couple is found in specialised high-
potential iron proteins from purple bacteria. The [2Fe2S] cluster is also relatively common; 
it operates mostly by the [2Fe2S]2+/1+ redox couple, and it is present in ferredoxins, and in 
enzymes of both the respiratory and photosynthetic electron transfer chains (Beinert et al., 
1997). 
 The iron atoms in iron-sulphur clusters are tetrahedrally coordinated, and exist in 
high spin states. In the 3+ oxidation state, the iron atom has five unpaired d-electrons, 
whilst in the 2+ state, it has six d-electrons, four of which are unpaired. Each electron has 
spin s = ½; therefore, Fe3+ and Fe2+ have total spins of s = 5/2 and s = 2, respectively. In 
oxidised [2Fe2S]2+ clusters, both irons are in the Fe3+ state and antiferromagnetic coupling 
of the two s = 5/2 centres gives a total cluster spin of S = 0, which is not detectable by EPR 
(Beinert et al., 1997). Upon reduction to the [2Fe2S]1+ state, one Fe3+ is converted to an 
Fe2+ and antiferromagnetic coupling produces the EPR visible S = 1/2 state. In oxidised 
[4Fe4S]2+ clusters, the electron density is delocalised over all four iron atoms, considered 
as two pairs of equivalent Fe2.5+, and a total spin of S = 0 which cannot be detected by EPR 
(Beinert et al., 1997). The production of the [4Fe4S]1+ state upon one electron reduction 
results in one mixed-valence Fe2.5+ pair becoming an Fe2+ pair, and leads to an EPR 
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detectable total cluster spin of S = 1/2. Consequently, in order to detect [2Fe2S] and 
[4Fe4S] clusters, they have to be reduced. 
 
7.1.2 Electron paramagnetic resonance 
The foremost technique for studying iron-sulphur clusters is electron paramagnetic 
resonance (EPR). In EPR spectroscopy, only components which are paramagnetic, such as 
reduced 2Fe and 4Fe iron-sulphur clusters, are detected (Ohnishi, 1998).  
   
 
 
 
Figure 7.1: Schematic representation of the splitting of the spin populations into 
different energy levels in an increasing magnetic field. At a fixed microwave frequency, 
v, the magnetic field, H, is scanned to determine the position of resonance. Adapted from 
(Ohnishi, 2008). 
 
 
In the absence of a magnetic field, the spins of a paramagnetic substance are randomly 
orientated and have the same energy. When the sample is introduced into an external 
magnetic field, H, the magnetic moment of the unpaired spin will either align parallel or 
anti-parallel to the applied field. The spins are consequently split into two populations with 
energies +½gβH and -½gβH corresponding to the spins aligned parallel and anti-parallel to 
H, respectively (known as Zeeman splitting). The energy difference between these two 
alignments, ∆E, is dependent on the magnitude of H (Ohnishi, 1998). Resonance 
transitions between the populations occur when the applied microwave energy, hv, is equal 
to the energy difference between the spin states- it is this transition that is observed in EPR 
spectroscopy; a schematic of a typical experiment is shown in figure 7.1. 
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In a typical continuous wave EPR experiment, the microwave frequency, v, is fixed and 
the magnetic field is scanned. The most commonly used frequency is ~9.4 GHz, referred to 
as X-band EPR; W-band EPR, with a frequency of 94 GHz, will also be used in the course 
of these studies. As v varies slightly from experiment to experiment, positions of resonance 
are expressed as g-values (equation 7.1).  
  
 
H
g β
vh
=  
 
Equation 7.1: v is the microwave frequency (Hz), h is Planck’s constant (6.626 x 10-34 J 
s), β is the Bohr magneton (9.274 x 10-24 J T-1) and H is the magnetic field (G). 
 
 
Most of the unpaired electrons in iron-sulphur clusters are localised in the 3d atomic 
orbitals of the transition metal ions; their observed g-values deviate from the g-value for a 
free electron (g = 2.0023) due to electromagnetic interactions of the spin system with its 
molecular surroundings. In addition, the molecular environment is not spherically 
symmetrical, so the sample can exhibit as many as three intrinsic g-values, each 
corresponding to one of the molecular axes: gx, gy and gz (Ohnishi, 1998). Furthermore, 
very low temperatures are needed to observe the spectra of reduced iron-sulphur clusters; 
therefore, samples for EPR spectroscopy are frozen, and, as a result, exhibit powder 
spectra. Powder spectra fall into three classes depending on the symmetry of the molecular 
environment of the spin system - isotropic, axial or rhombic (Ohnishi, 1998). Whereas 
magnetically isotropic spins have a single g-value (gx = gy = gz), with axial or rhombic 
symmetry, the signal is described by two (gx = gy ≠ gz), or three (gx ≠ gy ≠ gz), parameters, 
respectively (figure 7.2).  
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Figure 7.2: The three types of signals commonly observed in EPR spectroscopy. Top; 
geometric shapes of isotropic, axial and rhombic moments are shown as a sphere, rugby 
ball and compressed rugby ball, respectively. The signals are shown as absorption spectra 
(middle) and the first derivative of the absorption spectra (bottom), which are the observed 
EPR spectra. Adapted from (Ohnishi, 1998). 
 
 
The populations of the spins in the higher, ‘parallel’ (NA) and lower, ‘anti-parallel’ (NB) 
energy levels are determined by the Boltzmann distribution (equation 7.2); in EPR 
experiments, the difference between the two populations is usually very small.  
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Equation 7.2: NA is the higher energy state, NB is the lower energy state, β is the Bohr 
magneton (9.274 x 10-24 J T-1), H is the magnetic field (G), k is Boltzmann’s constant (1.38 
x 10-23 J K-1) and T is the temperature.  
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Resonance transitions occur when microwaves are absorbed to flip the anti-parallel spin 
into the higher energy parallel state, and when relaxation back to the ground state is able to 
maintain a population difference: the net resonance absorption depends on the population 
difference of the upper and lower energy states. Relaxation back to the ground state is 
mediated by interactions of spins with the surrounding environment (spin-lattice 
interactions), and with other nearby paramagnetic centres (spin-spin interactions). 
 The time constants T1 and T2 describe the spin-lattice and spin-spin relaxation 
times, and are specific properties of individual paramagnetic centres (Ohnishi, 1998). 
When the relaxation rates are not fast enough, or the microwave power is too high to 
maintain the population difference, the EPR signal intensity diminishes. Quantitative 
analysis of this phenomenon, known as power saturation, can be used to differentiate iron-
sulphur clusters with similar g-values. Alternatively, at higher temperatures relaxation 
times decrease. If relaxation is too fast then EPR signals can not be detected because the 
excited state is very short lived and its energy is poorly defined. [4Fe4S] clusters have 
extremely short relaxation times, thus can only be detected at temperatures below 20 K; as 
[2Fe2S] clusters have longer relaxation times, they can be seen as high as 40 K (Ohnishi, 
1998).  
 All these characteristics (g values, power and temperature dependencies) provide 
iron-sulphur clusters with unique EPR ‘fingerprints’, by which to describe and distinguish 
them.     
 
7.1.3 The iron-sulphur clusters of complex I 
The structure of the hydrophilic domain of complex I from T. thermophilus revealed a 
chain of seven iron-sulphur clusters linking the flavin site to the proposed site of 
ubiquinone reduction close to the membrane. All the edge-to-edge distances conform to 
‘Dutton’s ruler’ for electron transfer; even the greatest distance, 14 Å between clusters 
4Fe[75]H and 4Fe[TY]1, is small enough to allow for electron transfer at physiologically 
relevant rates (Page et al., 1999). Two additional clusters are present; cluster 2Fe[24], on 
the opposite side of the flavin, is not directly involved in electron transfer to quinone, and 
cluster 4Fe[75], which is separated from the chain and only found in some bacterial 
species such as T. thermophilus and E. coli (Hinchliffe et al., 2006).  
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B. taurus complex I 
 
N1a N1b N2 N3 N4 N5 
gz 2.00 2.02 2.05 2.04 2.10 2.07 
gy 1.95 1.94 1.92 1.93 1.94 1.93 
gx 1.92 1.92 1.92 1.86 1.88 1.90 
 
Figure 7.3: EPR spectra and g-values of the iron-sulphur clusters of complex I from 
bovine heart mitochondria reduced by NADH. Left; EPR spectra were recorded over a 
range of temperatures; the positions of the EPR signals are indicated. Right; the spectrum 
recorded at 12 K (black) is compared to the simulated spectrum (red). The inset (not on the 
same x-axis scale) has been expanded two-fold along the y-axis to show how the modelled 
spectrum comprises signals N1b (grey), N2 (green), N3 (blue), N4 (magenta), and N5 
(orange). Taken from (Reda et al., 2007). Bottom; g-values of the EPR signals N1a, N1b, 
N2, N3, N4 and N5 (see figure 7.4). Signal N1a is only observed in subcomplex Fp, and its 
corresponding g-values are taken from (Zu et al., 2002). Other values are taken from 
(Ohnishi, 1998). 
 
 
Five iron-sulphur clusters are typically observed in complex I from B. taurus reduced by 
NADH; their continuous wave EPR signals are denoted N1b, N2, N3, N4 and N5. A sixth, 
signal N1a, is not observed in the intact enzyme, but is detected in the overexpressed 24 
kDa subunit and in subcomplex Fp (Zu et al., 2002; Reda et al., 2008). Typical EPR 
spectra of complex I from bovine heart mitochondria are shown in figure 7.3. 
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Signals N1a, N1b, N2 and N3 have been unambiguously assigned to their structurally 
defined clusters: 
• The relaxation properties of signal N1a show that it is a [2Fe2S] cluster. As it is 
exhibited in the overexpressed 24 kDa subunit and by subcomplex Fp, containing 
the 24 and 51 kDa subunits, it has been assigned to cluster 2Fe[24] (Barker et al., 
2007). 
• The relaxation properties of signal N1b show that it is a [2Fe2S] cluster; thus it 
must come from the remaining [2Fe2S] cluster in complex I, 2Fe[75]  (Yano et al., 
1995).   
• Signal N2 has been unambiguously assigned to cluster 4Fe[PS], as it interacts 
paramagnetically with ubisemiquinone radicals (Yano et al., 2005).  
• Signal N3 has been unambiguously assigned to cluster 4Fe[51], as it interacts 
paramagnetically with the flavosemiquinone radical (Sled et al., 1994).  
The assignment of EPR signals N4 and N5 has been more controversial. Several groups 
have overexpressed the 75 kDa subunit from species such as P. denitrificans, T. 
thermophilus and E. coli with the aim of characterising the iron-sulphur clusters 
coordinated by this subunit. Yano and co-workers overexpressed the Nqo3 subunit from P. 
denitrificans in E. coli. Using chemical analyses and UV-visible and EPR spectroscopic 
studies, the authors showed that the overexpressed subunit contained at least two iron-
sulphur clusters: a [2Fe2S] cluster, and a [4Fe4S] cluster attributed to signal N4 (Yano et 
al., 1995). Further analyses suggested that the signal from the [4Fe4S] cluster comprised 
two overlapping signals with similar g-values, but different relaxation properties; the 
authors attributed these two signals, N4 and N5, to clusters 4Fe[75]C and 4Fe[75]H, 
respectively (Yano et al., 2003). Nakamura-Ogiso and co-workers reported that EPR 
spectra from a maltose-binding protein-fused construct of Nqo3 from T. thermophilus were 
consistent with one [2Fe2S] cluster and two [4Fe4S] clusters; however, it was necessary to 
reconstitute the clusters chemically, and the individual [4Fe4S] signals could not be 
distinguished (Nakamaru-Ogiso et al., 2002). The same group subsequently reported EPR 
spectra from a maltose-binding protein-fused construct of NuoG from E. coli, and a 
construct in which mutations in each of the iron-sulphur binding motifs were made. Again, 
the clusters required chemical reconstitution, and no [2Fe2S] signals were observed, even 
in the wild-type protein. The authors attributed the two [4Fe4S] signals to clusters 
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4Fe[75]C (signal N4) and 4Fe[75] (signal N7) based on mutational analyses (Nakamaru-
Ogiso et al., 2005).  
 Analysing the EPR spectra from the overexpressed NuoG subunit from E. coli, and 
comparing the data to the intact enzyme, Yakovlev and Hirst suggested signals N4 and N5 
had been previously misassigned by Ohnishi and co-workers (Yakovlev and Hirst, 2007). 
They proposed that signal N4 is from NuoI (and not NuoG as proposed by Ohnishi and co-
workers), and signal N5 is from the conserved cysteine-ligated [4Fe4S] cluster in NuoG 
(and not from the cluster with a histidine ligand). Supporting this assignment, Waletko and 
co-workers replaced the conserved His129 in the 75-kDa subunit from Y. lipolytica with 
alanine; EPR analysis showed signal N5 remained unchanged, suggesting His129 is not a 
ligand for the cluster that evokes signal N5 (Waletko et al., 2005).  
  
 
 
 
Figure 7.4: Arrangement of the redox cofactors in B. taurus complex I, based on the 
structure of T. thermophilus. Left; the iron-sulphur clusters of B. taurus, named 
according to their type ([2Fe2S] or [4Fe4S]), B. taurus subunit homologue (75 = 75 kDa, 
51 = 51 kDa, 24 = 24 kDa, PS = PSST, TY = TYKY), and if necessary as C (all cys 
ligated) or H (one his ligand), or as 1 or 2. Distances are centre-to-centre for the iron-
sulphur clusters or the centre ring of the isoalloxazine system. Right; extant assignments of 
the five EPR signals observed in B. taurus complex I reduced by NADH, Model A: 
(Ohnishi, 1998; Ohnishi and Nakamaru-Ogiso, 2008). Models B/C: (Reda et al., 2008; 
Yakovlev et al., 2007).   
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Figure 7.4 summarises the arrangement of the cofactors in complex I, and the current 
controversies over the assignment of signals N4 and N5. There are three contending 
assignments of EPR signals N4 and N5 to their structurally defined clusters. Ohnishi’s 
model (model A) assigns signals N4 and N5 to clusters 4Fe[75]C and 4Fe[75]H, 
respectively (Ohnishi, 1998; Ohnishi and Nakamaru-Ogiso, 2008), whereas Hirst’s models 
(models B and C) assign signal N4 to one, or both, of clusters 4Fe[TY]1 and 4Fe[TY]2, 
and signal N5 to cluster 4Fe[75]C (Yakovlev et al., 2007; Reda et al., 2008). Importantly, 
these assignments rely on data from over-expressed subunits, enzyme fragments, and point 
mutations, rather than on direct measurements on the intact enzyme; this type of analysis 
often compromises iron-sulphur cluster integrity, making cluster assignment unreliable 
(Nakamaru-Ogiso et al., 2002; Nakamaru-Ogiso et al., 2005).   
 Further analysis of the iron-sulphur clusters of complex I requires advanced pulsed-
EPR spectroscopy. One such technique is double electron electron resonance (DEER), 
which measures the dipolar coupling between specially separated pairs of paramagnetic 
centres. A typical DEER experiment detects the modulation of the echo amplitude of one 
spin population, when the second spin population is excited with intense microwave 
radiation (Hemminga and Berliner, 2007). If the two populations, A and B, are spatially 
close, and A ‘sees’ the dipolar field generated by B, the echo of A will be modulated as the 
timing of the pulse applied to B is altered. The frequency of the modulation (which is 
related to the inter-centre separation by r-3) can be found by Fourier transforming the 
signal into the frequency domain; from this analysis, the distance between the A and B 
paramagnetic centres can be calculated (Hemminga and Berliner, 2007). 
 
7.1.4 Aims  
To understand the mechanism of energy transduction by complex I, it is essential to assign 
the set of spectroscopically determined cluster properties to the set of structurally defined 
clusters.  The correct assignment defines the properties of individual clusters (for example, 
reduction potentials), and of the cluster ensemble (for example, the free-energy profile for 
electron transfer along the chain), and thus allows rates of intramolecular electron transfer 
and possible energy coupling sites to be determined (Page et al., 1999).   
 The work described in this chapter is a result of collaboration between the 
laboratories of Dr. Judy Hirst and Dr. Alan Robinson at the MRC Mitochondrial Biology 
Unit, and the laboratories of Professor Fraser Armstrong (Inorganic Chemistry Laboratory, 
Department of Chemistry) and Dr. Jeffrey Harmer (The Centre for Advanced Electron 
  
 194 
Spin Resonance) at the University of Oxford. The aim of the collaboration was to assign 
signal N4 directly by DEER spectroscopy, by determining the position of the origin of 
signal N4 relative to the other paramagnetic centres. Once signal N4 is assigned, signal N5 
can be assigned. DEER is well established for determining the distances between organic 
radicals (Jeschke et al., 2002). In contrast, applying it to measure the distances between 
paramagnetic metal centres, such as iron-sulphur clusters in enzymes, is significantly more 
challenging. My role in the collaboration was to prepare samples of complex I of sufficient 
quality and quantity for analysis. EPR spectra were recorded and analysed by Maxie 
Roessler and Dr. Jeffrey Harmer in Oxford, and analysis of the suitability of the T. 
thermophilus enzyme as a structural model for the bovine enzyme was carried out by Dr. 
Alan Robinson. 
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7.2 Preparation of EPR samples 
Three different types of EPR sample were made, each of which yields useful information: 
X-band EPR spectroscopy is the ‘standard’ experiment, and has been used extensively to 
characterise the iron-sulphur clusters of complex I (for examples, see (Ohnishi, 1998; 
Barker et al., 2007; Yakovlev et al., 2007; Reda et al., 2008)). W-band EPR spectroscopy 
was used to investigate the frequency-dependence of the signals, and would help to reveal 
any coupling between the paramagnetic centres. As explained above, the pulsed-EPR 
technique DEER was used to define the distances between paramagnetic centres directly. 
 The quality of an EPR spectrum is dependent on the quality of the protein sample; 
furthermore, as a typical set of experiments encompassing the three types of sample 
required up to 400 µL of ~60 mg mL-1 complex I, the first aim of the project was to 
produce complex I of sufficient quality, in sufficient quantity, to permit EPR analysis. 
Previous work in the laboratory aimed at optimising the preparation of protein to maximise 
catalytic activity rather than optimising the spectral properties of the enzyme (Sharpley et 
al., 2006).  
 First, complex I was prepared according to the protocol reported by Sharpley and 
co-workers (Sharpley et al., 2006), concentrated to ~60 mg mL-1, and reduced 
anaerobically by 10 mM NADH. Each EPR sample required different amounts of reduced 
protein: X-band samples required 110 µL, DEER samples required 60 µL, and W-band 
samples, 2 µL. Whereas the preparation of the X-band and DEER samples were relatively 
straightforward, the preparation of the W-band samples was technically challenging. 
Although the W-band samples required only 2 µL of protein, the aperture of the capillary-
type tube was less than 1 mm. The sample was dispensed into the tube using a 22-gauge 
syringe; to ensure the sample was concentrated at the base of the tube, it was secured to, 
and sealed in, a 50 mL falcon tube, removed from the glove box, and centrifuged at 40 g 
for two minutes. The W-band sample was subsequently placed in a larger, X-band EPR 
tube to protect it, and snap frozen in liquid nitrogen. All three EPR sample types, made in 
duplicate, were shipped to our collaborators in Oxford, and their spectra recorded and 
analysed by Maxie Roessler and Dr. Jeffrey Harmer. 
 Figure 7.5 shows the W-band EPR spectra of complex I prepared according to the 
protocol reported by Sharpley and co-workers (Sharpley et al., 2006). Although not 
observed in the X-band spectra (data not shown), the W-band experiments show that Mn2+ 
is present in the sample. Using X-band EPR spectroscopy, Reda and co-workers reported 
the presence of two small signals of unknown origin at g = 2.001 and 1.993 that do not 
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correlate to sample potential; although these signals are significantly smaller than those 
observed in the W-band experiment, it is possible that these too result from manganese 
(Reda et al., 2008).   
 
 
 
 
Figure 7.5: W-band EPR absorption spectra of complex I prepared using standard 
(blue trace) or ultrapure (red trace) buffers. Complex I was prepared using standard or 
ultrapure buffers. The sample was reduced anaerobically by 10 mM NADH (ca. −0.4 V) to 
a final concentration of ~55 mg mL−1, and frozen using liquid nitrogen. The spectra were 
recorded and analysed by Maxie Roessler and Dr. Jeffrey Harmer (The Centre for 
Advanced Electron Spin Resonance, University of Oxford). The manganese signal is 
indicated by an arrow.  
 
 
The observation that manganese may be bound to complex I may be interesting in its own 
right. Hosler and co-workers reported that sub-stoichiometric amounts of Mn2+ is bound to 
cytochrome c oxidase of Rhodobacter sphaeroides, appearing in the EPR spectrum of the 
purified enzyme as signals that overlaid those of CuA in the g = 2.00 region, consistent 
with the observations of Reda and co-workers (Reda et al., 2008). The authors 
demonstrated that Mn2+ was tightly bound to the enzyme, and was not removed by a high 
degree of purification or by washing with 50 mM EDTA. Furthermore, when bound Mn2+ 
was depleted by growth in high Mg2+, there was no change in electron transfer activity, 
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suggesting that Mg2+ can effectively substitute for Mn2+. The authors proposed that Mn2+ 
competes for the site that normally binds a stoichiometric Mg2+ ion (Hosler et al., 1995). 
These observations suggest that Mn2+/Mg2+ could be physiologically relevant cofactors for 
complex I function, rather than a simple contaminant. To test this, a time-course was set up 
investigating the effect of 5 mM EDTA, 5 mM MgCl2 and 5 mM MnSO4 on the 
NADH:DQ activity of complex I. There were no discernable differences between the rates 
of the enzyme incubated in the presence or absence of EDTA, MgCl2 and MnSO4, 
suggesting:  
i. Mn2+/Mg2+ are an integral part of the enzyme, and over the period tested (seven 
hours), ion exchange does not occur and therefore is not detected 
ii. Mn2+/Mg2+ function downstream of the quinone binding site, therefore changes are 
not detected by the assay; this would suggest that Mn2+/Mg2+ may be involved in 
proton translocation 
iii. Mn2+ has no role in complex I function, and is simply a contamination introduced 
during enzyme preparation 
If manganese is a contaminant, it should be possible to eliminate it during the preparation 
of the enzyme. First, mitochondrial membranes were prepared according to the protocol 
stated in materials and methods, section 2.2.2, except ultrapure trizma base and EDTA 
were used in place of less-pure reagents, and ethylene glycol was used instead of glycerol. 
Reagents considered not essential in the purification of complex I were omitted from the 
protocol. These included PMSF, a protease inhibitor used during membrane solubilisation, 
and asolectin. As listed in table 7.1, ultrapure versions of chemicals considered essential in 
the preparation of complex I were used in place of less-pure reagents. Complex I was 
prepared using this modified protocol, concentrated to ~60 mg mL-1, reduced by 10 mM 
NADH, and EPR samples prepared as above; figure 7.5 compares the W-band EPR 
absorption spectra of complex I prepared in standard and ultrapure buffers. As shown by 
the arrow, the level of manganese contamination decreased dramatically upon the use of 
ultrapure buffers. 
 To further assess the effect of buffer composition on the level of metal ion 
contamination, samples of complex I, prepared according to the two protocols, were sent 
to Dr. Jason Day (Department of Earth Sciences, University of Cambridge) for elemental 
analysis; the results, standardised to iron, are presented in table 7.2. Assuming that 
manganese is bound to protein, the amount of Mn2+ bound per complex I decreased from 
0.22 atoms per complex I when prepared in the standard buffers, to 0.04 atoms per 
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complex I when prepared in the ultrapure buffers. The number of magnesium and copper 
atoms also decreased from 1.37 to 0.5, and 1.91 to 0.62, respectively, on the preparation of 
complex I in ultrapure buffers. Surprisingly, the levels of zinc associated with the protein 
remains high irrespective of the purity of the buffers. These data suggest that manganese is 
not a cofactor for complex I; rather it is simply introduced during the preparation of the 
enzyme. 
 
 
Chemical Purity Manganese  Mn2+ in buffer/ nM 
DDM Not known Not known Not known 
PMSF Eliminated from preparation 
DTT > 99.5% < 5 mg kg-1 14 
Trizma base > 99.9% < 5 mg kg-1 220 
Ethylene glycol > 99.5% < 0.05 mg kg-1 90 
EDTA > 99.0% < 5 mg kg-1 30 
Asolectin Eliminated from preparation 
NaCl > 99.999% < 0.01 mg kg-1 4 
Glycerol Ethylene glycol was used in place of glycerol 
TCEP Eliminated from preparation 
NADH Not known Not known Not known 
 
Table 7.1: Manganese content of the ultrapure chemicals used to make the ultrapure 
Q-Sepharose and gel filtration buffers.  
 
 
Metal Standard buffers Ultrapure buffers  
Iron 28.00 28.00 
Manganese 0.22 + 0.06 0.04 + 0.03 
Magnesium 1.37 + 0.46 0.50 + 0.11 
Zinc 3.78 + 0.21 2.79 + 0.36 
Copper 1.91 + 0.31 0.62 + 0.01 
 
Table 7.2: Elemental analysis of complex I samples. Elemental analysis was carried out 
by Dr. Jason Day (Department of Earth Sciences, University of Cambridge) using a DRCII 
quadrupole based inductively coupled plasma-mass spectrometer (ICP-MS). Results are 
standardised to iron; the values are reported as metal ions per complex I. 
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These data suggest the modified protocol for the preparation of complex I produces protein 
of sufficient quality for EPR analysis. A further consideration was the concentration and 
volume of protein needed for EPR analysis; a set of experiments required up to 400 µL of 
complex I at a concentration of ~60 mg mL-1; for comparison, a typical preparation for 
crystallisation trials used ~15 mL of mitochondrial membranes, which gave ~3 mg of 
purified protein. Therefore, the preparation needed to be scaled-up approximately eight-
fold. To prepare complex I in the quantities needed for EPR analysis, ~120 mL of 
mitochondrial membranes were used, which gave ~25 mg of highly pure protein. The 
purification steps were adjusted accordingly; a 75 mL Q-Sepharose column was prepared, 
and up to eight injections of protein onto the gel filtration column were performed. In total, 
~100 milligrams of highly purified complex I was prepared for this study. 
 Finally, Reda and co-workers have shown that signal N1b is essentially absent 
when the enzyme is ‘poised’ at -0.3 V (Reda et al., 2008). In addition to the samples 
reduced by 10 mM NADH, complex I was ‘poised’ at a potential, set by the Nernst 
equation (table 3.2), that would eliminate signal N1b, thus simplifying the DEER analyses. 
Table 7.3 lists the EPR samples made for the final analysis, the concentrations of NADH 
and NAD+ required to ‘poise’ the enzyme at the required potential, the volume of protein 
needed for the sample, and the final concentration of protein after reduction with 
NADH/NAD+. Each sample was prepared in duplicate (X-band and DEER), or triplicate 
(W-band), and three independent preparations of complex I investigated whether the 
findings were reproducible. 
 
 
Sample [NADH] [NAD+] Potential Volume Protein 
DEER 10 mM - -0.4 V 60 µL 60 mg mL-1 
DEER 2 mM 32 mM -0.3 V 60 µL 57 mg mL-1 
X-band 10 mM - -0.4 V 110 µL 60 mg mL-1 
X- band 2 mM 32 mM -0.3 V 110 µL 57 mg mL-1 
W-band 10 mM - -0.4 V 3 µL 60 mg mL-1 
W-band 2 mM 32 mM -0.3 V 3 µL 57 mg mL-1 
 
Table 7.3: The EPR samples made for the final analysis. Complex I was prepared using 
the ultrapure buffers (table 7.1).  
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7.3 Summary of the EPR analysis 
7.3.1 Determination of principal g-values 
EPR spectra of complex I from B. taurus at X-band (9.393 GHz, 12 K) and W-band 
(93.871 GHz, 8.5 K) are shown in figure 7.6. The spectra comprise four overlapping 
signals (N1b, N2, N3 and N4) from four reduced iron-sulphur clusters; each signal is 
described by three principal g-values, as listed in table 7.4.   
 
 
Principal g-value Amplitude (%) 
Signal 
gx gy gz EPR DEER 
N1b 1.927 1.939 2.023 9 (3) 4 (1) 
N2 1.921 1.927 2.054 32 (34) 61 (55) 
N3 1.863 1.934 2.039 26 (23) 9 (13) 
N4 1.886 1.928 2.107 33 (40) 26 (31) 
 
Table 7.4: Principal g-values and relative intensities of spectra from the four reduced 
iron-sulphur clusters observed in B. taurus complex I. Principal g-values were derived 
from modelling continuous wave EPR X-band and W-band spectra. Relative amplitudes 
were derived by integrating the individual simulated spectra from continuous wave X-band 
spectra, and from refocused-echo-detected spectra using the DEER pulse sequence. Values 
from −0.4 V samples are compared to those from −0.3 V in brackets.  
 
 
As expected from their reduction potentials (Ohnishi, 1998), signals N2, N3, and N4 
contribute significantly at both -0.4 and -0.3 V. Signal N1b is present only sub-
stoichiometrically, and signal N5 is not observed under the conditions used here as it 
relaxes too rapidly (Reda et al., 2008). Importantly, when plotted on a g-value axis to 
remove the microwave frequency/magnetic field dependence, the X- and W-band spectra 
essentially overlay, suggesting that the paramagnetic centres are separated spatially, and 
not affected by coupling. This observation supports an ‘alternating-chain’ theory, where 
every other cluster is reduced. Their close agreement indicates that the spectral peak 
positions correspond closely to the principal g-values: indeed, a common set of parameters 
describes the data from both frequencies. Importantly, these g-values values are in 
agreement with those presented in figure 7.3. 
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Figure 7.6: EPR spectra of complex I from B. taurus, and simulations for signals N1b, 
N2, N3 and N4. X-band continuous EPR spectra of complex I reduced to -0.4 V and -0.3 
V were recorded at 12 K, at 9.408 and 9.393 GHz, respectively. The W-band (93.875 
GHz) echo-detected EPR spectrum of complex I reduced to -0.4 V was recorded at 8.5 K. 
The three spectra (black) are compared to one another and to their modelled spectra (red, 
comprising signals N1b, N2, N3 and N4, see table 7.1), by plotting all the spectra on the g-
value scale. Signals N1b, N2, N3 and N4 are shown from the -0.4 V X-band spectra; at -
0.3 V N1b is essentially absent.  
 
 
7.3.2 DEER traces of complex I from B. taurus  
Analysing data from a DEER experiment first involves simulating the spectra using a 
physical model that incorporates the distances between paramagnetic centres (Hemminga 
and Berliner, 2007). The program used to simulate the DEER spectra was written by Dr. 
Jeffrey Harmer; spectra were simulated according to the cluster assignments proposed in 
models A, B and C; for example, in model A, the clusters that give rise to signals N2 and 
N4 are proposed to be 49.1 Å apart; in model B, they are 25.8 Å apart, and finally, in 
model C, they are 13.6 Å apart (Jeschke, 2002; Roessler et al., 2010). These simulated 
spectra were then compared against the experimental data, and are shown in figure 7.7.  
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Figure 7.7: DEER data from B. taurus complex I reduced to -0.4 V and -0.3 V 
measured at 10 K. DEER traces (black) and simulations (red) for models A, B and C. 
Traces 3* and 4* refers to the -0.3 V sample, all others are from the -0.4 V sample. All 
traces are normalised to the intensity at t = 0; intensity changes are denoted by the scale 
bar.  
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In figure 7.7, traces 3* and 3 (matching traces from samples at -0.3 and -0.4 V, 
respectively) are essentially identical. Signal N1b is only observed at -0.4 V, and therefore 
it does not contribute significantly; signal N5 is not observed because it relaxes too 
rapidly. The remaining signals, N2, N3, and N4, yield three pairs: N2–N3, N2–N4, and 
N3–N4. Clusters 4Fe[PS] and 4Fe[51] are too far apart to contribute anything more than a 
weak, indiscernible decay. In model A the N2–N4 and N3–N4 distances are 49 and 17 Å, 
in model B 26 and 41 Å, and in model C 14 Å and 49 Å, respectively. In models A and C 
neither distance is in the 20 to 35 Å range that is detected best by the DEER experiment, 
indicating already that model B is most likely.  
 A quantitative evaluation of each model requires the numerical simulation and 
analysis of a comprehensive set of DEER traces, and is beyond the scope of this chapter; 
the data is presented in the corresponding PNAS paper (Direct assignment of EPR spectra 
to structurally defined iron-sulfur clusters in complex I from Bos taurus by double electron 
electron resonance (DEER) spectroscopy; Roessler et al., 2010). However, extensive 
analysis revealed that model B is the only model that is consistent with the observed data. 
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7.4 Discussion 
7.4.1 The assignment of signal N4 to cluster 4Fe[TY]1 
DEER spectroscopic data provide the first definitive assignment of EPR signal N4 to a 
structurally defined cluster in complex I, because they are based on direct measurements, 
rather than on data from over-expressed subunits and subcomplexes, which may not retain 
their structural or spectral integrity (Yakovlev et al., 2007; Ohnishi, 2008). The analyses 
conclude unambiguously that signal N4 derives from cluster 4Fe[TY]1, as first suggested 
by Yakovlev and co-workers (Yakovlev et al., 2007), and support the consensus 
assignment of signal N1b to cluster 2Fe[75], signal N2 to cluster 4Fe[PS], and signal N3 to 
cluster 4Fe[51]. The DEER spectra recorded are inconsistent with the assignment of signal 
N4 to cluster 4Fe[75]C, as contended by Ohnishi and co-workers (model A; Ohnishi, 
1998; Ohnishi and Nakamaru-Ogiso, 2008), or with the assignment of signal N4 to cluster 
4Fe[TY]2, an alternative suggestion by Hirst and co-workers (model C; Yakovlev et al., 
2007). Although these analyses do not address directly the assignment of signal N5, 
mutation of the histidine ligand of cluster 4Fe[75]H to alanine did not affect signal N5 in 
Y. lipolytica complex I, although it did prevent catalysis, suggesting the assignment of 
signal N5 to cluster 4Fe[75]H is not correct (Waletko et al., 2005; Ohnishi and Nakamaru-
Ogiso, 2008). Hirst and co-workers concur that signal N5 derives from the 75 kDa subunit, 
as it was observed in the over-expressed 75 kDa subunit from E. coli, but assigned it 
instead to cluster 4Fe[75]C (Yakovlev et al., 2007), an assignment that is consistent with 
all extant data and with the analysis described above. The N5 signal is unusual and worthy 
of further consideration: it is observed only in a subset of eukaryotic enzymes, and it 
relaxes very rapidly in complex I reduced by NADH, but more slowly in complex I 
reduced to yet lower potential (Reda et al., 2008).   
 
7.4.2 The biological consequences of signal N4 assignment 
Confirming the relationship between the structurally defined iron-sulphur clusters and their 
EPR signals has clear implications for our understanding of the ‘energy-profile’ for 
electron transfer along the cluster chain. Combining these data with the EPR signal 
assignment produces a reduction potential ‘profile’ for electron transfer along the cofactor 
chain (figure 7.8, top). Redox titrations of mitochondrial complex I have shown that 
cluster 4Fe[PS]/N2 has the highest potential, being reduced at about -0.1 V; clusters 
4Fe[51]/N3, 4Fe[TY]1/N4 and 4Fe[75]C/N5 are all considered ‘isopotential’, being 
reduced at around -0.25 V (Ohnishi, 1998). Cluster 2Fe[75]/N1b is reduced over an 
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unusually wide potential range, but its potential is almost certainly below -0.25 V (Reda et 
al., 2008). Further reduction of complex I from bovine heart mitochondria requires very 
low potential donors: new signals are observed at ~ -1 V, but as they are not simple 
rhombic signals, they are probably due to interactions between adjacent reduced clusters; 
interestingly, cluster N1a was not observed, even at -1 V (Reda et al., 2008). In figure 7.8, 
top, the estimated potentials for clusters 2Fe[24]/N1a, 2Fe[75]/N1b, 4Fe[75]H and 
4Fe[TY]2 include a consideration of their positions between clusters that are reduced at 
higher potentials, so that electrostatic interactions decrease their apparent reduction 
potentials in redox titrations (Hirst, 2010). With this in mind, the ‘rollercoaster’ profile in 
figure 7.8, top, is consistent with rapid electron transfer along the chain (single low-
potential clusters impede electron transfer much less than adjacent low-potential clusters; 
Page et al., 1999).  
 Dr. Judy Hirst analysed the rates of electron transfer using the scheme presented in 
figure 7.8, top (Hirst, 2010). The longest distance for electron transfer, the 14 Å between 
clusters 4Fe[75]H and 4Fe[TY]1, is compensated for by an increase in reduction potential, 
giving a ‘forward’ rate of electron transfer of 1.8 x 105 s-1 (estimated by Dutton’s equation; 
Page et al., 1999). The predicted rate-limiting step in the forward direction is from cluster 
4Fe[51] to cluster 2Fe[75] (7.1 x 104 s-1). During reverse electron transfer, when electrons 
tunnel from cluster 4Fe[PS] to cluster 4Fe[51], the rate-limiting step is predicted to be the 
transfer of electrons between clusters 4Fe[TY]1 and 4Fe[75]H (4.3 x 103 s-1).  
 It is likely that the cluster chain in complex I is already partially reduced during 
steady-state catalysis, so that a single electron pair does not traverse the complete chain 
during a single turnover (Hirst, 2010). Figure 7.8, bottom, shows a model for rapid and 
efficient intramolecular electron transfer in complex I. At -0.3 V, the potential of the 
mitochondrial NAD+/NADH pool, four electrons occupy the seven iron-sulphur clusters 
spaced alternately along the chain (4Fe[51] = N3, EpH7 = -0.25 V; 4Fe[75]C = N5, EpH7 =   
-0.25 V; 4Fe[TY]1 = N4, EpH7 = -0.25 V; 4Fe[PS] = N2, EpH7 = -0.1 V (Ohnishi, 1998)). 
Their alternating occupancy enhances the rate of electron transfer by optimising the rate at 
which an electron is transferred to quinone following input of an electron from the flavin 
(Hirst, 2010).  
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Figure 7.8: Electron transfer reactions in complex I. Top; potential energy profile for 
the substrates and cofactors in complex I. The substrate potential are two electron 
potentials, and two values for Q are included, for ∆p = 0 V and ∆p = 0.15 V. The substrate 
potentials and the two flavin potentials, FMN1 (oxidised/semi-reduced) and FMN2 (semi-
reduced/reduced) (Sled et al., 1994) are at pH ~7.8, and they include the coupled 
protonations. Cluster 2Fe[24] is not part of the chain. Values for clusters 4Fe[51], 
4Fe[75]C, 4Fe[TY]1 and 4Fe[PS] are from (Sled et al., 1993); values for the other clusters 
are estimates. Edge-to-edge distances are indicated in Å. Bottom; possible scheme for the 
transfer of two electrons to bound quinone, upon the oxidation of NADH. Two electrons 
are highlighted in red for their identification. Taken from (Hirst, 2010). 
 
 
More importantly, it is likely that the alternating occupancy is key to efficient energy 
conversion by complex I; the energy of the incoming electron is conserved in the outgoing 
electron (in analogy to the conservation of energy in Newton’s cradle), allowing close to 
the full redox potential drop from NADH to quinone to be trapped in proton translocation. 
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Chapter 8: 
In conclusion 
 
 
NADH:ubiquinone oxidoreductase (complex I) is an entry point into the mitochondrial 
electron transfer chain, catalysing the oxidation of NADH, the reduction of ubiquinone, 
and the concomitant translocation of four protons across the mitochondrial inner 
membrane, maintaining the proton motive force used for ATP synthesis. In 2006, Sazanov 
and Hinchliffe published the atomic resolution structure of the hydrophilic domain of 
complex I from Thermus thermophilus (Sazanov and Hinchliffe, 2006). This landmark 
paper provided a framework that has enabled researchers to investigate the mechanisms of 
NADH oxidation and intramolecular electron transfer by complex I, and also formed the 
basis for much of the work described in this thesis. 
 The aim of the work presented in the first half of this thesis was to determine the 
structure of either a subcomplex of mitochondrial complex I, or of the intact enzyme itself. 
With a mass of approximately 980 kDa spread over 45 subunits, complex I from bovine 
heart mitochondria is a most complex enzyme. As well as its size, its extreme 
hydrophobicity and asymmetry make the intact enzyme difficult to work with; 
consequently, numerous reports have aimed at preparing subcomplexes of the enzyme, 
with the ultimate goal of providing a simplified model system for functional and structural 
studies (Finel et al., 1992, Finel, 1994, Sazanov, 2000; Hirst et al., 2003). The structural 
determination of the hydrophilic domain of complex I from T. thermophilus provided a 
starting point for crystallisation trials of the two most hydrophilic domains of the 
mitochondrial enzyme, subcomplexes Iλ and Iα. As initial crystallisation experiments 
yielded no promising leads, a comprehensive investigation into the effect of subcomplex 
resolution on the structural and functional integrity of the protein was undertaken. Using a 
range of techniques such as kinetic assays, electron paramagnetic resonance and size 
exclusion chromatography, it was concluded that subcomplexes of bovine complex I are 
not suitable for use as a model system of the intact enzyme. The success of crystallising 
subcomplexes of complex I from bacterial species such as T. thermophilus and Escherichia 
coli is likely due to the different methods of resolution; in both cases, resolution occurs 
without the need for a ‘harsh’ detergent such as LDAO (Sazanov and Hinchliffe, 2006; 
Efremov et al., 2010). 
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Subsequent crystallisation attempts focused on the intact enzyme. A range of tests 
ascertained the conditions in which complex I retains its structural and functional integrity, 
and also investigated the effects of factors such as temperature, pH and additives on the 
overall stability of the enzyme. Using this knowledge, several strategies were used to try 
and crystallise the complex. The effects of phospholipids, which have been shown to be 
important in crystallising membrane proteins such as the cytochrome b6f complex (Zhang 
and Cramer, 2005), and detergent concentration, which has been shown to be an important 
factor in the crystallisation of complex I from E. coli (Dr. Christopher Thompson, PhD 
thesis), were investigated. Another important factor in crystallisation is protein 
homogeneity; attempts to produce homogeneous protein involved trying to ‘lock’ the 
enzyme in one specific conformational state using substrates and inhibitors such as NAD+ 
and piericidin A, or to ensure the protein was either uniformly in the ‘active’ or the 
‘deactive’ form (Galkin and Moncada, 2007; Galkin et al., 2008). Although over 50,000 
crystallisation trials were set up using commercially available and homemade screens, 
success was limited. However, the low resolution structure of the enzyme from Yarrowia 
lipolytica provides a proof-of-principle that a protein of the size, hydrophobicity and 
asymmetry of complex I can be crystallised (Hunte et al., 2010), and work in our 
laboratory using complexes I from a range of eukaryotic species continues (Bridges et al., 
2009). 
 The second part of this thesis describes three studies of the function and 
mechanism of complex I from bovine heart mitochondria. NADH:quinone oxidoreduction 
can be inhibited by a diverse set of hydrophobic compounds, such as rotenone and 
piericidin A. Although the reaction between NADH and the quinone analogue 
decylubiquinone is essentially abolished in the presence of rotenone or piericidin A, the 
reaction with more hydrophilic quinone analogues is incompletely inhibited; this lead to 
the proposal that additional sites for quinone reduction are present on complex I (Schatz 
and Racker, 1966; Ragan, 1978; Degli Esposti et al., 1996). Using a subcomplex of the 
enzyme that lacked a functional quinone binding site, and investigating the dependence of 
rate on NADH concentration, the flavin mononucleotide was identified as the site of the 
‘inhibitor-insensitive’ reaction. Like ferricyanide (an obligatory one-electron acceptor), 
and APAD+ (an obligatory two-electron acceptor), hydrophilic quinone analogues, such as 
coenzymes Q0, Q1 and idebenone, react by a ping-pong-(pong) mechanism at the flavin; 
the subsequent formation of semiquinones initiates redox cycling reactions with oxygen, 
producing vast amounts of reactive oxygen species. Further studies investigated the 
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promiscuity of the flavin in complex I, and revealed that other oxidants, such as the 
herbicides paraquat and diquat, can also react at this site and initiate redox cycling 
reactions. The finding that a diverse range of structurally unrelated compounds can redox 
cycle with the flavin of complex I may have profound implications; for example, the 
usefulness of some chemotherapeutic agents such as doxorubicin and daunorubicin is 
limited by a dose-dependent cardiotoxicity (Davies and Doroshow, 1986). These 
compounds undergo one-electron reduction to semiquinone species catalysed by complex 
I; in the presence of molecular oxygen, the semiquinone radicals are rapidly reoxidised, 
producing reactive oxygen species and regenerating the parent quinone (Davies and 
Doroshow, 1986).  
 
 
 
 
The production, interconversion and detection of the reactive oxygen and 
semiquinone species produced by the reduced flavin in complex I. 
 
 
Although the mechanisms of ferricyanide, APAD+ and O2 reduction by the flavin in 
complex I are well understood, the reactions of electron acceptors such as 
hexaammineruthenium (III) (HAR) and paraquat have not been fully characterized. Kinetic 
analyses showed that these positively charged oxidants can only react with the reduced 
flavin in a ternary complex with nucleotide, such as NADH, ATP and ADP. This unusual 
mechanism can also result in the initiation of redox cycling reactions with oxygen, 
stimulating reactive oxygen species generation as described above. 
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Five iron-sulphur clusters are typically observed in complex I from B. taurus reduced by 
NADH; their continuous wave EPR signals are denoted N1b, N2, N3, N4 and N5. A sixth, 
signal N1a, is not observed in the intact enzyme, but is detected in the overexpressed 24 
kDa subunit and in subcomplex Fp (Zu et al., 2002; Reda et al., 2008). Although spectra 
N1b, N2 and N3 have been unambiguously assigned to clusters 2Fe[75], 4Fe[PS] and 
4Fe[51], respectively (Sled et al., 1994; Yano et al., 2005), controversy surrounds the 
assignment of signals N4 and N5 to their structurally defined clusters. In collaboration 
with the groups of Prof. Fraser Armstrong and Dr. Jeffrey Harmer at the University of 
Oxford, double electron-electron resonance spectroscopy was used to show 
unambiguously that iron sulphur cluster 4Fe[TY]1 gives rise to electron paramagnetic 
resonance signal N4. These data provide an alternating potential energy profile for electron 
transfer along the cluster chain between the flavin and the quinone-binding site.   
 Although our knowledge of the mechanisms of NADH oxidation and 
intramolecular electron transfer have developed significantly since the publication of the 
atomic resolution structure of the hydrophilic domain of complex I from T. thermophilus, 
little is known about the mechanisms of quinone reduction and proton translocation, and 
how the two are coupled. However, the recently published structures of the membrane 
domain of complex I from E. coli (Efremov et al., 2010), and of the intact enzymes from 
T. thermophilus (Efremov et al., 2010) and Yarrowia lipolytica (Hunte et al., 2010) will 
hopefully provide new insights into these mechanisms, and dictate complex I research for 
the foreseeable future.  
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Appendix 9.1: 
PEG 400-based crystallisation screen 
 
    Well                Precipitant                       Salt                       Buffer / pH_______            
     A1  40% PEG 400  150 mM KCl  100 mM HEPES pH 6.5             
     A2         43% PEG 400       150 mM KCl        100 mM HEPES pH 6.5             
     A3         46% PEG 400       150 mM KCl        100 mM HEPES pH 6.5  
     A4       49% PEG 400       150 mM KCl        100 mM HEPES pH 6.5 
     A5         52% PEG 400   150 mM KCl        100 mM HEPES pH 6.5 
     A6         55% PEG 400    150 mM KCl        100 mM HEPES pH 6.5 
     A7        40% PEG 400   150 mM KCl        100 mM HEPES pH 7.0 
     A8         43% PEG 400       150 mM KCl        100 mM HEPES pH 7.0 
     A9         46% PEG 400       150 mM KCl        100 mM HEPES pH 7.0 
     A10       49% PEG 400       150 mM KCl        100 mM HEPES pH 7.0 
     A11       52% PEG 400       150 mM KCl        100 mM HEPES pH 7.0 
     A12       55% PEG 400       150 mM KCl        100 mM HEPES pH 7.0 
     B1         40% PEG 400       150 mM KCl        100 mM HEPES pH 7.5             
     B2         43% PEG 400       150 mM KCl        100 mM HEPES pH 7.5             
     B3         46% PEG 400       150 mM KCl        100 mM HEPES pH 7.5  
     B4         49% PEG 400       150 mM KCl        100 mM HEPES pH 7.5 
     B5         52% PEG 400       150 mM KCl        100 mM HEPES pH 7.5 
     B6         55% PEG 400       150 mM KCl        100 mM HEPES pH 7.5 
     B7         40% PEG 400       150 mM KCl        100 mM HEPES pH 8.0 
     B8         43% PEG 400       150 mM KCl        100 mM HEPES pH 8.0 
     B9         46% PEG 400       150 mM KCl        100 mM HEPES pH 8.0 
     B10       49% PEG 400       150 mM KCl        100 mM HEPES pH 8.0 
     B11       52% PEG 400       150 mM KCl        100 mM HEPES pH 8.0 
     B12       55% PEG 400       150 mM KCl        100 mM HEPES pH 8.0 
     C1         40% PEG 400       150 mM NaCl      100 mM HEPES pH 6.5             
     C2         43% PEG 400       150 mM NaCl      100 mM HEPES pH 6.5             
     C3         46% PEG 400       150 mM NaCl      100 mM HEPES pH 6.5  
     C4         49% PEG 400       150 mM NaCl      100 mM HEPES pH 6.5 
     C5         52% PEG 400       150 mM NaCl      100 mM HEPES pH 6.5 
     C6         55% PEG 400       150 mM NaCl      100 mM HEPES pH 6.5 
     C7         40% PEG 400       150 mM NaCl      100 mM HEPES pH 7.0 
     C8         43% PEG 400      150 mM NaCl     100 mM HEPES pH 7.0 
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     C9         46% PEG 400       150 mM NaCl      100 mM HEPES pH 7.0 
     C10       49% PEG 400       150 mM NaCl      100 mM HEPES pH 7.0 
     C11      52% PEG 400       150 mM NaCl      100 mM HEPES pH 7.0 
     C12       55% PEG 400       150 mM NaCl      100 mM HEPES pH 7.0 
     D1        40% PEG 400       150 mM NaCl      100 mM HEPES pH 7.5             
     D2         43% PEG 400       150 mM NaCl      100 mM HEPES pH 7.5             
     D3        46% PEG 400       150 mM NaCl      100 mM HEPES pH 7.5  
     D4       49% PEG 400       150 mM NaCl      100 mM HEPES pH 7.5 
     D5       52% PEG 400       150 mM NaCl      100 mM HEPES pH 7.5 
     D6       55% PEG 400       150 mM NaCl      100 mM HEPES pH 7.5 
     D7       40% PEG 400       150 mM NaCl      100 mM HEPES pH 8.0 
     D8        43% PEG 400       150 mM NaCl      100 mM HEPES pH 8.0 
     D9        46% PEG 400       150 mM NaCl      100 mM HEPES pH 8.0 
     D10       49% PEG 400       150 mM NaCl      100 mM HEPES pH 8.0 
     D11       52% PEG 400       150 mM NaCl      100 mM HEPES pH 8.0 
     D12       55% PEG 400      150 mM NaCl      100 mM HEPES pH 8.0 
     E1          40% PEG 400     150 mM MgCl2    100 mM HEPES pH 6.5             
     E2          43% PEG 400     150 mM MgCl2         100 mM HEPES pH 6.5             
     E3          46% PEG 400       150 mM MgCl2      100 mM HEPES pH 6.5  
     E4          49% PEG 400     150 mM MgCl2      100 mM HEPES pH 6.5 
     E5          52% PEG 400     150 mM MgCl2         100 mM HEPES pH 6.5 
     E6          55% PEG 400     150 mM MgCl2         100 mM HEPES pH 6.5 
     E7          40% PEG 400     150 mM MgCl2         100 mM HEPES pH 7.0 
     E8          43% PEG 400     150 mM MgCl2         100 mM HEPES pH 7.0 
     E9          46% PEG 400     150 mM MgCl2         100 mM HEPES pH 7.0 
     E10        49% PEG 400     150 mM MgCl2         100 mM HEPES pH 7.0 
     E11        52% PEG 400     150 mM MgCl2         100 mM HEPES pH 7.0 
     E12        55% PEG 400     150 mM MgCl2         100 mM HEPES pH 7.0 
     F1          40% PEG 400     150 mM MgCl2         100 mM HEPES pH 7.5             
     F2          43% PEG 400     150 mM MgCl2         100 mM HEPES pH 7.5             
     F3         46% PEG 400     150 mM MgCl2         100 mM HEPES pH 7.5  
     F4          49% PEG 400     150 mM MgCl2         100 mM HEPES pH 7.5 
     F5          52% PEG 400     150 mM MgCl2         100 mM HEPES pH 7.5 
     F6         55% PEG 400    150 mM MgCl2         100 mM HEPES pH 7.5 
     F7          40% PEG 400     150 mM MgCl2         100 mM HEPES pH 8.0 
     F8          43% PEG 400     150 mM MgCl2         100 mM HEPES pH 8.0 
     F9          46% PEG 400     150 mM MgCl2         100 mM HEPES pH 8.0 
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     F10        49% PEG 400     150 mM MgCl2        100 mM HEPES pH 8.0 
     F11        52% PEG 400     150 mM MgCl2         100 mM HEPES pH 8.0 
     F12        55% PEG 400     150 mM MgCl2         100 mM HEPES pH 8.0 
     G1          40% PEG 400     150 mM CaCl2       100 mM HEPES pH 6.5             
     G2          43% PEG 400     150 mM CaCl2           100 mM HEPES pH 6.5             
     G3          46% PEG 400     150 mM CaCl2           100 mM HEPES pH 6.5  
     G4          49% PEG 400     150 mM CaCl2           100 mM HEPES pH 6.5 
     G5          52% PEG 400     150 mM CaCl2           100 mM HEPES pH 6.5 
     G6          55% PEG 400     150 mM CaCl2           100 mM HEPES pH 6.5 
     G7          40% PEG 400     150 mM CaCl2           100 mM HEPES pH 7.0 
     G8          43% PEG 400     150 mM CaCl2           100 mM HEPES pH 7.0 
     G9          46% PEG 400     150 mM CaCl2           100 mM HEPES pH 7.0 
     G10        49% PEG 400     150 mM CaCl2           100 mM HEPES pH 7.0 
     G11        52% PEG 400     150 mM CaCl2           100 mM HEPES pH 7.0 
     G12        55% PEG 400     150 mM CaCl2           100 mM HEPES pH 7.0 
     H1          40% PEG 400     150 mM CaCl2           100 mM HEPES pH 7.5             
     H2          43% PEG 400     150 mM CaCl2           100 mM HEPES pH 7.5             
     H3          46% PEG 400     150 mM CaCl2           100 mM HEPES pH 7.5  
     H4          49% PEG 400     150 mM CaCl2           100 mM HEPES pH 7.5 
     H5          52% PEG 400     150 mM CaCl2           100 mM HEPES pH 7.5 
     H6          55% PEG 400     150 mM CaCl2           100 mM HEPES pH 7.5 
     H7          40% PEG 400     150 mM CaCl2           100 mM HEPES pH 8.0 
     H8          43% PEG 400     150 mM CaCl2           100 mM HEPES pH 8.0 
     H9          46% PEG 400     150 mM CaCl2           100 mM HEPES pH 8.0 
     H10        49% PEG 400     150 mM CaCl2           100 mM HEPES pH 8.0 
     H11        52% PEG 400     150 mM CaCl2           100 mM HEPES pH 8.0 
     H12        55% PEG 400     150 mM CaCl2           100 mM HEPES pH 8.0
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Appendix 9.2: 
PEG 1500-based crystallisation screen 
 
    Well                Precipitant                       Salt                        Buffer / pH_______             
     A1  10% PEG 1500  150 mM KCl  100 mM HEPES pH 6.5             
     A2         13% PEG 1500       150 mM KCl        100 mM HEPES pH 6.5             
     A3         16% PEG 1500       150 mM KCl        100 mM HEPES pH 6.5  
     A4       19% PEG 1500       150 mM KCl        100 mM HEPES pH 6.5 
     A5         22% PEG 1500   150 mM KCl        100 mM HEPES pH 6.5 
     A6         25% PEG 1500    150 mM KCl        100 mM HEPES pH 6.5 
     A7        10% PEG 1500   150 mM KCl        100 mM HEPES pH 7.0 
     A8         13% PEG 1500       150 mM KCl        100 mM HEPES pH 7.0 
     A9         16% PEG 1500       150 mM KCl        100 mM HEPES pH 7.0 
     A10       29% PEG 1500       150 mM KCl        100 mM HEPES pH 7.0 
     A11       22% PEG 1500       150 mM KCl        100 mM HEPES pH 7.0 
     A12       25% PEG 1500       150 mM KCl        100 mM HEPES pH 7.0 
     B1         10% PEG 1500       150 mM KCl        100 mM HEPES pH 7.5             
     B2         13% PEG 1500       150 mM KCl        100 mM HEPES pH 7.5             
     B3         16% PEG 1500       150 mM KCl        100 mM HEPES pH 7.5  
     B4         19% PEG 1500       150 mM KCl        100 mM HEPES pH 7.5 
     B5         22% PEG 1500       150 mM KCl        100 mM HEPES pH 7.5 
     B6         25% PEG 1500       150 mM KCl        100 mM HEPES pH 7.5 
     B7         10% PEG 1500       150 mM KCl        100 mM HEPES pH 8.0 
     B8         13% PEG 1500       150 mM KCl        100 mM HEPES pH 8.0 
     B9         16% PEG 1500       150 mM KCl        100 mM HEPES pH 8.0 
     B10       19% PEG 1500       150 mM KCl        100 mM HEPES pH 8.0 
     B11       22% PEG 1500       150 mM KCl        100 mM HEPES pH 8.0 
     B12       25% PEG 1500       150 mM KCl        100 mM HEPES pH 8.0 
     C1         10% PEG 1500       150 mM NaCl      100 mM HEPES pH 6.5             
     C2         13% PEG 1500       150 mM NaCl      100 mM HEPES pH 6.5             
     C3         16% PEG 1500       150 mM NaCl      100 mM HEPES pH 6.5  
     C4         19% PEG 1500       150 mM NaCl      100 mM HEPES pH 6.5 
     C5         22% PEG 1500       150 mM NaCl      100 mM HEPES pH 6.5 
     C6         25% PEG 1500       150 mM NaCl      100 mM HEPES pH 6.5 
     C7         10% PEG 1500       150 mM NaCl      100 mM HEPES pH 7.0 
     C8         13% PEG 1500      150 mM NaCl     100 mM HEPES pH 7.0 
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     C9         16% PEG 1500       150 mM NaCl      100 mM HEPES pH 7.0 
     C10       19% PEG 1500       150 mM NaCl      100 mM HEPES pH 7.0 
     C11      22% PEG 1500       150 mM NaCl      100 mM HEPES pH 7.0 
     C12       25% PEG 1500       150 mM NaCl      100 mM HEPES pH 7.0 
     D1        10% PEG 1500       150 mM NaCl      100 mM HEPES pH 7.5             
     D2         13% PEG 1500       150 mM NaCl      100 mM HEPES pH 7.5             
     D3        16% PEG 1500      150 mM NaCl      100 mM HEPES pH 7.5  
     D4        19% PEG 1500      150 mM NaCl      100 mM HEPES pH 7.5 
     D5        22% PEG 1500      150 mM NaCl      100 mM HEPES pH 7.5 
     D6        25% PEG 1500      150 mM NaCl      100 mM HEPES pH 7.5 
     D7        10% PEG 1500      150 mM NaCl      100 mM HEPES pH 8.0 
     D8        13% PEG 1500       150 mM NaCl      100 mM HEPES pH 8.0 
     D9        16% PEG 1500       150 mM NaCl      100 mM HEPES pH 8.0 
     D10       19% PEG 1500       150 mM NaCl      100 mM HEPES pH 8.0 
     D11       22% PEG 1500       150 mM NaCl      100 mM HEPES pH 8.0 
     D12       25% PEG 1500      150 mM NaCl      100 mM HEPES pH 8.0 
     E1          10% PEG 1500     150 mM MgCl2    100 mM HEPES pH 6.5             
     E2          13% PEG 1500     150 mM MgCl2         100 mM HEPES pH 6.5             
     E3          16% PEG 1500       150 mM MgCl2      100 mM HEPES pH 6.5  
     E4          19% PEG 1500     150 mM MgCl2      100 mM HEPES pH 6.5 
     E5          22% PEG 1500     150 mM MgCl2         100 mM HEPES pH 6.5 
     E6          25% PEG 1500     150 mM MgCl2         100 mM HEPES pH 6.5 
     E7          10% PEG 1500     150 mM MgCl2         100 mM HEPES pH 7.0 
     E8          13% PEG 1500     150 mM MgCl2         100 mM HEPES pH 7.0 
     E9          16% PEG 1500     150 mM MgCl2         100 mM HEPES pH 7.0 
     E10        19% PEG 1500     150 mM MgCl2         100 mM HEPES pH 7.0 
     E11        22% PEG 1500     150 mM MgCl2         100 mM HEPES pH 7.0 
     E12        25% PEG 1500     150 mM MgCl2         100 mM HEPES pH 7.0 
     F1          10% PEG 1500     150 mM MgCl2         100 mM HEPES pH 7.5             
     F2          13% PEG 1500     150 mM MgCl2         100 mM HEPES pH 7.5             
     F3         16% PEG 1500     150 mM MgCl2         100 mM HEPES pH 7.5  
     F4          19% PEG 1500     150 mM MgCl2         100 mM HEPES pH 7.5 
     F5          22% PEG 1500     150 mM MgCl2         100 mM HEPES pH 7.5 
     F6         25% PEG 1500    150 mM MgCl2         100 mM HEPES pH 7.5 
     F7          10% PEG 1500     150 mM MgCl2         100 mM HEPES pH 8.0 
     F8          13% PEG 1500     150 mM MgCl2         100 mM HEPES pH 8.0 
     F9          16% PEG 1500     150 mM MgCl2         100 mM HEPES pH 8.0 
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     F10        19% PEG 1500     150 mM MgCl2        100 mM HEPES pH 8.0 
     F11        22% PEG 1500     150 mM MgCl2         100 mM HEPES pH 8.0 
     F12        25% PEG 1500     150 mM MgCl2         100 mM HEPES pH 8.0 
     G1          10% PEG 1500     150 mM CaCl2       100 mM HEPES pH 6.5             
     G2          13% PEG 1500     150 mM CaCl2           100 mM HEPES pH 6.5             
     G3          16% PEG 1500     150 mM CaCl2           100 mM HEPES pH 6.5  
     G4          19% PEG 1500     150 mM CaCl2           100 mM HEPES pH 6.5 
     G5          22% PEG 1500     150 mM CaCl2           100 mM HEPES pH 6.5 
     G6          25% PEG 1500     150 mM CaCl2           100 mM HEPES pH 6.5 
     G7          10% PEG 1500     150 mM CaCl2           100 mM HEPES pH 7.0 
     G8          13% PEG 1500     150 mM CaCl2           100 mM HEPES pH 7.0 
     G9          16% PEG 1500     150 mM CaCl2           100 mM HEPES pH 7.0 
     G10        19% PEG 1500     150 mM CaCl2           100 mM HEPES pH 7.0 
     G11        22% PEG 1500     150 mM CaCl2           100 mM HEPES pH 7.0 
     G12        25% PEG 1500     150 mM CaCl2           100 mM HEPES pH 7.0 
     H1          10% PEG 1500     150 mM CaCl2           100 mM HEPES pH 7.5             
     H2          13% PEG 1500     150 mM CaCl2           100 mM HEPES pH 7.5             
     H3          16% PEG 1500     150 mM CaCl2           100 mM HEPES pH 7.5  
     H4          19% PEG 1500     150 mM CaCl2           100 mM HEPES pH 7.5 
     H5          22% PEG 1500     150 mM CaCl2           100 mM HEPES pH 7.5 
     H6          25% PEG 1500     150 mM CaCl2           100 mM HEPES pH 7.5 
     H7          10% PEG 1500     150 mM CaCl2           100 mM HEPES pH 8.0 
     H8          13% PEG 1500     150 mM CaCl2           100 mM HEPES pH 8.0 
     H9          16% PEG 1500     150 mM CaCl2           100 mM HEPES pH 8.0 
     H10        19% PEG 1500     150 mM CaCl2           100 mM HEPES pH 8.0 
     H11        22% PEG 1500     150 mM CaCl2           100 mM HEPES pH 8.0 
     H12        25% PEG 1500     150 mM CaCl2           100 mM HEPES pH 8.0 
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Appendix 9.3: 
PEG 4000-based crystallisation screen 
 
    Well                Precipitant                       Salt                      Buffer/ pH________             
     A1  4% PEG 4000  150 mM KCl  100 mM HEPES pH 6.5             
     A2         6% PEG 4000       150 mM KCl        100 mM HEPES pH 6.5             
     A3         8% PEG 4000       150 mM KCl        100 mM HEPES pH 6.5  
     A4       10% PEG 4000       150 mM KCl        100 mM HEPES pH 6.5 
     A5         12% PEG 4000   150 mM KCl        100 mM HEPES pH 6.5 
     A6         14% PEG 4000    150 mM KCl        100 mM HEPES pH 6.5 
     A7        4% PEG 4000   150 mM KCl        100 mM HEPES pH 7.0 
     A8         6% PEG 4000       150 mM KCl        100 mM HEPES pH 7.0 
     A9         8% PEG 4000       150 mM KCl        100 mM HEPES pH 7.0 
     A10       10% PEG 4000       150 mM KCl        100 mM HEPES pH 7.0 
     A11       12% PEG 4000       150 mM KCl        100 mM HEPES pH 7.0 
     A12       14% PEG 4000       150 mM KCl        100 mM HEPES pH 7.0 
     B1         4% PEG 4000       150 mM KCl        100 mM HEPES pH 7.5             
     B2         6% PEG 4000       150 mM KCl        100 mM HEPES pH 7.5             
     B3         10% PEG 4000       150 mM KCl        100 mM HEPES pH 7.5  
     B4         12% PEG 4000       150 mM KCl        100 mM HEPES pH 7.5 
     B5         14% PEG 4000       150 mM KCl        100 mM HEPES pH 7.5 
     B6         16% PEG 4000       150 mM KCl        100 mM HEPES pH 7.5 
     B7         4% PEG 4000       150 mM KCl        100 mM HEPES pH 8.0 
     B8         6% PEG 4000       150 mM KCl        100 mM HEPES pH 8.0 
     B9         8% PEG 4000       150 mM KCl        100 mM HEPES pH 8.0 
     B10       10% PEG 4000       150 mM KCl        100 mM HEPES pH 8.0 
     B11       12% PEG 4000       150 mM KCl        100 mM HEPES pH 8.0 
     B12       14% PEG 4000       150 mM KCl        100 mM HEPES pH 8.0 
     C1         4% PEG 4000       150 mM NaCl      100 mM HEPES pH 6.5             
     C2         6% PEG 4000       150 mM NaCl      100 mM HEPES pH 6.5             
     C3         8% PEG 4000       150 mM NaCl      100 mM HEPES pH 6.5  
     C4         10% PEG 4000       150 mM NaCl      100 mM HEPES pH 6.5 
     C5         12% PEG 4000       150 mM NaCl      100 mM HEPES pH 6.5 
     C6         14% PEG 4000       150 mM NaCl      100 mM HEPES pH 6.5 
     C7         4% PEG 4000       150 mM NaCl      100 mM HEPES pH 7.0 
     C8         6% PEG 4000      150 mM NaCl     100 mM HEPES pH 7.0 
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     C9         8% PEG 4000       150 mM NaCl      100 mM HEPES pH 7.0 
     C10       10% PEG 4000       150 mM NaCl      100 mM HEPES pH 7.0 
     C11      12% PEG 4000       150 mM NaCl      100 mM HEPES pH 7.0 
     C12       14% PEG 4000       150 mM NaCl      100 mM HEPES pH 7.0 
     D1        4% PEG 4000       150 mM NaCl      100 mM HEPES pH 7.5             
     D2         6% PEG 4000       150 mM NaCl      100 mM HEPES pH 7.5             
     D3      8% PEG 4000       150 mM NaCl      100 mM HEPES pH 7.5  
     D4     10% PEG 4000       150 mM NaCl      100 mM HEPES pH 7.5 
     D5        12% PEG 4000       150 mM NaCl      100 mM HEPES pH 7.5 
     D6       14% PEG 4000       150 mM NaCl      100 mM HEPES pH 7.5 
     D7        4% PEG 4000       150 mM NaCl      100 mM HEPES pH 8.0 
     D8        6% PEG 4000       150 mM NaCl      100 mM HEPES pH 8.0 
     D9        8% PEG 4000       150 mM NaCl      100 mM HEPES pH 8.0 
     D10       10% PEG 4000       150 mM NaCl      100 mM HEPES pH 8.0 
     D11       12% PEG 4000       150 mM NaCl      100 mM HEPES pH 8.0 
     D12       14% PEG 4000      150 mM NaCl      100 mM HEPES pH 8.0 
     E1          4% PEG 4000     150 mM MgCl2    100 mM HEPES pH 6.5             
     E2          6% PEG 4000     150 mM MgCl2         100 mM HEPES pH 6.5             
     E3          8% PEG 4000       150 mM MgCl2      100 mM HEPES pH 6.5  
     E4          10% PEG 4000     150 mM MgCl2      100 mM HEPES pH 6.5 
     E5          12% PEG 4000     150 mM MgCl2         100 mM HEPES pH 6.5 
     E6          14% PEG 4000     150 mM MgCl2         100 mM HEPES pH 6.5 
     E7          4% PEG 4000     150 mM MgCl2         100 mM HEPES pH 7.0 
     E8          6% PEG 4000     150 mM MgCl2         100 mM HEPES pH 7.0 
     E9          8% PEG 4000     150 mM MgCl2         100 mM HEPES pH 7.0 
     E10        10% PEG 4000     150 mM MgCl2         100 mM HEPES pH 7.0 
     E11        12% PEG 4000     150 mM MgCl2         100 mM HEPES pH 7.0 
     E12        14% PEG 4000     150 mM MgCl2         100 mM HEPES pH 7.0 
     F1          4% PEG 4000     150 mM MgCl2         100 mM HEPES pH 7.5             
     F2          6% PEG 4000     150 mM MgCl2         100 mM HEPES pH 7.5             
     F3         8% PEG 4000     150 mM MgCl2         100 mM HEPES pH 7.5  
     F4          10% PEG 4000     150 mM MgCl2         100 mM HEPES pH 7.5 
     F5          12% PEG 4000     150 mM MgCl2         100 mM HEPES pH 7.5 
     F6         14% PEG 4000    150 mM MgCl2         100 mM HEPES pH 7.5 
     F7          4% PEG 4000     150 mM MgCl2         100 mM HEPES pH 8.0 
     F8          6% PEG 4000     150 mM MgCl2         100 mM HEPES pH 8.0 
     F9          8% PEG 4000     150 mM MgCl2         100 mM HEPES pH 8.0 
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     F10        10% PEG 4000     150 mM MgCl2        100 mM HEPES pH 8.0 
     F11        12% PEG 4000     150 mM MgCl2         100 mM HEPES pH 8.0 
     F12        14% PEG 4000     150 mM MgCl2         100 mM HEPES pH 8.0 
     G1          4% PEG 4000     150 mM CaCl2       100 mM HEPES pH 6.5             
     G2          6% PEG 4000     150 mM CaCl2           100 mM HEPES pH 6.5             
     G3          8% PEG 4000     150 mM CaCl2           100 mM HEPES pH 6.5  
     G4          10% PEG 4000     150 mM CaCl2           100 mM HEPES pH 6.5 
     G5          12% PEG 4000     150 mM CaCl2           100 mM HEPES pH 6.5 
     G6          14% PEG 4000     150 mM CaCl2           100 mM HEPES pH 6.5 
     G7          4% PEG 4000     150 mM CaCl2           100 mM HEPES pH 7.0 
     G8          6% PEG 4000     150 mM CaCl2           100 mM HEPES pH 7.0 
     G9          8% PEG 4000     150 mM CaCl2           100 mM HEPES pH 7.0 
     G10        10% PEG 4000     150 mM CaCl2           100 mM HEPES pH 7.0 
     G11        12% PEG 4000     150 mM CaCl2           100 mM HEPES pH 7.0 
     G12        14% PEG 4000     150 mM CaCl2           100 mM HEPES pH 7.0 
     H1          4% PEG 4000     150 mM CaCl2           100 mM HEPES pH 7.5             
     H2          6% PEG 4000     150 mM CaCl2           100 mM HEPES pH 7.5             
     H3          8% PEG 4000     150 mM CaCl2           100 mM HEPES pH 7.5  
     H4          10% PEG 4000     150 mM CaCl2           100 mM HEPES pH 7.5 
     H5          12% PEG 4000     150 mM CaCl2           100 mM HEPES pH 7.5 
     H6          14% PEG 4000     150 mM CaCl2           100 mM HEPES pH 7.5 
     H7          4% PEG 4000     150 mM CaCl2           100 mM HEPES pH 8.0 
     H8          6% PEG 4000     150 mM CaCl2           100 mM HEPES pH 8.0 
     H9          8% PEG 4000     150 mM CaCl2           100 mM HEPES pH 8.0 
     H10        10% PEG 4000     150 mM CaCl2           100 mM HEPES pH 8.0 
     H11        12% PEG 4000     150 mM CaCl2           100 mM HEPES pH 8.0 
     H12        14% PEG 4000     150 mM CaCl2           100 mM HEPES pH 8.0 
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Notes: 
After the initial crystallisation trials described in section 4.3.2.1, the screens listed in 
appendices 9.1 – 9.3 were modified: 
 
PEG 400 screen: 
45 – 50% PEG 400 in 1% increments (as opposed to 40 – 55% PEG 400 in 3% 
increments) 
 
PEG 1500 screen: 
18 – 23% PEG 1500 in 1% increments (as opposed to 10 – 25% PEG 1500 in 3% 
increments) 
 
PEG 4000 screen: 
7 – 12% PEG 4000 in 1% increments (as opposed to 4 – 14% PEG 4000 in 2% 
increments) 
  
 221 
Appendix 9.4: 
PEG 3350 crystallisation screen: PEG/Ion condition G1  
50 mM sodium acetate trihydrate pH 7.0, 10 mM tris pH 7.5, 6% PEG 
3350 
 
    Well                Precipitant               Additive                                 Buffer/ pH___________             
     A1  5% PEG 3350     -  50 mM sodium acetate trihydrate pH 6.3             
     A2         6% PEG 3350             -         50 mM sodium acetate trihydrate pH 6.3             
     A3         7% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.3  
     A4       8% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.3 
     A5         9% PEG 3350      -         50 mM sodium acetate trihydrate pH 6.3 
     A6         10% PEG 3350       -         50 mM sodium acetate trihydrate pH 6.3 
     A7        11% PEG 3350      -         50 mM sodium acetate trihydrate pH 6.3 
     A8         12% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.3 
     A9         13% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.3 
     A10       14% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.3 
     A11       15% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.3 
     A12       16% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.3 
     B1         5% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.5             
     B2         6% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.5             
     B3         7% PEG 3350             -         50 mM sodium acetate trihydrate pH 6.5  
     B4         8% PEG 3350             -         50 mM sodium acetate trihydrate pH 6.5 
     B5         9% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.5 
     B6         10% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.5 
     B7         11% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.5 
     B8         12% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.5 
     B9         13% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.5 
     B10       14% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.5 
     B11       15% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.5 
     B12       16% PEG 3350          -         50 mM sodium acetate trihydrate pH 6.5 
     C1         5% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.7             
     C2         6% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.7             
     C3         7% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.7  
     C4         8% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.7 
     C5         9% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.7 
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     C6         10% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.7 
     C7         11% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.7 
     C8         12% PEG 3350         -      50 mM sodium acetate trihydrate pH 6.7 
     C9         13% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.7 
     C10       14% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.7 
     C11      15% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.7 
     C12       16% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.7 
     D1        5% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.9             
     D2         6% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.9             
     D3      7% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.9  
     D4     8% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.9 
     D5        9% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.9 
     D6       10% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.9 
     D7       11% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.9 
     D8        12% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.9 
     D9        13% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.9 
     D10       14% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.9 
     D11       15% PEG 3350          -       50 mM sodium acetate trihydrate pH 6.9 
     D12       16% PEG 3350         -       50 mM sodium acetate trihydrate pH 6.9 
     E1          5% PEG 3350        -     50 mM sodium acetate trihydrate pH 7.1             
     E2          6% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.1             
     E3          7% PEG 3350          -       50 mM sodium acetate trihydrate pH 7.1  
     E4          8% PEG 3350        -
 
      50 mM sodium acetate trihydrate pH 7.1 
     E5          9% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.1 
     E6          10% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.1 
     E7          11% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.1 
     E8          12% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.1 
     E9          13% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.1 
     E10        14% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.1 
     E11        15% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.1 
     E12        16% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.1 
     F1          5% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.3             
     F2          6% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.3             
     F3         7% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.3  
     F4          8% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.3 
     F5          9% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.3 
     F6         10% PEG 3350       -
          
50 mM sodium acetate trihydrate pH 7.3 
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     F7          11% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.3 
     F8          12% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.3 
     F9          13% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.3 
     F10        14% PEG 3350        -
         
50 mM sodium acetate trihydrate pH 7.3 
     F11        15% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.3 
     F12        16% PEG 3350        -
          
50 mM sodium acetate trihydrate pH 7.3 
     G1          5% PEG 3350        -        50 mM sodium acetate trihydrate pH 7.5             
     G2          6% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.5             
     G3          7% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.5  
     G4          8% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.5 
     G5          9% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.5 
     G6          10% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.5 
     G7          11% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.5 
     G8          12% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.5 
     G9          13% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.5 
     G10        14% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.5 
     G11        15% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.5 
     G12        16% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.5 
     H1          5% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.7             
     H2          6% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.7             
     H3          7% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.7  
     H4          8% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.7 
     H5          9% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.7 
     H6          10% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.7 
     H7          11% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.7 
     H8          12% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.7 
     H9          13% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.7 
     H10        14% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.7 
     H11        15% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.7 
     H12        16% PEG 3350        -
            
50 mM sodium acetate trihydrate pH 7.7 
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Appendix 9.5: 
PEG 2000 crystallisation screen: MemGold condition C7 
20 mM bis tris pH 7.0, 15% PEG 2000 
 
    Well                Precipitant                         Additive                      Buffer/ pH______             
     A1  9% PEG 2000   -  10 mM bis tris pH 6.1             
     A2         10% PEG 2000        -         10 mM bis tris pH 6.1             
     A3         11% PEG 2000        -         10 mM bis tris pH 6.1  
     A4       12% PEG 2000        -         10 mM bis tris pH 6.1 
     A5         13% PEG 2000    -         10 mM bis tris pH 6.1 
     A6         14% PEG 2000     -         10 mM bis tris pH 6.1 
     A7        15% PEG 2000    -         10 mM bis tris pH 6.1 
     A8         16% PEG 2000        -         10 mM bis tris pH 6.1 
     A9         17% PEG 2000        -         10 mM bis tris pH 6.1 
     A10       18% PEG 2000        -         10 mM bis tris pH 6.1 
     A11       19% PEG 2000        -         10 mM bis tris pH 6.1 
     A12       20% PEG 2000        -         10 mM bis tris pH 6.1 
     B1         9% PEG 2000        -         10 mM bis tris pH 6.3             
     B2         10% PEG 2000        -         10 mM bis tris pH 6.3             
     B3         11% PEG 2000        -         10 mM bis tris pH 6.3  
     B4         12% PEG 2000        -         10 mM bis tris pH 6.3 
     B5         13% PEG 2000        -         10 mM bis tris pH 6.3 
     B6         14% PEG 2000        -         10 mM bis tris pH 6.3 
     B7         15% PEG 2000        -         10 mM bis tris pH 6.3 
     B8         16% PEG 2000        -         10 mM bis tris pH 6.3 
     B9         17% PEG 2000        -         10 mM bis tris pH 6.3 
     B10       18% PEG 2000        -         10 mM bis tris pH 6.3 
     B11       19% PEG 2000        -         10 mM bis tris pH 6.3 
     B12       20% PEG 2000        -         10 mM bis tris pH 6.3 
     C1         9% PEG 2000        -       10 mM bis tris pH 6.5             
     C2         10% PEG 2000        -       10 mM bis tris pH 6.5             
     C3         11% PEG 2000        -       10 mM bis tris pH 6.5  
     C4         12% PEG 2000        -       10 mM bis tris pH 6.5 
     C5         13% PEG 2000        -       10 mM bis tris pH 6.5 
     C6         14% PEG 2000        -       10 mM bis tris pH 6.5 
     C7         15% PEG 2000        -       10 mM bis tris pH 6.5 
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     C8         16% PEG 2000       -      10 mM bis tris pH 6.5 
     C9         17% PEG 2000        -       10 mM bis tris pH 6.5 
     C10       18% PEG 2000        -       10 mM bis tris pH 6.5 
     C11      19% PEG 2000        -       10 mM bis tris pH 6.5 
     C12       20% PEG 2000        -       10 mM bis tris pH 6.5 
     D1        9% PEG 2000        -       10 mM bis tris pH 6.7             
     D2         10% PEG 2000        -       10 mM bis tris pH 6.7             
     D3      11% PEG 2000        -       10 mM bis tris pH 6.7  
     D4     12% PEG 2000        -       10 mM bis tris pH 6.7 
     D5        13% PEG 2000        -       10 mM bis tris pH 6.7 
     D6       14% PEG 2000        -       10 mM bis tris pH 6.7 
     D7       15% PEG 2000        -       10 mM bis tris pH 6.7 
     D8        16% PEG 2000        -       10 mM bis tris pH 6.7 
     D9        17% PEG 2000        -       10 mM bis tris pH 6.7 
     D10       18% PEG 2000        -       10 mM bis tris pH 6.7 
     D11       19% PEG 2000        -       10 mM bis tris pH 6.7 
     D12       20% PEG 2000       -       10 mM bis tris pH 6.7 
     E1          9% PEG 2000      -     10 mM bis tris pH 6.9             
     E2          10% PEG 2000      -
          
10 mM bis tris pH 6.9             
     E3          11% PEG 2000        -       10 mM bis tris pH 6.9  
     E4          12% PEG 2000      -
 
      10 mM bis tris pH 6.9 
     E5          13% PEG 2000      -
          
10 mM bis tris pH 6.9 
     E6          14% PEG 2000      -
          
10 mM bis tris pH 6.9 
     E7          15% PEG 2000      -
          
10 mM bis tris pH 6.9 
     E8          16% PEG 2000      -
          
10 mM bis tris pH 6.9 
     E9          17% PEG 2000      -
          
10 mM bis tris pH 6.9 
     E10        18% PEG 2000      -
          
10 mM bis tris pH 6.9 
     E11        19% PEG 2000      -
          
10 mM bis tris pH 6.9 
     E12        20% PEG 2000      -
          
10 mM bis tris pH 6.9 
     F1          9% PEG 2000      -
          
10 mM bis tris pH 7.1             
     F2          10% PEG 2000      -
          
10 mM bis tris pH 7.1             
     F3         11% PEG 2000      -
          
10 mM bis tris pH 7.1  
     F4          12% PEG 2000      -
          
10 mM bis tris pH 7.1 
     F5          13% PEG 2000      -
          
10 mM bis tris pH 7.1 
     F6         14% PEG 2000     -
          
10 mM bis tris pH 7.1 
     F7          15% PEG 2000      -
          
10 mM bis tris pH 7.1 
     F8          16% PEG 2000      -
          
10 mM bis tris pH 7.1 
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     F9          17% PEG 2000      -
          
10 mM bis tris pH 7.1 
     F10        18% PEG 2000      -
         
10 mM bis tris pH 7.1 
     F11        19% PEG 2000      -
          
10 mM bis tris pH 7.1 
     F12        20% PEG 2000      -
          
10 mM bis tris pH 7.1 
     G1          9% PEG 2000      -        10 mM bis tris pH 7.3             
     G2          10% PEG 2000      -
            
10 mM bis tris pH 7.3             
     G3          11% PEG 2000      -
            
10 mM bis tris pH 7.3  
     G4          12% PEG 2000      -
            
10 mM bis tris pH 7.3 
     G5          13% PEG 2000      -
            
10 mM bis tris pH 7.3 
     G6          14% PEG 2000      -
            
10 mM bis tris pH 7.3 
     G7          15% PEG 2000      -
            
10 mM bis tris pH 7.3 
     G8          16% PEG 2000      -
            
10 mM bis tris pH 7.3 
     G9          17% PEG 2000      -
            
10 mM bis tris pH 7.3 
     G10        18% PEG 2000      -
            
10 mM bis tris pH 7.3 
     G11        19% PEG 2000      -
            
10 mM bis tris pH 7.3 
     G12        20% PEG 2000      -
            
10 mM bis tris pH 7.3 
     H1          9% PEG 2000      -
            
10 mM bis tris pH 7.5             
     H2          10% PEG 2000      -
            
10 mM bis tris pH 7.5             
     H3          11% PEG 2000      -
            
10 mM bis tris pH 7.5  
     H4          12% PEG 2000      -
            
10 mM bis tris pH 7.5 
     H5          13% PEG 2000      -
            
10 mM bis tris pH 7.5 
     H6          14% PEG 2000      -
            
10 mM bis tris pH 7.5 
     H7          15% PEG 2000      -
            
10 mM bis tris pH 7.5 
     H8          16% PEG 2000      -
            
10 mM bis tris pH 7.5 
     H9          17% PEG 2000      -
            
10 mM bis tris pH 7.5 
     H10        18% PEG 2000      -
            
10 mM bis tris pH 7.5 
     H11        19% PEG 2000      -
            
10 mM bis tris pH 7.5 
     H12        20% PEG 2000      -
            
10 mM bis tris pH 7.5 
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Appendix 9.6: 
PEG 4000 crystallisation screen: MemStart/Sys condition G8 
100 mM MES pH 6.5, 12% PEG 4000 
 
    Well                Precipitant                         Additive                     Buffer/ pH_____             
     A1  5% PEG 4000   -  100 mM MES pH 5.5             
     A2         6% PEG 4000        -         100 mM MES pH 5.5             
     A3         7% PEG 4000        -         100 mM MES pH 5.5  
     A4       8% PEG 4000        -         100 mM MES pH 5.5 
     A5         9% PEG 4000    -         100 mM MES pH 5.5 
     A6         10% PEG 4000     -         100 mM MES pH 5.5 
     A7        11% PEG 4000    -         100 mM MES pH 5.5 
     A8         12% PEG 4000        -         100 mM MES pH 5.5 
     A9         13% PEG 4000        -         100 mM MES pH 5.5 
     A10       14% PEG 4000        -         100 mM MES pH 5.5 
     A11       15% PEG 4000        -         100 mM MES pH 5.5 
     A12       16% PEG 4000        -         100 mM MES pH 5.5 
     B1         5% PEG 4000        -         100 mM MES pH 5.7             
     B2         6% PEG 4000        -         100 mM MES pH 5.7             
     B3         7% PEG 4000        -         100 mM MES pH 5.7  
     B4         8% PEG 4000        -         100 mM MES pH 5.7 
     B5         9% PEG 4000        -         100 mM MES pH 5.7 
     B6         10% PEG 4000        -         100 mM MES pH 5.7 
     B7         11% PEG 4000        -         100 mM MES pH 5.7 
     B8         12% PEG 4000        -         100 mM MES pH 5.7 
     B9         13% PEG 4000        -         100 mM MES pH 5.7 
     B10       14% PEG 4000        -         100 mM MES pH 5.7 
     B11       15% PEG 4000        -         100 mM MES pH 5.7 
     B12       16% PEG 4000        -         100 mM MES pH 5.7 
     C1         5% PEG 4000        -       100 mM MES pH 5.9             
     C2         6% PEG 4000        -       100 mM MES pH 5.9             
     C3         7% PEG 4000        -       100 mM MES pH 5.9  
     C4         8% PEG 4000        -       100 mM MES pH 5.9 
     C5         9% PEG 4000        -       100 mM MES pH 5.9 
     C6         10% PEG 4000        -       100 mM MES pH 5.9 
     C7         11% PEG 4000        -       100 mM MES pH 5.9 
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     C8         12% PEG 4000       -      100 mM MES pH 5.9 
     C9         13% PEG 4000        -       100 mM MES pH 5.9 
     C10       14% PEG 4000        -       100 mM MES pH 5.9 
     C11      15% PEG 4000        -       100 mM MES pH 5.9 
     C12       16% PEG 4000        -       100 mM MES pH 5.9 
     D1        5% PEG 4000        -       100 mM MES pH 6.1             
     D2         6% PEG 4000        -       100 mM MES pH 6.1             
     D3      7% PEG 4000        -       100 mM MES pH 6.1  
     D4     8% PEG 4000        -       100 mM MES pH 6.1 
     D5        9% PEG 4000        -       100 mM MES pH 6.1 
     D6       10% PEG 4000        -       100 mM MES pH 6.1 
     D7       11% PEG 4000        -       100 mM MES pH 6.1 
     D8        12% PEG 4000        -       100 mM MES pH 6.1 
     D9        13% PEG 4000        -       100 mM MES pH 6.1 
     D10       14% PEG 4000        -       100 mM MES pH 6.1 
     D11       15% PEG 4000        -       100 mM MES pH 6.1 
     D12       16% PEG 4000       -       100 mM MES pH 6.1 
     E1          5% PEG 4000      -     100 mM MES pH 6.3             
     E2          6% PEG 4000      -
          
100 mM MES pH 6.3             
     E3          7% PEG 4000        -       100 mM MES pH 6.3  
     E4          8% PEG 4000      -
 
      100 mM MES pH 6.3 
     E5          9% PEG 4000      -
          
100 mM MES pH 6.3 
     E6          10% PEG 4000      -
          
100 mM MES pH 6.3 
     E7          11% PEG 4000      -
          
100 mM MES pH 6.3 
     E8          12% PEG 4000      -
          
100 mM MES pH 6.3 
     E9          13% PEG 4000      -
          
100 mM MES pH 6.3 
     E10        14% PEG 4000      -
          
100 mM MES pH 6.3 
     E11        15% PEG 4000      -
          
100 mM MES pH 6.3 
     E12        16% PEG 4000      -
          
100 mM MES pH 6.3 
     F1          5% PEG 4000      -
          
100 mM MES pH 6.5             
     F2          6% PEG 4000      -
          
100 mM MES pH 6.5             
     F3         7% PEG 4000      -
          
100 mM MES pH 6.5  
     F4          8% PEG 4000      -
          
100 mM MES pH 6.5 
     F5          9% PEG 4000      -
          
100 mM MES pH 6.5 
     F6         10% PEG 4000     -
          
100 mM MES pH 6.5 
     F7          11% PEG 4000      -
          
100 mM MES pH 6.5 
     F8          12% PEG 4000      -
          
100 mM MES pH 6.5 
  
 229 
     F9          13% PEG 4000      -
          
100 mM MES pH 6.5 
     F10        14% PEG 4000      -
         
100 mM MES pH 6.5 
     F11        15% PEG 4000      -
          
100 mM MES pH 6.5 
     F12        16% PEG 4000      -
          
100 mM MES pH 6.5 
     G1          5% PEG 4000      -        100 mM MES pH 6.7             
     G2          6% PEG 4000      -
            
100 mM MES pH 6.7             
     G3          7% PEG 4000      -
            
100 mM MES pH 6.7  
     G4          8% PEG 4000      -
            
100 mM MES pH 6.7 
     G5          9% PEG 4000      -
            
100 mM MES pH 6.7 
     G6          10% PEG 4000      -
            
100 mM MES pH 6.7 
     G7          11% PEG 4000      -
            
100 mM MES pH 6.7 
     G8          12% PEG 4000      -
            
100 mM MES pH 6.7 
     G9          13% PEG 4000      -
            
100 mM MES pH 6.7 
     G10        14% PEG 4000      -
            
100 mM MES pH 6.7 
     G11        15% PEG 4000      -
            
100 mM MES pH 6.7 
     G12        16% PEG 4000      -
            
100 mM MES pH 6.7 
     H1          5% PEG 4000      -
            
100 mM MES pH 6.9             
     H2          6% PEG 4000      -
            
100 mM MES pH 6.9             
     H3          7% PEG 4000      -
            
100 mM MES pH 6.9  
     H4          8% PEG 4000      -
            
100 mM MES pH 6.9 
     H5          9% PEG 4000      -
            
100 mM MES pH 6.9 
     H6          10% PEG 4000      -
            
100 mM MES pH 6.9 
     H7          11% PEG 4000      -
            
100 mM MES pH 6.9 
     H8          12% PEG 4000      -
            
100 mM MES pH 6.9 
     H9          13% PEG 4000      -
            
100 mM MES pH 6.9 
     H10        14% PEG 4000      -
            
100 mM MES pH 6.9 
     H11        15% PEG 4000      -
            
100 mM MES pH 6.9 
     H12        16% PEG 4000      -
            
100 mM MES pH 6.9 
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Appendix 9.7:  
Derivation of equation 5.1 
 
 
Figure 9.1: The ping-pong mechanism of quinone reduction at the flavin of complex 
I. To simplify the derivation, the flavin species and rate and binding constants in the left 
hand figure have been replaced by the characters in the right hand figure; for example, 
[Flox] has been replaced with ‘A’, kcatNADH with ‘k2’ and NADH with ‘N’. 
 
The steady state approximation is applied to the following species: 
Equation 1: 
(k1N + k-10Q)A = k-1B + k5E + k10I 
Equation 2: 
(k
-1 + k2)B = k1NA 
Equation 3: 
(k3Q + k4N)C = k2B + k-3E + k-4D 
Equation 4: 
k
-4D = k4NC 
Equation 5: 
(k
-3 + k5)E = k3QC 
Equation 6: 
k
-10I = k10QA 
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Rearrange and simplify equations 2, 4, 5 and 6: 
Equation 7: 
1
21-NADH
MNADH
M k
k kK        Where                                                  
K
AN
 B +==  
Equation 8: 
4
4-NADH
redNADH
red k
 kK        Where                                                  
K
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 D ==  
Equation 9: 
3
53-Q
MQ
M k
k-kK     ere        Wh                                                  
K
CQ
 E ==  
Equation 10: 
10
10-Q
oxQ
ox k
kK     here         W                                                  
K
AQ
 I ==  
 
The rate of reaction is k5E; express all equations in E. Insert equations 7, 8, 9 and 10 
into equation 1: 
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Q
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Equation 11: 
Ek  
K
NAk
5NADH
M
2
=  
 
Express equations 11, 7, 8, 9 and 10 in k5E 
Equation 12: 
E 
Nk
KkA
2
NADH
M5
=  
 
Equation 13: 
E 
k
kB
2
5
=  
 
Equation 14: 
E Q
KC
Q
M
=  
 
Equation 15: 
E QK
NKD NADH
red
Q
M
=  
 
Equation 16: 
E 
NkK
KQkI
5
Q
ox
NADH
M5
=  
 
Introduce [E]TOT, the total enzyme concentration of all enzyme species: 
Equation 17: 
A + B + C + D + E + I = 1 
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Rate = k5E 
 
 
 
Equation 5.1: Final derivation 
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Appendix 9.8:  
Derivation of equation 5.2 
 
 
Figure 9.2: The ping-pong-pong mechanism of quinone reduction at the flavin of 
complex I. To simplify the derivation, the flavin species and rate and binding constants in 
the top figure have been replaced by the characters in the bottom figure; for example, 
[Flox] has been replaced with ‘A’, kcatNADH with ‘k2’ and NADH with ‘N’. 
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The steady state approximation is applied to the following species: 
Equation 1: 
(k1N + k10Q)A = k-1B + k9H + k-10I 
Equation 2: 
(k
-1 + k2)B = k1NA 
Equation 3: 
(k3Q + k4N)C = k2B + k-3E + k-4D 
Equation 4: 
k
-4D = k4NC 
Equation 5: 
(k
-3 + k6)E = k3QC 
Equation 6: 
(k8N + k7Q)F = k-7H + k-8G + k6E 
Equation 7: 
k
-8G = k8NF 
Equation 8: 
(k9 + k-7)H = k7QF 
Equation 9: 
k
-10I = k10QA 
 
Insert equations 2 and 9 into equation 1 and simplify: 
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Equation 10: 
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Express equations 2 and 9 in k9H: 
Equation 11: 
 
                                     
k
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Equation 12: 
 
                                    
k
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Insert equations 4 and 5 into equation 3 and simplify: 
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Express equations 4, 5, 8 and 7 in k9H: 
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Introduce [E]TOT, the total enzyme concentration of all enzyme species: 
Equation 18: 
A + B + C + D + E + F + G + H + I = 1 
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Equation 5.2: Final derivation 
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Appendix 9.9:  
Derivation of equation 6.1 
 
 
 
Figure 9.3: The ‘empty-site’ pathway of HAR reduction at the flavin of complex I. To 
simplify the derivation, the flavin species and rate and binding constants in the left hand 
figure have been replaced by the characters in the right hand figure; for example, ‘Ox’ has 
been replaced with ‘A’. 
 
The steady state approximation is applied to the following species: 
Equation 1: 
k1NA = k-1B + k5HF 
Equation 2: 
(k
-1 + k2)B = k1NA + k-2C 
Equation 3: 
(k
-2 + k3)C = k2B  
Equation 4: 
(k7N + k4H)D = k3C + k-7E 
Equation 5: 
k
-7E = k7ND  
Equation 6: 
(k6N + k5H)F = k4HD + k-6G 
Equation 7: 
k
-6G = k6NF 
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Rate = k3C, therefore express equations 1 – 7 in terms of C 
Rearrange equation 3:  
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Insert equation 3 into equation 2: 
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Insert equation 5 into equation 4: 
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Equation 11: 
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Insert equation 11 into equation 7: 
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Introduce [E]TOT, the total enzyme concentration of all enzyme species: 
Equation 10: 
A + B + C + D + E + F + G = 1 
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Rate = k3C  
 
 
 
Equation 6.1: Final derivation 
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Appendix 9.10:  
Derivation of equation 6.2 
 
 
 
Figure 9.4: The ‘NADH-bound’ pathway of HAR reduction at the flavin of complex I. 
To simplify the derivation, the flavin species and rate and binding constants in the left 
hand figure have been replaced by the characters in the right hand figure; for example, 
‘Ox’ has been replaced with ‘A’. 
 
The steady state approximation is applied to the following species: 
Equation 1: 
k1NA = k-1B  
Equation 2: 
(k
-1 + k2)B = k1NA + k13HG + k-2C 
Equation 3: 
(k
-2 + k3)C = k2B  
Equation 4: 
k7ND = k3C + k-7E 
Equation 5: 
(k
-7 + k12H)E = k7ND  
Equation 6: 
k6NF = k-6G 
Equation 7: 
(k
-6 + k13H)G = k12EH + k6FN 
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Rate = k3C, therefore express equations 1 – 7 in terms of C 
Rearrange equation 3:  
( )
                                                        
k
kkC
  B
2
32 +
=⇒
-
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       Ek  Ck  H)Ek  (k 73127 -- +=+⇒  
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Introduce [E]TOT, the total enzyme concentration of all enzyme species: 
Equation 10: 
A + B + C + D + E + F + G = 1 
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Rate = k3C  
 
 
 
Equation 6.2: Final derivation 
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